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Abstract 
 
The activation of carbon-hydrogen (C–H) and carbon-carbon (C–C) bonds by transition metal 
catalysts is an attractive strategy to streamline organic synthesis. Herein this manuscript, the 
two main areas of research are described.  
Firstly, it was found that a nickel catalyst can promote the insertion of alkynes into the C–C 
bond of 3-azetidinones and 3-oxetanones to enable quicker access to pyranones and 
pyridinones in high yields and excellent regioselectivity. 
Secondly, a rhodium-catalysed pyridine directed C–H bond activation enables the 
rearrangement of 1,6-heptadienes into bicyclo[2.2.1]heptanes in good yields. Importantly, 
three stereogenic centres are created with complete diastereocontrol in this atom-efficient 
reaction. 
In chapter 1, an overview of the literature on transition metal-catalysed C–C bond activation of 
four membered rings is described. In chapter 2, our efforts to optimise the catalytic conditions 
and build the scope of the nickel-catalysed reaction are reported. In chapter 3, the results of 
the mechanistic investigations of the nickel-catalysed reaction are reported.  
Finally in chapter 4, a brief overview of the transition metal-catalysed functionalisation of an 
alkene C–H bond with another alkene is described. Subsequently, the optimisation of the 
catalytic conditions and the scope of the diastereoselective carbocyclisation of 1,6-
heptadienes triggered by rhodium-catalysed activation of an alkene C–H bond are reported.
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Abbreviations and Definitions 
 
ṽ   wavenumber 
δ   chemical Shift 
°C   Degree Celsius 
1,2-DCE  1,2-Dichloromethane 
1,2-DME  1,2-Dimethoxyethane 
BINAP   2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
Bn   Benzyl 
BnBr   Benzyl Bromide 
br   Broad 
calcd   calculated 
CI   Chemical Ionisation 
cod   cyclooctadiene 
coe   cyclooctene 
d   doublet 
DMAc   Dimethylacetamide 
DMAP   4-Dimethylaminopyridine 
DMI   1,3-Dimethyl-2-imidazolidinone 
DMSO   Dimethyl Sulfoxide 
DM-SegPHOS  5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole 
DPEPHos  (Oxydi-2,1-phenylene)bis(diphenylphosphine) 
dppe   1,2-Bis(diphenylphosphino)ethane 
dppb  1,2-Bis(diphenylphosphino)butane 
ee  Enantiomeric Excess 
5 
 
equiv   equivalent 
ESI   Electrospray Ionisation 
EtOAC   Ethyl Acetate 
Et2O  Diethyl Ether 
g   gram 
GC   Gas Chromatography 
hr   hour 
HMBC   Heteronuclear Multiple Bond Correlation 
HRMS   High Resolution Mass Spectrometry 
HSQC   Heteronuclear Single-Quantum Correlation 
Hz   Hertz 
IMes  1,3-bis(2,4,6-trimethylphenyl)-imidazolium 
IPr   1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene 
IR  Infrared Red 
J   Coupling Constant 
m   Multiplet 
M  Molar 
LDA   Lithium Diisopropylamide 
m.p.   melting point 
mg   miligram 
MHz   Megahertz 
min   minute 
ml   millilitre 
mmol   millimole 
MS   Mass Spectroscopy 
MTBE    Methyl tertbutyl ether 
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NaHMDS  Sodium bis(trimethylsilyl)amide 
nbd   Norbordiene 
NMR   Nuclear Magnetic Resonance 
noe   Nuclear Overhauser effect 
NOESY    Nuclear Overhauser effect spectroscopy 
PE   Petroleum Ether (40/60) 
Ph   Phenyl 
ppm   Part per million 
q   quadruplet 
rt   room temperature 
rac   racemic 
s   singlet 
SIPr  1,3-bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene 
t   triplet 
T   Temperature 
TBAF   Tetra-n-butylammonium fluoride 
THF   Tetrahydrofuran 
TLC   Thin Layer Chromatography 
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 Carbon–Carbon Bond Chapter 1
Activation of Four-Membered Rings 
 
 Introduction 1.1
 
Carbon–Carbon (C–C) σ bond activation by transition metals is an attractive atom-economical 
methodology for organic chemists as it can potentially streamline the synthesis to targets of 
interest.1 However, C–C activation is thermodynamically unfavourable as a C–C σ bond (90 kcal 
mol-1) is broken to form two weaker metal carbon bonds (20-30 kcal mol-1).1d Moreover, by 
comparison of the orbital alignment of C–C π bonds versus C–C σ bonds (Scheme 1), the C–C σ 
bond orbitals lie along the bond axis and render them less accessible for a good overlap with 
the incoming orbitals of the transition metal.2 Whereas for C–C π bonds, the orbitals are more 
accessible as they are projected out of the C–C axis. 
 
 
Scheme 1 Orbital diagram 
 
To overcome the barriers for C-C σ bond activation, substrates with high strain energy are 
commonly employed as the release of this energy drives the reaction forward. The orbital 
alignment of C–C σ bonds in strained systems such as 3- or 4-membered rings generally do not 
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lie in the plane of the ring but are commonly distorted out of plane which allows for increased 
orbital interaction with the orbitals of the transition metal.3  
Hence, Wiberg reported that orbitals of the C–C bond of cyclobutane are bent out of plane by 
approximately 7° (Scheme 2).4 In cyclohexane, the bond path angles of the C–C bond are 
closed to ideal. However, the bond path angle in cyclobutane is distorted.  
 
 
Scheme 2 Bond path angles 
 
Experimentally, the C–C–C bond angle in cyclobutane is found to be 89°. This large angle 
deviation from the ideal contributes to the high angle strain in cyclobutane. Furthermore, 
many C–H bonds are eclipsing which results in high torsional strain. To minimise the torsional 
strain, the cyclobutane adopts a puckered conformation to reduce some of the eclipsing 
interactions. Both angle strain and torsional strain contribute to the high ring strain energy 
observed in cyclobutane as determined theoretically5 and experimentally6 (Scheme 3). 
Therefore, the relief of this high ring strain energy serves as a thermodynamic driving force for 
the C–C cleavage of cyclobutane. As mentioned earlier, the strength of a typical C–C bond is 
roughly 90 kcal / mol and it can be seen that the high ring strain of cyclobutane substantially 
weakens the C–C bond of cyclobutane. 
 
 
Scheme 3 Ring strain energy in cyclobutane vs cyclohexane 
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Due to the aforementioned kinetic and thermodynamic factors of four-membered ring 
systems, these systems are amenable to cleavage of a C–C σ bond by a variety of transition 
metals. Three of the most common mechanisms for the C–C bond cleavage are direct oxidative 
insertion, β-C elimination and [1,2]-shift (Scheme 4).1k 
On the one hand, the direct oxidative insertion of a transition-metal complex into a four-
membered ring system 1 results in the formation of 5-membered ring metallacycle 2. 
Metallacycle 2 can then be subjected to a variety of transformations.  
On the other hand, transition-metal complexes can activate four-membered ring systems 3 to 
undergo β-C elimination. β-C elimination is a rearrangement process whereby the relief of ring 
strain serves as a thermodynamic driving force. The resulting alkyl metal intermediate 4 can 
then be exploited for further transformations.  
Finally, [1,2]-shift is a carbocation rearrangement commonly observed in four-membered ring 
systems 5. Unlike, oxidative addition and β-C elimination, the metal never comes in direct 
contact with the C–C bond cleaved in the process. The resulting metal intermediate 6 can then 
be subjected to further transformations. 
 
 
Scheme 4 Three Common C–C bond cleavage processes 
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 Transition metal catalysed C–C σ bond cleavage 1.2
 
 Cyclobutanones 1.2.1
 
In 1994, Ito and co-workers reported the first catalytic C–C bond activation of cyclobutanone 7 
(Scheme 5).7 It was proposed that oxidative insertion of the rhodium catalyst into the less 
sterically hindered acyl-carbon bond of 7 would afford pentarhodacycle 8. Under 50 
atmospheres of hydrogen, hydrogenolysis of 8 would eventually afford alcohol 9 as product. 
 
 
Scheme 5 Rhodium-catalysed hydrogenolysis of cyclobutanone 
 
After this preliminary work, Murakami and co-workers reported a rhodium-catalysed 
rearrangement of strained spiro-cyclobutanone 10 into cyclohexenone 11 whereby the 
putative rhodacycle 12 is trapped by another C–C bond cleavage process (Scheme 6).8 The 
authors postulated that oxidative insertion of the rhodium catalyst into the acyl-carbon bond 
of 10 would form the initial pentarhodacycle 12. Ring enlargement by β-C elimination would 
then afford heptarhodacycle 13, which after reductive elimination and isomerisation of the 
double bond would afford cyclohexenone 11 as product. 
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Scheme 6 Rhodium-catalysed ring opening of spiro-cyclobutanone 
 
Murakami and co-workers also reported some striking ligand effects on the C–C bond cleavage 
of cyclobutanone 14 (Scheme 7).9 With dppe as a ligand, oxidative insertion of the rhodium 
complex was assumed to be directed by the alkene moiety into bond b of 14 to form 
pentarhodacycle 15. Subsequent β-H elimination would afford intermediate 16. Finally, 
reductive elimination would occur to afford enone 17. However, with dppp as a ligand, the 
oxidative insertion of the rhodium complex into bond a of 14 would result in the formation of 
pentarhodacycle 18, which could then be trapped by intramolecular insertion of the alkene to 
afford the tricyclic intermediate 19. Finally, reductive elimination would afford the tricyclic 
ketone 20. Recently, Cramer and co-workers have reported the enantioselective variation of 
the same sequence of elementary steps.10  
Murakami and co-workers also reported a change of reactivity of cyclobutanone 14 with a 
nickel-catalyst (Scheme 7).11 Oxidative cyclisation of the ketone and alkene moiety by the 
nickel catalyst would afford nickelapentacycle 21. Afterwards, ring enlargement by β-C 
elimination would afford intermediate 22. Finally, reductive elimination would afford tricyclic 
ketone 23 as the product. Later, the same group reported an enantioselective version of this 
reaction.12 The different transformations of 14 highlight the ongoing research in C–C activation 
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to generate a diverse range of structures and the difference in reactivity induced by different 
catalysts. 
 
 
Scheme 7 Different catalytic systems  
 
In 2006, Murakami and co-workers extended the reaction to a formal nickel catalysed [4+2+2] 
cycloaddition to form eight membered rings 26 (Scheme 8).13 It is proposed that it would begin 
by the initial oxidative cyclisation of the diyne 24, the ketone 25 and the nickel catalyst to 
afford nickelaheptacycle 27. Afterwards, ring enlargement by β-C elimination would give 
intermediate 28. Finally, reductive elimination would afford cyclooctadienone 26. Symmetrical 
diynes which processed either internal or terminal alkynes proceeded in good yields. Several 
modifications to the tether were tolerated under the reaction conditions. Furthermore, non-
symmetrical diynes proceeded with excellent regioselectivity under a Ni/IPr catalyst system. 
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Scheme 8 Nickel-catalysed [4+2+2] cycloaddition of cyclobutanones and diynes 
 
Wender and co-workers reported a rhodium catalysed [6+2] cycloaddition of 
vinylcyclobutanones 29 to form eight-membered ring systems 30 (Scheme 9).14 Theoretical 
studies suggest the formation of rhodacycle 31 happens first.15 Afterwards, ring opening via β-
carbon elimination and concomitant cleavage of bond b would afford rhodacycle 32. Then 
reductive elimination would occur to afford product 30. Several eight-membered ring ketones 
were formed in good to excellent yields. 
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Scheme 9 Rhodium-catalysed [6+2] cycloaddition 
 
Rhodium-catalysed addition of boronic acids to a carbonyl moiety have been reported to 
proceed through an organorhodium intermediate which would undergo a 1,2-addition to the 
carbonyl moiety.16 Organorhodium intermediates can also add across an alkyne triple bond to 
generate an alkenyl rhodium intermediate.17 From these work, Murakami and co-workers 
reported a rhodium-catalysed ring expansion towards seven-membered-ring ketones 33 which 
involves the exploitation of the initial formation of the alkenyl rhodium intermediate 35 and 
C–C bond cleavage (Scheme 10).18 The initial vinyl rhodium species 35, arising from the 
regioselective carborhodation of alkyne 33, would undergo an intramolecular 1,2-addition to 
the ketone  which would result in the formation of rhodium alkoxide 36. Subsequent 
regioselective β-C elimination would afford intermediate 37. Then hydrolysis would afford 
ketone 34. While several seven-membered ring ketones were synthesised in good to high 
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yields, the authors found that additional substitution on the cyclobutanone prevented the 
formation of the desired product. 
 
 
Scheme 10 Intramolecular 1,2-addition of vinyl rhodium species 
 
 Cyclobutenones and benzocyclobutenones 1.2.2
 
Liebeskind and Huffman reported a rhodium-catalysed insertion into cyclobutenone 38 to 
form eight-membered ring ketones 39 whereby both oxidative insertion and β-C elimination 
processes had taken place (Scheme 11).19 Therefore, it was postulated that oxidative insertion 
of rhodium complex into cyclobutenone 38 would form rhodacycle 40. Subsequent ring 
enlargement by β-C elimination would then trap rhodacycle 40 and as a result would form 
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intermediate 41. This would then be followed by reductive elimination to afford 
cyclooctadienone 39 in a 90% yield. 
 
 
Scheme 11 Rhodium-catalysed insertion into cyclobutenone 
 
Liebeskind and Huffman reported a nickel-catalysed annulation of cyclobutenones 42 with 
alkynes to form phenols 43 (Scheme 12).20 Initial cleavage of the acyl-carbon bond of 
cyclobutenone 42 would result in the formation of intermediate 44 or 45. Insertion of alkyne 
would form intermediate 46. Reductive elimination and aromatisation would then afford 
phenol 43.  
Electron-rich substituents on the cyclobutenone were found to be unfavourable under the 
reaction conditions as decomposition will occur. The insertion of various non-symmetrical 
internal alkynes proceeded in moderate to good yields. However, the regioselectivity of the 
alkyne insertion was generally poor. More recently, Harrity and Auvinet reported the nickel-
catalysed annulation of cyclobutenones and alkynylboronates which proceeded with excellent 
regioselectivity.21 In 2007, Kondo and co-workers reported an improved substrate scope to 
also include electron poor alkenes with a rhodium catalyst.22  
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Scheme 12 Nickel-catalysed annulation of cyclobutenone with alkyne 
 
Mitsudo and co-workers reported a rhodium-catalysed transformation of cyclobutenones 47 
with alkenes to afford product 51 or 52 depending on the atmosphere (Scheme 13).23 In the 
presence of the rhodium-catalyst, either intermediate 48 or 49 would form from the initial 
acyl-carbon bond cleavage. Insertion of the alkene fragment would form intermediate 50. 
When the reaction was carried out under an atmosphere of Ar, decarbonylation would then 
be followed by reductive elimination to afford product 51. However, when the reaction was 
carried out under 30 atmospheres of CO, the amount of product arising from decarbonylation 
was reduced and the direct reductive elimination would occur to form mainly product 52. 
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Scheme 13 Atmosphere dependent rhodium-catalysed transformations of cyclobutenones 
 
In the previous examples, the rhodium catalyst is postulated to undergo oxidative insertion 
into the acyl –C sp3 bond. In the subsequent examples, the rhodium is postulated to undergo 
oxidative insertion into the acyl–C sp2 bond. Dong and co-workers reported a rhodium-
catalysed intramolecular alkene insertion into benzocyclobutenone 53 to form tricyclic ketone 
54 (Scheme 14).24 Interestingly, the major product comes from the rhodium insertion into the 
C–C sp2 bond. To account for their results, the authors proposed that the pendant alkene 
would direct the oxidative insertion of the rhodium catalyst into the more sterically hindered 
bond of 53 to form rhodacycle 55 and intramolecular alkene insertion would then form 
intermediate 56. Finally, reductive elimination would afford product 54. An enantioselective 
version of this reaction was later reported by the same group.25 Furthermore, this 
methodology was used as a key step in the total synthesis of the proposed structure of 
cycloinumakiol 59 (Scheme 15).26 
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Scheme 14 Rhodium-catalysed intramolecular alkene insertion into cyclobutanone 
 
Scheme 15 Total synthesis of proposed structure of cycloinumakiol 
 
This work was later extended to include alkyne insertion to form either a β-napthol 63 or 
indene 64 (Scheme 16).27 It is proposed the tether alkyne would direct the oxidative insertion 
of the rhodium catalyst into the more sterically hindered bond of 60 would form rhodacycle 
61. Intramolecular alkyne insertion would form intermediate 62. Finally, reductive elimination 
and aromatisation would afford β-napthol 63 when the reaction was carried out in a sealed 
tube in dioxane at 130°C. However, if the reaction was carried out in xylene under reflux under 
Argon, decarbonylation of intermediate 62 and then reductive elimination would afford 
indene 64. 
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Scheme 16 Rhodium-catalysed intramolecular alkyne insertion into cyclobutanone 
 
Liebeskind and co-workers reported experimental evidence of the oxidative insertion of a 
rhodium complex into the C–C bond of cyclobutenone 65 (Scheme 17) and the C–C bond of 
benzocyclobutenone 68 (Scheme 18).28 The insertion into either cyclobutenone or 
benzocyclobutenone requires high temperatures which is a common requirement for 
rhodium-catalysed reactions. Furthermore, the oxidative insertion into benzocyclobutenone 
68 was shown to happen at both the more and the least sterically hindered acyl–carbon bond 
and Liebeskind found that the ratio of 69 and 70 is different depending on the time of the 
reaction. Equilibrium is reached after 5 days, and 69 and 70 were obtained in almost 
equimolar ratio. This equilibration demonstrates the oxidative insertion is a reversible process.  
Murakami and co-workers reported the oxidative addition into the least sterically hindered C–
C bond of benzocyclobutenone 68 to occur at room temperature which is likely facilitated by 
the electron rich ligand (Scheme 19).29 
 
 
Scheme 17 Oxidative addition of rhodium into a C–C bond of cyclobutenone 
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Scheme 18 Oxidative addition of rhodium into a C–C bond of benzocyclobutenone 
 
Scheme 19 Experimental proof of the oxidative addition into the C–C bond 
 
 Cyclobutadienones 1.2.3
 
Mitsudo and co-workers reported a ruthenium-catalysed intermolecular decarbonylative 
cycloaddition of cyclobutadienone 73 with alkene to form cyclopentenone 74 (Scheme 20).30 It 
was necessary to carry the reaction under three atmospheres of CO because external CO was 
assumed to be required to suppress complete decarbonylation of cyclobutadienone 73 to the 
corresponding alkyne. Furthermore, 70% scrambling was observed when the reaction was 
carried out with labelled 13CO. Therefore, it was proposed the oxidative insertion of the 
ruthenium catalyst was directed by the alkoxy substituent into bond b over bond a to form 
pentarhodacycle 75. Subsequent decarbonylation would afford intermediate 76. Afterwards, 
stereoselective alkene insertion would form intermediate 77. This would then undergo 
reductive elimination to give product 74. Various substituted cyclobutadienones were 
tolerated under the reaction conditions. Also, the use of ethene as a coupling partner was 
effective. 
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Scheme 20 Ruthenium-catalysed intermolecular decarbonylative cycloaddition 
 
Yamamoto and co-workers reported a rhodium-catalysed intramolecular decarbonylative 
cycloaddition of cyclobutadienone 78 with pendant alkene to cyclopentenone 79 (Scheme 
21).31 It was proposed that if X is a heteroatom, it would direct the oxidative insertion of the 
rhodium complex into bond a of 78 to form pentarhodacycle 80. However, reactivity was still 
observed when X was methine. Regardless, subsequent decarbonylation would afford 
intermediate 81. Afterwards, alkene insertion followed by reductive elimination would afford 
product 79. Unlike the intermolecular decarbonylative decoupling reported by Mitsudo and 
co-workers, no external CO was necessary.30 
Various substitution patterns on the alkene system were tolerated. However, gem-
disubstituted alkenes were the most reactive. Cyclobutadienone bearing aromatic or alkyl 
substituents were tolerated. Furthermore, modifications to the tether did not affect the 
overall reactivity. 
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Scheme 21 Rhodium-catalysed intramolecular decarbonylative cycloaddition 
 
 Vinyl-Cyclobutanols and Allenylcyclobutanols 1.2.4
 
Uemura and co-workers reported a regioselective oxidative palladium-catalysed ring opening 
of cyclobutanols 82 to form bicyclic ketones 85 (Scheme 22).32 After the formation of the 
putative palladium alkoxide 83, ring opening of the least sterically hindered bond b via β-C 
elimination would afford alkylpalladium complex 84. An intramolecular Mizoroki-Heck reaction 
would then occur to give product 85. The presence of base might be vital to facilitate the 
formation of the palladium alkoxide 83. Conversely, Clark and Thiensathit reported the ring 
opening of cyclobutanol 82 proceeded in a different manner under another oxidative 
palladium catalytic system.33 The palladium-catalyst would coordinate to the alkene of 82 to 
form 86. This would activate the system for ring enlargement by the cleavage of bond a via 
[1,2]-shift which would form intermediate 87. Afterwards, β-H elimination and isomerisation 
of the double bond would afford product 88. Since the report by Clark and Thiensathit, related 
ring expansions of cyclobutanols have been reported. 34  
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 Scheme 22 Palladium-catalysed ring opening of cyclobutanols 
 
Cramer and Souillart reported an enantioselective rhodium-catalysed domino reaction of 
cyclobutanols 89 (Scheme 23).35 After the formation of putative rhodium alkoxide 91, ring 
opening via β-C elimination would form intermediate 92. Then intramolecular oxidative 
addition of 92 would form intermediate 93. Afterwards, insertion of the alkene and then 
reductive elimination would afford product 90. Various substituents and substitution patterns 
on the aryl ring were tolerated. Various substituents on the cyclobutanol ring were also 
tolerated. However, only non-substituted and 1,1-disubstituted alkenes were tolerated under 
the reaction conditions. 
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Scheme 23 Rhodium-catalysed domino-reaction of cyclobutanols 
 
Cramer and Seiser reported a related rhodium-catalysed ring expansion of 1-allenyl 
cyclobutanols 94 to cyclohexenones 95 (Scheme 24).36 The mechanism of this reaction is 
analogous to the rhodium catalysed C–C cleavage of 1-vinyl cyclobutanols. After the formation 
of the putative rhodium alkoxide 96, ring enlargement via β-C elimination would afford 
heptarhodacycle 97. Reductive elimination would give 6-membered ring 98 which would then 
undergo isomerism to give product 95. Various functional groups on the cyclobutanol were 
tolerated under the reaction conditions. Coordinating groups such as the vinyl and pyridyl 
group required slightly more forced conditions for full conversion. Cyclic substituted allenes 
and terminal allenes were tolerated under the reaction condition. 
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Scheme 24 Rhodium catalysed ring expansion of 1-allenyl cyclobutanols 
 
Wender and co-workers reported a rhodium-catalysed [6+1] cycloaddition of 
allenylcyclobutane ether 99 (Scheme 25).37 The mechanism of the reaction is now different 
from 1-allenyl cyclobutanols. Since the oxygen is now protected, the rhodium catalyst will first 
form a π-complex with the allene to form intermediate 102. It was then proposed that a 
rhodium-catalysed ring opening of 102 via β-C elimination of the least sterically hindered bond 
a would then occur to form intermediate 103. Insertion of CO and then reductive elimination 
would afford product 100. Occasionally, product 101 arising from the cleavage of the more 
sterically hindered bond b was observed. 
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Scheme 25 Rhodium-catalysed [6+1] cycloaddition 
 
 Cyclobutenols and benzocyclobutenols 1.2.5
 
Matsuda and Miura reported a rhodium-catalysed [4+2] annulation of cyclobutenols 105 with 
alkynes to form tetrasubstituted benzenes 106 (Scheme 26).38 After the formation of the 
putative rhodium alkoxide 107, ring opening of 107 by β-C elimination would form 
alkenylrhodium complex 108. Insertion of alkyne into the rhodium-carbon bond would form 
rhodium complex 109. Subsequent nucleophilic addition to the ketone would afford 
cyclohexadiene 110. Protonation would afford alcohol 111. Finally, dehydration would afford 
tetra-substituted benzene 106. Several tetrasubstituted benzenes were synthesised in a high 
yield. Silylated alkyne was tolerated and preceded with excellent regioselectivity but poor 
reactivity. Modification of the reaction conditions improved the yield but slightly diminished 
the regioselectivity. The insertion of various other non-symmetrical internal alkynes 
proceeded with good to high regioselectivity.  
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Scheme 26 Rhodium-catalysed [4+2] annulation 
 
Murakami and co-workers reported a rhodium-catalysed benzannulation of alkyne and 
benzocyclobutenols 112 (Scheme 27).39 Recent theoretical studies by Morokuma and co-
workers reported that after the formation of rhodium alkoxide 114, cleavage of bond a would 
occur preferentially over bond b because the extra π-bond interaction of the benzene ring of 
the substrate with the rhodium catalyst would stabilise the transition state to form 
intermediate 115.40 Afterwards, alkyne insertion would form alkenylrhodium complex 116. 
Subsequent nucleophilic addition to the ketone and protonation would afford 
dihydronaphthalene 113. Interestingly, unlike the examples with cyclobutanol as reported by 
Matsuda and Miura,38 the major product is not the aromatised naphthalene.  
Various functional groups on the aryl ring were tolerated under the reaction conditions. 
Alteration of the electronic character of the aryl ring had no significant effect in the reaction 
outcome. Furthermore, the insertion of non-symmetrical alkynes proceeded with moderate to 
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excellent regioselectivity. Different functional groups on the alkyne were tolerated but 
terminal alkynes were not. 
 
 
Scheme 27 Rhodium-catalysed benzannulation of benzocyclobutenol and alkyne 
 
 Cyclobutanone O-Benzoyloximes 1.2.6
 
Uemura and co-workers reported ligand effects in the palladium-catalysed ring opening of 
cyclobutane 117 (Scheme 28).41 Oxidative insertion into the N–O bond of the oxime would 
form intermediate 120. With PPFCyA as a ligand, bond a of intermediate 120 was postulated 
to be broken via β-C elimination which would form intermediate 121. Intramolecular 
cyclisation followed by β-H elimination would then afford 118. However, with BINAP as a 
ligand, bond b of intermediate 120 was assumed to be preferentially broken via β-C 
elimination which would form intermediate 122. Subsequent β-H elimination would afford 
119. 
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Scheme 28 Ligand effects in the ring opening of cyclobutane 117 
 
 Biphenylenes 1.2.7
 
Products resulting from the stoichiometric cleavage of a C–C σ bond of biphenylene 123 by the 
oxidative insertion of a transition metal complex have been isolated and characterised.42 
However, it wasn’t until 1990 that Vollhardt and co-workers demonstrated the first catalytic 
C–C σ bond cleavage of biphenylene 123 (Scheme 29).43 Oxidative insertion of the nickel 
catalyst into the strained C–C bond of biphenylene 123 would form intermediate 125. 
Dimerisation of intermediate 125 would form intermediate 126. Subsequent reductive 
elimination would afford dimer 124. 
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Scheme 29 Nickel-catalysed dimerisation of biphenylene 
 
Jones and co-workers reported a nickel-catalysed [4+2] cycloaddition of biphenylene 123 with 
alkynes to form phenanthrenes 127 (Scheme 30).42,44 Oxidative insertion of the nickel catalyst 
128 into 123 would form intermediate 129. Insertion of the alkyne would form intermediate 
130. Reductive elimination would afford 127. No cyclotrimerisation was observed. The hemi-
labile ligand was found to be essential for the catalytic cycle. Interestingly, when dippe (1,2-
bis(diisopropylphosphino)ethane) was used as a ligand, 6 mol% of O2 was required to make 
the reaction catalytic.45 
 
 
37 
 
 
Scheme 30 Nickel-catalysed [4+2] cycloaddition 
 
 Alkylidenecyclobutanes 1.2.8
 
Aissa and co-workers reported a rhodium-catalysed a C–H / C–C bond activation sequence to 
form 8-membered ring ketones 132 (Scheme 31).46 Subtle modifications to the catalytic 
system were required for optimal yields. Mechanistically, initial C–H activation of 131 would 
give intermediate 133. This would then be followed hydrometalation onto the 
alkylidenecyclobutane to give intermediate 134. Subsequent ring enlargement by β-C 
elimination to trap intermediate 134 would give intermediate 135. Afterwards, reductive 
elimination would afford product 132. Mono-substitution and gem-diphenyl substitution on 
the cyclobutane ring were tolerated under the reaction conditions. Tetra-substitution on the 
alkene resulted in no reaction under various rhodium-catalysed conditions. Furthermore, 
various modifications on the tether were also compatible.  
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Scheme 31 Rhodium-catalysed C–H / C–C bond activation sequence 
 
 Conclusion and Outlook 1.3
 
Transition metal catalysed C–C cleavage of four-membered cabocycles is an area of extensive 
research. This has led to the discovery of many different intermolecular and intramolecular 
restructuring of the carbon framework. C–C cleavage via oxidative addition, β-C elimination or 
[1,2] shift are common mechanistic processes used to explain the reaction outcome.  
However, C–C bond cleavage of small heterocycles had been studied less extensively. The ring 
strain energy in cyclobutane 136 is similar to the ring strain energy in oxetane 137 and 
azetidine 138 by both experimental and computational studies (Scheme 32).47  
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Scheme 32 Ring strain energies 
 
In 2010, Aissa and co-workers reported the first example of a C–C bond cleavage of a small 
heterocycle 139 (Scheme 33).46 Replacing the alkylidenecyclobutane moiety with 
alkylideneazetidine moiety still resulted in the formation of the desired 8-membered ring 140 
in good yields. The mechanistic pathway was proposed to be identical to the all carbon 
equivalent whereby the C–C bond a of intermediate 142 was broken to eventually afford 8-
membered ring ketone 140. Despite the increased loading in catalyst, this work demonstrated 
the viability of C–C bond cleavage of small heterocycles. 
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Scheme 33 Rhodium-catalysed C–H / C–C bond activation sequence of alkylideneazetidines 
 
Afterwards, we became curious about whether or not other small heterocycles can undergo 
selective C–C cleavage. In 2005, Murakami and co-workers reported the first intermolecular 
insertion of alkyne into cyclobutanone 144 to afford the corresponding cyclohexenone 145 in 
a formal [4+2] cycloaddition with a nickel-catalyst (Scheme 34).48 Therefore it is proposed, the 
nickel catalyst would coordinate to both the ketone and the alkyne to form intermediate 146. 
Then oxidative cyclisation would afford nickelapentacycle intermediate 147. Afterwards, ring 
enlargement by β-C elimination would afford nickelaheptacycle 148. Finally, reductive 
elimination would afford cyclohexenone 145. Various cyclohexenones were successfully 
synthesised in moderate to excellent yields. The insertion of non-symmetrical alkynes 
proceeded with good and consistent regioselectivity regardless of the electronic properties of 
the alkyne. 
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Scheme 34 Nickel-catalysed alkyne insertion into cyclobutanone 
 
Drawing inspiration from Murakami’s work, it was of interest to determine if azetidinone 149 
could behave like cyclobutanone 144 in a transition-metal catalysed [4+2] cycloaddition with 
alkyne 150 to generate pyridinone 151 (Scheme 2).  
 
 
Scheme 35 Hypothesis 
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Drawing an analogy to the proposed mechanism of the [4+2] cycloaddition of cyclobutanone 
144 with an alkyne, it was hypothesised that the nickel-catalyst will first associate azetidinone 
149 and alkyne 150 to form intermediate 152. Afterwards, oxidative cyclisation would form 
nickelapentacycle 153. Ring enlargement by β-C elimination will form nickelaheptacycle 154. 
Finally, reductive elimination should afford desired product 151. 
This work towards the synthesis of pyridinones 151 would offer an alternative approach to the 
other methods already published. The approach by ring closing metathesis is generally low 
yielding as the formation of a tetra-substituted alkene is difficult (Scheme 36).49 Alternatively, 
a relay metathesis approach can circumvent this issue but requires a more advanced substrate 
(Scheme 37). 50 
 
 
Scheme 36 Ring closing metathesis 
 
Scheme 37 Relay metathesis 
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Another approach towards pyridinones 164 is by a palladium-catalysed intramolecular Heck-
type reaction of oxime 162 as reported by Tong and co-workers (Scheme 38).51 After the 
palladium step, acid hydrolysis of oxime 163 is then carried out to furnish pyridinone 164. 
 
 
Scheme 38 Palladium catalysed Heck-type reaction 
 
In light of what is known in the literature towards the synthesis of pyridinones 151, the formal 
[4+2] cycloaddition of azetidinone 149 and alkyne 150 should offer a more direct approach. 
Furthermore, this method can also be seen as a rapid build-up of molecular complexity. 
Furthermore, the formal [4+2] cycloaddition is seen as a convergent synthesis rather than a 
linear synthesis. As a result, the overall steps required to synthesise pyridinones 151 are 
reduced. 
 
In this context, the initial aims of the work presented herein were to: 
a.) To validate the hypothesis of the insertion of an alkyne into the C–C bond of 
azetidinone to give pyridinones 151 
b.) Optimise the reaction  
c.) Examine the scope 
d.) Investigate the mechanism of the reaction 
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During the development of the work presented in this thesis, Murakami and co-workers 
reported an example of C–C cleavage of 3-azetidinol 165 to form tetralone 166 (Scheme 39).52 
After the formation of rhodium alkoxide 167, oxidative addition into the carbon-bromine bond 
would form rhodacycle 168. C–C cleavage of bond a via β-C elimination would afford 
heptarhoacycle 169. Finally, reductive elimination would generate tetralone 166. 
 
 
Scheme 39 Rhodium catalysed formation of tetralone 
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 Nickel-Catalysed Chapter 2
Cycloaddition of 3-Azetinones and 3-
Oxetanones with Alkynes 
 
 Aim and Hypothesis 2.1
 
As mentioned in the previous section, Aïssa and co-workers reported the first example of C–C 
bond cleavage of small heterocycles.1 Afterwards, we became curious about whether or not 
other small heterocycles can undergo selective C–C cleavage. As discussed in the previous 
section, Murakami and co-workers reported the nickel-catalysed insertion of alkyne 2 into 
cyclobutanone 1 to form cyclohexenone 3 (Scheme 1).2 As a result, a variety of 
cyclohexenones were synthesised via this methodology. 
 
 
Scheme 1 Nickel-catalysed insertion of alkyne 2 into cyclobutanone 1 
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From this work, it was therefore of interest to determine if azetidinone 4 could behave like 
cyclobutanone 1 in a transition-metal catalysed [4+2] cycloaddition with alkyne 5 to generate 
pyridinone 6 (Scheme 2).  
 
 
Scheme 2 Hypothesis 
 
 Optimisation 2.2
 
Using the conditions described by Murakami and co-workers,2 treatment of commercially 
available N-Boc-Azetidinone 7 with diphenylacetylene 5a in the presence of 10 mol% Ni(cod)2 
and 20 mol% PCy3 in toluene at 100°C gave the expected six-membered ring 6a but also a four-
membered ring 8 in a near 1:1 ratio (Scheme 3). Both products were characterised by 1H and 
13C NMR, IR and HRMS.  
The formation of the four-membered ring 8 is believed to be a result of a Boc-group directed   
C–H bond activation to form intermediate 9. Afterwards, hydrometalation onto alkyne 5a 
would form intermediate 10. Finally, reductive elimination would give four-membered ring 8. 
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Scheme 3 Initial screen with azetidinone 7 under Murakami’s conditions 
 
A screening of ligands was then carried out to optimise the formation of 6a (Table 1). 
Phosphines with alkyl groups tend to favour the formation of 8 (Table 1, Entry 1-3). Ligands 
with ortho substitution (Table 1, Entry 4 and 5) have large cone angles and inhibited the 
reaction. Ligands with a heteroatom (Table 1, Entry 6 and 7) appear to be somewhat tolerated 
with electron poor L33 (Table 1, Entry 7) favouring high selectivity towards 6a but with 
incomplete conversion. Electron poor triphenylphosphite (Table 1, Entry 8) was found to be 
ineffective. PPh3 (Table 1, Entry 9) had some selectivity towards 6a. Modifying the para 
substituents on the phenyl ring (Table 1, Entry 10-12) showed that the electronic effects4  had 
little influence on the formation of 6a or 8 except for P(p-ClC6H4)3 (Table 1, Entry 13) which led 
to high selectivity towards 6a but with incomplete conversion.  
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Table 1 Ligand Screening 
 
Entry Ligand (20 mol%) Conversion (%) 6a/8 vco (cm
-1) Cone angle (q) 
1.  PCy3 100 50 : 50 2056.4 170 
2.  PtBu3 95 21 : 79 2056.1 182 
3.  P(Ph2)Me 100 21 : 79 2067.0 136 
4.  L1 55 50 : 50 2066.1  
5.  P(o-MeC6H4)3 0 0 : 0 2066.6 194 
6.  L2 94 37 : 63   
7.  L3 44 100 : 0 2078.4  
8.  P(OPh)3 7 100 : 0 2085.3 128 
9.  PPh3 100 59 : 41 2068.9 145 
10.  P(p-MeOC6H4)3 100 71 : 29 2066.1 145 
11.  P(p-MeC6H4)3 100 50 : 50 2066.7 145 
12.  P(p-CF3C6H4)3 >97 61 : 39  145 
13.  P(p-ClC6H4)3 50 100 : 0 2072.8 145 
14.  dppe 0 0 : 0   
15.  dppb 36 100 : 0   
16.  Xantphos <5% 100 : 0   
17.  L4 0 0 : 0   
18.  IPr 0 0 : 0   
19.  SIPr 0 0 : 0   
[a] γCO  (cm
-1) of Ni(CO)3L in CH2Cl2  
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Analysis of the various properties of the phosphines revealed there is no correlation between 
product selectivity and the electronic properties of the ligand (Table 2). Carrying out the 
reaction with PtBu3 as the ligand gave the same selectivity as PPh2Me despite both ligands 
being electronically (νCO) different. In fact, PPh2Me has similar electronic properties to PPh3 
and P(pMeOC6H4)3 but the selectivity obtained with PPh2Me is reversed compared to the latter 
two phosphines. Furthermore, the selectivity observed with the ligand PtBu3 is the same as 
with PPh2Me despite the huge difference in cone angle between the two ligands. This 
illustrates that there is no correlation between the cone angle and product selectivity. 
 
Table 2 Comparison 
 PtBu3 PPh2Me PPh3 P(pMeOC6H4)3
[a] 
νCO (cm
-1) 2056.1 2067.0 2068.9 2066.1 
Cone angle (θ) 182 136 145 145[a] 
Conversion (%) 100 100 100 100 
Selectivity (6a:8) 21 : 79 21 : 79 59 : 41 71 : 29 
[a] assumed that para-substitution will have no effect on the cone angle 
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Bidentate ligand, dppe (Table 1, Entry 14) proved to be ineffective. However, dppb (Table 1, 
Entry 15) displayed some reactivity with complete selectivity towards 6a. A much more rigid 
bidentate ligand, Xantphos (Table 1, Entry 16), was found to be ineffective. Hemi labile ligand, 
L4 (Table 1, Entry 17) was also ineffective. None of the NHCs tested led to the formation of an 
active catalyst (Table 1, entry 18 and 19). Despite P(p-MeOC6H4)3 and P(p-CF3C6H4)3 displaying 
slightly better selectivity towards 6a, PPh3 was chosen for the subsequent solvent screening 
since it is a much cheaper ligand.  
A screening of anhydrous solvents was then carried out with PPh3 as ligand to optimise the 
formation of 6a (Table 3). Carrying out the reaction in toluene (Table 3, Entry 1) resulted in 
little selectivity. However, carrying out the reaction in dioxane (Table 3, Entry 2) increased the 
selectivity for 6a. However, using MeCN (Table 3, Entry 3) showed better selectivity for 8 and 
1, 2-DCE (Table 3, Entry 4) gave no conversion.  
 
Table 3 Initial anhydrous solvent screen 
 
Entry Solvent Conversion 6a/8 
1.  Toluene 100% 59 : 41 
2.  Dioxane 93% 91 : 9 
3.  MeCN 100% 33 : 67 
4.  1, 2-DCE 0% 0 : 0 
 
During the study of alkyne insertion into cyclobutanones, Murakami and co-workers reported 
that 3 equivalents of alkyne were sometimes necessary in order to compensate for alkyne 
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oligomerisation. Therefore, with dioxane as solvent, a study was commenced to determine the 
optimal loading of alkyne (Table 4). In our study, lowering the alkyne stoichiometry from 3 
equivalents (Table 4, Entry 1) to 1.5 equivalents (Table 4, Entry 2) resulted in only a slight 
decrease in selectivity for 6a but with a better isolated yield. Reducing the loading of alkyne to 
1.1 equivalents (Table 4, Entry 3) resulted in a further slight decrease in selectivity for 6a but 
with a similar isolated yield. However, a loading of 1.5 equivalents of alkyne was used in 
further screening as it was a low alkyne loading with good selectivity towards 6a.  
 
Table 4 Alkyne loading screening in dioxane 
 
Entry Alkyne (eq.) Conversion 6a/8 Yield of 6a (%) 
1 3 96% 91 : 9 69 
2 1.5 100% 86 : 14 80 
3 1.1 100% 83 : 17 78 
 
Afterwards, the solvent screen was resumed with a loading of 1.5 equivalents of alkyne (Table 
5). Using 2-pentanone (Table 5, Entry 1) led to a good selectivity towards 8 but, c-pentanone 
(Table 5, Entry 2) displayed poor selectivity for either 6a or 8. Both 2-MeTHF (Table 5, Entry 3) 
and 1,2-DME (Table 5, Entry 4) led to a good selectivity towards 8. However, THF (Table 5, 
Entry 5) started to re-orientate the selectivity towards 6a. MTBE (Table 5, Entry 6) led to a 
good selectivity towards 6a. However, no solvent that was screened was able to match or 
exceed the performance of dioxane in orientating the selectivity towards 6a. It is noteworthy 
that most of the solvents used in this second screening were used directly from bottles 
exposed to air and moisture. Hence, it was thought “wet” solvents might display better 
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selectivity towards 8. When “wet” dioxane (Table 5, Entry 7) was used, lower selectivity 
towards 6a was observed.  
 
Table 5 Further solvent screen with 20 mol% PPh3  
 
Entry Solvent Conversion 6a/8 
1.  2-pentanone* >95% 24 : 76 
2.  c-Pentanone* >95% 40 : 60 
3.  2-MeTHF* >95% 19 : 81 
4.  1,2-DME* >95% 29 : 71 
5.  THF >95% 56 : 44 
6.  MTBE* >95% 75 : 25 
7.  Dioxane*  >95% 71 : 29 
*wet solvents used 
 
A study on the stoichiometry and ratio of Ni(cod)2/PPh3 was carried out in anhydrous dioxane 
(Table 6). Carrying out the reaction with 5 mol% Ni(cod)2 and 10 mol% PPh3 (Table 6, Entry 1) 
or 5 mol% Ni(cod)2 and 10 mol% PPh3 (Table 6, Entry 2) gave incomplete conversion. Changing 
the stoichiometry of PPh3 with respect to Ni(cod)2 (Table 6, Entry 3-6) revealed that selectivity 
for 6a is optimal when the stoichiometry of PPh3 is greater than 20 mol% with respect to 10 
mol% Ni(cod)2 with isolated yields greater than 69%. As expected, with 10 mol% Ni(cod)2 and 
20 mol% PPh3, reducing the alkyne loading from 1.5 equivalents to 1.1 equivalents (Table 6, 
Entry 4 vs 7) reduced the selectivity towards 6a. However, when the loading of PPh3 was then 
increased to 30 mol% (Table 6, Entry 8), the selectivity towards 6a is very high with an average 
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isolated yield of 81%. In the end, further optimisation towards 6a was carried out with 10 
mol% Ni(cod)2 and 30 mol% PPh3. 
 
Table 6 Study on the influence of stoichiometry 
 
Entry Alkyne (eq.) Ni (mol %) PPh3 (mol %) Conversion 6a/8 Yield of 6a (%)
[a] 
1.  1.5 5 10 18% 100 : 0  
2.  1.5 5 15 0% 0 : 0  
3.  1.5 10 10 93% 81 : 19  
4.  1.5 10 20 >95% 83 : 17 79 
5.  1.5 10 30 >95% 87 : 13 85 
6.  1.5 10 40 >95% 91 : 9  
7.  1.1 10 20 >95% 78 : 22 77 
8.  1.1 10 30 >95% 90 : 10 81 
[a]Isolated yield of an average of 2-3 runs 
 
Lowering the concentration from 0.22M to 0.1M resulted in incomplete conversion and 
increasing the concentration had no effect over the timescale of the reaction. Therefore, the 
concentration used in the subsequent optimisations was kept at 0.22M. 
Temperature effects were then studied (Table 7). Increasing the temperature to 120°C gave 
virtually identical results to that obtained at 100°C (Table 7, Entry 1 vs 2). With dioxane, 
variable conversions were obtained when the temperature was lowered to 80°C (Table 7, 
Entry 3 and 4).  With 2-pentanone (Table 7, Entry 5 and 6), variable conversions were also 
obtained but the selectivity towards 6a is much higher suggesting that the formation of 8 is a 
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higher energy pathway. Carrying out the reaction in dioxane and at 90°C allowed for a high 
selectivity towards 6a (Table 7, Entry 7 and 8). When 20% of PPh3 was used (Table 7, entry 7), 
an isolated yield of 84% of 6a was obtained. A 90% isolated yield of 6a was obtained when 
30% PPh3 (Table 7, entry 8) was used. 
 
Table 7 Temperature effects on C–C activation 
 
Entry Temp (oC) 5a (eq.) PPh3 (mol %) Solvent Conv. 6a/8 Yield of 6a (%)
[a] 
1.  100 1.5 30 Dioxane >95% 91 : 9  
2.  120 1.5 30 Dioxane >95% 91 : 9  
3.  80 1.5 30 Dioxane >95% 100 : 0  
4.  80 1.5 30 Dioxane 63%[b] 100 : 0  
5.  80 1.5 30 2-Pentanone 71% 100 : 0  
6.  80 1.5 30 2-Pentanone >95%[b] 83 : 17  
7.  90 1.1 20 Dioxane >95% 94 : 6 84 
8.  90 1.1 30 Dioxane >95% >95 : <5 90 
 [a] Isolated yield of an average of 2-3 runs; [b] reaction left over the weekend 
 
Attempts to use Ni(PPh3)2Cl2/Zn instead of Ni(cod)2 proved unsuccessful, giving only unreacted 
starting material or trace formation of 3. Ni(PPh3)4 also failed to give any reaction. Blank tests 
without Ni(cod)2 and without both Ni(cod)2 and PPh3 resulted in no conversion therefore 
confirming it is a Ni-catalysed reaction. Therefore, the optimised condition was set at 10 mol% 
Ni(cod)2, 30 mol% PPh3 in dioxane at 90°C. The azetidinone and alkyne were added 
sequentially after the formation of the active catalyst. 
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 Scope of the reaction 2.3
 Cycloaddition of N-Boc Azetidinone with alkynes 2.3.1
 
With the optimised reaction condition in hand, the scope of the reaction was examined (Table 
8). The insertion of symmetrical alkynes diphenylacetylene 5a and 4-octyne 5b into 
azetidinone 7 proceeded in high yields to give 6a and 6b respectively. With unsymmetrical 
alkyne, the insertion of 1-phenyl-1 propyne 5c proceeded with good regioselectivity as 
determined from isolated yields of 6c and 11c. Furthermore, the isomers were easily separable 
by standard flash column chromatography. The regioselectivity of insertion of other non-
symmetrical alkynes 5d – 5i was good. However, the reactivity of non-symmetrical alkynes 5h 
and 5i was not initially reproducible. However, the addition of a solution of both azetidinone 7 
and the alkyne in dioxane (0.29 mM) gave reproducible results. Furthermore, despite the 
increase of the steric bulk on the alkyl substituent (Table 8, entries 8 and 9), only a small 
erosion of the regioselectivity was observed. The regiochemistry of all isomers was 
determined by NOESY and HMBC experiments (Scheme 4).  
 
 
Scheme 4 NOESY experiments 
 
The results obtained with alkynes 5e and 5g suggest that electronic differentiation had little 
influence on the regioselectivity. This was confirmed with the reaction involving 5j. On this 
substrate, both substituents of the alkyne were differentiated only electronically and 
displayed identical steric hindrance. The two isomers 6k and 11k were not separable by 
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column chromatography but from crude NMR, the regioisomers ratio was established as 
almost equimolar. Comparison of alkynes 5k and 5l, revealed that the increase of steric 
differentiation between the substituents resulted in improved regioselectivity.  
 
Table 8 Alkyne scope 
 
Entry Alkyne 5 Major Product 6 Ratio (6 / 11)[a] Yield[b] 
1 
 
 
 90 
2 
 
 
 88 
3 
 
 
87 : 13 92 
4 
 
 
91 : 9 91 
5 
 
 
89 : 11 89 
60 
 
6 
 
 
90:10 69[e] 
7 
 
 
89 : 11 99 
8 
 
 
86 : 14 88[c] 
9 
 
 
84 : 16 91[c] 
10 
 
 
55 : 45 82[d] 
11 
 
 
60 : 40 90[d] 
12 
 
 
>99: 1 87[d] 
[a] Unless otherwise stated, this ratio was determined from the isolated yields of separated 
regioisomers 6 and 11. [b]Combined isolated yields of 6 and 11. [c] Alkyne and Azetidinone 
were premixed. [d] Ratio determined by 1H NMR spectroscopy on an inseparable mixture of 6 
and 11. [e] Yield of major isomer 
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By comparison of the experimental results of nickel-catalysed reductive coupling of simple 
internal alkynes (alkyl-C≡C-alkyl and alkyl-C≡C-aryl) and aldehydes, the regioselectivities that 
were obtained followed the same trend as the results we obtained.5 Jamison and co-workers 
reported the nickel-catalysed reductive coupling of alkyne 5c with aldehyde 12 (Scheme 5).5f 
The coupling proceeded with a similar regioselectivity as the insertion of alkyne 5c into 
azetidinone 7. Furthermore, the major isomer has the Me group appear nearest to the C(O)–C 
bond. 
 
 
Scheme 5 Comparison of our result with the result reported by Jamison 
 
Furthermore, computation studies of nickel-catalysed reductive couplings of simple alkynes 
and aldehydes revealed the energy of the transition states are affected by the orientation of 
the alkyne (Scheme 6).6 It was calculated that transition state 19a is lower than transition state 
19b purely because of steric effects. This study suggests the steric repulsion between the 
alkyne substituent and the aldehyde is more influential than between the alkyne substituent 
and the nickel-phosphine catalyst in the oxidative cyclisation step. Due to the greater steric 
repulsion between the alkyne substituent and the aldehyde, the lowest transition state has 
the smallest alkyne substituent next to the aldehyde. Therefore, this subtle difference would 
then explain why some alkynes added onto the aldehyde with good regioselectivity.  
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Scheme 6 Experimental and theoretical study of nickel-catalysed reductive coupling 
 
Therefore, from the work done on nickel-catalysed reductive couplings of simple internal 
alkynes and aldehydes, we proposed the regioselectivity of the insertion of alkynes 5c-5l are 
determined by the steric differentiation between the substituents of the alkyne.  
For the mechanism, we propose that prior to the oxidative cyclisation, the alkyne has two 
orientations whereby the small alkyne substituent in 21 or the large alkyne substituent in 24 
can be in proximity to the azetidinone (Scheme 7). For the major regioisomer, the 
minimisation of the steric interaction between the Boc protective group on the azetidinone 
and the large alkyne substituent would afford metallacycle 22. Ring enlargement by β-C 
elimination would then afford nickelaheptacycle 23. Finally, reductive elimination would 
afford product 6.  
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Scheme 7 Steric differentiation to explain the formation of the regioisomer 
 
There appears to be some correlation between regioselectivity and steric differentiation 
(Scheme 8). A-values are derived from the energy for the interconversion of a 
monosubstituted cyclohexane ring and these values can be used as a measure of the steric 
bulk of a substituent.7 Comparison of the difference in A-value for alkyne 5k, 5c and 5l 
indicates that the greater the difference, the better the regioselectivity. However, comparison 
of alkyne 5c and 5h suggests the regioselectivity is not completely influenced by the steric 
differentiation between the two substituents. Both have a phenyl group conjugated to the 
alkyne and therefore, the phenyl group could behave as a directing group.  
 
 
Scheme 8 Correlation between regioselectivity and steric differentiation 
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Furthermore, insertion of 1,3-enynes into azetidinone 7 proceeded successfully (Table 9). 
Enyne 5m was found to insert with good regioselectivity which suggests the alkene moiety can 
behave as a directing group. However, enyne 5n was found to insert with poor regioselectivity 
which suggests both the alkene and the aryl substituent can complete as a directing group. 
This could also explain why the insertion of alkynes 5c – 5i proceeded with near consistent 
regioselectivity. Furthermore, both directing groups appear to be able to over-ride or minimise 
any steric influences. 
 
Table 9 Insertion of 1,3 enyne 
 
Entry Alkyne 5 Major Product 6 Ratio (6 : 11)[a] Yield (%)[b] 
1 
 
 
88 : 12 88 
2 
 
 
60 : 40 86[c] 
[a] Unless otherwise stated, this ratio was determined from the isolated yields of separated 
regioisomers 6 and 11. [b]Combined isolated yields of 6 and 11. [c] Ratio determined by 1H 
NMR spectroscopy on an inseparable mixture of 6 and 11.  
 
According to a computational study, the insertion of 1,3-enynes into aldehydes could proceed 
via one of three pathways (Scheme 9). 6b From the modelled example of the reductive coupling 
of 1, 3-butenyne and acetaldehyde, the oxidative cyclisation is the rate determining step. 
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Coupling at the alkene was calculated to have a high activation energy. By comparison, 
coupling at the alkyne was calculated to be lower in energy. Pathway A is the 1,4 attack to 
enyne. Pathway B is the 1,2 attack to enyne. Finally, pathway C is the 1,2 attack to enyne to 
form the minor regioisomer. It is calculated the activation energy to the transition state in 
pathway A is the lowest out of the three pathways. Furthermore, it is calculated the extra η3-
allyl/metal interaction in pathway A lowers the energy of the transition state. Interestingly, the 
authors reported that the activation energy barrier for coupling with 1,3 enynes is lower than 
coupling with simple alkynes. Therefore, 1,3 enynes should be more reactive as a coupling 
partner.  
 
 
Scheme 9 Theoretical study of the nickel-catalysed reductive coupling of 1,3-enyne with 
aldehydes 
 
66 
 
Therefore, based on the computational study, enyne 5n or 5m will first form complex 27 
whereby the alkene or aryl will coordinate to the nickel metal centre (Scheme 10). Then 
oxidative cyclisation would occur to give metallacycle 28 which subsequently would undergo 
β-C elimination to give metallacycle 29. Then reductive elimination would afford pyridinone 6 
as the major isomer with the vinyl group in the β-position to the carbonyl.  
 
 
Scheme 10 Directing group effects to explain the formation of the major regioisomer 
 
Experimental results of the reductive coupling of enynes with aldehydes also proceeded with 
similar regioselectivities if the other alkyne substituent is an alkyl group.8 When the other 
alkyne substituent is an aryl group, the regioselectivity tended to be better rather than 
worse.8a To exemplify this, Montgomery and co-workers reported a nickel catalysed reductive 
coupling of enyne 30 and aldehyde 31 which proceeded in an excellent regioselectivity 
(Scheme 11) whereas with the nickel-catalysed cycloaddition developed in this thesis, the 
insertion of 5n into 7 proceeded with poor regioselectivity (Scheme 12).5e 
 
 
Scheme 11 Nickel catalysed reductive couplings of enyne and aldehyde 
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Scheme 12 Nickel catalysed [4+2] cycloaddition of enyne and azetidinone 
 
The reaction of silylated alkynes was unexpected as none worked in the nickel-catalysed 
insertion into cyclobutanone as reported by Murakami and co-workers.2 However, insertion of 
alkyne 5o proceeded in a high yield and with excellent regioselectivity.9 Even with a larger silyl 
group 5p, the insertion still proceeded in an excellent yield and regioselectivity. Slightly 
diminished regioselectivity of the insertion was observed with alkyne 5q. It appears that if an 
aryl group is conjugated to the silylated alkyne, the directing group effect of the aryl group and 
the preference of the silicon being in the α-position will make the insertion more 
regioselective. However, insertion of alkyne 5r and 5s failed to take place. 
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Table 10 Silylated alkyne scope 
 
Entry Alkyne 5 Major Product 6 Ratio 6 / 11[a] Yield 6 (%)[b] 
1 
 
 
97 : 3 91 
2 
 
 
97 : 3 98 
3 
 
 
80 : 20[c] 78[d] 
4 
 
 
n / a 0 
5 
 
 
n / a 0 
[a] Unless otherwise stated, this ratio was determined from the isolated yields of separated 
regioisomers 6 and 11. [b]Combined isolated yields of 6 and 11. [c] Ratio determined by 1H 
NMR spectroscopy on an inseparable mixture of 6 and 11. [d] 1.5 equiv. of alkyne was used 
 
Furthermore, the nickel-catalysed reductive coupling reactions with silylated alkynes generally 
proceeded with better regioselectivity when compared to the more simple alkynes. As a 
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representative example, Jamison and co-workers reported the reductive coupling of alkynes 5 
with aldehydes 34 to afford allylic alcohol 35 proceeded with superior regioselectivities when 
silylated alkynes are used (35b and 35d) compared to when 1-phenyl-1-propyne is used (35a 
and 35c) (Scheme 13).5b  
 
 
Scheme 13 Comparison of the reductive coupling of silylated and simple alkynes with 
aldehydes 
 
The principles used to explain the regioselectivity outcome are different with silylated alkynes. 
By looking at the axial strain values and comparing the outcome between the alkyne insertion 
of 5k and 5o revealed that steric differentiation was more or less irrelevant with respect to 
silylated alkynes (Scheme 14). If steric differentiation was important, insertion of alkyne 5k 
should have proceeded with better regioselectivity than alkyne 5o. 
 
 
Scheme 14 Axial strain values 
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Therefore, electronic effects are likely to be the prevalent factor in the highly regioselective 
insertion of silylated alkynes. Nickel-alkynes complexes have been studied extensively.10 The 
13C NMR of a nickel-silylated alkyne complex 36 shows there is a large chemical shift difference 
between the two carbons of the coordinated alkyne which reveals the alkyne is significantly 
polarised. Compared to 1-phenyl-1-propyne, the chemical shift difference between the two 
coordinated alkyne carbons of complex 37 is significantly smaller as judged by 13C NMR 
(Scheme 15). The greater polarisation in silylated alkynes might facilitate the proposed 
oxidative cyclisation step and its direction appears to dictate the regioselectivity. 
 
 
Scheme 15 Polarisation exhibited in known nickel alkyne complexes 
 
 Limitations 2.3.2
2.3.2.1 Terminal Alkynes 
 
Terminal alkynes 38 and 39 were ineffective in the reaction (Scheme 16). It is believed that the 
cyclotrimerisation pathway is also operating. Regardless, there are examples of nickel-
catalysed reactions whereby a terminal alkyne has been successfully incorporated.5a,e,h,11 
Furthermore, Kumar and Louie reported a successful insertion of tertbutylacetylene 40 into 
azetidinone 7 under modified reaction conditions (Scheme 17).12 The requirement of an 
increased loading of alkyne was necessary due to competing co-oligomerisation. Furthermore, 
slow addition of the alkyne and a reaction temperature of 100°C were necessary. The 
successful insertion of tertbutylacetylene might be imputed to size of the tertbutyl substituent 
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on the acetylene which makes it harder for another acetylene molecule to coordinate to the 
metal centre. 
 
 
Scheme 16 Terminal alkynes attempted 
 
Scheme 17 Kumar and Louie example 
 
2.3.2.2 Alkynyl pyridines 
 
No reaction was observed when an alkyne conjugated to a pyridine was used (Scheme 18). 
Furthermore, there are examples in the literature of substrates containing heterocyclic 
moieties which were tolerated in nickel-catalysed reactions (Scheme 19).13 The success of 
these reactions suggest that the pyridine on alkyne 43 and 44 makes the alkyne more electron 
poor and as a result will bind stronger to the nickel centre and render the desired catalytic 
pathway inactive. Alternatively, the pyridine could coordinate to the nickel-catalyst and render 
the catalyst inactive. 
 
 
Scheme 18 Alkynes conjugated to a pyridine attempted 
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Scheme 19 Heterocyclic moieties tolerated in nickel-catalysed reactions 
 
2.3.2.3 Electron-deficient alkynes 
 
Electron deficient alkynes 45 – 47 were then examined (Scheme 20). However, the formation 
of the desired six-membered ring was never observed. This is likely due to the stronger binding 
of electron deficient alkynes to the nickel centre.6 Interestingly, there is a report of a nickel 
catalysed alkynoate insertion.5g Montgomery and co-workers reported the reductive coupling 
of enone 48 and alkynoate 49 which was carried out at room temperature to give ketone 50 as 
the major regioisomer (Scheme 21). Large excess of 49 was not required nor was careful 
control of reagent addition necessary. Surprisingly, no homocoupling products were observed. 
 
 
Scheme 20 Alkyne conjugated to electron withdrawing functional group 
 
Scheme 21 Successful nickel catalysed coupling of enone and alkynoate  
73 
 
2.3.2.4 Alkynyl boronate esters 
 
Alkynyl boronate esters were then studied (Scheme 22). With alkyne 5t, the insertion into 7 
took place with 73% conversion. Product 6t that was isolated identified to have had the 
pinacolborane moiety cleaved off and was isolated in a yield of 44%. Attempts to insert alkyne 
5u into azetidinone 7 were unsuccessful.  
 
 
Scheme 22 Studied of alkynyl boronate esters 
 
2.3.2.5 Propargyl ethers 
 
Non-symmetrical propargyl ethers were then examined (Table 11). No asymmetrical propargyl 
alkynes (Table 11, Entry 1-3) were found to successfully insert into azetidinone 7. When the 
propargyl oxygen atom was replaced with a methine (Table 11, Entry 1 vs 4), there was full 
conversion with an isolated yield of 72% but with poor regioselectivity. Homologation of the 
carbon chain between the alkyne and the oxygen (Table 11, Entry 5) resulted in reactivity. 
Unfortunately, poor regioselectivity was observed. These results suggest oxygen is a poor 
directing group.  
 
 
 
74 
 
Table 11 Alkynes with a heteroatom 
 
Entry Alkyne 5 Major Product 6 Ratio (6/11) Yield (%) 
1 
 
 
n/a 0 
2 
 
 
n/a 0 
3 
 
 
n/a 0 
4 
 
 
58 : 42 75% 
5 
 
 
55 : 45 91% 
 
However, Jamison and co-workers reported a nickel-catalysed coupling of non-symmetrical 
propargylic ether 51 with aldehydes 52 to afford allylic alcohol 53 at -25°C (Scheme 23).5d This 
result indicates that the ligand or the reaction temperature could be influential factors. 
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Scheme 23 Nickel-catalysed reductive coupling of aldehyde 52 and propargyl ether 51 
 
A competition experiment was then carried out to determine if the catalytic system is 
rendered inactive by propargyl ethers (Scheme 24). Previously, the insertion of 4-octyne 6b 
into 7 proceeded in an excellent yield. However, no reaction occurred when 0.55 equivalent of 
4-octyne 5b was added to the nickel catalyst, 7 and 0.55 equivalent of alkyne 5v. Even when 
the loading of both alkynes were increased to 1.1 equivalent, there was still no reaction. 
Therefore, propargyl ethers might bind more strongly to the nickel-catalyst than 4-octyne 5b 
and render the catalyst inactive. 
 
 
Scheme 24 Competition experiment 
 
Due to the lack of reactivity with propargyl ether 5v, it was of interest to see if another 
transition metal catalytic system could effect the insertion (Table 12). However, no catalytic 
systems examined were successful. However, the temperature of the reaction was likely to be 
too low as there are reports of several rhodium catalysed C–C bond cleavage of four-
membered rings which require a higher temperature.14 
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Table 12 Attempted insertion of alkyne 5v into azetidinone 7 
 
Entry Cat. (mol%) Ligand (mol%) Result 
1 Pd2dba3 (5) PPh3 (20) No reaction 
2 [Rh(CO)2Cl]2 (5) none Decomp 
3 [Rh(CO)2Cl]2 (5) PPh3 (20) No reaction 
4 [Rh(CO)2Cl]2 (5) dppp (10) No reaction 
5 [Rh(cod)2]BF4 (10) none No reaction 
 
Out of curiosity, it was of interest to then see if propargylic ether 5w could insert into 
azetidinone 7 (Table 13). Due to the lack of reactivity with propargylic ether 5v by a nickel 
catalyst, it was of interest to see if another transition metal could catalyst the insertion of 
silylated equivalent 5w into 7. However, a brief screen of different catalytic systems revealed 
no catalytic system could effect successful [4+2] cycloaddition. 
 
Table 13 Attempted insertion of alkyne 5w into azetidinone 7 
 
Entry Cat. Ligand Result 
1 Ru3(CO)12 none No reaction 
2 Ru3(CO)12 PPh3 No reaction 
3 Pd(OAc)2 2xPPh3 No reaction 
4 Sc(OTf)3 none No reaction 
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The insertion of propargylic ethers 5aa into azetidinone 7 was then studied (Scheme 25). 
Carrying out the reaction with an increased loading of catalyst and at a lower reaction 
temperature gave rise to a regioselective insertion of alkyne 5aa into azetidinone 7 to form 
6aa. Furthermore, another product 54 was formed from the cleavage of the Boc-group. 
 
 
Scheme 25 Insertion of alkyne 5aa into azetidinone 7 
 
Attempts to reduce the loading of catalyst were then carried out by Jet-Sing Lee (Table 14). 
Reattempting the reaction with the increased loading of catalyst (Table 14, Entry 1) 
reproduced the initial result. When the loading of catalyst was reduced, no formation of the 
cleaved product 54 was observed. Instead, the other regioisomer 11aa was observed and both 
isomers were isolated in a ratio of 50:50 (Table 14, Entry 2). With PPh3 (Table 14, Entry 3), the 
selectivity towards 6aa improved. Changing the solvent to dioxane (Table 14, Entry 4) did 
make a difference to the outcome. Changing the ligand to 30 mol% of PPh2Cy (Table 14, Entry 
5) and carrying the reaction out in dioxane improved the selectivity towards 6aa a little. 
However, with 30 mol% PPhCy2 as ligand (Table 14, Entry 6) in dioxane slightly reduced the 
selectivity towards 6aa and suffered from poor reactivity. 
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Table 14 Catalytic loading screen 
[a] Ratio determine by 1H NMR of the crude material; [b] Combined isolated yield of 6aa and 
11aa; [c] Isolated yield; [d] in dioxane 
 
2.3.2.6 Miscellaneous alkynes 
 
Several other alkynes were then tested and were found to remain inert or decomposed under 
the optimised conditions (Scheme 26). Propargyl alcohols 55-58 were ineffective. Ynamides 59 
and 60 were unproductive. Alkynol 61 also failed to insert. Halogen directly attached to the 
alkyne 62 or an alkyne with the halogen further along a tether 63 failed to give rise to the 
desired 6-membered ring. However, there have been examples in the literature of nickel-
catalysed reactions whereby chloro15, protected alcohol,15 mono-protected amines5f functional 
groups are tolerated. An example of this is the report by Liebeskind and Huffman on a nickel-
catalysed annulation of cyclobutenones 64 with alkynes 65 to form phenols 66 (Scheme 27). 15 
 
Entry Ni (mol %) L (mol %) Temp (°C) (6aa/11aa)[a] Yield (%)[b] Yield 54 (%)[c] 
1 30 PPhCy2 (90) 70 100 : 0 68 32 
2 10 PPhCy2 (30) 70 50 : 50 40 0 
3 10 PPh3 (30) 60 69 : 31 56 0 
4[d] 10 PPh3 (30) 60 68 : 32 71 0 
5[d] 10 PPh2Cy (30) 60 72 : 28 41 0 
6[d] 10 PPhCy2 (30) 60 64 : 36 17 0 
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Scheme 26 Ineffective alkynes 
 
Scheme 27 Nickel-catalysed reaction that tolerated hetero-functionality on the alkyne 
 
 Cycloaddition of N-Benzhydryl azetidinone 76 with alkyne 5b 2.3.3
 
The insertion of alkyne 5b into azetidinone 67 was then examined (Scheme 28). However, no 
reactivity was observed with our optimised reaction conditions. In 2012, Murakami and co-
workers examined this reaction and reported a 82% isolated yield of the desired pyridinone 68 
when carried out with 10 mol% Ni(cod)2, 20 mol% PCy3 and in toluene at room temperature.
16 
 
 
Scheme 28 Insertion of azetidinone 67 
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 Cycloaddition of N-Ts Azetidinones with alkynes 2.3.4
 
Harsher conditions were required when N-Ts-azetidinone 69 was used in the place of N-Boc-
Azetidinone 7 for full conversion (Table 15). Insertion of alkyne 5b proceeded in good yields in 
1 hour. Insertion of alkyne 5c required a higher catalyst loading and proceeded with a lower 
regioselectivity. The higher temperature might explain the poorer outcome in regioselectivity. 
 
Table 15 Screen with N-Ts-azetidinone 69  
 
Entry Alkyne Major Product 70 Ratio (70/71) Yield[a] 
1 
 
 
 73 
2 
 
 
83 : 17 75[b] 
[a] combined isolated yield. [b] 20 mol% Ni(cod)2, 80 mol% PPh3, 1.5 equiv. of 2b, dioxane, 
100°C. 
 
The reaction also worked with α-substituted azetidinones 72 (Table 16). Insertion of 
symmetrical alkynes 5a and 5b proceeded in excellent yields. In the cycloaddition to form 73b, 
the enantiomeric purity was slightly eroded with an ee of 97%. Good regioselectivity was 
observed in the insertion of alkyne 5c. Finally with silylated alkyne 5o, the regioselectivity was 
high but more decomposition was noted. Notably, the results in the regioselectivity were 
comparable to the results obtained with N-Boc-Azetidinone 7.  
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Table 16 α-substituted N-Ts-azetidinone 
 
Entry Alkyne Major Product 73[a] Ratio (73/74)[b] Yield (%)[c] 
1 
 
 
n/a 92 
2 
 
 
n/a 91[c] 
3 
 
 
93 : 7 99 
5 
 
 
>95 : 5 71[d] 
[a] 72 has an ee of >99% as determined by HPLC [a] Unless otherwise stated, this ratio was 
determined from the isolated yields of separated regioisomers 73 and 74. [b] Combined 
isolated yields of 73 and 74. [c] ee of product is 97% as determined by HPLC. [d] Only 73o was 
isolated 
 
The principles discussed to explain the regioselectivity of the alkyne insertion into N-Boc-
azetidinone 7 appears to be equally applicable here. After the oxidative cyclisation to form 
intermediate 75, the ring opening proceeded exclusively with the least sterically hindered C–C 
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bond broken to form intermediate 78 rather than intermediate 77 (Scheme 29). Finally, 
reductive elimination would afford product 73 as the major isomer. 
 
 
Scheme 29 C–C cleavage of the least sterically hindered C–C bond 
 
The insertion of 4-octyne 5b into azetidinone 79 proved to be unsuccessful as no reaction was 
observed. Large α-substitution appears to hinder the reaction.  However, Murakami and co-
workers reported that after a slight modification to the reaction conditions, the insertion of 
alkyne 5l into azetidinone 81 proceeded with an isolated yield of 56% of pyridinone 82 
(Scheme 31).16  
 
 
Scheme 30 Failed insertion of alkyne 5b into azetidinone 79 
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Scheme 31 Insertion of alkyne 5l into azetidinone 81 
 
The insertion of alkyne 5b into azetidinone 83 was then studied (Table 17). With PPh3 as ligand 
(Table 17, Entry 1), trace amounts of pyridinone 84 was formed as judged from the 1H NMR 
spectra of the crude. Attempts to use nitrogen based ligands (Table 17, Entry 2 and 3) did not 
give rise to the formation of 84. 
 
Table 17 Attempted insertion of alkyne 5b into azetidinone 83 
 
Entry Ligand mol % Result 
1 PPh3 30 trace 
2 Phen 15 trace 
3 Bipy 15 No reaction 
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 Aromatisation to pyridinols 2.3.5
 
Several research groups have demonstrated the transformation of pyridinones to the 
corresponding pyridinols. However, no procedures were reported to deprotect the Boc group 
and aromatise the deprotected pyridinone to give the corresponding pyridinol. Aromatisation 
using DDQ as the aromatising agent was ineffective as no reaction occurred even after two 
nights at rt (Scheme 32). It was found acid hydrolysis of the Boc group of pyridine 6a give a 
mixture of 85a and 86a (Scheme 33). Complete consumption of 6a always occurs after 18 hrs 
and usually, mostly 86a is formed but the mixture ratio could never be reproduced. Therefore, 
it became of interest to force the formation towards 85a. A report on the use of NaNO2 in the 
presences of wet SiO2 as a aromatisation agent of 1,2-dihydroquinolines was reported.
17 
Consequently, a procedure was developed to successfully transform pyridinones 6a to the 
corresponding pyridinols 85 (Scheme 34). Firstly, acid hydrolysis of the Boc group followed by 
a NaNO2 mediated aromatisation and subsequent neutralisation with triethylamine furnished 
the desired pyridinol 92 in a one pot process in good yields. Synthesis of 85d and 85o required 
another batch of NaNO2 and allowed to stir for a further hour prior to quenching with Et3N. 
For the synthesis of 85f, the solution was diluted with CH3CN prior to addition of NaNO2. The 
role of CH3CN is currently unclear but it did allow the aromatisation to be carried out within 1 
hour. Compounds 85f, 85h and 85o are not fully characterised in this thesis. Nonetheless, the 
examples given demonstrate the functional group tolerance of this methodology. 
 
 
Scheme 32 Aromatisation with DDQ 
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Scheme 33 Initial attempts on aromatisation 
 
 
Scheme 34 Aromatisation of pyridinones to corresponding pyridinols 
 
 Cycloaddition of oxetanones with alkynes  2.3.6
 
Using the same optimised conditions as those reported with N-Boc-azetidinone 7 allowed the 
insertion of alkyne 5 into commercially available 3-oxetanone 87 (Table 18). Insertion of alkyne 
5a proceeded in high yields. Insertion of alkyne 5g proceeded with a lower regioselectivity 
when compared to the insertion of the same alkyne into N-Boc-azetidinone 7. The poorer 
regioselectivity might be due to the less steric hindrance of the oxygen of the oxetane when 
compared to the larger carbamoyl group of then N-Boc-azetidinone 7. Due to the different 
behaviour of silylated alkynes, alkyne 5o still proceeded with excellent regioselectivity. 
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Table 18 Insertion of alkyne into oxetanone 
 
Entry Alkyne 5 Major Product 88 Ratio (88/89)[a] Yield (%)[b] 
1 
 
 
n/a 82 
2[c] 
 
 
79 : 21 92 
3 
 
 
96 : 4 99 
[a] Unless otherwise stated, this ratio was determined from the isolated yields of separated 
regioisomers 88 and 89. [b] Combined isolated yields of 88 and 89. [c] Alkyne and Azetidinone 
were premixed.  
 
It was found that α-substituted oxetanone 90 underwent the nickel-catalysed cycloaddition, 
whereby the ring opening of the oxetanone proceeded with less regioselectivity. Products 
arising from the C–C cleavage of both the least and the most sterically bonds were isolated 
under the standard reaction conditions. The insertion of 4-octyne 5b into 90 with the 
optimised reaction condition proceeded to give two isomers 91 and 92 in a 4:1 ratio with 32% 
recovered starting material (Table 19, entry 1). On increasing the catalytic loading to 20 mol% 
Ni(cod)2 and 40 mol% PPh3, the conversion was complete with an isolated yield of 70% of 91 
and 14% yield of 92 (Table 19, entry 2). The insertion of diphenylacetylene 5a into 90 was then 
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studied with the higher catalyst loading of 20 mol% Ni(cod)2 and 40 mol% PPh3. An isolated 
yield of 42% of 93 and combined mass recovery of 33% which contained 94 and recovered 90 
was achieved (Scheme 35). Due to the difficulty in separating 94 from 90, no characterisation 
of 94 was carried out. The lower reactivity with 5a might be imputed to the lower reactivity of 
5a in general. 
 
Table 19 Nickel catalysed ring opening of α-substituted oxetanones and 4-octyne 
 
Ni(cod)2 (mol %) PPh3 (mol %) 90 (%)
[a] 91 (%)[b] 92 (%)[b] 
10 30 32 44 11 
20 40 n/a[c] 70 14 
[a] recovered starting material. [b] isolated yield. [c] all starting material consumed 
 
 
Scheme 35 Nickel catalysed ring opening of α-substituted oxetanones and diphenylacetylene 
 
The ring opening of α-substituted oxetanones proceeded differently when compared to α-
substituted azetidinones. Whereas α-substituted azetidinones proceeded with cleavage of 
only the least sterically hindered bond, α-substituted oxetanones proceeded with the cleavage 
of preferentially the least sterically hindered bond (Scheme 36). The steric crowding provided 
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by the protecting group of the azetidinone might contribute to the selective C–C bond 
cleavage. The mechanistic proposal for the ring opening of oxetanone 90 is as follows. The 
oxidative cyclisation would form intermediate 95 and then the ring opening could either 
proceed with the least sterically hindered C–C bond or the more sterically hindered bond 
broken to form intermediate 96 and 98 respectively. Finally, reductive elimination would then 
afford product 97 or 99 respectively. 
 
 
Scheme 36 Mechanistic proposal for the ring opening of α-substituted oxetanones 
 
 Optimisation of the formation of four-membered ring 8 2.3.7
 
During the optimisation of pyridinone 6a, solvent effects were found to be significant in the 
selectivity between pyridinone 6a and four-membered ring 8. Previously, carrying out the 
reaction in 2-MeTHF at 100°C gave good selectivity towards 8. However, carrying out the 
reaction in 2-MeTHF at 90°C resulted in only the formation of 6a (Scheme 37). Therefore, the 
reaction pathway towards 8 operates at a higher temperature. 
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Scheme 37 Carrying out the reaction in 2-MeTHF 
 
A screen of different conditions was then carried out to optimise the selectivity towards four-
membered ring 8 (Table 20). Previously, it was noted that alkyl phosphines generally gave 
good selectivity towards four-membered ring 8. As most alkyl phosphines are liquid and air-
sensitive, it was of interest to see if there was a solid alkyl phosphine alternative.  
The replacement of one of the phenyl rings of PPh3 with a cyclohexyl ring (Table 20, Entry 1) 
gave a slight increase in selectivity towards 8. The replacement of another phenyl ring with a 
cyclohexyl ring (Table 20, Entry 2) resulted in the selectivity towards 8 becoming comparable 
to those observed with alkyl phosphines (Table 1, Entry 2 and 3). 
Increasing or decreasing the loading of PPhCy2 (Table 20, Entry 3 and 4) had little effect on the 
selectivity but with 20 mol% PPhCy2, the selectivity towards 8 was slightly better. The 
reduction of alkyne loading (Table 20, Entry 5 – 7) had little detriment in the selectivity 
towards 8. However, 1.5 equivalent of alkyne was used in further screening as it is a low 
alkyne loading with good selectivity towards 8. 
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Table 20 Optimisation Table 
 
Entry Alkyne (equiv.) Ligand mol % Conversion 6a/8 
1 3 Ph2PCy 20 >95% 43 : 57 
2 3 PhPCy2 20 >95% 19 : 81 
3 3 PhPCy2 10 >95% 22 : 78 
4 3 PhPCy2 30 >95% 21 : 79 
5 2 PhPCy2 20 >95% 20 : 80 
6 1.5 PhPCy2 20 >95% 20 : 80 
7 1.1 PhPCy2 20 >95% 21 : 79 
        
A screening of different solvents which previously displayed a good selectivity toward the four-
membered ring 8 was then carried out (Table 21). Toluene (Table 21, Entry 1) gave good 
selectivity and reactivity toward 8. Carrying out the reaction in 2-pentanone (Table 21, Entry 2) 
gave identical selectivity as before (Table 4, Entry 1) but with poorer conversion. 2-MeTHF 
(Table 21, Entry 3) gave near identical selectivity as before (Table 4, Entry 3) with full 
conversion and an isolated yield of 63%. Also, 2-pentanone and 2-MeTHF was used directly 
out of a bottle exposed to air and moisture. Isopropanol (Table 21, Entry 4) gave full 
conversion but with no selectivity. Increasing the temperature did not enhance the selectivity 
towards 8. Therefore, the optimised condition for the synthesis of 8 was 10 mol% Ni(cod)2, 20 
mol% PPhCy2 and in toluene at 100°C.  
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Table 21 Solvent screen 
 
Entry Solvent Conversion (%) 6a/8[a] 
1 Toluene >95 20 : 80 
2[b] 2-pentanone 25 24 : 76 
3[b] 2-MeTHF >95 18 : 82 
4 isopropanol >95 50 : 50 
[a] Ratio determined by 1H NMR spectroscopy on a crude mixture of 6 and 11 [b] wet solvent 
 
With the optimised reaction condition in hand, the insertion of symmetrical alkyne 100 was 
found to proceed with poor selectivity for 102 (Scheme 38). A near 1:1 isolated ratio of 101 
and 102 was observed. Furthermore, carrying out the reaction with 4-octyne 5b in toluene 
resulted in a 62% isolated yield of pyridinone 6b. 1-Phenyl-1-propyne 5c resulted in an 88% 
conversion to pyridinones 6c and 11c. Neither alkyne 5b nor 5c reacted to form the 
corresponding four-membered ring. Attempts to incorporate the terminal alkyne 
phenylacetylene 38 were unsuccessful. Therefore, the methodology towards the four-
membered ring appears to be restricted to only bis-aryl alkynes. 
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Scheme 38 Nickel catalysed reaction of azetidinone 7 and alkyne 5 
 
 Initial attempts of formal [4+2] cycloaddition of azetidinone with alkenes  2.3.8
 
Jamison and co-workers reported a nickel catalysed coupling of aldehydes 104 with alkenes 
103 (Scheme 39).18 After a screen of different ligands, PPhCy2 was found to give a good 
selectivity for allylic product 105 over homoallylic product 106. 
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Scheme 39 Nickel catalysed coupling of aldehydes with alkenes 
 
It was then decided to see if the insertion of alkenes into NBoc-azetidinone 7 was possible 
with the optimised reaction condition used for the synthesis of four-membered ring 8 (Scheme 
40). However, no reactivity took place with ethylacrylate 107. Also, no reactivity took place 
with alkenes 108 and 109, even when the temperature of the reaction was increased to 120°C. 
 
  
Scheme 40 Alkenes screened 
 
 Future development of air-stable Ni(II) pre-catalyst 2.4
 Introduction and initial optimisation 2.4.1
 
Ni(cod)2 is an air sensitive complex which is required to be stored cold under an inert 
atmosphere and is handled inside a glovebox. However, there are many commercially 
available nickel-catalysts which can be conveniently stored outside of the glovebox. There are 
reports of commercially air-stable Ni(II) pre-catalysts that can be reduced by a reducing agent 
in situ to become the active Ni(0).19 We then became interested to see if we can find a 
commercially available and air stable Ni(II) pre-catalyst that can do the [4+2] cycloaddition of 
azetidinone with alkyne. This would primarily allow the reaction to be setup and be carried on 
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the benchtop which would circumvent the need for a glovebox. Secondly, this method could 
potentially improve the scope of the methodology. 
The commercially available and air stable Ni(PCy3)2Cl2 was chosen as it exhibits better air 
stability than Ni(PPh3)2Cl2. Zinc was chosen as the reducing agent as it can be stored outside 
the glovebox. It was found that no activation was necessary and the zinc can be used directly 
out of a bottle which has been exposed to air and moisture. The initial optimisation with 
Ni(PCy3)2Cl2 began with 50 mg of azetidinone 7 and 1.1 equivalents of alkyne 5b at 60°C. It was 
found that the conversion was low when the reaction was carried out in toluene (Table 22, 
Entry 1). However, THF or iPrOH (Table 22, Entry 2 and 3) gave full conversion in both cases 
and a 72% isolated yield of pyridinone 6b was obtained with iPrOH. Interestingly, formation of 
the desired Ni(PPh3)2Cl2 can be achieved by mixing NiCl2•6H2O and PPh3 together in a suitable 
solvent. Unfortunately, THF and EtOH proved to be poor solvents (Table 22, Entry 4 and 5). On 
the other hand, iPrOH allowed at least a reasonable conversion to 6b (Table 22, Entry 6). 
Furthermore, the last 3 entries suggest that the excess water from the NiCl2•6H2O is 
potentially detrimental to the reaction. As a result, the initial formation of Ni(PCy3)2Cl2 from 
NiCl2•6H2O might require better examination. 
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Table 22 Optimisation with 5b 
 
Entry Ni cat. (10 mol%) PCy3 (mol%) Solvent Conv. Isolated yield of 6b (%) 
1 Ni(PCy3)2Cl2 0 Toluene trace 
 
2 Ni(PCy3)2Cl2 0 THF >95% 
 
3 Ni(PCy3)2Cl2 0 iPrOH >95% 72% 
4 NiCl2•6H2O 20 THF 6%  
5 NiCl2•6H2O 20 EtOH <5%  
6 NiCl2•6H2O 20 iPrOH 77%  
 
With these promising results in hand, we became interested to see if the insertion of alkyne 5c 
could proceed with good regioselectivity. Therefore, the study with 50 mg of azetidinone 7 
and 1.1 equivalents of alkyne 5c was carried out (Table 23). However, a mixture of 
NiCl2•6H2O/PCy3 was ineffective (Table 23, entry 1). Carrying out the reaction with Ni(PCy3)2Cl2 
at 80°C was ineffective in either THF or iPrOH (Table 23, entry 1 and 2). Ni(PPh3)2Br2, is a more 
air-stable nickel pre-catalyst than Ni(PPh3)2Cl2 and can be stored for at least several months 
outside of the glovebox without loss of activity. Ni(PPh3)2Br2 proved to be an effective pre-
catalyst and good conversion towards 6c was observed at 80°C in both THF and iPrOH (Table 
23, entry 4 and 5). Furthermore, the insertion of 5c proceeded with good regioselectivity in 
both solvents. On reducing the temperature to 60°C and the loading of Ni(PPh3)2Br2 to 5 mol%, 
the reaction proceeded with excellent conversion towards 6c and the regioselectivity was 
maintained (Table 23, entry 6 and 7). Carrying out the reaction at 40°C in THF gave poorer 
conversion (Table 23, entry 8). However in iPrOH at 40°C, the regioselectivity remained 
unchanged and an isolated yield of 84% of 6c was obtained (Table 23, entry 9). Furthermore, 
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the reaction can be carried out successfully on a 500 mg scale and 7 was isolated in a 83% 
yield (Table 23, entry 10). 
 
Table 23 Optimisation with 5c 
 
Entry Ni. cat. mol % Solvent Temp. (°C) Conv. Ratio of 6c/11c 6c (%)[a] 
1[b] NiCl2•6H2O 10 iPrOH 60 trace n/a  
2 Ni(PCy3)2Cl2 10 THF 80 <5% n/a  
3 Ni(PCy3)2Cl2 10 iPrOH 80 20% n/a  
4 Ni(PPh3)2Br2 10 THF 80 85% 88 : 12  
5 Ni(PPh3)2Br2 10 iPrOH 80 82% 86 : 14  
6 Ni(PPh3)2Br2 5 THF 60 92% 90 : 10  
7 Ni(PPh3)2Br2 5 iPrOH 60 >95% 89 : 11  
8 Ni(PPh3)2Br2 5 THF 40 60% 91 : 9  
9 Ni(PPh3)2Br2 5 iPrOH 40 >95% 89 : 11 84 
10[c] Ni(PPh3)2Br2 5 iPrOH 40 >95% 90 : 10 83 
[a] Isolated yield, [b] 20 mol% PCy3 also used to form the catalyst, [c] carried out on a 500 mg 
scale 
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 1,3-Enyne as alkyne surrogate to improve regioselectivity 2.4.2
2.4.2.1 Regioselectivity issues with alkyne 5k 
 
Matsubara and co-workers reported a nickel-catalysed reaction involving the insertion of 
alkyne 5k into 110 which proceeded with a better regioselectivity when compared to the 
insertion of alkyne 5k into azetidinone 7 with our original optimised reaction conditions 
(Scheme 41).20  
 
 
Scheme 41 Nickel-catalysed insertion of alkyne 5k 
 
Therefore, a screen was carried out to determine if the regioselectivity of the insertion of 
alkyne 5k into azetidinone 7 could be improved (Table 24). From entry 2 onwards, the work 
was carried out by Daniel J. Tetlow and Jet-Sing Lee. On changing the ligand from PPh3 (Table 
24, Entry 1) to PCy3 (Table 24, Entry 2), the regioselectivity switched but the selectivity 
remained poor. Any changes to the alkyne equivalents, solvent or temperature did little to 
influence the regioselectivity (Table 24, Entry 3-6). Using P(OMe)3 as the ligand reversed the 
regioselectivity towards 6k with a better selectivity towards 6k than PPh3 but suffers from a 
poorer conversion (Table 24, Entry 7 vs 1). However, triphenyl phosphite (Table 24, Entry 8) 
had no reactivity. Afterwards, several other ligands were screened and a trend was noticed. 
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With the exception of L1 (Table 24, Entry 9) which proceeded with full conversion and with 
one of the highest regioselectivities, large phosphines tend to erode the regioselectivity and 
can actually cause the regioselectivity to reverse (Table 24, Entry 10 – 15). 
 
Table 24 Insertion of alkyne 5k into azetidinone 7 
 
Entry Alkyne equiv. Ligand (mol %) Solvent Temp (oC) Ratio Conv. (%) 
1 1.1 PPh3 (30) Dioxane 90 60 : 40 100 
2 1.1 PCy3 (30) Dioxane 90 45 : 55 100 
3 1.5 PCy3 (30) Dioxane 90 43 : 57 99 
4 1.5 PCy3 (30) Toluene 90 43 : 57 92 
5 1.1 PCy3 (30) Dioxane 70 44 : 56 100 
6 1.1 PCy3 (30) Dioxane 40 44 : 56 100 
7 1.1 P(OMe)3 (30) Dioxane 60 69 : 31 45 
8 1.1 P(OPh)3 (30) Dioxane 60 - 0 
9 1.1 L1 (30) Dioxane 40 67 : 33 100 
10 1.1 L2 (30) Dioxane 40 63 : 37 85 
11 1.1 L3 (30) Dioxane 40 62 : 38 100 
12 11 PPh3 (30) Dioxane 40 58 :42 100 
13 1.1 L4 (30) Dioxane 40 55 : 45 100 
14 1.1 L5 (30) Dioxane 40 53 : 47 100 
15 1.1 PCy3 (30) Dioxane 40 44 : 56 100 
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2.4.2.2 1,3-Enyne as alkyne surrogate 
 
In 2008, Fagnou and co-workers reported a rhodium-catalysed indole synthesis (Scheme 42).21 
However, it was found that there is little regiocontrol in the coupling of acetanilide 113 with 
asymmetrical alkyne 114 to afford unsymmetrical 2,3-aliphatic-substituted indole 115 and 
116. 
 
 
Scheme 42 Rhodium-catalysed indole synthesis.  
 
In order to circumvent this problem, Fagnou and co-workers reported a highly regioselective 
coupling of alkyne 118 with acetanilide 117 by a rhodium-catalyst (Scheme 43).22 The highly 
regioselective coupling of alkyne 118 is attributed to the vinyl moiety acting as a directing 
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group. Afterwards, the vinyl moiety can then be converted by hydrogenation (Scheme 44). As 
a result, good regiocontrol in the synthesis of various unsymmetrical 2,3-aliphatic-substituted 
indoles 120 is achieved. 
 
 
Scheme 43 Rhodium-catalysed indole synthesis.  
 
 
Scheme 44 Hydrogenation  
 
Therefore, we became interested to see if enyne 5m can circumvent the low regiocontrol 
problem observed with non-symmetrical alkyl alkynes. Also, it was of interest if an air-stable 
nickel pre-catalyst can be used to effect the insertion of alkyne 5m into azetidinone 69 on a 50 
mg scale of 69 (Table 25). It was found that 10 mol% of the catalyst and 50 mol% of Zinc at 
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60°C gave full conversion with a combined isolated yield of 75% and a regioselectivity of 88:12 
(Table 25, entry 1). However, reduction of the loading of Ni/Zn reduced the conversion (Table 
25, entry 2 and 3). Reducing the Ni/Zn ratio also reduced the conversion which is not too 
surprising, as the reaction is a suspension (Table 25, entry 4 and 5). When the temperature 
was increased to 80°C, full conversion was observed but the isolated yield was rather low 
(Table 25, entry 6). A brief screen of alternative solvents revealed that THF and 2-MeTHF gave 
slightly better regioselectivities but the difference is not significant (Table 25, entry 7-12). 
Furthermore, the reaction can be carried out in THF at 40°C but with poorer conversion (Table 
25, entry 13).  Using a solvent mixture of iPrOH/THF (1:1) at 60°C did not allow the reaction to 
go to complete conversion but a good regioselectivity was obtained (Table 25, entry 14). When 
the reaction carried out on a 150 mg scale of 69, the loading of Ni/Zn can be reduced to 1:2 
but the regioselectivity decreased (Table 25, entry 15). This result was then reproduced (Table 
25, entry 16). 
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Table 25 Optimisation with 5m 
 
Entry 
Ni.     
(mol %) 
Zinc  
(mol %) 
Solvent 
Temp. 
(°C) 
Conv. Yield [a] 
Ratio  
(121/122) 
1 10 50 iPrOH 60 >95% 75% 88 : 12 
2 5 25 iPrOH 60 88% 53% 88 : 12 
3 3 15 iPrOH 60 34% 21% 87 : 13 
4 5 20 iPrOH 60 86% 50% 88 : 12 
5 5 10 iPrOH 60 45% 30% 86 : 14 
6 5 20 iPrOH 80 >95% 61% 88 : 12 
7 5 20 MeCN 60 50% 21% 88 : 12 
8 5 20 THF 60 >95% 74% 89 : 11 
9 5 20 Acetone 60 44% 33% 88 : 12 
10 5 20 Toluene 60 0% n/a n/a 
11 5 20 1,2-DCE 60 <10% n/a n/a 
12 5 20 2-MeTHF 60 56% 39% 90 : 10 
13 5 20 THF 40 55% 41% 91 : 9 
14 5 20 iPrOH/THF[b] 60 80% 61% 92:8 
15[c] 5 10 THF 60 >95% 79% 83:17 
16[c] 5 10 THF 60 >95% 83% 77:23 
[a] Combined isolated yield of 121 and 122. [b] 1:1 solvent ratio. [c] On 150 mg scale of 69 
 
Furthermore, the in situ formation of Ni(PPh3)2Br2 can be achieved by the direct mixing of 
NiBr2•xH2O and PPh3. The insertion of alkyne 5m into azetidinone 69 on a 200 mg scale of 69 
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was found to proceed to give 121 in 69% yield and 122 on 13% yield (Scheme 45). The 
experiment was setup without the requirement of a glovebox. Also, this result will allow the 
screening of ligands to be carried out with ease. 
 
 
Scheme 45 The in situ formation of Ni(PPh3)2Br2 
 
Akin to the work by Fagnou, hydrogenation of pyridinone 121 formed 123 (Scheme 46). The 
product of the hydrogenation was shown to be pure as judged by 1H NMR and used directly in 
the next reaction. Prolonged hydrogenation led to a variety of unidentified side products. 
After the filtration to remove the palladium catalyst, 123 was aromatised with potassium 
tertbutoxide to give pyridinol 124 in a 43% yield over two steps. Therefore, the aromatisation 
step requires some more optimisation. 
 
 
Scheme 46 Hydrogenation, deprotection and aromatisation 
 
Therefore, some optimisation of the aromatisation was carried out on model substrate 70b 
(Table 26). Organic bases Et3N and imidazole were ineffective regardless of temperature (Table 
26, entry 1-4). The aromatisation with 3 equiv. KOtBu in THF without an aqueous workup 
furnished the desired product in a 58% but the yield could be higher as the column leaked 
(Table 26, entry 5). Increasing the equivalents of KOtBu to 5 increased the isolated yield to 
92% (Table 26, entry 6). However, with 3 equiv. KOtBu in THF that involves initial purification 
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by standard aqueous workup with a saturated solution of brine resulted in an isolated yield of 
42% (Table 26, entry 7). Using a saturated solution of NH4Cl instead resulted in an isolated 
yield of 63% (Table 26, entry 8). 
 
Table 26 Model substrate for aromatisation 
 
Entry Base (equiv.) Solvent Temp (°C) Workup Isolated yield (%) 
1 Et3N (3) DCM rt None 0 
2 Et3N (3) DCM 40 None 0 
3 Imidazole (3) DCM rt None 0 
4 Imidazole (3) DCM 40 None 0 
5 KOtBu (3) THF rt None 58[a] 
6 KOtBu (5) THF rt None 92 
7 KOtBu (3) THF rt Brine 42 
8 KOtBu (3) THF rt NH4Cl 63 
[a] column leaked 
 
This initial work with the air-stable nickel pre-catalyst demonstrates the reaction can now be 
set up outside of the glovebox on the benchtop. However, much work remains to optimise the 
conditions. On the other hand, it is clear that the ligand on the nickel can have a significant 
influence on the success on the reaction. Furthermore, the regioselectivity of the insertion of 
non-symmetrical alkynes are in in line with those observed when the mixture of air sensitive 
Ni(cod)2/PPh3 was used. 
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 Conclusion 2.5
 
The [4+2] cycloaddition of four-membered ring heterocycles with alkynes has been 
successfully developed. This rapid build-up of six-membered heterocycles offers an alternative 
approach to previous approaches.23 Initially, the choice of ligand and solvent were critical to 
minimise the formation of the four-membered ring. Upon re-examination, the four-membered 
ring is found to be both substrate specific and temperature dependent. Furthermore, the 
reaction towards six-membered ring 127 proceeded smoothly with various azetidinones and 
oxetanones (Scheme 47). Furthermore, α-substitution on the small heterocycle is tolerated 
providing the substituent is not too large. The insertion of various alkynes proceeded with 
good regioselectivity. Moreover, the insertion of silylated alkynes proceeded successfully.  
 
 
Scheme 47 Summary of the [4+2] cycloaddition 
 
The development of setting up the reaction without the need for a glovebox with an air-stable 
Ni(II) pre-catalyst is of interest. Furthermore, seeking to improve upon the original scope will 
be of interest. To determine if the regioselectivity of the alkyne insertion can be improved or 
even reversed will be of synthetic importance. 
As alluded to, since the publication of some of the work which has been presented in this 
thesis,24 the groups of Murakami16 and Louie12 have published similar results which indicate 
that small heterocycles are indeed competent partners in C–C activation reactions. 
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 Synthesis of Precursors 2.6
 Synthesis of 3-azetidinones 2.6.1
 
The synthesis of azetidinone 69 was easily achieved in a two-step procedure from 3-
hydroxyazetidine hydrochloride S1 (Scheme 48). Compound S2 was obtained by mono-
protection with 1 equivalent of tosyl chloride in methanol and three equivalents of 
triethylamine following a modification to the original reaction procedure.25 Afterwards, 
carrying out a standard Swern oxidation26 afforded azetidinone 69 in 69% yield. 
 
 
Scheme 48 Synthesis of azetidinone 69 
 
The synthesis of azetidinone 72, 79 and 83 began with the corresponding commercially 
available amino acid S3, S5 and S8 (Scheme 50 - 49). The protection with tosyl chloride of S5 to 
give S6 was carried out in a 54% yield. Carboxylic acids S3, S6, S8 were first transformed to the 
corresponding acyl chloride. All volatiles were removed on the high vacuum line to minimise 
the inclusion of water. Afterwards, trimethylsilyldiazomethane was added to form diazo S4, S7 
and S9 which could be purified by flash column chromatography or used directly in the next 
step. Then the copper catalysed N–H insertion formed azetidinone 72 in 84% yield from S4, 79 
in 48% yield from S7 and 83 in 38% yield over 3 steps from S8. 
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Scheme 49 Synthesis of α-aryl azetidinone 
 
Scheme 50 Synthesis of α-aryl azetidinone 
 
Scheme 51 Synthesis of α-substituted azetidinone 
 
 Synthesis of 3-oxetanones 2.6.2
 
The gold catalyst S11 was generated by a salt metathesis of the commercially available 
phosphine gold chloride S9 with silver bis(trifluoromethanesulfonyl)imide in DCM at rt. The 
silver chloride was separated by filtration and the catalyst was of good quality as judged by 31P 
NMR. S14 was made by Dr Christophe Aissa and is not described in this thesis. Afterwards, the 
synthesis of α-substituted oxetanone 90 was carried out by following the procedure described 
by Zhang and co-workers (Scheme 53).27 The synthesis began with the in situ formation of the 
lithium acetylide. Aldehyde S12 was then added to form propagryl alcohol S13 which was then 
isolated after workup. Afterwards, the TMS group was cleaved by TBAF to give the terminal 
alkyne S14. Finally, the gold-catalysed synthesis was carried out to give 90 in a 51% yield. 
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Scheme 52 Synthesis of gold complex 
 
 
Scheme 53 Synthesis of α-substituted oxetanone 
 
 Synthesis of alkynes 2.6.3
 
The synthesis of alkynes 5e, 5g-j, 63 and 100 were achieved by a Sonogashira reaction (Table 
27).24 In each case, the palladium-catalysed coupling of an aryl halide with a terminal alkyne in 
THF proceeded in good to high yields. 
 
 
 
 
 
 
 
 
 
109 
 
Table 27 Sonogashira reaction 
 
Entry R1 X R2 Alkyne Yield 
1 MeO I nBu 
 
Quant 
2[a] CH3C(O) Br nBu 
 
89% 
3 MeO I Cy 
 
81% 
4 MeO I iBu 
 
Quant 
5 MeO I pCF3Ph 
 
Quant 
6 H I -CH2CH2Br 
 
86% 
7 MeO I pMeOPh 
 
70% 
[a] 3 mol% Pd(PPh3)4 and 3mol% CuI were used 
 
With 2-iodopyridine, the Sonogashira reaction was slightly more difficult (Table 28). 
Regardless, the desired product was still isolated in moderate to good yields. 
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Table 28 Sonohashira reaction with 2-iodopyridine 
 
Entry R Alkyne Result 
1 Ph 
 
73% 
2 nButyl 
 
58% 
 
The syntheses of propargylic alkynes 56 – 58 and 5v were carried out in one step from 
commercially available starting materials (Scheme 54). Alkyne 57 and 5v were synthesised by 
benzylation with benzyl bromide S23 as the electrophile. Alkyne 56 was synthesised by 
acetylation with acetyl chloride S21 as the electrophile. Alkyne 58 was synthesised by silylation 
with tert-butyldimethylsilyl chloride S22 as the electrophile. 
 
 
Scheme 54 Synthesis of propargylic alkynes 
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The synthesis of alkyne 5d began with a modified Ohira-Bestmann using 
trimethylsilyldiazomethane on aldehyde S25 to form terminal alkyne S26 and was isolated in a 
91% yield (Scheme 55). Afterwards, deprotection of alkyne S26 with nBuLi and subsequent 
trapping with iodomethane afforded desired alkyne 5d in 90% yield. The synthesis of alkyne 5n 
was a Sonogashira reaction between S26 and 2-bromopropene S27 to form 5n in 86% yield. 
 
 
Scheme 55 Synthesis of alkyne 5d 
 
Scheme 56 Synthesis of alkyne 5n 
 
The syntheses of alkyne 5f, 5p-r, 5y, 61 and 62 were carried out in one step from commercially 
available alkynes (Table 29).  In all cases, treatment of alkyne S28 with nBuLi as the base 
formed the anion. The anion was then trapped with an electrophile to furnish the desired 
alkyne. For the synthesis of alkyne 61, an additive was required (Table 28, entry 6). 
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Table 29 Synthesis of alkyne 
 
Entry S28 Electrophile Additive Product Yield (%) 
1 
 
MeI n/a 
 
44 
2 
 
SiMe2PhCl n/a 
 
Quant. 
3  TMSCl n/a 
 
96 
4 
 
TMSCl n/a 
 
91 
5  MeI n/a 
 
93 
6  nC8H17Br HMPA 
 
65 
7 
 
NCS n/a 
 
76 
 
The synthesis of alkyne 5w and 5z began from the corresponding commercially available 
alkyne S29 and S31 (Scheme 57).  The benzylation of alkyne S29 with benzyl bromide as the 
electrophile gave terminal alkyne S30 whereby the silyl group was cleaved. Afterwards, the 
silyl group was reintroduced by trapping the terminal alkyne anion with trimethylsilyl chloride 
to form alkyne 5w.28 On the hand, the benzylation of alkyne S31 with benzyl bromide as the 
electrophile gave terminal alkyne S32. The anion of S32 was generated by treatment with 
nBuli. Subsequent trapping of the terminal alkyne anion with methyl iodide gave alkyne 5z in 
87% yield. 
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Scheme 57 Synthesis of alkyne 5w and 5z 
 
The synthesis of ynamide 59 and 60 started with the silver-catalysed bromination of 
phenylacetylene 38 (Scheme 58). The bromide S33 was then used directly in the next step 
without purification by flask column chromatography. Then a copper-catalysed coupling was 
carried out to form the ynamide. Both ynamides were synthesised by the following the 
procedure by Liu.29 
 
 
Scheme 58 Synthesis of ynamides 59 and 60 
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 Experimental Section 2.7
 
General. Otherwise noted, all reactions were carried out in flame-dried glassware under dry 
nitrogen atmosphere. The solvents were purified with the solvent purification system Pure 
Solv MD-6 (THF, Et2O, CH2Cl2, benzene, toluene, hexane). Dry dioxane was purchased from 
Aldrich. All commercially available compounds were used as received. Flash chromatography: 
Merck silica gel 60 (230-400 mesh) with petroleum ether (PE, 40–60°C) and EtOAc or Et2O 
analytical grade. NMR: spectra were recorded on a Bruker DRX 500, Bruker DPX 400, and 
Bruker AVANCE 400 spectrometers in CDCl3; chemical shifts (δ) are given in ppm relative to 
TMS. The solvent signals were used as references and the chemical shifts converted to the 
TMS scale (CDCl3: δC = 77.0 ppm; residual CHCl3 in CDCl3: δH = 7.24 ppm). IR: PerkinElmer 
Spectrum 100 FT-IR spectrometer, wavenumbers (ṽ) in cm-1. HRMS at the University of 
Liverpool: VG7070E (CI), micromass LCT mass spectrometer (ES+). Melting points: Griffin 
melting point apparatus (not corrected). Elemental analyses: University of Liverpool. Optical 
rotations were measured on a PerkinElmer 343plus polarimeter. 
 
 Synthesis of 3-azetidinones 2.7.1
 
Compound 69 
 
A round-bottom flask was charged with 3-hydroxyazetidine hydrochloride (1000 mg, 9.13 
mmol) and suspended in MeOH (9 ml). Triethylamine (1.9 ml, 13.69 mmol) was added 
dropwise at 0°C and after the addition, the clear solution was allowed to stir at rt for 20 mins. 
Afterwards, tosyl chloride (1740 mg, 9.13 mmol) and triethylamine (1.9 ml, 13.69 mmol) were 
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added and allowed to stir at rt overnight.  Afterwards, all volatiles were removed and then 
partitioned between EtOAc and H2O. Extraction from the aqueous layer was carried out three 
times with EtOAc. The organic layer was then washed with H2O, a saturated solution of brine, 
dried over Na2SO4, filtered and concentrated. Purification by flash column chromatography 
(PE/EtOAc, 1/11/2) gave S2 (1.86g, 89%) as a white solid. Under N2, DMSO (1.5 mL, 21.2 
mmol) in CH2Cl2 (5 mL) was added to a solution of oxalyl chloride (911 μL, 10.6 mmol) in CH2Cl2 
(25 mL) at –78°C. After 10 minutes of stirring at –78°C, a solution of S2 (1.86g, 8.16 mmol) in 
CH2Cl2 (10 mL) was added. After 20 minutes of stirring at –78°C, triethylamine (5.7 mL, 40.8 
mmol) was added rapidly and the mixture was stirred at room temperature during 10 minutes. 
A saturated solution of NH4Cl was added to the reaction mixture which was then extracted 
three times with EtOAc. The organic layer was washed with H2O, a saturated solution of brine, 
dried over Na2SO4, filtered and concentrated. Purification by flash column chromatography 
(PE/EtOAc, 3/12/1) gave 69 as a white solid (1.12 g, 61%). This compound is known.30 1H 
NMR (500 MHz, CDCl3): δ = 7.78 (d, J = 8.2 Hz, 2H), 7.38 (d, J = 8.0 Hz, 2H), 4.61 (s, 4H), 2.45 (s, 
3H). 
 
Compound 72 
 
Under N2, a flame-dried Schlenk flask was charged with N-Ts-(L)-Alanine S3 (300 mg, 1.23 
mmol), dry DMF (50 μL) and dry DCM (2.4 ml). At 0 °C, (COCl)2 (0.12 ml, 1.36 mmol) was then 
added drop wise. After stirring at room temperature for 1 hour, all volatiles were removed 
under high vacuum and THF (3 ml) was then added to the pale yellow oil. Then at 0°C, 2.0 M 
TMSCHN2 in Et2O (0.74 ml, 1.48 mmol) was added. After stirring at room temperature for 2 
hours, all volatiles were then removed by evaporation and the residue was purified by flash 
column chromatography (PE/EtOAc, 4/12/1) to give S4 (195 mg, 59 %) as a pale yellow solid. 
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This compound was diluted in benzene (14 ml), and Cu(OAc)2•H2O (14mg, 0.07 mmol) was 
added under N2 to this refluxing solution. Immediate evolution of N2 was observed. 
Completion was reached within 10 minutes stirring at reflux. After evaporation, purification by 
flash column chromatography (PE/EtOAc, 4/12.5/ 1) gave 69 as a white solid (143 mg, 84 %). 
Enantiomeric excess > 99%.^ m.p. 75–77 °C [lit.: 78–79 °C];31 [α]20 D  = 76.9 (c = 1 in CHCl3) [lit.: 80 
(c = 1 in CHCl3)];
31 1H NMR (500 MHz, CDCl3): δ = 7.75 (d, J = 8.3 Hz, 2H), 7.36 (d, J = 8.2 Hz, 2H), 
4.73 (qd, J = 7.1 Hz, 1.2 Hz, 1H), 4.50– 4.41 (m, 2H), 2.43 (s, 3H), 1.42 (d, J = 7.0 Hz, 3H); 13C 
NMR (125 MHz, CDCl3): δ = 196.7, 145.0, 131.5, 130.0 (2C), 128.4 (2C), 80.9, 69.5, 21.6, 15.7; IR 
(neat): ṽ = 2978 (w), 2930 (w), 1867 (w), 1825 (s), 1597 (w), 1493 (w), 1444 (w), 1419 (w), 1338 
(s), 1323 (m), 1299 (m), 1251 (w), 1238 (w), 1182 (w), 1156 (s), 1132 (s), 1101 (s), 1085 (s), 
1051 (s), 1013 (s), 973 (s), 848 (w), 822 (m), 812 (s), 803 (m), 778 (m), 731 (s), 708 (m), 668 (s) 
cm-1; MS (CI): m/z (rel. intensity): 257 (100) [M+NH4]+, 240 (7) [M+H]
+  
^ Determined by chiral HPLC, Chiralpak AD - H Column, iPrOH:hexane = 8/92, 1 mL/min, 230 
nm on a Agilent technologies 1200 apparatus 
 
Compound 79 
 
A flask was charged with (R)-(-)-2-phenylglycine (1000 mg, 6.62 mmol) and 2M NaOH (8.25 
ml). Then TsCl (1.5g, 7.94 mmol) in Et2O (6.6 ml) was added dropwise. The suspension was 
then left to stir at rt overnight. Afterwards, conc HCl was added until a pH of 2 was reached. 
Et2O was added. The precipitate was then collected by filtration and washed with Et2O to give 
S6 as a white solid (1.1g, 54%). Under N2, a flame-dried Schlenk flask was charged with S6 (300 
mg, 0.98 mmol), dry DMF (2 drops) and dry DCM (2 ml). At 0 °C, (COCl)2 (93 μl, 1.08 mmol) was 
then added drop wise. After stirring at room temperature for 1 hour, all volatiles were 
removed under high vacuum and THF (1 ml) was then added to the pale yellow oil. Then at 
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0°C, 2.0 M TMSCHN2 in Et2O (1 ml, 2 mmol) was added. After stirring at room temperature for 
2 hours, all volatiles were then removed by evaporation and the residue was purified by flash 
column chromatography (PE/EtOAc, 4/12/1) to give S6 (177 mg, 56 %) as a pale yellow solid. 
This compound was diluted in toluene (11 ml), and Cu(OAc)2•H2O (11mg, 0.05 mmol) was 
added under N2 to this refluxing solution. Immediate evolution of N2 was observed. 
Completion was reached within 10 minutes stirring at reflux. After evaporation, purification by 
flash column chromatography (PE/EtOAc, 4/12.5/ 1) gave 79 as a white solid (77 mg, 48 %). 
This compound is known.32; 1H NMR (500 MHz, CDCl3): δ = 7.80 – 7.75 (m, 2H), 7.39 – 7.28 (m, 
7H), 5.73 (d, J = 3.9 Hz, 1H), 4.76 (d, J = 16.2 Hz, 1H), 4.61 (dd, J = 16.2, 4.0 Hz, 1H), 2.44 (s, 3H)  
 
Compound 83 
 
This compound was prepared from N-Ts-(DL)-phenylalanine S8 (500 mg, 1.57 mmol) according 
to the procedure described for the preparation of 69. This compound is known.33 White solid 
(173 mg, 35%); 1H NMR (500 MHz, CDCl3): δ = 7.73 (d, J = 8.2 Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 
7.30 – 7.25 (m, 2H), 7.23 – 7.18 (m, 3H), 4.97 – 4.92 (m, 1H), 4.39 (d, J = 16.1 Hz, 1H), 4.15 (d, J 
= 16.1, 4.0 Hz, 1H), 3.15 (dd, J = 14.6, 6.9 Hz, 1H), 3.09 (dd, J = 14.4, 4.3 Hz, 1H), 2.44 (s, 3H) 
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 Synthesis of 3-oxetanones and precursor 2.7.2
 
Compound S11 
 
Under N2, DCM (1 ml) was added to silver bis(trifluoromethanesulfonyl)imide (50 mg, 0.1 
mmol) and S9 (39 mg, 0.1 mmol).  After 1 hour of stirring at rt, the precipitate was removed by 
filtration through a celite plug. The plug was washed with DCM. Afterwards, all volatiles were 
removed to give a S11 as a white solid (71 mg, 94%). This compound has been described.34; 1H 
NMR (500 MHz, CDCl3): δ = 7.60 – 7.42 (m, 15H); 
31P NMR (202 MHz, CDCl3): δ = 30.5 
 
Compound 90 
 
Compound 90 was obtained according to a modified procedure described by Zhang.27 Under 
N2, S15 (307mg, 1.87 mmol) and then MsOH (73µl, 1.12 mmol) were added to a solution of 
S14 (150mg, 0.94 ml) in 1,2-DCE (4 ml). Then S11 (35mg, 0.05 mmol) in 1,2-DCE (4ml) was 
added. Left to stir at rt overnight. A saturated solution of NaHCO3 was added and extracted 
three times with DCM. Extracts dried over Na2SO4, filtered and concentrated. Purification by 
flash column chromatography (PE/EtOAc, 19/19/ 1) gave 90 as a colourless oil (83 mg, 51%). 
1H NMR (500 MHz, CDCl3): δ = 7.31 – 7.25 (m, 2H), 7.22 – 7.15 (m, 3H), 5.47 – 5.41 (m, 1H), 
5.29 (d, J = 14.9 Hz, 1H), 5.24 (dd, J = 15.0, 4.2 Hz, 1H), 2.84 – 2.71 (m, 2H), 2.22 – 2.05 (m, 2H). 
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 Synthesis of alkynes 2.7.3
 
Compound S26  
 
Under N2, a flame-dried RB flask was charged with DIPA (0.5 ml, 3.56 mmol) and THF (10 ml). 
At 0°C, 2.5M of nBuLi in hexanes (1.3 ml, 3.29 mmol) was added. After 10 mins at 0°C, the 
vessel was cooled to -78°C and 2M of TMSCHN2 in Et2O (1.65 ml, 3.29 mmol) was added. It was 
then allowed to stir at -78°C for 30 mins. Afterwards, biphenyl-4-carboxaldehyde (500 mg, 
2.74 mmol) in THF (5 ml) was cannulated into the flask. Afterwards, the ice-bath was removed 
and allowed to warm to rt. After 1h, the reaction was complete and a saturated solution of 
NH4Cl was added. Then Et2O was added and the organic layer was washed with water and a 
saturated solution of brine. Dried over Na2SO4, filtered and concentrated. Purification by flash 
column chromatography (PE/EtOAc, 1/060/ 1) gave S26 as a white solid (452 mg, 91%). This 
compound has been described.x 1H NMR (500 MHz, CDCl3): 7.59 – 7.52 (m, 6H), 7.46 – 7.40 (m, 
2H), 7.37 – 7.32 (m, 1H), 3.11 (s, 1H). 
 
Compound 5d 
 
At -20°C, 2.5M of nBuLi was added to a solution of S26 (200 mg, 1.12 mmol) in THF (8 ml). 
After 40 mins of stirring at -20°C, iodomethane (154 µl, 2.47 mmol) was added. The solution 
was allowed to stir overnight whilst allowing it to warm to rt. Afterwards, the reaction was 
quenched with a saturated solution of NH4Cl. Et2O was added and the organic layer was 
washed with water and a saturated solution of brine. Dried over Na2SO4, filtered and 
concentrated. Purification by flash column chromatography (PE/EtOAc, 60/ 1) gave 5d as a 
white solid (194 mg, 90%).   This is a known compound. 35; 1H NMR (500 MHz, CDCl3): δ = 7.57 
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(d, J = 7.8 Hz, 2H), 7.51 (d, J = 8.2 Hz, 2H), 7.47 – 7.40 (m, 4H), 7.36 – 7.30 (m, 1H), 2.07 (s, 3H); 
13C NMR (125 MHz, CDCl3): δ = 140.4, 140.2, 131.9, 128.8, 127.4, 127.0, 126.9, 122.9, 86.5, 
79.6, 4.4 
 
Compound 5e 
 
Under N2, a flame-dried round-bottom flask was charged sequentially with PdCl2 (91 mg, 0.5 
mmol), PPh3 (224 mg, 0.9 mmol), CuI (130 mg, 0.7 mmol) and MeCN (32 ml). The mixture was 
stirred at rt for 5 mins to give a dark brown solution. 4-Iodoanisole (4 g, 17.1 mmol), 1-hexyne 
(2.9 ml, 25.6 mmol) and  Et3N (7.2 mL, 51.3 mmol) were then added. The solution was allowed 
to stir at rt overnight. The crude mixture was then partitioned between water and Et2O at 
room temperature. The organic layer washed with a saturated aqueous solution of NH4Cl, 
dried over Na2SO4, filtered and concentrated. Purification by flash chromatography (PE) 
afforded alkyne 5e as an orange oil (3.2 g, quantitative). This is a known compound.36; 1H NMR 
(500 MHz, CDCl3): δ = 7.35 – 7.28 (m, 2H), 6.83 – 6.76 (m, 2H), 3.77 (s, 3H), 2.37 (t, J = 7.0 Hz, 
2H), 1.61 – 1.51 (m, 2H), 1.51 – 1.40 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H). 
 
Compound 5f 
 
This compound was prepared from 4-(trifluoromethoxy)phenylacetylene S7 (300 µl, 1.96 
mmol) according to the procedure described for the preparation of 5d. Colourless Oil (251 mg, 
64%).; 1H NMR (500 MHz, CDCl3): δ = 7.40 – 7.35 (m, 2H), 7.13 – 7.08 (m, 2H), 2.03 (s, 3H); 
13C 
NMR (125 MHz, CDCl3): δ = 148.3 (q, J = 1.7 Hz), 132.9, 122.8, 120.8, 120.4 (q, J = 257.6 Hz), 
86.8, 78.4, 4.3; IR (neat): ṽ = 2958 (w), 2922 (w), 2860 (w), 1604 (w), 1507 (m), 1468 (w), 1379 
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(w), 1251 (s), 1220 (s), 1201 (s), 1161 (s), 1100 (w), 1019 (w), 971 (w), 922 (w), 887 (w), 851 
(m), 831 (w), 808 (w),  734 (w), 670 (w), 662 (w) cm-1 
 
Compound 5g 
 
Under N2, a flame-dried Schlenk flask was charged with Pd(PPh3)4 (697 mg, 0.60 mmol), CuI 
(115 mg, 0.60 mmol) and parabromoacetophenone (4 g, 20.1 mmol). THF (84 ml), Et3N (32 ml) 
and 1-Hexyne (3.4 ml, 30.1 mmol) were then added in that order. After stirring at 60°C for 18 
hours, the crude mixture was partitioned between water and Et2O at room temperature. The 
organic layer washed with a saturated aqueous solution of NH4Cl, dried over Na2SO4, filtered 
and concentrated. Purification by flash chromatography (PE  PE/Et2O: 10/1) afforded alkyne 
5g as a pale yellow oil (3.68g, 89%). 1H NMR (500 MHz, CDCl3): δ = 7.82 (d, J = 8.9 Hz, 2H), 7.41 
(d, J = 7.5 Hz, 2H), 2.53 (s, 3H), 2.39 (t, J = 7.0 Hz, 2H), 1.55 (quint, 7.5 Hz, 2H), 1.49–1.39 (m, 
2H), 0.91 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 197.2, 135.5, 131.5 (2C), 129.1, 
128.0 (2C), 94.3, 80.0, 30.5, 26.4, 21.9, 19.1, 13.5; IR (neat): ṽ = 2958 (w), 2933 (w), 2873 (w), 
2229 (w), 1682 (s), 1601 (s), 1555 (w), 1466 (w), 1428 (w), 1403 (m), 1357 (m), 1329 (w), 1284 
(m), 1259 (s), 1178 (m), 1109 (w), 1075 (w), 1015 (w), 956 (m), 838 (s), 738 (w) cm-1; MS (CI): 
m/z (rel. intensity): 218 (44) [M+NH4]
+, 201 (100) [M+H]+; elemental analysis (%) calcd for 
C14H16O: C 83.96, H 8.05; found: C 82.89, H 8.26. 
 
Compound 5h 
 
Under N2, a flame-dried Schlenk flask was charged sequentially with Pd(PPh3)2Cl2 (37 mg, 0.05 
mmol), THF (4 ml), Et3N (450 μL, 3.2 mmol), CuI (14 mg, 0.07 mmol) and 4-iodoanisole (250 
mg, 1.07 mmol). After stirring for 5 minutes, cyclohexylacetylene (181 μL, 1.39 mmol) was 
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added. After stirring at room temperature for 18 hours, the crude mixture was partitioned 
between water and Et2O at room temperature. The organic layer washed with a saturated 
aqueous solution of NH4Cl, dried over Na2SO4, filtered and concentrated. Purification by flash 
chromatography (PE/Et2O: 200/1) afforded alkyne 5h as an orange oil (188 mg, 81%). This is a 
known compound.37 1H NMR (500 MHz, CDCl3): δ = 7.34 – 7.29 (m, 2H), 6.81 – 6.76 (m, 2H), 
3.77 (s, 3H), 2.59 – 2.49 (m, 1H), 1.91 – 1.81 (m, 2H), 1.79 – 1.68 (m, 2H), 1.57 – 1.45 (m, 3H), 
1.38 – 1.26 (m, 3H)  
 
Compound 5i 
 
This compound was prepared from 4-iodoanisole (250 mg, 1.07 mmol) and 4-methyl-1-
pentyne (163 μL, 1.39 mmol) according to the procedure described for the preparation of 5h. 
Orange oil (204 mg, quantitative). 1H NMR (500 MHz, CDCl3): δ = 7.32 (d, J = 8.9 Hz, 2H), 6.79 
(d, J = 9.0 Hz, 2H), 3.77 (s, 3H), 2.26 (d, J = 6.5 Hz, 2H), 1.93–1.80 (m, 1H), 1.02 (d, J = 6.7 Hz, 
6H); 13C NMR (125 MHz, CDCl3): δ = 158.9, 132.8 (2C), 116.3, 113.8 (2C), 87.7, 81.1, 55.2, 28.6, 
28.3, 22.0; IR (neat): ṽ = 2957 (m), 2932 (w), 2905 (w), 2870 (w), 2836 (w), 1607 (m), 1568 (w), 
1507 (s), 1464 (m), 1442 (m), 1385 (w), 1368 (w), 1344 (w), 1282 (m), 1245 (s), 1172 (m), 1105 
(w), 1035 (m), 830 (s), 800 (w), 665 (w) cm-1; elemental analysis (%) calcd for C13H16O: C 82.94, 
H 8.57; found: C 82.17, H 9.01. 
 
Compound 5j 
 
This compound was prepared from commercially available 4-ethynyl-α,α,α-trifluorotoluene 
(227 µl, 1.37 mmol) and 4-iodoanisole (250 mg, 1.07 mmol) according to the procedure 
described for the preparation of 5h. Yellow solid (300 mg, quant). This is a known compound. 
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38; 1H NMR (500 MHz, CDCl3): δ = 7.61 – 7.55 (m, 4H), 7.47 (d, J = 8.8 Hz, 2H), 6.88 (d, J = 8.8 Hz, 
2H), 3.82 (s, 3H). 
 
Compound 5n 
 
This compound was prepared from commercially available 4-ethynylbiphenyl (150 mg, 0.84 
mmol) and 2-bromopropene (112 μL, 1.26 mmol) according to the procedure described for the 
preparation of 5h. White Solid (160 mg, 86%). m.p. 70–72°C; 1H NMR (500 MHz, CDCl3): δ = 
7.59 (d, J = 7.4 Hz, 2H), 7.55 (d, J = 8.2 Hz, 2H), 7.51 (d, J = 8.2 Hz, 2H), 7.44 (t, J = 7.6 Hz, 2H), 
7.35 (t, J = 7.3 Hz, 1H), 5.42 (s, 1H), 5.31 (s, 1H), 2.01 (s, 3H); 13C NMR (125 MHz, CDCl3): δ = 
140.8, 140.3, 132.0 (2C), 128.8 (2C), 127.6, 127.0 (2C), 126.93 (2C), 126.86, 122.2, 122.0, 91.2, 
88.3, 23.5; IR (neat): ṽ = 3056 (w), 3033 (w), 2975 (w), 2920 (w), 2855 (w), 2199 (m), 1671 (m), 
1612 (w), 1599 (m), 1581 (w), 1521 (w), 1486 (m), 1448 (m), 1405 (w), 1373 (w), 1316 (m), 
1286 (w), 1155 (w), 1113 (m), 1076 (w), 1039 (w), 1006 (m), 976 (w), 893 (m), 840 (s), 761 (s), 
721 (m), 692 (s) cm-1; elemental analysis (%) calcd for C17H14: C 93.54, H 6.46; found: C 92.14, H 
6.68. 
 
Compound 5p 
 
This compound was prepared from Phenylacetylene 38 (300 µl, 2.7 mmol) and 
chloro(dimethyl)phenylsilane (688 µl, 4.1 mmol) according to the procedure described for the 
preparation of 5d. Colourless Oil (660 mg, quantitative).; 1H NMR (500 MHz, CDCl3): δ = 7.71 – 
7.65 (m, 2H), 7.51 – 7.47 (m, 2H), 7.40 – 7.36 (m, 3H), 7.33- 7.28 (m, 3H), 0.48 (s, 6H); 13C NMR 
(125 MHz, CDCl3): δ = 137.0, 133.7, 132.1, 129.4, 128.7, 128.2, 127.9, 122.9, 106.8, 92.0, -0.8; 
IR (neat): ṽ = 3068 (w), 3020 (w), 2960 (w), 2158 (m), 1952 (w), 1883 (w), 1817 (w), 1593 (w), 
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1574 (w), 1488 (m), 1443 (w), 1428 (m), 1407 (w), 1302 (w), 1249 (m), 1219 (w), 1189 (w), 
1157 (w), 1118 (m), 1069 (w), 1027 (w), 999 (w), 844 (s), 779 (s), 729 (s), 689 (s), 663 (m) cm-1; 
HRMS (CI): calcd for (C16H16Si + NH4)
+: 254.1360; found: 254.1358 
 
Compound 5q 
 
This compound was prepared from 1-decyne (500 µl, 2.77 mmol) and chlorotrimethylsilane 
(527 µl, 4.16 mmol) according to the procedure described for the preparation of 5d except at -
78°C. This is a known compound.39 Colourless oil (558 mg, 96%).; 1H NMR (500 MHz, CDCl3): δ 
= 2.19 (t, J = 2.19 Hz, 2H), 1.53 – 1.45 (m, 2H), 1.39 – 1.31 (m, 2H), 1.31 – 1.20 (m, 8H), 0.86 (t, 
J = 6.9 Hz, 3H), 0.12 (s, 9H) 
 
Compound 5r 
 
This compound was prepared from cyclohexylacetylene (400 µl, 3.06 mmol) and 
chlorotrimethylsilane (583 µl, 4.59 mmol) according to the procedure described for the 
preparation of 5d except at -78°C. This compound is known. 40 Colourless Oil (505 mg, 91%).; 
1H NMR (500 MHz, CDCl3): δ = 2.41 – 2.30 (m, 1H), 1.82 – 1.72 (m, 2H), 1.72 – 1.63 (m, 2H), 
1.52 – 1.35 (m, 3H), 1.33 – 1.19 (m, 3H), 0.12 (s, 9H); HRMS (CI): calcd for (C11H20Si + NH4)
+: 
198.1673; found: 198.1675 
 
Compound 5v 
 
A flamed dried schlenk was charged with 60% NaH (177mg, 4.4 mmol) and DMF (4 ml). At 0°C, 
2-butyn-1-ol (300 µl, 4 mmol) was added dropwise. It was then allowed to stir at 0°C for 30 
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mins. Then, benzyl bromide (525 µl, 4.4 mmol) was added dropwise. Allowed to stir overnight 
at rt. Quenched with solution of aqueous NH4Cl and Et2O was added. Washed three timed with 
water, a saturated solution of brine, dried over Na2SO4, filtered and concentrated.  Purification 
by flash chromatography (PE/EtOAc: 1/075/1) afforded alkyne 5v as a colourless oil (579 
mg, 90%). This a known compound.41; 1H NMR (500 MHz, CDCl3): δ = 7.38 – 7.25 (m, 5H), 4.57 
(s, 2H), 4.12 (q, J = 2.3 Hz, 2H), 1.86 (t, J = 2.2 Hz, 3H) 
 
Compound 5w 
 
A flamed dried schlenk was charged with 60% NaH (297 mg, 7.42 mmol) and DMF (6.1 ml). At 
0°C, 3-(trimethylsilyl)propargyl alcohol (1 ml, 6.77 mmol) was added dropwise. It was then 
allowed to stir at 0°C for 30 mins. Then, benzyl bromide (900 µl, 7.42 mmol) was added 
dropwise. Allowed to stir for 2 hours at rt. Quenched with solution of aqueous NH4Cl and Et2O 
was added. Washed three timed with water, a saturated solution of brine, dried over Na2SO4, 
filtered and concentrated. Purification by flash chromatography (PE/Et2O: 40/133/1) 
afforded alkyne S30 as a colourless oil (701 mg, 71%). At -78°C, 1.7M of nBuLi (2.4 ml, 4.10 
mmol) was added to a solution of S30 (500 mg, 3.42 mmol) in THF (3.4 ml). After 15 mins of 
stirring at -78°C, trimethylsilylchloride (651 µl, 5.13 mmol) was added. The solution was 
allowed to stir for 15 mins at -78°C. Then the ice-bath was removed and allowed to stir at rt 
for 30 mins. Afterwards, the reaction was quenched with a saturated solution of NH4Cl. Et2O 
was added and the organic layer was washed with water and a saturated solution of brine. 
Dried over Na2SO4, filtered and concentrated. Purification by flash column chromatography 
(PE/Et2O, 66/150/1) gave 5w as a colourless oil (653 mg, 88%).; 
1H NMR (500 MHz, CDCl3): δ 
= 7.37 – 7.25 (m, 5H), 4.58 (s, 2H), 4.15 (s,2H), 0.18 (s, 9H); 13C NMR (125 MHz, CDCl3): δ = 
137.4, 128.4, 128.2, 127.9, 101.4, 91.6, 71.5, 57.9, -0.2; IR (neat): ṽ = 3066 (w), 3031 (w), 2960 
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(w), 2898 (w), 2174 (w), 1455 (w), 1350 (w), 1250 (m), 1088 (m), 1076 (m), 1028 (w), 994 (m), 
841 (s), 760 (m), 737 (m), 697 (m) cm-1 
 
Compound 5x 
 
A flame-dried schlenk was charged with TBSCl (244mg, 1.6 mmol) and imidazole (202mg, 3.0 
mmol). Then dissolved in DMF (0.85 ml) and 3-(trimethylsilyl)propargyl alcohol (200µl, 1.3 
mmol) was added. Allowed to stir at rt overnight. Afterwards, Et2O was added. Washed three 
timed with water, a saturated solution of brine, dried over Na2SO4, filtered and concentrated.  
Purification by flash chromatography (PE/Et2O: 1/0100/1) afforded 5x as a colourless oil 
(191 mg, 58%).; 1H NMR (500 MHz, CDCl3): δ = 4.29 (s, 2H), 0.89(s, 9H), 0.14 (s, 9H), 0.10 (s, 
6H); 13C NMR (125 MHz, CDCl3): δ = 104.5, 89.6, 52.3, 25.8, 18.3, -0.3, -5.1; IR (neat): ṽ = 2957 
(w), 2929 (w), 2899 (w), 2332 (w), 2178 (w), 1472 (w), 1463 (w), 1408 (w), 1390 (w), 1362 (w), 
1251 (m), 1092 (m), 1003 (m), 939 (w), 831 (s), 776 (m), 759 (m), 722 (w), 699 (w), 668 (w) cm-
1; HRMS (CI): calcd for (C12H26OSi2 + NH4)
+: 243.1595; found: 243.1602 
 
Compound 5y 
 
This compound was prepared from 5-phenyl-1-pentyne (200 µl, 1.32 mmol) and iodomethane 
(123 µl, 1.98 mmol) according to the procedure described for the preparation of 5d except at -
78°C.  Colourless oil (195 mg, 93%).; 1H NMR (500 MHz, CDCl3): δ = 7.30 – 7.23 (m, 2H), 7.20 – 
7.14 (m, 3H), 2.69 (t, J = 7.6 Hz, 2H), 2.17 – 2.09 (m, 2H), 1.82 – 1.74 (m, 5H); 13C NMR (125 
MHz, CDCl3): δ = 141.8, 128.5, 128.3, 125.8, 78.8, 75.9, 34.8, 30.6, 18.2, 3.5; IR (neat): ṽ = 3027 
(w), 2919 (m), 2859 (m), 1604 (w), 1497 (m), 1454 (m), 1332 (w), 1080 (w), 1031 (w), 744 (m), 
699 (s) cm-1 
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Compound 5z 
 
A flamed dried schlenk was charged with 60% NaH (271 mg, 6.77 mmol) and DMF (6.5 ml). At 
0°C, 4-pentyn-1-ol (0.6 ml, 6.45 mmol) was added dropwise. It was then allowed to stir at 0°C 
for 30 mins. Then, benzyl bromide (800 µl, 6.77 mmol) was added dropwise. Allowed to stir for 
2 hours at rt. Quenched with solution of aqueous NH4Cl and Et2O was added. Washed three 
timed with water, a saturated solution of brine, dried over Na2SO4, filtered and concentrated.  
Purification by flash chromatography (PE/Et2O: 100/180/1) afforded alkyne S32 as a 
colourless oil (552 mg, 49%). At -78°C, 1.7M of nBuLi (0.8 ml, 1.38 mmol) was added to a 
solution of S32 (200 mg, 1.15 mmol) in THF (1.2 ml). After 15 mins of stirring at -78°C, 
iodomethane (107 µl, 1.72 mmol) was added. The solution was allowed to stir for 15 mins at -
78°C. Then the ice-bath was removed and allowed to stir at rt for 30 mins. Afterwards, the 
reaction was quenched with a saturated solution of NH4Cl. Et2O was added and the aqueous 
layer was extracted two times with Et2O. The organic layer was washed with water and a 
saturated solution of brine. Dried over Na2SO4, filtered and concentrated. Purification by flash 
column chromatography (PE/Et2O, 50/1) gave 5z as a colourless oil (187 mg, 87%).; 
1H NMR 
(500 MHz, CDCl3): δ = 7.36 – 7.25 (m, 5H), 4.50 (s, 2H), 3.54 (t, J = 6.2 Hz, 2H), 2.28 – 2.20 (m, 
2H), 1.81 – 1.72 (m, 5H); IR (neat): ṽ = 3064 (w), 3030 (w), 2946 (w), 2919 (w), 2856 (m), 1496 
(w), 1454 (m), 1364 (m), 1204 (w), 1102 (s), 1079 (s), 1028 (w), 909 (w), 735 (s), 697 (s) cm-1; 
HRMS (CI): calcd for (C13H16O + H)
+: 189.1274; found: 189.1274 
 
Compound 5aa 
 
This compound was prepared by Jet-Sing Lee. Under N2, a solution of biphenyl-4-methanol 
(400 mg, 2.17 mmol) in DMF (5.5 mL) was added NaH (60 wt%, 130 mg, 3.26 mmol) at 0˚C. The 
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mixture was left to stir at r.t. for 1 hour. To this mixture was then added dropwise 1-bromo-2-
butyne (300 µL, 3.26 mmol) at 0˚C. The mixture was left to stir at r.t. overnight. The golden 
coloured mixture was quenched with a saturated solution of NH4Cl at 0˚C, diluted with Et2O 
and washed with brine. The organic phase was dried over Na2SO4, filtered and concentrated in 
vacuo. The residue was purified by column chromatography (PE/EtOAc, 50:1) to yield 5aa as a 
white solid (452 mg, 89%). 1H NMR (500Mz, CDCl3): 7.64-7.59 (m, 4H), 7.50-7.44 (m, 4H), 7.40-
7.35 (m, 1H), 4.66 (s, 2H), 4.21-4.18 (d, J = 2.3 Hz, 2H), 1.92 (t, J = 2.3 Hz, 3H). 
 
Compound 43 
 
This compound was prepared from commercially available phenylacetylene (153 µl, 1.39 
mmol) and 2-iodopyridine (115 µl, 1.07 mmol) according to the procedure described for the 
preparation of 5h. White solid (100 mg, 58%). This is a known compound.42; 1H NMR (500 MHz, 
CDCl3): δ = 8.60 (d, J = 4.6Hz, 1H), 7.65 (apt dt, J = 7.7, 1.3 Hz,1H), 7.61 – 7.55 (m, 2H), 7.50 (d, J 
= 7.8 Hz, 1H), 7.37 – 7.31 (m, 3H), 7.23 – 7.18 (m, 1H) 
 
Compound 44 
 
This compound was prepared from commercially available 1-hexyne (160 µl, 1.39 mmol) and 
2-iodopyridine (115 µl, 1.07 mmol) according to the procedure described for the preparation 
of 5h. Colourless oil (142 mg, 73%).This is a known compound.43; 1H NMR (500 MHz, CDCl3): δ 
= 8.51 (d, J = 4.4 Hz, 1H), 7.57 (apt dt, J = 7.7, 1. 50 Hz, 1H), 7.34 (d, J = 7.9 Hz, 1H), 7.14 (dd, J = 
7.0, 5.4 Hz, 1H), 2.42 (t, J = 7.1 Hz, 2H), 1.59 (pent, J = 7.4 Hz, 2H), 1.47 (sext, J = 7.3 Hz, 2H), 
0.92 (t, J = 7.3 Hz, 3H) 
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Compound 56 
 
In a flame-dried schlenk, 2-butyne-1,4-diol (200 mg, 2.3 mmol), Et3N (1 ml, 6.97 mmol) and 
DCM (4.7 ml) were added. At 0°C, acetyl chloride (0.5 ml, 6.97 mmol) was added dropwise 
over 5 mins. Then allowed to stir overnight at rt. Afterwards, the reaction was quenched with 
H2O and EtOAc was added. The organic layer was washed with a saturated solution of NaHCO3, 
water and a saturated solution of brine. Dried over Na2SO4, filtered and concentrated. 
Purification by flash column chromatography (PE/Et2O, 7/1) gave 56 as a colourless oil (328 
mg, 83%). This is a known compound. 44; 1H NMR (500 MHz, CDCl3): δ = 4.68 (s, 4H), 2.07 (s, 
6H) 
 
Compound 57 
 
This compound was prepared from commercially available 2-butyne-1,4-diol (200 mg, 2.3 
mmol), benzyl bromide (608 µl, 5.1 mmol) and 60% NaH (205 mg, 5.1 mmol) according to the 
procedure described for the preparation of 5v. Colourless Oil (401 mg, 65%): 1H NMR (500 
MHz, CDCl3): δ = 7.42 – 7.28 (m, 10H), 4.62 (s, 4H), 4.25 (s, 4H); 
13C NMR (125 MHz, CDCl3): δ = 
137.3, 128.4, 128.1, 127.9, 82.5, 71.6, 57.4; IR (neat): ṽ = 3064 (w), 3031 (w), 2860 (w), 1717 
(w), 1603 (w), 1454 (m), 1349 (m), 1264 (w), 1119 (m), 1069 (s), 1026 (m), 908 (w), 739 (s), 698 
(s) cm-1; HRMS (CI): calcd for (C18H18O2 + NH4)
+: 284.1645; found: 284.1643 
 
Compound 58 
 
This compound was prepared from commercially available 2-butyne-1,4-diol (200 mg, 2.3 
mmol), TBSCl (840 mg, 5.6 mmol) and imidazole (840 mg, 10.2 mmol) in DMF (2ml) according 
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to the procedure described for the preparation of 5x. Colourless oil (768 mg, quantitative). 
This a known compound.45; 1H NMR (500 MHz, CDCl3): δ = 4.32 (s, 4H), 0.88 (s, 18H), 0.09 (s, 
12H) 
 
Compound 59 
 
Compound 59 was obtained using a procedure described by Liu and is fully described within.29a 
White solid (109 mg, 53%).; 1H NMR (500 MHz, CDCl3): δ = 7.45 – 7.39 (m, 2H), 7.31 – 7.26 (m, 
3H), 4.48 (apt t, J = 8.0 Hz, 2H), 4.00 (apt t, J = 8.0 Hz, 2H) 
 
Compound 60 
 
Compound 59 was obtained using a modified procedure described by Liu.29a This compound is 
known.46 Purple solid (356 mg, 89%).; 1H NMR (500 MHz, CDCl3): δ = 7.77 (d, J = 8.2 Hz, 2H), 
7.35 – 7.26 (m, 7H), 7.24 – 7.19 (m, 5H), 4.56 (s, 2H), 2.43 (s, 3H) 
 
Compound 61 
 
At -78°C, 1.8M nBuli (0.4 ml, 0.7 mmol) was added to a yellow solution of ethoxyacetylene 
solution (~40 wt. % in hexanes) S7 (150 µl, 0.61 mmol) in THF (0.7 ml). The solution was stirred 
for 15 mins at -78°C. Afterwards, HMPA (212 µl, 1.22 mmol) was added and the solution was 
stirred for a further ten minutes. Then, 1-bromooctane (84 µl, 0.49 mmol) was added. The 
solution was allowed to stir for 15 mins at -78°C. Then the ice-bath was removed and allowed 
to stir at rt for 90 mins. Afterwards, the reaction was quenched with a saturated solution of 
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NH4Cl. Et2O was added and extracted two times with Et2O. The organic layer was washed with 
water and a saturated solution of brine. Dried over Na2SO4, filtered and concentrated. 
Purification by flash column chromatography (PE) gave 61 as a colourless oil (55 mg, 65%).; 1H 
NMR (500 MHz, CDCl3): δ = 4.00 (q, J = 7.0 Hz, 2H), 2.08 (t, J = 6.9 Hz, 2H), 1.46 – 1.38 (m, 2H), 
1.37 – 1.16 (m, 13H), 0.89 – 0.83 (m, 3H); 13C NMR (125 MHz, CDCl3): δ = 89.3, 73.8, 37.4, 31.8, 
29.7,29.2, 29.1,28.8, 22.7, 17.2, 14.4, 14.1; IR (neat): ṽ = 2952 (w), 2926 (m), 2854 (m), 2271 
(m), 1466 (w), 1439 (w), 1379 (w), 1289 (w), 1222 (s), 1089 (w), 1010 (m), 924 (w), 864 (w), 
723 (w) cm-1 
 
Compound 62 
 
This compound was prepared from 4-ethynylanisole (300 µl, 2.3 mmol) and NCS (402mg, 3.0 
mmol) according to the procedure described for the preparation of 5d except at -78°C.  Yellow 
Oil (294 mg, 76%).; 1H NMR (500 MHz, CDCl3): δ = 7.38 – 7.33 (m, 2H), 6.84 – 6.79 (m, 2H), 3.79 
(s, 3H); 13C NMR (125 MHz, CDCl3): δ = 159.8, 133.4, 114.2, 114.0, 69.3, 66.4, 55.3; IR (neat): ṽ 
= 3005 (w), 2934 (w), 2838 (w), 2220 (w), 1606 (m), 1507 (s), 1291 (m), 1248 (s), 1172 (m), 
1034 (m), 888 (w), 830 (m) cm-1; HRMS (CI): calcd for (C9H7ClO + NH4)
+: 184.0524; found: 
184.0528 
 
Compound 63 
 
This compound was prepared from commercially available iodobenzene (120 µl, 1.07 mmol) 
and 4-bromo-1-butyne (130 µl, 1.39 mmol) according to the procedure described for the 
preparation of 5h. Colourless oil (192 mg, 86%). This is a known compound.47; 1H NMR (500 
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MHz, CDCl3): δ = 7.45 – 7.37 (m, 2H), 7.31 – 7.26 (m, 2H), 3.51 (t, J = 7.4 Hz, 2H), 2.96 (t, J = 7.3 
Hz, 2H) 
 
Compound 100 
 
This compound was prepared from commercially available 4-iodoanisole (250 mg, 1.07 mmol) 
and 4-ethynylanisole (180 µl, 1.39 mmol) according to the procedure described for the 
preparation of 5h. Yellow solid (176 mg, 70%). This is a known compound.48; 1H NMR (500 
MHz, CDCl3): δ = 7.45 – 7.40 (m, 2H), 6.87 – 6.82 (m, 2H), 3.81 (s, 3H) 
 
 Nickel(0): Synthesis of pyridinones and pyranones 2.7.4
 
Procedures 
Method I. Inside a glovebox, a Teflon-screw flame-dried Schlenk flask equipped with a small 
stirrer bar was charged with Ni(cod)2 (8 mg, 0.03 mmol) and taken out of the glovebox. Under 
N2, PPh3 (23 mg, 0.09 mmol) and dioxane (1.3 ml) were added. The suspension was stirred for 
5 minutes and then commercially available azetidinone 7 (49 mg, 0.29 mmol) was added as 
solid in one portion. After stirring for 5 more minutes, bis-phenylacetylene 5a (57 mg, 0.32 
mmol) was added and the flask was sealed and immersed into an oil bath pre-heated at 90 oC. 
After stirring for 17 hours at that temperature, the mixture was allowed to cool and filtered 
through a silica plug before evaporation. Purification by flash chromatography (PE/Et2O, 10/1 
→ 1/1) afforded 6a as white solid (91 mg, 90%). 
 
Method II. Used for alkynes which are oils or liquids, the procedure is identical to method I 
except that Ni(cod)2 and PPh3 were diluted in 1 ml dioxane and that the alkyne was added as a 
dioxane solution (0.3 ml) under N2. 
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Method III. Identical to method I except that Ni(cod)2 and PPh3 were diluted in 0.3 mL of 
dioxane before azetidinone and alkyne were added via canula as a premixed dioxane solution 
(1 mL).  
 
The NMR spectra of some compounds were recorded at the different temperatures and using 
a modified delay (d given in s) for the 13C spectra in order to obtain optimum resolution, which 
was poor at room temperature due to slow conformer equilibration. Details mentioned after 
description of the compound. 
 
Compound 6a 
 
White solid. (91 mg, 90% using method I): m.p. 127–129°C; 1H NMR (500 MHz, CDCl3): δ = 
7.21–7.13 (m, 6H), 7.12–7.06 (m, 2H), 7.00–6.94 (m, 2H), 4.61 (br s, 2H), 4.31 (s, 2H), 1.51 (s, 
9H); 13C NMR (100 MHz, CDCl3): δ = 192.3, 154.9 (br),^ 154.3, 137.0, 135.9, 133.6, 130.8 (2C), 
128.7, 128.5 (2C), 128.2 (2C), 127.7 (2C), 127.3, 81.2, 51.8 (br), 48.0 (br), 28.4 (3C); IR (neat): ṽ 
= 3057 (w), 3007 (w), 2974 (w), 2929 (w), 1682 (s), 1619 (w), 1596 (w), 1574 (w), 1492 (w), 
1479 (w), 1443 (m), 1421 (s), 1366 (m), 1326 (m), 1250 (m), 1232 (m), 1155 (s), 1194 (s), 1104 
(s), 1083 (w), 994 (w), 936 (w), 924 (w), 904 (w), 858 (m), 768 (m), 757 (s), 694 (s) cm-1; HRMS 
(ESI): calcd for (C22H23NO3 + Na): 372.1576; found: 372.1589; elemental analysis (%) calcd for 
C22H23NO3: C 75.62, H 6.63, N 4.01; found: C 75.03, H 6.50, N 3.75. 
^ Carbon appears as a very broad peak in 13C CPD NMR spectrum and is not visible in the 13C 
APT NMR spectrum. Similar observation was made on related Boc-protected compounds.49 
(13C APT NMR (d = 2) and 13C CPD NMR (d = 4): 40°C) 
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Compound 8 
 
Colourless oil isolated in 30% yield following conditions of table 1, entry 1. 1H NMR (400 MHz, 
CDCl3): δ = 7.95–7.51 (br s, 1H), 7.39 (d, J = 7.7 Hz, 2H), 7.32 (t, J = 7.5 Hz, 2H), 7.29–7.14 (m, 
6H), 4.57 (d, J = 1.6 Hz, 1H), 4.20 (d, J = 18.9 Hz, 1H), 3.95 (dd, J = 18.8 Hz, 2.1 Hz, 1H), 1.53 (s, 
9H); 13C NMR (100 MHz, CDCl3): δ = 201.7, 151.9 (br), 137.7, 135.7, 129.3 (2C), 128.6 (2C), 
127.9, 127.7 (2C), 127.0, 125.3 (2C + 1C), 116.0, 82.5, 56.0 (br), 50.2 (br), 28.3 (3C); IR (neat): ṽ 
= 3058 (w), 2978 (w), 2930 (w), 1759 (m), 1702 (s), 1599 (w), 1492 (w), 1448 (w), 1394 (w), 
1369 (m), 1316 (w), 1239 (s), 1149 (s), 1117 (m), 1072 (w), 1026 (w), 852 (w), 764 (m), 698 (s) 
cm-1; HRMS (ESI): calcd for (C22H23NO3 + Na): 372.1576; found: 372.1581. 
(13C APT NMR (d = 2): 50°C, 13C CPD NMR (d = 4): 50°C) 
 
Compound 6b 
 
Colourless oil (65 mg, 88% using method I); 1H NMR (500 MHz, CDCl3): δ = 4.09 (br s, 2H), 4.00 
(s, 2H), 2.22 (dt, J = 7.2 Hz, 4H), 1.52 (sext, J = 7.6 Hz, 2H), 1.43 (s, 9H), 1.32 (sext, J = 7.6Hz, 
2H), 0.95 (t, J = 7.3 Hz, 3H), 0.88 (t, J = 7.3Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 193.1, 154.2, 
155.8,^ 134.3, 80.6, 51.4, 46.1, 34.2, 28.3, 26.6, 22.4, 21.4, 14.1, 14.1; IR (neat): ṽ = 2962 (m), 
2032 (w), 2873 (w), 1700 (s), 1672 (s), 1633 (m), 1417 (m), 1366 (s), 1281 (m), 1240 (m), 1164 
(s), 1130 (s), 1095 (m), 1032 (w), 978 (w), 904 (m), 861 (w), 766 (m), 737 (w) cm-1; MS (ESI): 
calcd for (C16H27NO3 + Na): 304.1889; found: 304.1895; elemental analysis (%) calcd for 
C16H27NO3: C 68.29, H 9.67, N 4.98; found: C 66.50, H 9.53, N 4.98. 
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^ Carbon is not visible in the 13C APT NMR spectrum but its chemical shift could be determined 
by HMBC correlation 
 
Compound 6c 
 
Colourless oil (64 mg, 80% from 48 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 
7.46–7.33 (m, 3H), 7.29–7.22 (m, 2H), 4.39 (br s, 2H), 4.17 (s, 2H), 1.75 (s, 3H), 1.46 (s, 9H); 13C 
NMR (100 MHz, CDCl3): δ = 193.9, 154.1, 153.6 (br),^ 137.3, 130.6, 128.8, 128.6 (2C), 127.6 
(2C), 80.8, 51.2 (br), 47.8 (br), 28.3 (3C), 11.9; IR (neat): ṽ = 3053 (w), 2977 (w), 2929 (w), 1694 
(s), 1675 (s), 1632 (w), 1575 (w), 1476 (w), 1416 (m), 1383 (m), 1381 (m), 1364 (s), 1326 (m), 
1281 (m), 1244 (s), 1230 (s), 1163 (s), 1116 (s), 1068 (w), 1032 (w), 1003 (w), 994 (w), 896 (w), 
861 (w), 763 (m), 701 (s) cm-1; HRMS (ESI): calcd for (C17H21NO3 + Na): 310.1419; found: 
310.1432; elemental analysis (%) calcd for C17H21NO3: C 71.06, H 7.37, N 4.87; found: C 70.74, 
H 7.51, N 4.92. 
^ Carbon appears as a very broad peak in 13C CPD NMR spectrum and is not visible in the 13C 
APT NMR spectrum.  
(13C APT NMR (d = 2): 40°C) 
 
Compound 11c 
 
White solid (10 mg, 12% from 48 mg of 7 using method II): m.p.: 104–106°C; 1H NMR (500 
MHz, CDCl3): δ = 7.37 (t, J = 7.3 Hz, 2H), 7.33–7.28 (m, 1H), 7.07 (d, J = 7.4 Hz, 2H), 4.28 (br s, 
2H), 4.20 (s, 2H), 1.84 (s, 3H), 1.48 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 191.6, {154.6},^ 
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154.2, 136.3, 133.8, 129.9 (2C), 128.2 (2C), 127.7, 81.0, 51.4 (br), 47.7 (br), 28.4 (3C), 19.5; IR 
(neat): ṽ = 2977 (w), 2931 (w), 1695 (s), 1677 (s), 1636 (w), 1600 (w), 1495 (w), 1479 (w), 1417 
(m), 1393 (w), 1365 (m), 1323 (w), 1285 (w), 1243 (s), 1217 (w), 1157 (s), 1107 (m), 1075 (w), 
1047 (w), 977 (w), 946 (w), 895 (m), 857 (w), 763 (m), 701 (w); HRMS (ESI): calcd for 
(C17H21NO3 + Na): 310.1419; found: 310.1422. 
(13C APT NMR (d = 2): 45°C) 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets. 
 
Compound 6c 
 
White foam (86 mg, 83% from 49 mg of 7 using method I): 1H NMR (500 MHz, CDCl3): δ = 7.64 
(d, J = 8.2 Hz, 2H), 7.62–7.57 (m, 2H), 7.47–7.41 (m, 2H), 7.38–7.32 (m, 3H), 4.43 (br s, 2H), 
4.19 (s, 2H), 1.82 (t, J = 1.8 Hz, 3H), 1.49 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 193.9, 154.2, 
{153.8},^ 141.9, 140.2, 136.1, 130.8, 128.9 (2C), 128.2 (2C), 127.8, 127.3 (2C), 127.1 (2C), 80.9, 
51.4, 47.8, 28.4 (3C), 12.1; IR (neat): ṽ = 2975 (w), 2926 (w), 1698 (s), 1676 (s), 1629 (w), 1488 
(w), 1419 (m), 1401 (m), 1380 (m), 1364 (m), 1283 (w), 1240 (m), 1232 (m), 1165 (s), 1119 (m), 
1071 (w), 1007 (w), 898 (w), 861 (w), 841 (w), 766 (m), 735 (w), 698 (w) cm-1; MS (ESI): calcd 
for (C23H25NO3 + Na): 386.1732; found: 386.1745; elemental analysis (%) calcd for C23H25NO3: C 
76.01, H 6.93, N 3.85; found: C 75.08, H 7.04, N 3.71. 
(13C APT NMR (d = 2): 40°C) 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets. 
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Compound 11d 
 
 
Colourless oil (8 mg, 8% from 49 mg of 7 using method I): 1H NMR (500 MHz, CDCl3): δ = 7.63–
7.56 (m, 4H), 7.45–7.39 (m, 2H), 7.36–7.29 (m, 1H), 7.15 (d, J = 8.1 Hz, 2H), 4.30 (br s, 2H), 4.20 
(s, 2H), 1.90 (s, 3H), 1.50 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 191.6, {155.2},^ 154.1, 140.9, 
140.6, 136.0, 132.7, 130.3 (2C), 128.7 (2C), 127.3, 127.1 (2C), 126.9 (2C), 81.0, 51.5, 47.7, 28.4 
(2C), 19.6; IR (neat): ṽ = 3029 (w), 2977 (w), 2933 (w), 1696 (s), 1678 (s), 1636 (w), 1601 (w), 
1487 (w), 1417 (w), 1366 (m), 1325 (w), 1284 (w), 1243 (m), 1220 (w), 1157 (s), 1108 (w), 1040 
(w), 1008 (w), 977 (w), 938 (w), 895 (w), 837 (w), 766 (m), 732 (m), 698 (m) cm-1; HRMS (ESI): 
calcd for (C23H25NO3 + Na): 386.1732; found: 386.1733.  
(13C APT NMR (d = 2): 40°C) 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets. 
 
Compound 6e 
 
 
Yellow oil (80 mg, 79% from 48 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 7.18 
(d, J = 8.4 Hz, 2H), 6.92 (d, J = 8.6 Hz, 2H), 4.32 (br s, 2H), 4.12 (s, 2H), 3.82 (s, 3H), 2.24–2.14 
(m, 2H), 1.46 (s, 9H), 1.30–1.20 (m, 2H), 1.14 (sext, J = 7.3 Hz, 2H), 0.74 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 193.7, 160.0, 154.3, 153.7 (br),^ 135.2, 129.7, 128.8 (2C), 114.1 
(2C), 80.8, 55.3, 51.7 (br), 48.3 (br), 31.4, 28.3 (2C), 25.6, 22.6, 13.6; IR (neat): ṽ = 2960 (w), 
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2931 (w), 2861 (w), 1699 (m), 1675 (s), 1607 (m), 1510 (m), 1412 (m), 1366 (m), 1287 (w), 
1246 (s), 1163 (s), 1124 (s), 1040 (m), 1028 (m), 945 (w), 900 (w), 861 (w), 732 (s), 767 (m), 731 
(m) cm-1; HRMS (ESI): calcd for (C21H29NO4 + Na): 382.1994; found: 382.1985; elemental 
analysis (%) calcd for C21H29NO4: C 70.17, H 8.13, N 3.90; found: C 69.19, H 8.41, N 3.64. 
(13C APT NMR (d = 2): 40°C and 13C CPD NMR (d = 4): 45°C) 
^ Carbon marked with an asterisk appears as a very broad peak in 13C CPD NMR spectrum and 
is not visible in the 13C APT NMR spectrum. However, HMBC correlations are visible which 
confirms the 13C CPD NMR. 
 
Compound 11e 
 
Colourless oil (10 mg, 10% from 48 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 
6.97 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 4.28 (br s, 2H), 4.17 (s, 2H), 3.80 (s, 3H), 2.19–
2.11 (m, 2H), 1.48 (s, 9H), 1.46–1.36 (m, 2H), 1.25–1.14 (m, 2H), 0.79 (t, J = 7.3 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 192.5, 159.1, 158.1 (br),^ 154.3, 135.9, 131.0 (2C), 126.0, 113.8 
(2C), 80.9, 55.2, 51.7 (br), 46.1 (br), 33.0, 30.2, 28.4 (3C), 22.7, 13.6; IR (neat): ṽ = 2959 (w), 
2930 (w), 2862 (m), 1698 (m), 1676 (s), 1606 (m), 1510 (m), 1416 (m), 1366 (m), 1329 (w), 
1287 (m), 1243 (s), 1154 (s), 1107 (m), 1033 (m), 989 (w), 927 (w), 896 (w), 858 (w), 828 (m), 
798 (w), 766 (w) cm-1; HRMS (ESI): calcd for (C21H29NO4 + Na): 382.1994; found: 382.1996. 
 (13C APT NMR (d = 2) and 13C CPD NMR (d = 4): 45°C) 
^ Carbon marked with an asterisk appears as a very broad peak in 13C CPD NMR spectrum and 
is not visible in the 13C APT NMR spectrum. However, HMBC correlations are visible which 
confirms the 13C CPD NMR. 
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Compound 6f 
 
Colourless oil (72 mg, 69% from 48 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 
7.33 – 7.24 (m, 4H), 4.35 (br s, 2H), 4.16 (s, 2H), 1.77 – 1.71 (m, 3H), 1.46 (s, 9H); 13C NMR (100 
MHz, CDCl3): δ = 193.6, 154.1, 152.0,^ 149.5 (m), 135.9, 131.3, 129.3, 120.5 (q, 257.9 Hz), 
121.0, 81.1, 51.4, 47.8, 28.3, 12.0; IR (neat): ṽ = 2984 (w), 2922 (w), 1692 (m), 1677 (m), 1625 
(w), 1507 (w), 1420 (w), 1363 (w), 1244 (s), 1209 (s), 1152 (s), 1114 (s), 1016 (w), 1001 (w), 897 
(w), 834 (m), 762 (w), 685 (w)  cm-1; HRMS (ESI): calcd for (C18H20NO4F3 + Na): 394.1242; found: 
394.1258 
(13C APT NMR (d = 2) and 13C CPD NMR (d = 4): 45°C) 
^ Carbon marked with an asterisk appears as a very broad peak in 13C CPD NMR spectrum and 
is not visible in the 13C APT NMR spectrum. However, HMBC correlations are visible which 
confirms the 13C CPD NMR. 
 
Compound 6g 
 
Yellow oil (91 mg, 88% from 48 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 7.98 
(d, J = 7.4 Hz, 2H), 7.32 (d, J = 7.4 Hz, 2H), 4.32 (br s, 2H), 4.14 (s, 2H), 2.60 (s, 3H), 2.20–2.05 
(m, 2H), 1.44 (s, 9H), 1.28–1.18 (m, 2H), 1.15–1.03 (m, 2H), 0.70 (t, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ = 197.1, 193.2, 154.2, {152.8},^ 146.6, 142.1, 137.2, 135.9, 128.6 (2C), 
127.6 (2C), 82.1, 51.6 (br), 48.0 (br), 31.3, 28.3 (2C), 26.4, 25.6, 22.5, 13.6; IR (neat): ṽ = 2960 
(w), 2931 (w), 2872 (w), 1680 (s), 1604 (m), 1560 (w), 1401 (m), 1365 (s), 1264 (s), 1162 (s), 
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1128 (s), 1076 (w), 1037 (w), 1015 (w), 958 (m), 910 (w), 835 (m), 769 (w), 732 (m) cm-1; HRMS 
(ESI): calcd for (C22H29NO4 + Na): 394.1994; found: 394.2001. 
(13C APT NMR (d = 2): 40°C) 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets 
 
Compound 11g 
 
Colourless oil (12 mg, 11% from 48 mg of 7 using method II): 1H NMR (400 MHz, CDCl3): δ = 
7.95 (d, J = 8.1 Hz, 2H), 7.16 (d, J = 8.2 Hz, 2H), 4.31 (br s, 2H), 4.18 (s, 2H), 2.59 (s, 3H), 2.19–
2.09 (m, 2H), 1.49 (s, 9H), 1.47–1.36 (m, 2H), 1.26–1.14 (m, 2H), 0.78 (t, J = 7.4 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 197.6, 191.8, {158.8},^ 154.2, 139.2, 136.6, 135.6, 130.2 (2C), 128.2 
(2C), 81.2, 51.7 (br), 46.1 (br), 33.0, 30.2, 28.4 (3C), 26.5, 22.7, 13.6; IR (neat): ṽ = 2961 (w), 
2932 (w), 2872 (w), 1683 (s), 1628 (w), 1604 (w), 1430 (w), 1403 (w), 1366 (w), 1324 (w), 1265 
(w), 1244 (w), 1159 (m), 1110 (w), 958 (w), 897 (w), 830 (w) cm-1; MS (ESI): calcd for 
(C22H29NO4 + Na): 394.1994; found: 394.2000. 
(1H NMR: 45°C, 13C APT NMR (d = 2): 45°C) 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets 
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Compound 6h 
 
Colorless oil (88 mg, 76% from 51 mg of 7 using method III); 1H NMR (500 MHz, CDCl3): δ = 
7.20–7.11 (m, 2H), 6.92 (d, J = 8.0 Hz, 2H), 4.27 (br s, 2H), 4.05 (s, 2H), 3.83 (s, 3H), 2.25 (t, J = 
11.3 Hz, 1H), 1.90 (qd, J = 12.6 Hz, 2.8 Hz, 2H), 1.63 (d, J = 12.7 Hz, 2H), 1.55–1.48 (m, 1H), 1.46 
(s, 9H), 1.38 (d, J = 12.4 Hz, 2H), 1.26–1.11 (m, 2H), 1.06–0.93 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ = 193.8, 160.0, 154.3, 154.0 (br), 138.7, 130.1, 128.8 (2C), 114.1 (2C), 80.7, 55.3, 52.5 
(br), 48.9 (br), 40.1, 30.6, 28.4 (3C), 26.9, 25.8; IR (neat): ṽ = 2972 (w), 2926 (m), 2852 (w), 
1698 (s), 1674 (s), 1608 (m), 1572 (w), 1509 (m), 1442 (w), 1413 (w), 1393 (w), 1366 (s), 1328 
(w), 1307 (m), 1287 (m), 1244 (s), 1166 (s), 1129 (s), 1088 (w), 1031 (w), 996 (w), 926 (w), 890 
(w), 870 (w), 832 (m), 791 (w), 772 (m), 741 (w) cm-1; HRMS (ESI): calcd for (C23H31NO4 + Na): 
408.2151; found: 408.2145; elemental analysis (%) calcd for C23H31NO4: C 71.66, H 8.11, N 
3.63; found: C 70.08, H 8.18, N 3.39. 
(13C APT NMR (d = 2) and 13C CPD NMR (d = 4): 45°C) 
^ Carbon appears as a very broad peak in 13C CPD NMR spectrum and is not visible in the 13C 
APT NMR spectrum.  
 
Compound 11h 
 
Colourless oil (14 mg, 12% from 51 mg of 7 using method III); 1H NMR (500 MHz, CDCl3): δ = 
6.95 (d, J = 8.8 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 4.28 (br s, 2H), 4.14 (s, 2H), 3.81 (s, 3H), 2.40 (tt, 
J = 12.1 Hz, 3.1 Hz, 1H), 1.77–1.67 (m, 2H), 1.66–1.55 (m, 3H), 1.49 (s, 9H), 1.46–1.32 (m, 3H), 
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1.18–0.99 (m, 3H); 13C NMR (100 MHz, CDCl3): δ = 193.0, 162.1 (br),^ 159.1, 154.3, 134.9, 
130.7 (2C), 126.2, 113.8 (2C), 80.9, 55.2, 52.0 (br), 43.1 (br), 42.4, 30.7, 28.4 (3C), 25.9, 25.7; IR 
(neat): ṽ = 2967 (w), 2929 (m), 2854 (w), 1698 (s), 1678 (s), 1605 (m), 1510 (s), 1445 (m), 1422 
(m), 1393 (w), 1366 (m), 1324 (w), 1286 (m), 1243 (s), 1158 (s), 1107 (w), 1034 (w), 1002 (w), 
903 (w), 858 (w), 828 (m), 801 (w), 766 (w), 731 (w) cm-1; HRMS (ESI): calcd for (C23H31NO4 + 
Na): 408.2151; found: 408.2157. 
(13C APT NMR (d = 2) and 13C CPD NMR (d = 4): 45°C) 
^ Carbon appears as a very broad peak in 13C CPD NMR spectrum and is not visible in the 13C 
APT NMR spectrum.  
 
Compound 6i 
 
Colourless oil (76 mg, 76% from 47 mg of 7 using method III): 1H NMR (500 MHz, CDCl3): δ = 
7.19–7.13 (m, 2H), 6.91 (d, J = 8.6 Hz, 2H), 4.32 (br s, 2H), 4.13 (s, 2H), 3.82 (s, 3H), 2.17 (d, J = 
7.4 Hz, 2H), 1.65– 1.56 (m, 1H), 1.47 (s, 9H), 0.64 (d, J = 6.7, 6H); 13C NMR (100 MHz, CDCl3): δ = 
194.0, 159.9, {155.8},^ 154.4, 134.4, 129.7, 129.1 (2C), 114.1 (2C), 80.8, 55.2, 51.8 (br), 48.8 
(br), 34.1, 28.3 (3C), 27.6, 22.2; IR (neat): ṽ = 2957 (m), 2932 (w), 2869 (w), 1698 (s), 1674 (s), 
1608 (m), 1573 (w), 1510 (m), 1464 (m), 1440 (m), 1412 (m), 1394 (m), 1365 (s), 1323 (m), 
1306 (w), 1282 (m), 1242 (s), 1162 (s), 1124 (s), 1070 (m), 1042 (m), 1027 (m), 981 (w), 917 
(w), 880 (m), 858 (w), 832 (s), 769 (m), 733 (w) cm-1; HRMS (ESI): calcd for (C21H29NO4 + Na): 
382.1994; found: 382.2002; elemental analysis (%) calcd for C23H29NO4: C 70.17, H 8.13, N 
3.90; found: C 69.56, H 8.22, N 3.84. 
(13C APT NMR (d = 2): 45°C); 
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^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets 
 
Compound 11i 
 
Colourless oil (15 mg, 15% from 47 mg of 7 using method III): 1H NMR (500 MHz, CDCl3): δ = 
6.95 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 4.25 (br s, 2H), 4.17 (s, 2H), 3.80 (s, 3H), 2.10 (d, 
J = 7.4 Hz, 2H), 1.87–1.75 (m, 1H), 1.47 (s, 9H), 0.78 (d, J = 6.1 Hz, 6H); 13C NMR (100 MHz, 
CDCl3): δ = 192.6, 159.1, {157.7},^ 154.2, 136.8, 131.2 (2C), 126.1, 113.8 (2C), 81.0, 55.2, 51.8 
(br), 46.4 (br), 42.2, 28.4 (3C), 27.2, 22.5; IR (neat): ṽ = 2958 (m), 2932 (w), 2870 (w), 2837 (w), 
1697 (s), 1677 (s), 1606 (m), 1577 (w), 1510 (s), 1420 (m), 1393 (m), 1366 (s), 1322 (w), 1287 
(m), 1241 (s), 1154 (s), 1106 (m), 1034 (m), 990 (w), 926 (w), 900 (w), 856 (w), 828 (m), 810 
(w), 797 (w), 766 (w), 730 (w), 675 (w) cm-1; HRMS (ESI): calcd for (C21H29NO4 + Na): 382.1994; 
found: 382.2000. 
(13C APT NMR (d = 4): 45°C); 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets 
 
Compound 6j and 11j 
 
After purification by flash chromatography, a 55:45 mixture of regioisomers was obtained as 
white solid (102 mg, 82% from 47 mg of 7 using method I). However, solubilisation of this 
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material in 1 mL CH2Cl2 and adding a layer of PE (3 mL) induced precipitation of a solid which 
was filtered and washed with PE and dried. This solid was an enriched mixture (6j/11j = 6:1) 
and evaporation of the filtrate gave a mixture enriched in the other regioisomer (6j/11j = 1:4). 
This facilitated the interpretation of the NMR spectra. 1H NMR (400 MHz, CDCl3): (6j) δ = 7.44 
(d, J = 8.0 Hz, 2H), 7.13 (d, J = 8.0 Hz, 2H), 7.01 (d, J = 8.0 Hz, 2H), 6.71 (d, J = 8.0 Hz, 2H), 4.62 
(br s, 2H), 4.29 (s, 2H), 3.74 (s, 3H), 1.51 (s, 9H); (11j) δ = 7.46 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 8.0 
Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 6.71 (d, J = 8.4 Hz, 2H), 4.58 (br s, 2H), 4.30 (s, 2H), 3.73 (s, 3H), 
1.51 (s, 9H); 13C NMR (100 MHz, CDCl3): (6j) δ = 191.9, 159.2, {156.4},^ 154.2, 138.1, 134.0, 
131.4 (2C), 130.3 (2C), 129.3 (q, J = 32.7 Hz), 124.7 (q, J = 3.7 Hz, 2C), 124.2 (q, J = 272.2 Hz), 
114.0 (2C), 81.3, 55.2, 51.9, 47.8, 28.4 (3C); (11j) δ = 192.4, 160.5, 154.2, {153.1},^ 141.0, 
136.3, 132.0 (2C), 130.6, (q, J = 32.7 Hz), 128.9 (2C), 125.3 (q, J = 3.7 Hz, 2C), 123.7 (q, J = 272.3 
Hz), 113.6 (2C), 81.4, 55.1, 51.9, 47.8, 28.4 (3C); IR (neat): ṽ = 2978 (w), 2935 (w), 2840 (w), 
1677 (s), 1605 (m), 1571 (w), 1509 (m), 1408 (m), 1366 (m), 1322 (s), 1293 (m), 1247 (s), 1156 
(s), 1122 (s), 1109 (s), 1066 (s), 1029 (m), 1019 (m), 991 (w), 909 (m), 868 (w), 828 (s), 766 (w), 
729 (s), 692 (w) cm-1; HRMS (ESI): calcd for (C24H24NO4F3 + Na): 470.1555; found: 470.1574. 
(1H NMR: 45°C, 13C APT NMR (d = 2): 45°C); 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets 
 
Compound 6k and 11k 
 
Colourless oil (67 mg, 90% from 50 mg of 1 using method II), mixture of regioisomers (6k/11k 
= 60:40): 1H NMR (500 MHz, CDCl3): (6k) δ = 4.09 (br s, 2H), 3.98 (s, 2H), 2.95 (sept, J = 7.0 Hz, 
1H), 1.76 (t, J = 1.7 Hz, 3H), 1.41 (s, 9H), 1.08 (d, J = 7.0 Hz, 6H); (11k) δ = 4.01 (br s, 2H), 3.91 
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(s, 2H), 2.90 (sept, J = 7.1 Hz, 1H), 1.90 (s, 3H), 1.41 (s, 9H), 1.13 (d, J = 7.3 Hz, 6H); 13C NMR 
(100 MHz, CDCl3): (6k) δ = 193.7, 160.9 (br),^ 154.2, 128.4, 80.6, 51.3 (br), 42.0 (br), 30.6, 28.3 
(3C), 19.7 (2C), 9.4; (11k) δ = 192.5, 154.0, 151.7 (br),^ 138.8, 80.6, 51.8 (br), 48.0 (br), 28.3 
(3C), 27.0, 20.2 (2C), 17.8; IR (neat): ṽ = 2971 (m), 2932 (w), 2874 (w), 1697 (s), 1671 (s), 1628 
(m), 1419 (m), 1392 (m), 1382 (m), 1364 (s), 1318 (m), 1281 (m), 1242 (s), 1205 (w), 1159 (s), 
1125 (s), 1061 (w), 970 (w), 926 (w), 899 (m), 859 (w), 766 (m), 684 (w) cm-1; HRMS (ESI): calcd 
for (C14H23NO3 + Na): 276.1576; found: 276.1575. 
(1H NMR: 47°C; 13C APT NMR (d = 2) and 13C CPD NMR (d = 4): 45°C); 
^ Carbon marked with an asterisk appears as a very broad peak in 13C CPD NMR spectrum and 
is not visible in the 13C APT NMR spectrum. However, HMBC correlations are visible which 
confirms the 13C CPD NMR. 
 
Compound 6l  
 
 
Colourless oil (64 mg, 87% from 47 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 
4.20 (br s, 2H), 4.00 (s, 2H), 1.95 (t, J = 1.7 Hz, 3H), 1.44 (s, 9H), 1.26 (s, 9H); 13C NMR (100 
MHz, CDCl3): δ = 194.9, {162.4},^ 154.2, 130.4, 80.7, 50.9 (br), 44.9 (br), 36.9, 29.1 (3C), 28.3 
(3C), 13.2; IR (neat): ṽ = 2974 (w), 1698 (s), 1676 (s), 1606 (w), 1477 (w), 1421 (m), 1367 (m), 
1288 (w), 1249 (m), 1234 (w), 1167 (s), 1124 (m), 1072 (w), 1039 (w), 1020 (w), 972 (w), 901 
(w), 858 (w), 766 (w) cm-1; HRMS (ESI): calcd for (C15H25NO3 + Na): 290.1732; found: 290.1740; 
elemental analysis (%) calcd for C15H25NO3: C 67.38, H 9.42, N 5.24; found: C 66.86, H 9.70, N 
4.78. 
(13C APT NMR (d = 10): 32°C) 
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^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets. 
 
Compound 6m  
 
Colourless oil (56 mg, 77% from 47 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 
5.10 (s, 1H), 4.84 (br s, 1H), 4.12 (s, 2H), 4.02 (s, 2H), 2.26 (q, J = 7.4 Hz, 2H), 1.91 (s, 3H), 1.44 
(s, 9H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 193.4, 156.5 (br),^ 154.2, 141.4, 
134.7, 115.2, 80.8, 51.5 (br), 46.1 (br), 28.3 (3C), 21.8, 19.4, 14.2; IR (neat): ṽ = 2976 (w), 2935 
(w), 2876 (w), 1699 (s), 1679 (s), 1620 (w), 1477 (w), 1416 (m), 1394 (m), 1366 (s), 1336 (w), 
1276 (w), 1237 (s), 1166 (s), 1132 (s), 1085 (w), 1056 (w), 1011 (w), 981 (w), 905 (m), 865 (w), 
768 (w) cm-1; HRMS (ESI): calcd for (C15H23NO3 + Na): 288.1576; found: 288.1582; elemental 
analysis (%) calcd for C15H23NO3: C 67.90, H 8.74, N 5.28; found: C 67.66, H 8.83, N 5.27. 
(1H NMR: 45°C, 13C APT NMR (d = 2): 45°C) 
^ Carbon marked with an asterisk appears as a very broad peak in 13C CPD NMR spectrum and 
is not visible in the 13C APT NMR spectrum. However, HMBC correlations are visible which 
confirms the 13C CPD NMR. 
 
Compound 11m 
 
Colourless oil (8 mg, 11% from 50 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 5.19 
(s, 1H), 4.72 (s, 1H), 4.18 (br s, 2H), 4.05 (s, 2H), 2.31 (q, J = 7.6 Hz, 2H), 1.84 (s, 3H), 1.47 (s, 
9H), 1.12 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 192.1, {157.9},^ 154.2, 139.4, 137.5, 
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116.6, 80.9, 51.5 (br), 45.3 (br), 28.4 (3C), 26.1, 23.3, 13.0; IR (neat): ṽ = 2976 (w), 1699 (s), 
1678 (s), 1622 (w), 1419 (m), 1367 (m), 1326 (w), 1244 (m), 1163 (s), 1115 (w), 1018 (w), 888 
(w), 768 (w) cm-1; HRMS (ESI): calcd for (C15H23NO3 + Na): 288.1576; found: 288.1584. 
(1H NMR: 45°C, 13C APT NMR (d = 2): 45°C) 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets. 
 
Compound 6n and 11n 
 
Yellow oil (69 mg, 86% from 35 mg of 7 using method II), inseparable mixture of regioisomers 
(6n/11n = 60:40): 1H NMR (500 MHz, CDCl3): δ = 7.62 – 7.56 (m, 6H), 7.54 (d, J = 8.2 Hz, 2H), 
7.46 – 7.28 (m, 8H), 7.23 (m, 1.5H), 5.12 – 5.07 (m, 1.7H), 5.05 (s, 0.7H), 4.71 (s, 1H), 4.49 (br s, 
2H), 4.40 (br s, 1.3H), 4.23 (s, 1.3H), 4.20 (s, 2H), 1.77 (s, 3H), 1.62 (s, 2H), 1.53–1.48 (m, 17H); 
13C NMR (100 MHz, CDCl3):~ δ = 192.4, 192.2, 157.0 (br),^
 154.2, 153.2 (br),^ 141.8, 141.7, 
140.8, 140.6, 140.1, 138.4, 138.0, 136.3, 134.2, 133.0, 130.4, 128.8, 128.7, 128.0, 127.7, 127.3, 
127.04, 127.01, 126.97, 126.5, 119.2, 118.6, 81.1, 51.7 (br) , 47.7 (br), 47.0 (br), 28.4 (3C), 23.3, 
21.8; IR (neat): ṽ = 3031 (w), 2977 (w), 2932 (w), 2251 (w), 1677 (s), 1601 (w), 1553 (w), 1519 
(w), 1487 (w), 1393 (m), 1365 (s), 1323 (m), 1283 (w), 1240 (m), 1156 (s), 1113 (m), 1072 (w), 
1029 (w), 1008 (w), 996 (w), 908 (m), 866 (w), 836 (m), 765 (s), 729 (s), 696 (s) cm-1; HRMS 
(ESI): calcd for (C25H27NO3 + Na): 412.1889; found: 412.1880. 
(1H NMR: 47°C; 13C APT NMR (d = 2) and 13C CPD NMR (d = 4): 45°C) 
~Peaks common to 6n and 11n are underlined, peaks attributed to 11n are indicated in italic. 
^ Carbon appears as a very broad peak in 13C CPD NMR spectrum and is not visible in the 13C 
APT NMR spectrum. 
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Compound 6o 
 
Colourless oil (183 mg, 91% from 100 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 
7.42–7.34 (m, 3H), 7.27–7.20 (m, 2H), 4.29 (br s, 2H), 4.07 (s, 2H), 1.48 (s, 9H), -0.15 (s, 9H); 13C 
NMR (100 MHz, CDCl3): δ = 197.7, 168.0 (br),^ 154.2, 139.3, 137.5, 129.3, 128.4 (2C), 127.8 
(2C), 80.8, 51.3 (br), 49.3 (br), 28.3 (3C), 0.3; IR (neat): ṽ = 3053 (w), 2977 (w), 2897 (w), 1697 
(s), 1665 (s), 1604 (w), 1582 (m), 1477 (w), 1408 (m), 1365 (m), 1242 (s), 1223 (m), 1160 (s), 
1077 (w), 1024 (w), 999 (w), 940 (w), 927 (w), 905 (m), 842 (s), 759 (s), 700 (s) cm-1; MS (ESI): 
calcd for (C19H27NO3Si + Na): 368.1658; found: 368.1662; elemental analysis (%) calcd for 
C19H27NO3Si: C 66.05, H 7.88, N 4.05; found: C 65.82, H 7.96, N 3.86. 
(13C APT NMR (d = 2): 40°C); 
^ Carbon marked with an asterisk appears as a very broad peak in 13C CPD NMR spectrum and 
is not visible in the 13C APT NMR spectrum. However, HMBC correlations are visible which 
confirms the 13C CPD NMR. 
 
Compound 11o 
 
Colourless oil (5 mg, 3% using method I). 1H NMR (500 MHz, CDCl3): δ = 7.35–7.31 (m, 3H), 
7.08–7.04 (m, 2H), 4.35 (br s, 2H), 4.19 (s, 2H), 1.48 (s, 9H), -0.12 (s, 9H); IR (neat): ṽ = 2976 
(w), 1686 (s), 1477 (w), 1412 (m), 1366 (m), 1307 (w), 1250 (m), 1160 (s), 1109 (w), 1062 (w), 
927 (w), 841 (m), 759 (m), 701 (m) cm-1; MS (ESI): calcd for (C19H27NO3Si + Na): 368.1658; 
found: 368.1660 
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Compound 6p 
 
Colourless oil (108 mg, 91% from 48 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 
7.50 – 7.43 (m, 2H), 7.38 – 7.31 (m, 1H), 7.31 – 7.24 (m, 5H), 7.20 – 7.08 (m, 2H), 4.32 (br s, 
2H), 4.09 (s, 2H), 1.49 (s, 9H), 0.04 (s, 6H); 13C NMR (100 MHz, CDCl3): δ = 197.5, 169.0 (br),^ 
154.3, 139.0, 138.9, 136.4, 133.9, 129.4, 128.6, 128.3, 128.0, 127.5, 80.9, 51.5, 49.5, 28.4, -1.0; 
IR (neat): ṽ = cm-1; HRMS (ESI): calcd for (C24H29NO3Si + Na)
+: 430.1814; found: 430.1813 
^ Carbon marked with an asterisk appears as a very broad peak in 13C CPD NMR spectrum and 
is not visible in the 13C APT NMR spectrum. However, HMBC correlations are visible which 
confirms the 13C CPD NMR. 
 
Compound 11p 
 
Colourless oil (6 mg, 5% from 48 mg of 7 using method II): 1H NMR (500 MHz, CDCl3): δ = 7.40 
– 7.20 (m, 8H), 6.97 (d, J = 7.0 Hz, 2H), 4.28 (br s, 2H), 4.16 (s, 2H), 1.45 (s, 9H), 0.08 (s, 6H); IR 
(neat): ṽ = 2976 (w), 1685 (s), 1491 (w), 1477 (w), 1427 (m), 1365 (m), 1242 (m), 1157 (s), 1110 
(m), 1061 (m), 925 (w), 846 (m), 831 (m), 808 (m), 779 (m), 736 (w), 699 (s) cm-1; HRMS (ESI): 
calcd for (C24H29NO3Si + Na)
+: 430.1814; found: 430.1808 
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Compound 6q and 11q 
 
Colourless oil (55 mg, 80% from 30 mg of 7 following method II except that 1.5 equiv of alkyne 
was used), inseparable mixture of regioisomers (6q/11q = 80:20): 1H NMR (500 MHz, CDCl3): δ 
= 4.16 (br s, 0.33H), 4.05 (br s, 1.6H), 4.00 (s, 0.33H), 3.92 (s, 1.6H), 2.35–2.27 (m, 2H), 1.54–
1.41 (m, 1H), 1.45 (s, 9H), 1.39–1.19 (m, 11H), 0.90–0.82 (m, 3H), 0.24 (s, 1.6H), 0.21 (s, 7.4H); 
13C NMR (100 MHz, CDCl3):* δ = 197.5, 192.6, 154.3, {170.4},^ {155.2},^ 154.2, 146.0, 135.1, 
80.67, 80.65, 51.9 (br), 51.3 (br), 47.1 (br), 46.5 (br), 35.6, 31.83, 31.77, 30.1, 30.0, 29.9, 29.8, 
29.5, 29.4, 29.2, 29.1, 28.4 (3C), 22.6, 14.0, 1.3 (3C), -0.5 (3C); IR (neat): ṽ = 2954 (m), 2928 (s), 
2856 (m), 1702 (s), 1665 (m), 1590 (w), 1412 (w), 1368 (m), 1248 (s), 1159 (s), 904 (w), 844 (s), 
768 (w) cm-1; MS (ESI): calcd for (C21H39NO3Si + Na): 404.2597; found: 404.2601. 
(1H NMR: 47°C; 13C APT NMR (d = 2) and 13C CPD NMR (d = 4): 45°C) 
* Peaks common to 6q and 11q are underlined, peaks attributed to 6l are indicated in italic. 
^ Carbon marked with an asterisk is not visible in the 13C APT NMR spectrum but its chemical 
shift could be determined by HMBC correlation and is indicated in brackets. 
 
Compounds 6t 
 
Colourless oil (21 mg, 44% from 49 mg of 7 using method II): This compound has not been fully 
characterised but the assignment of the isolated isomer is based on the proton of 2-
cyclohexen-1-one.; 1H NMR (500 MHz, CDCl3): δ = 5.97 (s, 1H), 4.09 (br s, 2H), 4.01 (s, 2H), 2.21 
(t, J = 7.4 Hz, 2H), 1.56 (sext, J = 7.4 Hz, 2H), 1.44 (s, 9H), 0.94 (t, J = 7.3 Hz, 3H) 
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Compounds 6y and 11y 
 
Colourless oil (43 mg, 75% from 30 mg of 7 following method II), inseparable mixture of 
regioisomers (6y/11y = 58:42), this compound has not been fully characterised but the 
assignment of the two isomers is based on the proton of 6k/11k: 1H NMR (500 MHz, CDCl3): 
(6y) δ = 7.35 – 7.16 (m, 5H), 4.15 (br s, 2H), 4.07 (s, 2H), 2.71 (t, J = 7.5 Hz, 2H), 2.34 – 2.27 (m, 
2H), 1.87 (pent, J = 7.9 Hz, 2H), 1.78 (s, 3H), 1.49 (s, 9H); (11y) δ = 7.35 – 7.16 (m, 5H), 4.12 (br 
s, 2H), 4.06 (s, 2H), 2.66 (t, J = 7.8 Hz, 2H), 2.41 – 2.34 (m, 2H), 1.91 (s, 3H), 1.69 (pent, J = 7.9 
Hz, 2H), 1.49 (s, 9H) 
 
Compounds 6z and 11z 
 
Colourless oil (57 mg, 91% from 30 mg of 7 following method II), inseparable mixture of 
regioisomers (6z/11z = 55:45): 1H NMR (500 MHz, CDCl3): (6z) δ = 7.36 – 7.20 (m, 5H), 4.48 (s, 
2H), 4.12 (br s, 2H), 4.01 (s, 2H), 3.48 (t, J = 6.0 Hz, 2H), 2.44 – 2.34 (m, 2H), 1.86 – 1.75 (m, 
5H), 1.45 (s, 9H); (11z) δ = 7.36 – 7.20 (m, 5H), 4.46 (s, 2H), 4.08 (s, 2H), 3.44 (t, J = 6.2 Hz, 2H), 
2.44 – 2.34 (m, 2H), 1.94 (s, 3H), 1.71 – 1.61 (m, 2H), 1.46 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 
= 193.3, 192.5, 154.1, 138.7, 138.3, 134.0, 130.1, 128.4, 128.3, 127.6, 127.6, 127.5, 127.4, 
80.7, 80.7, 73.0, 72.8, 70.0, 69.4, 51.1, 47.7, 46.3, 29.3, 28.7, 28.3, 27.7, 21.5, 18.0, 9.9; IR 
(neat): ṽ = 2976 (w), 1930 (w), 2860 (w), 1698 (s), 1673 (s), 1641 (m), 1496 (w), 1454 (m), 1420 
(s), 1365 (m), 1328 (w), 1282 (w), 1242 (m), 1168 (m), 1134 (m), 1102 (m), 1029 (w), 899 (w), 
738 (m), 698 (m) cm-1; MS (ESI): calcd for (C21H29NO4 + Na): 382.1994; found: 382.2004. 
(1H NMR and 13C APT NMR (d = 2): 40°C) 
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Compound 6aa 
 
This product was made by Jet-Sing Lee: 1H NMR (400Mz, CDCl3): δ = 7.60-7.54 (m, 5H), 7.45-
7.37 (m, 5H), 7.36-7.31 (m, 1H), 4.58 (s, 2H), 4.33 (s, 2H), 4.29 (s, 2H), 4.08 (s, 2H), 1.79 (s, 3H), 
1.47 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 193.3, 154.1, 141.0, 140.7, 130.4, 128.7, 128.1, 
127.3, 127.2, 127.0 80.7, 72.9, 68.2, 44.4, 28.3 (3C), 9.8; HRMS (ES+): calcd for (C29H25NO4 + 
Na): 430.5; found: 430.2. 
 
Compound 11aa 
 
This product was made and characterised by Jet-Sing Lee. 1H NMR (400Mz, CDCl3): δ = 7.63-
7.58 (m, 4H), 7.48-7.42 (m, 4H), 7.38-7.33 (m, 1H), 4.60 (s, 2H), 4.35 (s, 2H), 4.20 (s, 2H), 4.11 
(s, 2H), 2.10 (s, 3H), 1.50 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 191.8, 140.9, 140.7, 137.2, 
128.7 (2C), 128.4 (2C), 127.2, 127.1 (2C), 127.1 (2C), 81.0, 72.8, 61.5, 29.7, 28.3 (3C), 18.2; 
HRMS (ES+): calcd for (C29H25NO4 + Na): 430.5; found: 430.2. 
 
Compound 54 
 
Colourless oil (6 mg, 49% from 10 mg of 7 using method I except with 30 mol% Ni(cod)2 and 90 
mol% PPhCy2): 
1H NMR (500 MHz, CDCl3): δ = 7.60 – 7.54 (m, 4H), 7.46 – 7.39 (m, 4H), 7.36 – 
7.31 (m, 1H), 5.12 (s, 2H), 1.49 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 153.5, 141.3, 140.7, 
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134.6, 128.8, 128.7, 127.4, 127.3, 127.1, 82.3, 68.4, 27.8; HRMS (ESI): calcd for (C18H20O3 + Na): 
307.1310; found: 307.1305 
 
Compound 70b 
 
White solid (21 mg, 73% from 69 (19 mg, 0.09 mmol) using method I, except that 1.5 equiv of 
alkyne was used and that the oil bath temperature was set at 110 °C): m.p: 51–55 °C; 1H NMR 
(500 MHz, CDCl3): δ = 7.62 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 3.83 (s, 2H), 3.70 (s, 2H), 
2.40 (s, 3H), 2.19–2.13 (m, 2H), 2.12–2.07 (m, 2H), 1.51–1.40 (m, 2H), 1.20–1.08 (m, 2H), 0.94 
(t, J = 7.5 Hz, 3H), 0.82 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 191.2, 153.8, 144.2, 
134.7, 132.8, 130.0 (2C), 129.7 (2C), 52.5, 47.8, 34.4, 26.5, 22.4, 21.5, 21.3, 14.3, 14.2; IR 
(neat): ṽ = 2961 (m), 2872 (w), 1675 (s), 1630 (w), 1598 (w), 1447 (w), 1350 (s), 1244 (w), 1165 
(s), 1138 (w), 1090 (m), 1038 (w), 1010 (w), 964 (m), 815 (w), 672 (m) cm-1; HRMS (ESI): calcd 
for (C18H25NO3S + Na): 358.1453; found: 358.1456; elemental analysis (%) calcd for C18H25NO3S: 
C 64.45, H 7.51, N 4.18; found: C 64.02, H 7.60, N 3.93. 
 
Compound 70c 
 
Colourless oil (23 mg, 62% from 69 (25 mg, 0.11 mmol) using method I, except that 1.5 equiv 
of alkyne was used and that the oil bath temperature was set at 100 °C); 1H NMR (500 MHz, 
CDCl3): δ = 7.65 (d, J = 8.0 Hz, 2H), 7.44 – 7.36 (m, 3H), 7.31 (d, J = 8.1 Hz, 2H), 7.19 – 7.15 (m, 
2H), 4.12 (s, 2H), 3.86 (s, 2H), 2.40 (s, 3H), 1.60 (s, 3H); 13C NMR (125 MHz, CDCl3): δ = 192.1, 
151.4, 144.3, 136.5, 132.7, 131.1, 130.0 (2C), 129.2, 128.7 (2C), 127.7 (2C), 127.6 (2C), 52.5, 
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49.5, 21.5, 11.9; IR (neat): ṽ = 3058 (w), 2925 (w), 1679 (s), 1633 (w), 1598 (w), 1493 (w), 1443 
(w), 1350 (s), 1327 (m), 1252 (w), 1165 (s), 1118 (w), 1089 (w), 1023 (w), 988 (w), 951 (w), 917 
(w), 867 (w), 816 (w), 804 (w), 793 (w), 765 (w), 702 (m), 669 (s) cm-1; MS (ESI): calcd for 
(C19H19NO3S + Na): 364.0983; found: 364.0992. 
 
Compound 71c 
 
Colourless oil (5 mg, 13% from 69 (25 mg, 0.11 mmol) using method I, except that 1.5 equiv of 
alkyne was used and that the oil bath temperature was set at 100 °C); 1H NMR (500 MHz, 
CDCl3): δ = 7.69 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.34–7.26 (m, 3H), 6.85–6.77 (m, 
2H), 4.05 (s, 2H), 3.93 (s, 2H), 2.44 (s, 3H), 1.77 (s, 3H);13C NMR (125 MHz, CDCl3): δ = 189.8, 
152.0, 144.4, 136.6, 133.3, 132.8, 130.1 (2C), 129.6 (2C), 128.1 (2C), 127.8, 127.7 (2C), 52.7, 
49.4, 21.5, 19.7; IR (neat): ṽ = 2924 (w), 1677 (m), 1634 (w), 1598 (w), 1495 (w), 1443 (w), 1380 
(w), 1349 (m), 1307 (w), 1187 (w), 1162 (s), 1092 (w), 1030 (w), 954 (w), 933 (w), 836 (w), 816 
(w), 787 (w), 762 (w), 688 (w), 671 (w) cm-1; HRMS (ESI): calcd for (C19H19NO3S + Na): 364.0983; 
found: 364.0986.  
 
Compound 73a 
 
 
Colourless oil (32 mg, 92% from 72 (20 mg, 0.08 mmol) using method I, except that 1.5 equiv 
of alkyne was used and that the oil bath temperature was set at 110 °C); 1H NMR (500 MHz, 
CDCl3): δ = 7.71 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.2 Hz, 2H), 7.22 – 7.13 (m, 3H), 7.10 – 7.00 (m, 
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3H), 6.93 – 6.88 (m, 2H), 6.43 (d, J = 6.9 Hz, 2H), 4.87 (d, J = 20.4 Hz, 1H), 4.72 (q, J = 7.3 Hz, 
1H), 4.40 (d, J = 20.4 Hz, 1H), 2.38 (s, 3H), 1.53 (d, J = 1.53 Hz, 3H); 13C NMR (125 MHz, CDCl3): 
δ = 194.0, 150.9, 144.1, 136.5, 136.0, 134.5, 132.9, 130.4, 130.1, 129.0, 128.3, 128.2, 127.5, 
127.3, 127.1, 57.0, 45.2, 21.4, 15.8; IR (neat): ṽ = 3057 (w), 2983 (w), 1673 (s), 1624 (w), 1597 
(w), 1491 (w), 1375 (s), 1351 (m), 1335 (s), 1241 (w), 1157 (s), 1086 (m), 1043 (m), 985 (w), 921 
(w), 867 (w), 819 (m), 769 (m), 757 (m), 738 (m) cm-1 
 
Compound 73b 
 
Colourless oil (32 mg, 91% from 72 (25mg, 0.10 mmol) using method I, except that 1.5 equiv of 
alkyne was used and that the oil bath temperature was set at 110°C); enantiomeric excess = 
97%.50 [α]20 D  = 59.1 (c = 2.7 in CHCl3); 
1H NMR (500 MHz, CDCl3): δ = 7.57 (d, J = 8.3 Hz, 2H), 
7.20 (d, J = 8.0 Hz, 2H), 4.43 (q, J = 7.2Hz, 1H), 4.30 (d, J = 19.8 Hz, 1H), 3.94 (d, J = 19.8 Hz, 1H), 
2.35 (s, 3H), 2.12 (ddd, J = 10.0 Hz, 9.3 Hz, 6.0 Hz, 1H), 2.07–2.01 (m, 1H), 2.00–1.88 (m, 2H), 
1.51–1.40 (m, 1H), 1.39– 1.30 (m, 1H), 1.25 (d, J = 7.3 Hz, 3H), 1.03–0.92 (m, 1H), 0.91 (t, J = 
7.4 Hz, 3H), 0.90–0.82 (m, 1H), 0.73 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 194.8, 
152.2, 143.7, 136.5, 133.1, 129.8 (2C), 127.0 (2C), 56.5, 43.7, 33.9, 26.4, 22.4, 21.4, 21.4, 15.7, 
14.3, 14.1; IR (neat): ṽ = 2961 (m), 2932 (w), 2872 (w), 1671 (s), 1630 (w), 1598 (w), 1457 (w), 
1380 (w), 1350 (m), 1335 (m), 1240 (w), 1206 (w), 1161 (s), 1092 (m), 1037 (w), 1011 (w), 912 
(m), 815 (w), 708 (w), 666 (m) cm-1; HRMS (ESI): calcd for (C19H27NO3S + Na): 372.1609; found: 
372.1618.  
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Compound 73c 
 
Colourless oil (27 mg, 93% from 72 (20 mg, 0.08 mmol) using method I, except that 1.5 equiv 
of alkyne was used and that the oil bath temperature was set at 100 °C); 1H NMR (400 MHz, 
CDCl3): δ = 7.65 (d, J = 8.2 Hz, 2H), 7.43 – 7.35 (m, 3H), 7.28 – 7.22 (m, 2H), 7.13 – 7.07 (m, 2H), 
4.65 – 4.52 (m, 2H), 4.22 – 4.12 (m, 1H), 2.37 (s, 3H), 1.44 (s, 3H), 1.36 (d, J =7.3 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 195.6, 150.1, 143.8, 136.4, 136.4, 129.8, 129.4, 129.1, 128.7, 127.4, 
127.1, 56.7, 45.2, 21.5, 15.5, 11.9; IR (neat): ṽ = 3058 (w), 2926 (w), 1673 (s), 1597 (w), 1442 
(m), 1351 (m), 1332 (s), 1187 (w), 1162 (s), 1091 (w), 1028 (m), 1002 (m), 906 (w), 815 (w), 764 
(m), 702 (m) cm-1 
 
Compound 74c 
 
Colourless oil (1.9 mg, 7% from 72 (20 mg, 0.08 mmol) using method I, except that 1.5 equiv of 
alkyne was used and that the oil bath temperature was set at 100 °C); 1H NMR (400 MHz, 
CDCl3): δ = 7.66 (d, J = 8.2 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 7.26 – 7.20 (m, 3H), 6.59 – 6.52 (m, 
2H), 4.59 (q, J = 7.3 Hz, 1H), 4.45 (d, J = 20.0 Hz, 1H), 4.14 (d, J = 20.1 Hz, 1H), 2.42 (s, 3H), 1.67 
(s, 3H), 1.42 (d, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 193.2, 150.3, 144.0, 136.9, 
135.2, 133.3, 130.1, 129.6, 128.0, 127.7, 127.1, 57.0, 45.4, 21.4, 19.1, 15.8; IR (neat): ṽ = 2984 
(w), 2932 (w), 1675 (m), 1663 (w), 1597 (w), 1495 (w), 1443 (w), 1381 (w), 1353 (m), 1333 (m), 
1160 (s), 1104 (m), 1059 (m), 1004 (m), 877 (w), 702 (w), 687 (w), 665 (m) cm-1; HRMS (ESI): 
calcd for (C20H21NO3S + Na)
+: 378.1140; found: 378.1154  
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Compound 73o 
 
Colourless oil (25 mg, 71% from 72 (20 mg, 0.18 mmol) using method I, except that 1.5 equiv 
of alkyne was used and that the oil bath temperature was set at 110 °C); 1H NMR (500 MHz, 
CDCl3): δ = 7.68 (d, J = 8.3 Hz, 2H), 7.42 – 7.34 (m, 3H), 7.26 (d, J = 8.1 Hz, 2H), 7.12 – 7.07 (m, 
2H), 4.59 (d, J = 20.6 Hz, 1H), 4.46 (q, J = 7.2 Hz, 1H), 4.06 (d, J = 20.6 Hz, 1H), 2.36 (s, 3H), 1.36 
(d, J = 7.3 Hz, 3H), -0.38 (s, 9H); 13C NMR (125 MHz, CDCl3): δ = 198.8, 164.4, 143.9, 138.4, 
136.5, 136.4, 130.0, 129.5, 128.5, 127.6, 127.1, 56.5, 46.7, 21.4, 15.8, 0.1; IR (neat): ṽ = 3060 
(w), 2954 (w), 2897 (w), 1662 (m), 1581 (w), 1490 (w), 1429 (w), 1351 (m), 1325 (w), 1247 (m), 
1161 (s), 1105 (w), 1042 (w), 990 (w), 902 (w), 838 (s), 773 (m), 700 (m), 667 (s) cm-1; MS (ESI): 
calcd for (C22H27NO3SiS + Na): 436.1379; found: 436.1378. 
 
Compound 88a 
 
White solid (64 mg, 82% from commercially available 87 (20 μL, 0.31 mmol) using method I); 
m.p. 100–103 °C; 1H NMR (500 MHz, CDCl3): δ = 7.22–7.15 (m, 6H), 7.09–6.99 (m, 4H), 4.76 (s, 
2H), 4.38 (s, 2H); 13C NMR (125 MHz, CDCl3): δ = 193.3, 155.3, 135.4, 134.6, 132.7, 130.7 (2C), 
128.9, 128.4 (2C), 128.3 (2C), 127.8 (2C), 127.4, 71.2, 69.5; IR (neat): ṽ = 3056 (w), 3023 (w), 
2969 (w), 2853 (w), 2816 (w), 1678 (s), 1613 (w), 1596 (w), 1573 (w), 1491 (w), 1443 (w), 1380 
(w), 1327 (m), 1280 (w), 1250 (w), 1195 (w), 1141 (m), 1080 (w), 1052 (w), 1038 (w), 1027 (w), 
1001 (w), 967 (w), 932 (w), 912 (w), 868 (w), 755 (m), 720 (w), 696 (s) cm-1; HRMS (ESI): calcd 
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for (C17H14O2 + Na): 273.0891; found: 273.0890; elemental analysis (%) calcd for C17H14O2: C 
81.58, H 5.64; found: C 80.98, H 5.73. 
 
Compound 88g 
 
Colourless oil (93 mg, 73% from commercially available 87 (20 μL, 0.47 mmol) using method 
II); 1H NMR (500 MHz, CDCl3): δ = 7.98 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 4.47 (s, 2H), 
4.20 (s, 2H), 2.59 (s, 3H), 2.22–2.13 (m, 2H), 1.34 – 1.21 (m, 2H), 1.13 (sext, J = 7.3 Hz, 2H), 0.71 
(t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 197.3, 194.3, 153.3, 140.5, 137.0, 135.0, 
128.6 (2C), 127.6 (2C), 71.9, 69.3, 31.3, 26.6, 24.9, 22.5, 13.6; IR (neat): ṽ = 2958 (w), 2932 (w), 
2860 (w), 1683 (s), 1604 (w), 1440 (w), 1403 (w), 1380 (w), 1359 (w), 1338 (w), 1266 (w), 1206 
(w), 1151 (w), 1119 (w), 1014 (w), 960 (w), 922 (w), 833 (w) cm-1; HRMS (ESI): calcd for 
(C17H20O3 + Na): 295.1310; found: 295.1311; elemental analysis (%) calcd for C17H20O3: C 74.97, 
H 7.40; found: C 74.95, H 7.75. 
 
Compound 89g 
 
Colourless oil (25 mg, 19% from commercially available 87 (30 μL, 0.47 mmol) using method 
II); 1H NMR (500 MHz, CDCl3): δ = 7.96 (d, J = 8.2 Hz, 2H), 7.20 (d, J = 8.2 Hz, 2H), 4.46 (s, 2H), 
4.24 (s, 2H), 2.59 (s, 3H), 2.14–2.07 (m, 2H), 1.41–1.32 (m, 2H), 1.19 (sext, J = 7.4 Hz, 2H), 0.77 
(t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 197.8, 192.7, 159.7, 138.1, 136.3, 134.4, 
130.0 (2C), 128.2 (2C), 72.0, 68.1, 31.5, 30.0, 26.6, 22.6, 13.6; IR (neat): ṽ = 2958 (w), 2931 (w), 
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2862 (w), 2819 (w), 1678 (s), 1626 (w), 1603 (m), 1560 (w), 1466 (w), 1438 (w), 1403 (w), 1384 
(w), 1358 (w), 1330 (w), 1265 (s), 1184 (w), 1126 (m), 1088 (w), 1017 (w), 960 (m), 830 (w), 
762 (w), 701 (w) cm-1; HRMS (ESI): calcd for (C17H20O3 + Na): 295.1310; found: 295.1313; 
elemental analysis (%) calcd for C17H20O3: C 74.97, H 7.40; found: C 74.74, H 7.42. 
 
Compound 88o 
 
White solid (73 mg, 95% from commercially available 87 (20 μL, 0.31 mmol) using method II); 
m.p. 39–41 °C; 1H NMR (500 MHz, CDCl3): δ = 7.43–7.34 (m, 3H), 7.24–7.18 (m, 2H), 4.41 (s, 
2H), 4.13 (s, 2H), -0.13 (s, 9H); 13C NMR (125 MHz, CDCl3): δ = 198.1, 169.0, 137.8, 136.2, 129.4, 
128.4 (2C), 127.9 (2C), 71.4, 70.3, 0.2 (3C); IR (neat): ṽ = 3059 (w), 2952 (w), 2897 (w), 2850 
(w), 2812 (w), 1665 (s), 1603 (w), 1581 (w), 1567 (w), 1490 (w), 1443 (w), 1433 (w), 1372 (w), 
1288 (m), 1275 (m), 1244 (s), 1216 (w), 1137 (m), 1077 (w), 1053 (w), 1033 (w), 1016 (w), 969 
(w), 937 (m), 835 (s), 756 (s), 699 (s), 682 (m) cm-1; HRMS (ESI): calcd for (C14H18O2Si+ Na): 
269.0974; found: 269.0975; elemental analysis (%) calcd for C14H18O2Si: C 68.25, H 7.36; found: 
C 68.10, H 7.42. 
 
Compound 89o 
 
Yellow oil (3 mg, 4% from commercially available 87 using method II); 1H NMR (500 MHz, 
CDCl3): δ = 7.35–7.29 (m, 3H), 7.15–7.05 (m, 2H), 4.53 (s, 2H), 4.25 (s, 2H), -0.13 (s, 9H); 
13C 
NMR (100 MHz, CDCl3): δ = 192.4, 159.9, 145.2, 135.7, 130.0 (2C), 128.2, 127.9 (2C), 72.4, 69.1, 
-1.2 (3C); IR (neat): ṽ = 3048 (w), 3028 (w), 2956 (w), 2896 (w), 2851 (w), 2810 (w), 1685 (s), 
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1492 (w), 1444 (w), 1374 (w), 1312 (w), 1251 (m), 1192 (w), 1138 (m), 1033 (w), 952 (w), 869 
(s), 840 (s), 755 (w), 701 (w) cm-1; MS (CI): m/z (rel. intensity): 264 (100) [M+NH4]
+, 247 (55) 
[M+H]+; HRMS (ESI): calcd for (C14H18O2Si + Na): 269.0974; found: 269.0967. 
 
Compound 91 
 
 
Colourless oil (14 mg, 44% from 90 (20 mg, 0.11 mmol) using method I); 1H NMR (500 MHz, 
CDCl3): δ = 7.29 – 7.23 (m, 2H), 7.22 – 7.13 (m, 3H), 4.30 (apt q, J = 17.5 Hz, 2H), 3.85 – 3.79 (m, 
1H), 2.82 – 2.64 (m, 2H), 2.30 – 2.08 (m, 5H), 2.01 – 1.91 (m, 1H), 1.49 (sext, J = 7.5 Hz, 2H), 
1.33 (sext, J = 7.4 Hz, 2H), 0.97 (t, J = 7.3 Hz, 3H), 0.89 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, 
CDCl3): δ = 196.0, 155.9, 141.6, 133.2, 128.6, 128.3, 125.8, 78.9, 66.9, 32.6, 31.7, 31.3, 26.3, 
22.5, 21.4, 14.3, 14.2; MS (ESI): calcd for (C19H26O2 + Na): 309.1831; found: 309.1827. 
 
Compound 92 
 
Colourless oil (4 mg, 11% from 90 (20 mg, 0.11 mmol) using method I); 1H NMR (500 MHz, 
CDCl3): δ = 7.31 – 7.26 (m, 2H), 7.22 – 7.16 (m, 3H), 4.26 (d, J = 16.6 Hz, 1H), 4.21 (d, J = 10.0 
Hz, 1H), 4.05 (d, J = 17.0 Hz, 1H), 2.90 – 2.81 (m, 1H), 2.81 – 2.68 (m, 1H), 2.35 – 2.27 (m, 1H), 
2.27 – 2.16 (m, 2H), 2.09 – 1.86 (m, 3H), 1.52 – 1.42 (m, 1H), 1.40 – 1.29 (m, 3H), 0.96 – 0.86 
(m, 6H); 13C NMR (125 MHz, CDCl3): δ = 194.5, 159.6, 141.4, 133.6, 128.5, 128.5, 126.1, 74.6, 
67.8, 32.7, 32.5, 32.3, 26.4, 22.6, 21.8, 14.4, 14.2. Further analytical data was not obtained. 
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Compound 93 
 
 
Colourless oil (17 mg, 42% from 90 (20 mg, 0.11 mmol) using method I); 1H NMR (500 MHz, 
CDCl3): δ = 7.32 – 7.23 (m, 4H), 7.22 – 7.14 (m, 7H), 7.07 (m, 2H), 7.01 – 6.96 (m, 2H), 4.86 (d, J 
= 18.0 Hz, 1H), 4.70 (dd, J = 17.9, 1.3 Hz, 1H), 4.15 – 4.09 (m, 1H), 2.93 – 2.76 (m, 2H), 2.41 – 
2.30 (m, 1H), 2.17 – 2.06 (m, 1H); 13C NMR (125 MHz, CDCl3): δ = 195.0, 154.7, 141.4, 135.5, 
134.4, 133.2, 130.8, 128.8, 128.7, 128.5, 128.4, 128.3, 127.8, 127.3, 126.0, 79.2, 68.4, 31.6, 
31.2; IR (neat): ṽ = 3059 (w), 3026 (w), 2927 (w), 2861 (w), 2810 (w), 1677 (s), 1598 (w), 1494 
(w), 1444 (w), 1327 (m), 1135 (m), 1030 (w), 1002 (w), 945 (w), 756 (m), 697 (s) cm-1; MS (ESI): 
calcd for (C25H22O2 + Na): 377.1517; found: 377.1521. 
 
Compound 101 
 
Colourless oil (48 mg, 41% from 7 (49 mg, 0.29 mmol) using method I, except that 1.5 equiv of 
alkyne and 20 mol% of PhCy2P were used. The reaction was also carried out in toluene and 
that the oil bath temperature was set at 100 °C)^; 1H NMR (400 MHz, CDCl3): δ = 7.05 (d, J = 
8.7 Hz, 2H), 6.92 (d, J = 8.7 Hz, 2H), 6.75 – 6.68 (m, 4H), 5.58 (s, 2H), 4.26 (s, 2H), 3.75 – 3.72 
(m, 6H), 1.51 (s, 9H); 13C NMR (125 MHz, CDCl3): δ = 192.7, 160.0, 158.8, 154.3,^ 153.9, 132.1, 
130.3, 134.6, 129.3, 126.3, 113.8, 113.5, 82.1, 55.2, 55.1, 51.9, 47.8, 28.4; IR (neat): ṽ = 2975 
(w), 2935 (w), 2837 (w), 1694 (m), 1675 (s), 1605 (m), 1508 (s), 1440 (w), 1366 (m), 1289 (m), 
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1245 (s), 1157 (s), 1110 (w), 1031 (m), 938 (w), 827 (m) cm-1; MS (ESI): calcd for (CxxHxxNOxS + 
Na): 432.1787; found: 432.1778. 
^ Carbon marked with an asterisk appears as a very broad peak in 13C CPD NMR spectrum and 
is not visible in the 13C APT NMR spectrum. However, HMBC correlations are visible which 
confirms the 13C CPD NMR. 
(13C APT NMR (d = 2): 40°C, 13C CPD NMR (d = 4): 40°C) 
 
Compound 102 
 
Orange oil (57 mg, 49% from 7 (49 mg, 0.29 mmol) using method I, except that 1.5 equiv of 
alkyne and 20 mol% of PhCy2P were used. The reaction was also carried out in toluene and 
that the oil bath temperature was set at 100 °C)^; 1H NMR (500 MHz, CDCl3): δ = 7.77 – 7.33 
(br m, 1H), 7.27 (d, J = 8.6 Hz, 2H), 7.18 (d, J = 8.7 Hz, 2H), 6.87 – 6.81 (m, 2H), 6.78 (d, J = 8.7 
Hz, 2H), 4.44 (d, J = 1.8 Hz, 1H), 4.18 (br d, J = 18.2 Hz, 1H), 3.91 (dd, J = 18.8, 2.0 Hz, 1H), 3.76 
(s, 3H), 3.74 (s, 3H), 1.52 (s, 9H); 13C NMR (125 MHz, CDCl3): δ = 202.1, 159.5, 159.0, 152.0, 
130.2, 128.8, 127.6, 126.4, 123.7, 114.7, 114.2, 82.2, 77.3, 55.5, 55.3, 50.3, 49.6, 28.3; IR 
(neat): ṽ = 2976 (w), 2933 (w), 2837 (w), 1702 (s), 1647 (m), 1607 (m), 1507 (s), 1441 (m), 1370 
(s), 1294 (s), 1246 (s), 1152 (s), 1111 (m), 1034 (s), 946 (w), 827 (m), 765 (w) cm-1; MS (ESI): 
calcd for (C24H27NO5 + Na)
+: 432.1787; found: 432.1779. 
(13C APT NMR (d = 2): 40°C, 13C CPD NMR (d = 2): 40°C) 
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 Nickel(II): Synthesis of pyridinones 2.7.5
 
Method I. Inside a glovebox, a Teflon-screw flame-dried Schlenk flask equipped with a small 
stirrer bar was charged with NiCl2(PCy3)2 (8.1 mg, 0.0.1 mmol) and zinc (16 mg, 0.58 mmol) and 
taken out of the glovebox. Under N2, azetidinone 7 (20 mg, 0.12 mmol) and alkyne 5b (19 μl, 
0.73 mmol) were then added. Afterwards, iPrOH (0.6 ml) was then added and the flask was 
sealed and immersed into an oil bath pre-heated at 60°C. After stirring for 17 hours at that 
temperature, the mixture was allowed to cool and filtered through a silica plug before 
evaporation. Purification by flash chromatography (PE/EtOAc, 9/1) gave 6b as colourless oil 
(23 mg, 72%). 
Method II. On the bench top, under N2, a flame-dried Schlenk flask equipped with a small 
stirrer bar was charged with NiBr2•xH2O (38.8 mg, 0.18 mmol) and PPh3 (93 mg, 0.36 mmol) 
and iPrOH (3.6 ml). The suspension was stirred at 60°C for 10 minutes and was then cooled 
back down to rt. Afterwards, zinc (58 mg, 0.89 mmol), azetidinone 69 (200 mg, 0.89 mmol) and 
alkyne 5m (121 μl, 0.98 mmol) were then added. Afterwards, the schlenk was immersed into 
an oil bath pre-heated at 60°C. After stirring for 17 hours at that temperature, the mixture was 
allowed to cool and filtered through a silica plug before evaporation. The crude ratio of 
120:121 is 86:14 as judged by 1H NMR analysis. Purification by flash chromatography 
(PE/EtOAc, 8/1 → 4/1) afforded 120 as a white solid (196 mg, 69%) and 121 as white solid (36 
mg, 13%). 
 
Compound 6b 
 
Colourless oil (23 mg, 72%) using method I; Full characterisation reported earlier. 
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Compound 6c 
 
Colourless oil (696 mg, 83% from 500 mg of 6c using method I), except 5 mol% NiBr2(PPh3)2 
and 50 mol% zinc were used and the oil bath was set at 40°C: Full characterisation reported 
earlier. 
 
Compound 121 
 
White solid (196 mg, 69%) from 69 (200 mg, 0.89 mmol) using method II; 1H NMR (500 MHz, 
CDCl3): δ = 7.63 (d, J = 8.3 Hz, 2H), 7.32 – 7.28 (m, 2H), 5.10 – 5.08 (m, 1H), 4.76 – 4.73 (m, 1H), 
3.92 (s, 2H), 3.80 (s, 2H), 2.40 (s, 3H), 2.11 (q, J = 7.5 Hz, 2H), 1.87 – 1.85 (m, 3H), 0.75 (t, J = 
7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 191.5, 153.8, 144.3, 140.7, 135.2, 133.3, 130.0, 
127.7, 115.7, 52.6, 47.6, 21.8, 21.5, 19.2, 14.0; IR (neat): ṽ = 2969 (w), 2928 (w), 2871 (w), 
1679 (s), 1618 (w), 1598 (w), 1494 (w), 1444 (w), 1350 (s), 1253 (w), 1163 (s), 1121 (w), 1090 
(w), 1029 (w), 960 (w), 910 (w), 815 (w) 785 (w), 768 (w), 662 (w) cm-1; MS (ESI): calcd for 
(C17H21NO3S + Na): 342.1140; found: 342.1135. 
 
Compound 122 
 
Colourless oil (36 mg, 13% from 69 (200 mg, 0.89 mmol) using method II); 1H NMR (500 MHz, 
CDCl3): δ = 7.64 (d, J = 8.3 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 5.10 – 5.06 (m, 1H), 4.45 – 4.41 (m, 
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1H), 3.95 (s, 2H), 3.81 (s, 2H), 2.40 (s, 3H), 2.20 (q, J = 7.6 Hz, 2H), 1.66 (s, 3H), 1.04 (t, J = 7.6 
Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 190.2, 155.4, 144.3, 138.6, 137.7, 133.3, 130.0, 127.6, 
113.7, 52.7, 47.0, 26.0, 23.0, 21.4, 12.8; IR (neat): ṽ = 2974 (w), 2937 (w), 2923 (w), 2878 (w), 
1677 (m), 1620 (w), 1598 (w), 1444 (w), 1350 (m), 1308 (w), 1241 (w), 1185 (w), 1163 (s), 1089 
(w), 1046 (w), 998 (w), 957 (w), 906 (w), 830 (w), 816 (w), 707 (w), 681 (w) cm-1; HRMS (ESI): 
calcd for (C17H21NO3S + Na)
+: 342.1140; found: 342.1129  
 
 Hydrogenation and Aromatisation 2.7.6
 
Compound 85a 
 
Under air, a suspension of 6a (50 mg, 0.14 mmol), SiO2 (50 mg) and TFA (0.15 ml) in 
dichloromethane (0.5 ml) was stirred at room temperature for 10 minutes. NaNO2 (15 mg, 
0.21 mmol) was then added and the suspension was stirred at room temperature for 30 
minutes. Afterwards, Et3N (0.5 ml) was added and the suspension was stirred for another 30 
minutes. Afterwards, SiO2 was added and all volatiles were removed in vacuo. The residue was 
loaded on a column and purified by flash chromatography (PE/EtAOc, 3/1  2/3) to give 85a 
as a white solid (33 mg, 83%): 1H NMR (500 MHz, CDCl3): δ = 8.44 (s, 1H), 8.21 (s, 1H), 8.06 (br 
s, OH), 7.35 – 7.25 (m, 3H), 7.21 – 7.13 (m, 5H), 7.09 – 7.03 (m, 2H); 13C NMR (125 MHz, CDCl3): 
δ = 150.6, 141.9, 137.2, 137.1, 136.6, 134.8, 133.0, 129.7, 128.8, 128.0, 127.3; IR (neat): ṽ = 
3028 (w), 2590 (br w), 1696 (w), 1578 w)1543 (w), 1491 (w), 1443 (w), 1415 (s), 1319 (w), 1287 
(m), 1195 (w), 1117 (m), 1073 (w), 999 (w), 910 (w), 763 (s), 696 (s) cm-1; HRMS (ESI): calcd for 
(C17H14NO + Na): 248.1075; found: 248.1071; elemental analysis (%) calcd for C17H14NO: C 
82.56, H 5.30, N 5.67; found: C 82.27, H 5.31, N 5.63. 
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Compound 85d 
 
Under air, a suspension of 6d (30 mg, 0.08 mmol), SiO2 (25 mg) and TFA (0.1 ml) in 
dichloromethane (0.25 ml) was stirred at room temperature for 1 hour. NaNO2 (8.5 mg, 0.12 
mmol) was then added and the suspension was stirred at room temperature for 1 hour before 
adding another batch of NaNO2 (8.5mg, 0.12 mmol). After 1 hour stirring for 1 hour, Et3N (0.25 
ml) was added and the suspension was stirred for another 30 minutes. Afterwards, SiO2 was 
added and all volatiles were removed in vacuo. The residue was loaded on a column and 
purified by flash chromatography (PE/EtAOc, 2/1  1/9) to give 85d as a white solid (13mg, 
68%): m.p. 158–163 °C (decomposition); 1H NMR (500 MHz, CDCl3): δ = 8.37 (s, 1H), 8.06 (s, 
1H), 7.68 (d, J = 8.1 Hz, 2H), 7.64 (d, J = 7.5 Hz, 2H), 7.46 (t, J = 7.6 Hz, 2H), 7.42 (d, J = 8.1 Hz, 
2H), 7.37 (t, J = 7.3 Hz, 1H), 2.31 (s, 3H); 13C NMR (125 MHz, CDCl3): δ = 154.4, 140.7, 140.5, 
139.3, 138.8, 136.1, 134.9, 132.8, 129.8 (2C), 128.9 (2C), 127.5, 127.2 (2C), 127.1 (2C), 13.3; IR 
(neat): ṽ = 3030 (m), 2962 (w), 2916 (w), 2841 (w), 2618 (br and m), 1596 (w), 1569 (m), 1486 
(s), 1422 (s), 1320 (m), 1293 (m), 1223 (w), 1142 (s), 1000 (m), 843 (m), 767 (s), 732 (w), 696 
(m) cm-1; HRMS (ESI): calcd for (C18H16NO + Na): 262.1232; found: 262.1236. 
 
Compound 85f 
 
Under air, a suspension of 6f (24 mg, 0.07 mmol) in dichloromethane (0.2 ml) was added TFA 
(0.2 ml) and was then stirred at room temperature for 1 hour. CH3CN (0.6 ml) was then added 
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and then NaNO2 (7 mg, 0.10 mmol) was added and the suspension was stirred at room 
temperature for 1 hour. Afterwards, SiO2 was added and all volatiles were removed in vacuo. 
The residue was loaded on a column and purified by flash chromatography (PE/EtAOc, 1/2) to 
give 85f as a white solid (14 mg, 81%): 1H NMR (500 MHz, CD3COCD3): δ = 8.68 (s, 1H), 8.35 (s, 
1H), 7.70 (d, J = 8.6 Hz, 2H), 7.56 (d, J = 8.1 Hz, 2H), 2.36 (s, 3H); 13C NMR (125 MHz, 
CD3COCD3): δ = 155.2, 149.3, 141.2, 139.6, 134.6, 133.7, 131.4, 128.1, 121.3, 120.5 (q, J = 
255.6 Hz), 13.2; HRMS (ESI): calcd for (C13H11NO2F3 + Na): 270.0742; found: 270.0752  
 
Compound 85h 
 
This compound was prepared from 6h (50 mg, 0.14 mmol) according to the procedure 
described for the preparation of 85a, except a second batch of NaNO2 (1.5 equiv.) was added 
and allowed to stir for 1 hour before quenching with Et3N. Yellow solid (25 mg, 66%): 
1H NMR 
(500 MHz, CDCl3): δ = 8.31 (s, 1H), 7.91 (s, 1H), 7.18 (d, J = 8.4 Hz, 2H), 6.95 (d, J = 8.4 Hz, 2H), 
3.86 (s, 3H), 2.71 (t, J = 11.9 Hz, 1H), 2.31 – 2.16 (m, 2H), 1.69 (d, J = 12.6 Hz, 2H), 1.63 – 1.47 
(m, 3H), 1.25 -1.03 (m, 3H). Further analytical data was not obtained. 
 
Compound 85o 
 
This compound was prepared from 6o (70 mg, 0.20 mmol) according to the procedure 
described for the preparation of 85a. White solid (27 mg, 53%); 1H NMR (500 MHz, CDCl3): δ = 
8.28 (s, 1H), 7.95 (s, 1H), 7.40 – 7.34 (m, 3H), 7.28 – 7.22 (m, 2H), 0.00 (s, 9H); 13C NMR (125 
168 
 
MHz, CD3COCD3): δ = 158.1, 144.3, 141.5, 141.2, 135.4, 131.2, 129.5, 127.9, 127.5, -0.1; IR 
(neat): ṽ =  cm-1; elemental analysis (%) calcd for C14H17NOSi: C 69.09, H 7.04, N 5.76; found: C 
67.65, H 6.79, N 5.56. 
 
Compound 124 
 
A vial was charged with 121 (63 mg, 0.20 ml), Pd/C (6 mg) and suspended in EtOAC (2 ml). The 
vial was quickly evacuated and backfilled with H2. Kept under 1 atm of H2 with a H2 balloon and 
stirred vigorously for 4 hours. Afterwards, the Pd/C was filtered off and concentrated. The 
residue was re-dissolved in THF (2 ml) and KOtBu (66 mg, 0.59 mmol) was added. After 
completion within 30 mins as judged by TLC, all volatiles were removed and the residue was 
loaded on top of a silica column. Purification by flash chromatography (PE/EtAOc, 1/1  1/5) 
afforded 124 as a white solid (14 mg, 43%): 1H NMR (500 MHz, CDCl3): δ = 8.16 (s, 1H), 8.00 (s, 
1H), 3.16 (sept, J = 6.9 Hz, 1H), 2.77 (q, J = 7.5 Hz, 2H), 1.27 (d, J = 6.9 Hz, 6H), 1.18 (t, J =7.5 Hz, 
3H); 13C NMR (125 MHz, CDCl3): δ = 153.2, 143.3, 139.1, 137.1, 132.9, 27.6, 23.8, 18.6, 13.8; IR 
(neat): ṽ = 2965 (w), 2933 (w), 2873 (w), 2596 (w), 1727 (w), 1678 (w), 1596 (w), 1569 (w), 
1511 (w), 1464 (w), 1429 (s), 1389 (w), 1301 (s), 1194 (w), 1168 (w), 1154 (w), 1084 (w), 1052 
(w), 953 (w), 869 (w) cm-1; HRMS (CI): calcd for (C10H15NO + H)
+: 166.1226; found: 166.1233 
 
Compound 125 
 
Compound 70b (40mg, 0.12 mmol) was dissolved in THF (1.2 ml) and KOtBu (67 mg, 0.60 
mmol) was added. After allowing it to stir at rt overnight, all volatiles were removed and the 
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residue was loaded on top of a silica column. Purification by flash chromatography (PE/EtAOc, 
1/1  1/5) afforded 125 as a white solid (10 mg, 92%). 1H NMR (500 MHz, CDCl3): δ = 8.68 (s, 
1H), 7.77 (s, 1H), 2.82-2.75 (m, 2H), 2.72 – 2.65 (m, 2H), 1.70 – 1.54 (m, 4H), 1.06 – 0.97 (m, 
6H). Further analytical data was not obtained. 
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 Mechanistic Investigations Chapter 3
 
 Introduction 3.1
 
At the outset of this work, we postulated that the mechanism of the [4+2] cycloaddition would 
begin with the nickel-catalyst associating both azetidinone 1 and alkyne 2 to form 
intermediate 4 (Scheme 1). Afterwards, oxidative cyclisation would form 
oxanickelacyclopentene 5. Ring enlargement by β-C elimination will form seven-membered 
nickelacycle intermediate 6. Finally, reductive elimination would afford pyridinone 3. 
 
 
Scheme 1 Original mechanistic proposal 
 
In 1997, Oblinger and Montgomery reported a nickel-catalysed alkylative cyclisation of ynal 7 
to form allylic alcohols 9 (Scheme 3).1 The authors proposed the formation of 
oxanickelacyclopentene 8 as an intermediate of the reaction. If a Ni(cod)2/PtBu3 (1:4 ratio of Ni 
to phosphine) catalytic system was employed, a reductive cyclisation of ynals 10 will form 
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allylic alcohols 11 (Scheme 3). The formation of an oxanickelacyclopentene 8 is postulated to 
occur. 
 
 
Scheme 2 Alkylative cyclisation 
 
Scheme 3 Reductive cyclisation 
 
In the same paper, the authors reported a nickel-catalysed three-component coupling to form 
allyl alcohols 15 whereby the formation of oxanickelacyclopentene 14 is postulated to occur 
(Scheme 4). Jamison and co-workers reported a nickel-catalysed intermolecular reductive 
coupling of aldehydes 16 and alkynes 17 to form allylic alcohols 18 but no mechanism was 
proposed (Scheme 5). Regardless, oxanickelacyclopentene 14 can be invoked.2 Furthermore, 
theoretical studies support the formation of 14.3 
 
 
Scheme 4 Nickel-catalysed three-component coupling 
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Scheme 5 Nickel-catalysed intermolecular reductive coupling 
 
Baxter and Montgomery carried out a mechanistic study of the nickel-catalysed intramolecular 
reductive cyclisation of ynal 19 to form silyl ether 20 (Scheme 6).4 It is postulated that the 
formation of oxanickelacyclopentene 21 is most likely. However, intermediates 22 - 24 could 
lead to the formation of 20. Therefore, a mechanistic study was commenced to gain 
mechanistic insight into the operative pathway.  
 
 
Scheme 6 Nickel-catalysed reductive cyclisation 
 
Kinetic studies by in situ IR monitoring allowed for real-time monitoring of the reaction. A first-
order dependence of the reaction rate on ynal 19, first-order dependence of the reaction rate 
on catalyst and zero-order dependence of the reaction rate on Et3SiH were observed. Kinetic 
isotopic effect studies revealed that Et3SiH and Et3SiD have no significant kinetic isotopic effect 
and crossover studies revealed little crossover (Scheme 7).  
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Scheme 7 Kinetic isotopic effect study and crossover study 
 
Afterwards, in situ IR monitoring of the addition of a solution of 1.0 equiv of the catalyst 
derived from Ni(cod)2 and PCy3 to a solution of Et3SiH resulted in no change to the silicon 
hydride stretch (2100 cm-1) which along with the other mechanistic data rules out 
intermediate 22. Interestingly, the addition of a solution of 1.0 equiv of the same catalyst to a 
solution of Et3SiH and hydrocinnamaldehyde resulted in no change to the silicon hydride 
stretch which rules out intermediate 23. Furthermore, the addition of a solution 1.0 equiv of 
the same catalyst to a solution of Et3SiH and phenyl propyne resulted in no change to the 
silicon hydride stretch which rules our intermediate 24. Finally, the addition of a solution of 
1.0 equiv of the same catalyst to a solution of Et3SiH and ynal 19 resulted in conversion to 20, 
which along with the previous mechanistic data support the intermediacy of 21. 
Ogoshi and co-workers reported a AlMe3-promoted oxidative cyclisation between an alkene, a 
ketone and nickel(0) to give oxanickelacyclopentene 28 (Scheme 8).5 The reaction of Ni(cod)2 
and PCy3 with ketone 26 gave complex 27. Complex 27 was isolated in a 86% and the X-ray 
structure confirmed that C=O and C=C bonds both coordinate to the nickel centre in η2-
fashion. After the formation of 27, heating to 60°C or the addition of Me3SiOTf did not induce 
the transformation to oxanickelacyclopentene 28. Reaction of 27 with AlMe3 in C6D6 then 
afforded 28 in a quantitative yield. The structure of 28 was confirmed by X-ray diffraction 
analysis. However, no further reaction was observed in C6D6. 
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Scheme 8 Oxidative cyclisation to form pentanickelacycle 
 
The addition of THF to oxanickelacyclopentene 28 generated complex 31 (Scheme 9). The 
authors proposed the initial transmetallation was followed by methane elimination to afford 
intermediate 29. Oxidation addition into the C–O bond would afford intermediate 30. Finally, 
transmetallation would afford complex 31 in a 56% yield. Interestingly, when catalytic amount 
of Ni(cod)2 and PCy3 were employed, rapid cycloisomerisation of ketone 26 formed allylic 
alcohol 32 after protonation in a 86% yield (Scheme 10). 
 
 
Scheme 9 Generation of complex 31 
 
Scheme 10 Cycloisomerisation of ketone 26 to form allylic alcohol 32 
 
Ogoshi and co-workers reported a nickel-catalysed transformation of aldehyde 33 to form 
ketone 34 (Scheme 11).6 Stoichiometric reactions were then carried out to gain insight into the 
mechanism. The treatment of 34 with Ni(cod)2 and ItBu resulted in the quick formation of 
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complex 35 and was isolated in a 83% yield. Complex 35 slowly dimerised to form a mixture of 
syn-36 and anti-36 over 33 days and the mixture was isolated together in a 84% yield. 
Furthermore, the structure of anti-35 was confirmed by X-ray diffraction analysis. It is 
assumed the dimerisation goes through monomeric intermediate 37 but 37 is never observed 
over the course of the reaction as judged by NMR analysis. The conversion of 36 into 34 was 
very slow. When 2.5 mol% of 36 was used, the transformation of 33 into 34 took place within 
5 hours and a yield of 101% (maximum 105%) was obtained. Therefore it is concluded that 
under the reaction conditions, monomeric 37 is part of the catalytic cycle and 37 is in 
equilibrium with 36. 
 
 
Scheme 11 Mechanistic study on the nickel-catalysed transformation of 33 into 34 
 
Ogoshi and co-workers reported the formation of nickeladihydrofuran 40 from the reaction of 
benzaldehyde 38, butyne 39, Ni(cod)2 and PCy3 (Scheme 12).
7 Furthermore, 40 was isolated in 
a 40% yield and the structure was confirmed by X-ray diffraction analysis. Also, the nickel 
centre exhibits a square planar geometry. 40 decomposed in THF to form enone 42 and was 
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isolated in a 70% yield. It is postulated that β-H elimination from 40 would afford 41. 
Subsequent reductive elimination would then afford 42. This result demonstrates that 40 can 
be a key intermediate in a nickel-catalysed reaction. 
 
 
Scheme 12 Formation of nickeladihydrofuran 40 and its decomposition 
 
The postulated mechanism for the [4+2] cycloaddition relied on the formation of an 
oxanickelacyclopentene via oxidative cyclisation. Overall, all experimental and theoretical 
studies discussed above are in support of this mechanistic proposal. 
In contrast, Li and Lin recently reported a theoretical study on the nickel-catalysed 
cycloaddition of 3-azetidinones with alkynes.8 After modelling the insertion of 2-butyne with 
the proposed model (Scheme 1),9 the barrier calculated for the β-C elimination step from 
oxanickelacyclopentene 43 was calculated to be 46.7 kcal/mol and is therefore inaccessible. 
Alternatively, a ligand could ligate to form oxanickelacyclopentene 45 but the barrier 
calculated for the subsequent β-C elimation step is still inaccessible (46.5 kcal/mal). Therefore, 
these calculations rule out the initial formation of oxanickelacyclopentene 43 or 45 (Scheme 
13).  
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Scheme 13 The β-C elimination pathway, L = PMe3 and R = Boc 
 
As a result, the authors proposed that the oxidative insertion of the nickel complex 50 into 
azetidinone 51 will occur instead (Scheme 14). The oxidative insertion of 50 into 51 is 
calculated to be the rate determining step with a barrier of 26.8 kcal/mol. Furthermore, this 
energy barrier is far lower than the energy barrier calculated for the β-C elimination step. 
Importantly, the authors’ new mechanistic proposal is very different from the mechanism 
proposed for the [4+2] cycloaddition.9 
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Scheme 14 Oxidative insertion pathway, L = PMe3 and R = Boc 
 
Furthermore, the theoretical study also looked at the nature of the insertion of 1-
(trimethylsilyl)propyne (Scheme 15). The oxidative insertion of the nickel-complex 57 into 51 
has the same energy barrier regardless of the orientation of the alkyne. The TMS group is a 
strong π acceptor and will decrease the electron density at the carbon atom of the alkyne 
which is substituted with the methyl group. This therefore makes it more difficult for the 
carbon atom of the alkyne which is substituted with the methyl group to attack the metal 
bonded C=O carbon centre. This is reflected in the higher energy requirements to reach 
transition states 61 and 66. Therefore, the authors proposed the insertion of the silylated 
alkyne into the Ni–C bond occurs instead. Furthermore, the calculations revealed that the 
orientation of the alkyne have a significant effect on the transition state. The authors 
proposed that since the carbon atom of the alkyne which is substituted with the methyl group 
is π electron poor, it will couple with the Ni-bonded carbon better. Also, the carbon atom of 
the alkyne which is substituted with the methyl group is less sterically hindered than the 
carbon atom of the alkyne which is substituted with the TMS group. This is reflected in the 
lower energy requirements to reach transition state 67 when compared to 60. Interestingly, 
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the predicted regioselectivity of the insertion is in good agreement with the experimental 
observation.9 
 
 
Scheme 15 Insertion of 1-(trimethylsilyl)propyne 
 
The mechanism of the nickel-catalysed cycloaddition of 3-azetidinones with alkynes has yet to 
be studied experimentally. From the theoretical work of Li and Lin, the β-C elimination step is 
not a feasible step due to the high energy barrier but proposed the insertion of nickel into the 
acyl–carbon bond of azetidinone to account for the C–C bond cleavage step. On the other 
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hand, experimental work by Ogoshi and co-workers demonstrated that 
oxanickelacyclopentene are real intermediates which could be potentially present in the 
nickel-catalysed [4+2] cycloaddition. Therefore, our efforts towards the understanding of the 
mechanism of the nickel-catalysed cycloaddition of 3-azetidinones with alkynes are described. 
 
 Results and Discussion 3.2
 
 Re-optimisation of the reaction conditions  3.2.1
 
Before commencing the kinetic study, it was of interest to re-optimise the reaction conditions 
in light of different conditions reported by Louie and Murakami (Table 1).10 Furthermore, the 
reaction had to be sufficiently slow for meaningful kinetic data to be obtained. Moreover, it 
was of interest to see if the kinetic study can be carried out in toluene. This will allow the 
possibility of NMR experiments to be carried out in d8-toluene which will be far more 
economical than using d8-dioxane. It was found that the reaction is complete in 10 minutes 
when carried out at 90°C in toluene (Table 1, entry 1). Lowering the temperature of the 
reaction to 70°C and 60°C resulted in the reaction being over within 30 minutes (Table 1, entry 
2 and 3). Lowering the temperature of the reaction to 40°C resulted in 50% conversion after 
30 minutes (Table 1, entry 4). However, the rate of the reaction became too slow when the 
reaction was carried out at rt (Table 1, entry 5).  
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Table 1 Re-optimisation of the reaction conditions in toluene 
 
Entry Temp (°C) Time (mins) Conversion[a] 
1 90 10 Full 
2 70 60 Full 
3 60 30 Full 
4 40 30 ~50% 
5 rt 30 ~10% 
[a] Conversion determined from the ratio of 70 and 72 by 1H NMR 
 
The progress of the reaction for the kinetic study is monitored by the appearance of product 
by taking aliquots from the reaction vessel at specific times. However, there was an issue with 
the mass balance and it was found that either 70 could azeotrope with the solvent during 
evaporation or decompose over silica. However, when the reaction of 1 equiv. of 70 and 1.1 
equiv. of 71 is monitored until >95% conversion as judged by integration of 72 against 1 equiv. 
of triphenylethylene as an internal standard, no unexpected disappearance of 72 was 
observed (Scheme 16). This therefore validates the initial rate method used in the subsequent 
kinetic study. 
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Scheme 16 Until full conversion, 0.2M scale 
 
 Rate law with silylated alkyne 74 3.2.2
3.2.2.1 “Initial Burst” Phase 
 
A systematic study was then commenced to determine the rate law to gain insight into the 
mechanism. Initial rates were monitored by taking aliquots from the reaction mixture 
periodically and analysed by 1H NMR.  It was of interest to carry out a kinetic study of the 
cycloaddition of azetidinone 70 with silylated alkyne 74 using the re-optimised conditions 
(Scheme 17).   
 
 
Scheme 17 Kinetic study 
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On the initial attempt with 10 mol% Ni(cod)2, 30 mol% PPh3 in toluene at 40°C with 1 
equivalent of 70 and 1.1 equivalents of 73, it was discovered the trend line would not give a 
good fit if passed through the intercept at 0 (Scheme 18). Therefore, this initial burst phase in 
the reaction was looked into with more detail. Attempts to maintain the “initial burst” phase 
by slow dropwise addition of either the alkyne or a solution of alkyne and azetidinone at 40°C 
proved to be unfruitful. Therefore, a more detailed study of the “initial burst” phase was 
carried out. 
 
 
Scheme 18 Initial discovery of the initial “burst” phase 
 
Temperature effects on the initial “burst” phase were then studied (Table 2). When the first 
point was taken at 10 minutes at 40°C, there was 32% conversion to 74 (Table 2, entry 1). On 
prolonging the reaction to 60 minutes, the conversion to 74 was at 54% (Table 2, entry 2). 
Interestingly, upon lowering the reaction temperature to rt, there was 21% conversion (Table 
2, entry 3). At the 30 minute mark, the conversion increased slightly to 23 % (Table 2, entry 4). 
Analysis of the aliquot taken at the 60 minute mark revealed only 30% conversion to 74 and 
some decomposition of the starting material was observed (Table 2, entry 5). These results tell 
us that they are two phases in the reaction; an initial “burst” phase at the start of the reaction 
and the steady state phase. The steady state phase appears to be the more energetically 
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demanding of the two phases of the reaction as a high temperature was required for a 
reasonable rate. 
 
Table 2 Temperature effects on the “initial burst” 
 
Entry Temp  (°C) Time (mins) Conv. (%)[a] 
1 40 10 32 
2 40 60 54 
3 r.t. 10 21 
4 r.t. 30 23 
5 r.t. 60 30 
[a] Conversion against triphenylethylene as internal standard 
 
However, there were some issues, as different batches of commercially available azetidinone 
70 gave slightly different results despite being from the same supplier but the conclusions 
remain the same (Table 3). The first batch of azetidinone was purified by flash column 
chromatography and stored inside the glove box. Furthermore, this batch was used in the 
examples of the previous table. The second batch of azetidinone was a separate purification 
by flash column chromatography and also stored inside the glove box. As azetidinone 70 is 
known to be hygroscopic, the varying time required for the solvent evaporation might have 
influenced how much water was absorbed by the azetidinone. Regardless, both 1H NMRs of 
the purified material were identical.  
The conversion after 10 minutes under the standard conditions with batch 1 is 32% (Table 3, 
entry 1). Interestingly, the conversion after 10 seconds was 17% (Table 3, entry 2). A 20 mol% 
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PPh3 resulted in 14% conversion to 74 at 10 seconds (Table 3, entry 3). Interestingly, when the 
experiment was repeated with batch 2 of azetidinone, the conversion at 10 minutes with 30% 
PPh3 averaged out at 23% over two runs (22% and 24%) (Table 3, entry 4). Furthermore, the 
conversion at 10 minutes is lower with batch 2 when compared with batch 1 (Table 3, entry 4 
vs 1). The conversion at 10 seconds with 30 mol% PPh3 averaged out at 13% over two runs 
(12% and 13%) (Table 3, entry 5). These results confirmed the reproducibility of the reaction 
when 70 is stored correctly. The conversion at 10 seconds with 20 mol% PPh3 is 11% (Table 3, 
entry 6). On the other hand, with 10 mol% PPh3, the conversion at 10 seconds is 5% and 12% 
at 10 minutes (Table 3, entry 7 and 8). Regardless of the two batches, the results reveal the 
initial “burst” phase is extremely fast and does not appear to go much past the 10% 
conversion mark which suggests the initial “burst” phase is stoichiometric in the active metal 
complex which promotes it. The little difference in the conversion in the initial “burst” phase 
between 20 and 30 mol% PPh3 suggests 20 mol% PPh3 is sufficient for the reaction. The big 
difference in the conversion between the two batches suggests trace water could indeed have 
a negative impact on the reaction. Then it was of interest to see if the initial “burst” was 
indeed promoted by a nickel-phosphine complex. Elimination of either or both Ni(cod)2 and 
PPh3 resulted in no reaction (Table 3, entry 9- 11).  
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Table 3 A study on the initial burst 
 
Entry Ni(cod)2 (mol %) PPh3 (mol %) Azetidinone Time Conv (%) 
1 10 30 Batch 1 10  min 32 
2 10 30 Batch 1 10 sec 17 
3 10 20 Batch 1 10 sec 14 
4 10 30 Batch 2 10 min 23[a] 
5 10 30 Batch 2 10 sec 13[a] 
6 10 20 Batch 2 10 sec 11 
7 10 10 Batch 2 10 sec 5 
8 10 10 Batch 2 10 min 12 
9 0 0 Batch 2 10 min 0 
10 0 30 Batch 2 10 min 0 
11 10 0 Batch 2 10 min 0 
[a] average of two runs 
 
It was then proposed that the formation of the nickel-alkyne complex was responsible for the 
suppression of the initial “burst” phase. Therefore, a study on the effect of the alkyne loading 
on the initial “burst” phase was then commenced (Table 4). After the generation of the nickel-
phosphine catalyst, a precise amount of alkyne was then added and after another 5 minutes, 
azetidinone and the remaining alkyne (to make it a total of 1.1 equiv.) were then added.  
An initial addition of 5 mol% of alkyne gave a 13% conversion after 10 seconds (Table 4, entry 
1) and 25% conversion at 10 minutes (Table 4, entry 2). On increasing the loading of initial 
alkyne to 10 mol%, the conversion was reduced to 9% at 10 seconds (Table 4, entry 3) and 15% 
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at 10 minutes (Table 4, entry 4). When 20 mol% PPh3 was used, the conversion at 10 seconds 
was worst with 5% (Table 4, entry 5). On increasing the alkyne loading further to 20 mol%, the 
conversion was reduced further to 5% at 10 seconds and 13% at 10 minutes (Table 4, entry 6 
and 7). The conversion with 20 mol% PPh3 at 10 seconds is now minimal (Table 4, entry 8). If 
all of the alkyne was added first before the azetidinone, the conversion at 10 seconds is barely 
noticeable (Table 4, entry 9) and the conversion at 10 minutes stands at 10% (Table 4, entry 
10). This result is reproducible (Table 4, entry 11). Furthermore, carrying out the same reaction 
with 20 mol% PPh3 gave 15% conversion at 10 minutes (Table 4, entry 12). 
As noted, there is a trend linking increased initial alkyne loading with decreased levels of 
conversion. Furthermore, these results confirmed the nickel-alkyne complex is not the active 
catalyst for the initial burst. It does appear that the higher loading of phosphine gave better 
conversion for the burst phase (Table 4, entry 3 vs 5). Perhaps, the extra phosphine prevents 
the formation of a less active Ni-alkyne complex. Furthermore, after the formation of the 
nickel-alkyne complex, the lower loading of phosphine is more effective as it displayed a 
higher reactivity (Table 4, entry 12 vs 10). Also, in the steady state, the extra phosphine will 
compete for binding with the reactants and the binding is reversible. However, the role of the 
extra phosphine in the initial “burst” phase remains speculative. 
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Table 4 Effects on the concentration of alkyne on the initial “burst” phase. 
 
Entry PPh3 (mol %) Initial alkyne (mol %) Time Conv (%) 
1 30 5 10 sec 13 
2 30 5 10  min 25 
3 30 10 10 sec 9 
4 30 10 10 min 15 
5 20 10 10 sec trace 
6 30 20 10 sec 5 
7 30 20 10 min 13 
8 20 20 10 sec trace 
11 30 110 10 sec trace 
9 30 110 10 min 10 
10 30 110 10 min 8 
12 20 110 10 min 15 
 
Afterwards, a study on the stoichiometry and ratio of Ni(cod)2 and PPh3 were carried out in 
anhydrous toluene. The conversion at 10 seconds was then analysed in all cases. As mentioned 
earlier, with 10 mol% Ni(cod)2, the conversion was 12% when 30 mol% PPh3 was used (Table 5, 
entry 1) and 11% when 20 mol% PPh3 was used (Table 5, entry 2). On reducing the loading of 
Ni(cod)2 to 7.5 mol%, the conversion was reduced to 8 % with 22.5 mol% PPh3 (Table 5, entry 
3) and 7% with 15 mol% PPh3 (Table 5, entry 4). On reducing the loading of Ni(cod)2 further to 
5 mol%, the conversion was reduced more to 6% with 15 mol% PPh3 (Table 5, entry 5) and 4% 
with 10 mol% PPh3 (Table 5, entry 6).  
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Table 5 A study on the stoichiometry and ratio of Ni(cod)2 and PPh3 
 
Entry Ni(cod)2 (mol %) PPh3 (mol %) Conversion (%) 
1 10 30 12 
2 10 20 11 
3 7.5 22.5 8 
4 7.5 15 7 
5 5 15 6 
6 5 10 4 
 
Then it was of interest to see if the initial burst was suppressed by the product when 30 mol% 
PPh3 was used (Table 6). Therefore, the reaction was carried out whereby a known amount of 
pyridinone 74 is added after the formation of the active catalyst. Then after five minutes, the 
remaining reactants were then added. If the reaction was started with 20 mol% 74, the 
conversion at 10 minutes is 22% (Table 6, entry 1) which is the virtually the same as the 
reaction that was carried out without 20 mol% 74 (Table 3, entry 4). Even with a lower loading 
of 10 mol% 74, the conversion at 10 minutes remained unaffected (Table 6, entry 2). Even the 
initial “burst” phase is not affected by 74 as the conversion is 12% (Table 6, entry 3) which is 
virtually the same as the reaction that was carried without the inclusion of the product (Table 
3, entry 5). Therefore, it can be concluded that the product does not inhibit the catalyst that 
allows for the initial “burst” phase. 
 
 
193 
 
Table 6 A study on the effect of product on the initial burst 
 
Entry 74 (mol %) Time Conv. (%) 
1 20 10 mins 22 
2 10 10 mins 22 
3 10 10 secs 12 
 
3.2.2.2  Kinetic study with silylated alkyne 73 
 
The kinetic study was carried out with the method of initial rate. The kinetic study was carried 
out in a round-bottom flask under an atmosphere of Argon with triphenylethylene as an 
internal standard. Aliquots were taken from the reaction vessel at specific times, filtered over 
a plug of silica, rinsed, all volatiles removed and analysed by 1H NMR to allow the monitoring 
of the reaction.  To gain the order dependence in each reactant, the appearance of product is 
plotted vs the time as the concentration of each reactant is varied. The kinetic study was first 
carried out with a Ni(cod)2 and PPh3 ratio of 1:3 (Scheme 19). 
 
 
Scheme 19 The reaction to be studied 
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Firstly, the concentration of the azetidinone was varied while the concentration of the other 
reactants remains constant. The concentration of azetidinone varied from 0.12 – 0.24 M.  
After obtaining the rate with each concentration of azetidinone, by plotting the log(initial rate) 
against log(M), first order dependence on the azetidinone was found (Figure 1).  
 
Order in Azetidinone    Order in Alkyne 
  
y = 1.3132x – 0.8731, R2 = 0.9472  y = -0.6566x – 2.1843, R2 = 0.9243 
Order in catalyst    Eyring Plot 
  
y = 0.9092x – 0.2133, R2 = 0.9434  y = -6842x + 9.274, R2 = 0.9789 
Figure 1 Ni(cod)2 and PPh3 ratio of 1:3 
 
Secondly, the concentration of the alkyne was varied while the concentration of the other 
reactants remains constant. The concentration of alkyne was varied from 0.10 – 0.30 M.  After 
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log(M), negative first order dependence on the alkyne was found. Finally, the concentration of 
the Ni(cod)2 and PPh3 were varied but the ratio of 1:3  was kept while the concentration of the 
other reactants remains constant. The concentration of Ni(cod)2  was varied from 0.005 – 
0.025M.  The concentration of PPh3 was varied from 0.015 – 0.075M. After obtaining the rate 
with each concentration of the catalyst, by plotting the log(initial rate) against log(M), first 
order dependence in the catalyst was found. As a result, the rate law can be formulated by the 
following: 
Rate = kobs[Azetidinone]
1.3[Alkyne]-0.7[Catalyst]0.9 
An Eyring plot was then plotted to elucidate the nature of the transition state of the rate 
determining step. From the Eyring plot an equation of y = -6842x + 9.274 was obtained. ΔH is 
obtained from the following equation whereby R is gas constant (8.314 J K-1 mol-1): 
∆𝐻 = 𝑚𝑅 
 As a result, ΔH is calculated to be 56.9 kJ mol-1.  ΔS is obtained from the following equation 
whereby h is the Planck constant (6.626 x 10-34 J•s) and kB is the Boltzmann’s constant (1.38 x 
10-23 J K-1): 
𝑦(𝑥 = 0) = ln
ℎ
𝑘𝑏
+ 
∆𝑆
𝑅
 
As a result, ΔS is calculated to be -120.4 J mol K-1. Finally, the ΔG is obtained from the following 
equation: 
∆𝐺 = ∆𝐻 − 𝑇∆𝑆 
 As a result, ΔG is calculated to be 94.6 kJ mol-1 at 40°C. These data demonstrate the high pre-
organisation that exists in the transition state. From the experimental rate law, both the 
azetidinone and the catalyst are present at the rate determining step. However, a negative 
order dependence on the alkyne revealed the alkyne competes for binding to the catalyst with 
the azetidinone.  
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Before postulating a mechanism, the role of the extra phosphine was studied. The 
cycloaddition of azetidinone 70 with silylated alkyne 73 was studied using the modified 
optimised conditions of 10 mol% Ni(cod)2 and 20 mol% PPh3.  
Firstly, the concentration of the azetidinone was varied while the concentration of the other 
reactants remains constant. The concentration of azetidinone varied from 0.12 – 3.0M.  After 
obtaining the rate with each concentration of azetidinone, by plotting the log(initial rate) 
against log(M), first order dependence on the azetidinone was found (Figure 2).  
 
Order in Azetidinone    Order in Alkyne 
  
y = 1.0998x – 0.9897, R2 = 0.7419  y = -0.7672x – 2.1317, R2 = 0.9989 
Order in catalyst    Eyring Plot 
  
y = 0.7346x – 0.3768, R2 = 0.9982  y = -7287+10.981, R2 = 0.9988 
Figure 2 Ni(cod)2 and PPh3 ratio of 1:2 
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Secondly, the concentration of the alkyne was varied while the concentration of the other 
reactants remain constant. The concentration of alkyne varied from 0.10 – 0.30M.  After 
obtaining the rate with each concentration of alkyne, by plotting the log(initial rate) against 
log(M), negative first order dependence on the alkyne was found. Finally, the concentration of 
the Ni(cod)2 and PPh3 were varied but the ratio of 1:2 was kept while the concentration of the 
other reactants remained constant. The concentration of Ni(cod)2 was varied from 0.008 – 
0.025M.  The concentration of PPh3 was varied from 0.016 – 0.050M. After obtaining the rate 
with each concentration of catalyst, by plotting the log(initial rate) against log(M), first order 
dependence on the catalyst was found. As a result, the rate law can be formulated by the 
following: 
Rate = kobs[Azetidinone]
1.1[Alkyne]-0.8[Catalyst]0.7 
An Eyring plot was then plotted to elucidate the nature of the transition state of the rate 
determining step. A ΔH of 60.6 kJ mol-1, ΔS -106.3 J mol K-1 and ΔG 93.8 kJ mol-1 at 40°C were 
obtained. 
 
3.2.2.3 NMR studies 
 
A NMR study in a J-Young NMR tube was then carried out to determine if there was any 
complexation of pyridinone 74 to the catalyst (Scheme 20). Treatment of 1 equiv of Ni(cod)2 
and 3 equiv of PPh3 in d8-toluene resulted in the rapid formation of a dark-red solution 
assumed to be PPh3-nickel-complex 75. Afterwards, 74 was added and then NMR 
measurements were taken. Analysis of the 1H and 31P NMR spectra showed peaks which are 
characteristic of 74 and 75. 75 has two PPh3 and a cod ligand attached to the nickel centre 
which is formed from the displacement of the first cod ligand. In the spectra, there is a second 
peak which is assumed to be either Ni(PPh3)3 or O=PPh3. However, no formation of nickel-
product complex 76 was observed as confirmed by analysis of the 1H NMR spectra which 
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suggests that the remaining cod ligand is not readily displaced by 74. Furthermore, this reveals 
that inhibition of the catalyst by 74 is unlikely as there is no complexation of 74 to the catalyst. 
 
 
Scheme 20 Attempted study on the complexation of 74 to the catalyst  
 
A competition study between alkyne 73 and product 74 was then carried out (Scheme 21). 
After 5 minutes of stirring to form phosphine-nickel complex 75 in d8-toluene, 74 and then 73 
were added. Observation by 31P NMR showed new peaks. The peak attributed to 75 was 
completely consumed and two new peaks (40.5 ppm, d, J = 31.7 Hz and 37.9 ppm, d, J = 
31.7Hz) were there instead. Since the nickel-alkyne complex 77 is described,11 we are 
confident complex 77 is indeed formed and the product remains uncoordinated. Furthermore, 
1H NMR peaks of 74 matched with the example given above which indicates that 74 is likely to 
be uncoordinated. Furthermore, this study revealed that the displacement of the alkyne with 
74 is a very difficult process.  
 
 
Scheme 21 Competition study between product and alkyne 
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The synthesis of complex 77 began with the addition of 73 to a pre-mixed solution of Ni(cod)2 
in PPh3 in toluene (Scheme 22). After stirring for 1 hour, the suspension was filtered and all the 
volatiles were removed and washed with hexane to give 77 in a yield of 97%. 77 is also 
catalytically competent as full conversion to 74 was observed under the modified standard 
reaction conditions (Scheme 23). 
 
 
Scheme 22 Synthesis of complex 77 
 
Scheme 23 Catalysis with 10 mol% of complex 77 as catalyst 
 
A NMR study was then commenced to see if complex 77 is the active catalyst. In the kinetic 
study, a negative first order dependence in alkyne 73 was found. Therefore, 77 could lose an 
alkyne to give the active catalyst or 77 is the active catalyst which came from bis-alkyne nickel-
complex 78. To test which of the two pathways were most plausible, an attempt to force the 
formation of the bis-alkyne complex 78 by addition of 5 equivalents of 73 was made (Scheme 
24). However, no new peaks were observed in either the 31P or 1H spectra. As a result of the 
difficulty in forcing the formation of 78, the active catalyst is most likely formed by the loss of 
alkyne 73 at the rate determining step.  
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Scheme 24 Forcing the formation of complex 78 
 
Furthermore, mixing complex 78 and alkyne 79 in d8-toluene resulted in the formation of 
complex 80 and 73 as determined by 31P NMR (Scheme 25). It is likely there is an equilibration 
between 77 and 80. However, no other peaks were observed in the 31P or 1H HNMR spectra. 
Therefore, this shows the exchange of alkyne occurs faster than the “NMR timescale”. 
 
 
Scheme 25 Alkyne equilibration 
 
The formation of the oxanickelacyclopentene 81 was attempted by mixing complex 77 with 1 
equiv. of azetidinone 70 in d8-toluene (Scheme 26). However, no formation of 81 was detected 
by 1H or 31P NMR. On the other hand, there was a slow appearance of product 74. Heating the 
solution to 40°C did not significantly improve the conversion to 74. 
 
 
Scheme 26 Attempted to force the formation of oxanickelacyclopentene 
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 Revised Mechanism and Conclusion 3.3
 
In light of the kinetic study and various NMR investigations, a mechanism is proposed (Scheme 
27). Nickel-complex 77 is a resting state of the reaction and is observed experimentally. From 
the kinetic study, a negative first order dependence on the alkyne, a first order dependence on 
the azetidinone and a first order dependence on the catalyst were observed. Furthermore, the 
formation of oxanickelacyclopentene 81 and bis-alkyne complex 78 were not possible. 
Therefore, a revised mechanism was hypothesised (Scheme 26). This revealed that 77 is an 
inactive resting state and is therefore off cycle because an alkyne has to be lost. Therefore, 
complex 83 is the active catalyst which will participate in the oxidative addition in the RDS 
which will account for the first order dependence on catalyst. The addition of azetidinone at 
the RDS will account for the first order dependence on azetidinone. Finally, the loss of an 
alkyne will account for the negative first order dependence on alkyne. 
 
 
Scheme 27 Revised mechanism 
 
Based on the revised mechanism, the following equation gives the rate of the reaction which 
depends on the concentration of intermediate 83 and azetidinone 70: 
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𝑑[𝟖𝟒]
𝑑𝑡
= 𝑘2[𝟖𝟑][𝟕𝟎] 
Equation 1 
Intermediate 83 is formed by the loss of an alkyne 73 from complex 77. However, 83 is 
depleted by the reverse reaction with 83 and 73. Also, 83 is depleted in the reaction with 70. 
Therefore, the concentration of 83 will change as a function of time: 
𝑑[𝟖𝟑]
𝑑𝑡
= 𝑘1[𝟕𝟕] − 𝑘−1[𝟕𝟑][𝟖𝟑] − 𝑘2[𝟖𝟑][𝟕𝟎] = 0 
Equation 2 
By carrying out a steady state approximation whereby the concentration of 83 does not 
change with time, upon rearrangement of the previous equation, the following equation is 
attained: 
[𝟖𝟑] =
𝑘1[𝟕𝟕]
𝑘−1[𝟕𝟑] + 𝑘2[𝟕𝟎]
 
Equation 3 
Substitution of the expression for [83] into equation 1 will arrive at the following equation: 
𝑑[𝟖𝟒]
𝑑𝑡
=  
𝑘1𝑘2[𝟕𝟕][𝟕𝟎]
𝑘−1[𝟕𝟑] + 𝑘2[𝟕𝟎]
 
Equation 4 
To fit the observed order dependence of each reactant, k2[Azetidinone]<<k-1[Alkyne]. This isn’t 
surprising as 77 is observed as a resting state by NMR. As a result, the kinetic expression is 
simplified to: 
𝑑[𝟖𝟒]
𝑑𝑡
=  
𝑘1𝑘2[𝟕𝟕][𝟕𝟎]
𝑘−1[𝟕𝟎]
 
Equation 5 
Therefore the kobs is: 
𝑘𝑜𝑏𝑠 =
𝑘1𝑘2
𝑘−1
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From the kinetic studies, an alkyne is lost at the rate determining step which is different from 
what is predicted theoretically by Li and Lin.8 Furthermore, the original proposed mechanism 
is now in doubt.9 As judged by NMR studies, a nickel-complex 77 is the resting state in the 
catalytic cycle and no other intermediates are observed over the course of the reaction. Also, 
the 77 is catalytically competent. However, further tests will be necessary to determine if the 
insertion of the catalyst into the azetidinone to form 84 is a reality.  
 
 Experimental data 3.4
 Kinetic study 3.4.1
 
General procedure for all kinetic studies: Kinetic experiments were run inside an argon filled 
glovebox. Reactions were run up to about 6 – 63% conversion and the data (% product versus 
time) was analysed using the initial rates method.  
 
3.4.1.1 Kinetic study:  Ni(cod)2/PPh3 (1:3) 
 
Order in azetidinone 70: The order in 70 was determined by studying the initial rate of 
reactions with different [70]: Inside a glovebox, a round bottom flask was charged with the 
Ni(cod)2 (6.4 mg, 0.02 mmol) and PPh3 (18.4 mg, 0.07 mmol). A rubber septa was used to seal 
the round bottom flask and taken out of the glovebox. Immediately, an argon balloon was 
used to keep the round bottom flask under inert atmosphere. Toluene (0.37 ml) was then 
added via syringe. After 5 mins of stirring at rt, a solution of azetidinone (0.14 – 0.28 mmol), 
alkyne (51 μl, 0.26 mmol) and triphenylethylene (59.9 mg, 0.24 mmol) in toluene (0.80 ml) was 
added via syringe. Immediately, the round bottom flask was transferred to a pre-heated oil 
bath set at 40°C. Aliquots were taken out with a syringe from the reaction vessel at specific 
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times and immediately filtered through a plug of SiO2 and washing with Et2O. After all the 
volatiles were removed, product yield from the corresponding reaction was monitored by 1H 
NMR analysis using triphenylethylene as internal standard.  
 
 
 
0.14 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
15 1 1.0562 0.052718 
30 1 1.3201 0.065889 
46 1 1.417 0.070726 
61 1 1.55 0.077364 
[a] Integration of 1H NMR 
 
0.14 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.1063 0.055218 
20 1 1.2086 0.060324 
30 1 1.2972 0.064746 
40 1 1.3877 0.069264 
[a] Integration of 1H NMR 
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0.19 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.1291 0.056356 
20 1 1.2909 0.064432 
30 1 1.4321 0.07148 
40 1 1.5346 0.076596 
[a] Integration of 1H NMR 
 
0.19 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.2184 0.060813 
20 1 1.393 0.069528 
30 1 1.54 0.076865 
40 1 1.6863 0.084167 
[a] Integration of 1H NMR 
 
0.24 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9558 0.047706 
10 1 1.0802 0.053915 
15 1 1.1888 0.059336 
20 1 1.2925 0.064512 
[a] Integration of 1H NMR 
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0.24 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.1691 0.058353 
20 1 1.3459 0.067177 
30 1 1.5452 0.077125 
40 1 1.7202 0.085859 
[a] Integration of 1H NMR 
 
0.28 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.2562 0.0627 
20 1 1.4971 0.074724 
30 1 1.7257 0.086134 
40 1 1.9437 0.097015 
[a] Integration of 1H NMR 
 
Order in alkyne 73: The order in 73 was determined by studying the initial rate of reactions 
with different [73]: Inside a glovebox, a round bottom flask was charged with the Ni(cod)2 (6.4 
mg, 0.02 mmol) and PPh3 (18.4 mg, 0.07 mmol). A rubber septa was used to seal the round 
bottom flask and taken out of the glovebox. Immediately, an argon balloon was used to keep 
the round bottom flask under inert atmosphere. Toluene (0.37 ml) was then added via syringe. 
After 5 mins of stirring at rt, a solution of azetidinone (40 mg, 0.23 mmol), alkyne (0.12 – 0.35 
mmol) and triphenylethylene (59.9 mg, 0.13 mmol) in toluene (0.80 ml) was added via syringe. 
Immediately, the round bottom flask was transferred to a pre-heated oil bath set at 40°C. 
Aliquots were taken out with a syringe from the reaction vessel at specific times and 
immediately filtered through a plug of SiO2 and washing with Et2O. After all the volatiles were 
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removed, product yield from the corresponding reaction was monitored by 1H NMR analysis 
using triphenylethylene as internal standard.  
 
 
0.12 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
3 1 0.699 0.034889 
6 1 0.8453 0.042191 
9 1 0.9328 0.046558 
12 1 1.0085 0.050337 
[a] Integration of 1H NMR 
 
0.14 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 1.0399 0.051904 
10 1 1.2625 0.063014 
15 1 1.4081 0.070282 
20 1 1.5401 0.07687 
[a] Integration of 1H NMR 
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0.16 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9538 0.047606 
10 1 1.1166 0.055732 
15 1 1.2583 0.062805 
20 1 1.416 0.070676 
[a] Integration of 1H NMR 
 
0.26 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9558 0.047706 
10 1 1.0802 0.053915 
15 1 1.1888 0.059336 
20 1 1.2925 0.064512 
[a] Integration of 1H NMR 
 
0.26 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.1691 0.058353 
20 1 1.3459 0.067177 
30 1 1.5452 0.077125 
40 1 1.7202 0.085859 
[a] Integration of 1H NMR 
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0.35 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 0.7665 0.038258 
20 1 0.9586 0.047846 
30 1 1.1214 0.055972 
40 1 1.315 0.065635 
[a] Integration of 1H NMR 
 
Order in catalyst: The order in catalyst was determined by studying the initial rate of reactions 
with different loadings of catalyst: Inside a glovebox, a round bottom flask was charged with 
the Ni(cod)2 (0.006 – 0.029 mmol) and PPh3 (0.018 – 0.088 mmol). A rubber septa was used to 
seal the round bottom flask and taken out of the glovebox. Immediately, an argon balloon was 
used to keep the round bottom flask under inert atmosphere. Toluene (0.37 ml) was then 
added via syringe. After 5 mins of stirring at rt, a solution of azetidinone (40 mg, 0.23 mmol), 
alkyne (51 μl, 0.26 mmol) and triphenylethylene (59.9 mg, 0.23 mmol) in toluene (0.80 ml) was 
added via syringe. Immediately, the round bottom flask was transferred to a pre-heated oil 
bath set at 40°C. Aliquots were taken out with a syringe from the reaction vessel at specific 
times and immediately filtered through a plug of SiO2 and washing with Et2O. After all the 
volatiles were removed, product yield from the corresponding reaction was monitored by 1H 
NMR analysis using triphenylethylene as internal standard.  
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0.006 mmol of Ni(cod)2 and 0.018 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
15 1 0.241 0.012029 
30 1 0.3172 0.015832 
45 1 0.4066 0.020294 
60 1 0.4864 0.024277 
[a] Integration of 1H NMR 
 
0.009 mmol of Ni(cod)2 and 0.028 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 0.482 0.024058 
20 1 0.5865 0.029274 
30 1 0.6644 0.033162 
40 1 0.7298 0.036426 
[a] Integration of 1H NMR 
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0.012 mmol of Ni(cod)2 and 0.035 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 0.6853 0.034205 
20 1 0.8329 0.041572 
30 1 0.9799 0.048909 
40 1 1.1045 0.055128 
[a] Integration of 1H NMR 
 
0.018 mmol of Ni(cod)2 and 0.053 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.7479 0.03733 
10 1 0.8333 0.041592 
15 1 0.9345 0.046643 
20 1 1.0044 0.050132 
[a] Integration of 1H NMR 
 
0.023 mmol of Ni(cod)2 and 0.070 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9558 0.047706 
10 1 1.0802 0.053915 
15 1 1.1888 0.059336 
20 1 1.2925 0.064512 
[a] Integration of 1H NMR 
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0.023 mmol of Ni(cod)2 and 0.070 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.1691 0.058353 
20 1 1.3459 0.067177 
30 1 1.5452 0.077125 
40 1 1.7202 0.085859 
[a] Integration of 1H NMR 
 
0.029 mmol of Ni(cod)2 and 0.088 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 1.0452 0.052168 
10 1 1.1927 0.059531 
15 1 1.2836 0.064068 
20 1 1.4143 0.070591 
[a] Integration of 1H NMR 
 
Eyring plot: The Eyring plot was determined by studying the initial rate of reactions at different 
temperatures: Inside a glovebox, a round bottom flask was charged with the Ni(cod)2 (6.4 mg, 
0.02 mmol) and PPh3 (18.4 mg, 0.07 mmol). A rubber septa was used to seal the round bottom 
flask and taken out of the glovebox. Immediately, an argon balloon was used to keep the 
round bottom flask under inert atmosphere. Toluene (0.37 ml) was then added via syringe. 
After 5 mins of stirring at rt, a solution of azetidinone (40 mg, 0.23 mmol), alkyne (51 μl, 0.26 
mmol) and triphenylethylene (59.8 mg, 0.23 mmol) in toluene (0.80 ml) was added via syringe. 
Immediately, the round bottom flask was transferred to a pre-heated oil bath (35 – 60°C). 
Aliquots were taken out with a syringe from the reaction vessel at specific times and 
immediately filtered through a plug of SiO2 and washing with Et2O. After all the volatiles were 
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removed, product yield from the corresponding reaction was monitored by 1H NMR analysis 
using triphenylethylene as internal standard.  
 
 
At 35°C 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 0.8106 0.040459 
20 1 1.007 0.050262 
30 1 1.1739 0.058592 
40 1 1.3122 0.065495 
[a] Integration of 1H NMR 
 
At 40°C 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9558 0.047706 
10 1 1.0802 0.053915 
15 1 1.1888 0.059336 
20 1 1.2925 0.064512 
[a] Integration of 1H NMR 
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At 40°C 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.1691 0.058353 
20 1 1.3459 0.067177 
30 1 1.5452 0.077125 
40 1 1.7202 0.085859 
[a] Integration of 1H NMR 
 
At 50°C 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.2286 0.061322 
15 1 1.4619 0.072967 
20 1 1.7046 0.085081 
25 1 1.8754 0.093606 
[a] Integration of 1H NMR 
 
At 60°C 
Time (min) Int Std[a] 74[a] 74 (M) 
4 1 1.0826 0.054035 
8 1 1.4499 0.072368 
12 1 1.8064 0.090162 
16 1 2.1283 0.106229 
[a] Integration of 1H NMR 
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3.4.1.2 Kinetic Study: Ni(cod)2/PPh3 (1:2) 
 
Order in azetidinone 70: The order in 70 was determined by studying the initial rate of 
reactions with different [70]: Inside a glovebox, a round bottom flask was charged with the 
Ni(cod)2 (6.4 mg, 0.02 mmol) and PPh3 (12.3 mg, 0.05 mmol). A rubber septa was used to seal 
the round bottom flask and taken out of the glovebox. Immediately, an argon balloon was 
used to keep the round bottom flask under inert atmosphere. Toluene (0.37 ml) was then 
added via syringe. After 5 mins of stirring at rt, a solution of azetidinone (0.14 – 0.35 mmol), 
alkyne (51 μl, 0.26 mmol) and triphenylethylene (59.8 mg, 0.23 mmol) in toluene (0.80 ml) was 
added via syringe. Immediately, the round bottom flask was transferred to a pre-heated oil 
bath set at 40°C. Aliquots were taken out with a syringe from the reaction vessel at specific 
times and immediately filtered through a plug of SiO2 and washing with Et2O. After all the 
volatiles were removed, product yield from the corresponding reaction was monitored by 1H 
NMR analysis using triphenylethylene as internal standard.  
 
 
0.14 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
15 1 0.9236 0.046099 
30 1 1.1116 0.055483 
45 1 1.2627 0.063024 
60 1 1.4134 0.070546 
[a] Integration of 1H NMR 
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0.19 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.0423 0.052024 
20 1 1.239 0.061842 
30 1 1.4324 0.071495 
40 1 1.5839 0.079056 
[a] Integration of 1H NMR 
 
0.24 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9166 0.04575 
10 1 1.0727 0.053541 
15 1 1.201 0.059945 
20 1 1.3401 0.066888 
[a] Integration of 1H NMR 
 
0.28 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9595 0.047891 
10 1 1.081 0.053955 
15 1 1.1918 0.059486 
20 1 1.3045 0.065111 
[a] Integration of 1H NMR 
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0.28 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.054 0.052608 
15 1 1.1658 0.058188 
20 1 1.2516 0.06247 
25 1 1.3379 0.066778 
[a] Integration of 1H NMR 
 
0.35 mmol of 70 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 1.0044 0.050132 
10 1 1.1932 0.059556 
15 1 1.3883 0.069293 
20 1 1.5537 0.077549 
[a] Integration of 1H NMR 
 
Order in alkyne 73: The order in 73 was determined by studying the initial rate of reactions 
with different [73]: Inside a glovebox, a round bottom flask was charged with the Ni(cod)2 (6.4 
mg, 0.02 mmol) and PPh3 (12.3 mg, 0.05 mmol). A rubber septa was used to seal the round 
bottom flask and taken out of the glovebox. Immediately, an argon balloon was used to keep 
the round bottom flask under inert atmosphere. Toluene (0.37 ml) was then added via syringe. 
After 5 mins of stirring at rt, a solution of azetidinone (40 mg, 0.23 mmol), alkyne (0.12 – 0.35 
mmol) and triphenylethylene (59.8 mg, 0.23 mmol) in toluene (0.80 ml) was added via syringe. 
Immediately, the round bottom flask was transferred to a pre-heated oil bath set at 40°C. 
Aliquots were taken out with a syringe from the reaction vessel at specific times and 
immediately filtered through a plug of SiO2 and washing with Et2O. After all the volatiles were 
218 
 
removed, product yield from the corresponding reaction was monitored by 1H NMR analysis 
using triphenylethylene as internal standard.  
 
 
0.12 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
3 1 0.737 0.036785 
6 1 0.8968 0.044761 
9 1 1.0595 0.052882 
12 1 1.2026 0.060025 
[a] Integration of 1H NMR 
 
0.16 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.3263 0.066199 
15 1 1.5382 0.076775 
20 1 1.7489 0.087292 
25 1 1.9338 0.096521 
[a] Integration of 1H NMR 
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0.21 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 1.1339 0.056596 
20 1 1.4984 0.074789 
30 1 1.8289 0.091285 
40 1 2.1232 0.105974 
[a] Integration of 1H NMR 
 
0.26 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9166 0.04575 
10 1 1.0727 0.053541 
15 1 1.201 0.059945 
20 1 1.3401 0.066888 
[a] Integration of 1H NMR 
 
0.35 mmol of 73 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 0.9663 0.04823 
20 1 1.2041 0.0601 
30 1 1.4113 0.070441 
40 1 1.6508 0.082395 
[a] Integration of 1H NMR 
 
Order in catalyst: The order in catalyst was determined by studying the initial rate of reactions 
with different loadings of catalyst: Inside a glovebox, a round bottom flask was charged with 
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the Ni(cod)2 (0.009 – 0.29 mmol) and PPh3 (0.018 – 0.58 mmol). A rubber septa was used to 
seal the round bottom flask and taken out of the glovebox. Immediately, an argon balloon was 
used to keep the round bottom flask under inert atmosphere. Toluene (0.37 ml) was then 
added via syringe. After 5 mins of stirring at rt, a solution of azetidinone (40 mg, 0.23 mmol), 
alkyne (51 μl, 0.26 mmol) and triphenylethylene (59.8 mg, 0.23 mmol) in toluene (0.80 ml) was 
added via syringe. Immediately, the round bottom flask was transferred to a pre-heated oil 
bath set at 40°C. Aliquots were taken out with a syringe from the reaction vessel at specific 
times and immediately filtered through a plug of SiO2 and washing with Et2O. After all the 
volatiles were removed, product yield from the corresponding reaction was monitored by 1H 
NMR analysis using triphenylethylene as internal standard.  
 
 
0.009 mmol of Ni(cod)2 and 0.018 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 0.5215 0.026029 
20 1 0.6776 0.033821 
30 1 0.8197 0.040913 
40 1 0.9608 0.047956 
[a] Integration of 1H NMR 
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0.012 mmol of Ni(cod)2 and 0.023 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 0.5424 0.027073 
20 1 0.73 0.036436 
30 1 0.8913 0.044487 
40 1 1.0524 0.052528 
[a] Integration of 1H NMR 
 
0.018 mmol of Ni(cod)2 and 0.036 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.66 0.032942 
10 1 0.7648 0.038173 
15 1 0.8989 0.044866 
20 1 1.007 0.050262 
[a] Integration of 1H NMR 
 
0.023 mmol of Ni(cod)2 and 0.047 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9166 0.04575 
10 1 1.0727 0.053541 
15 1 1.201 0.059945 
20 1 1.3401 0.066888 
[a] Integration of 1H NMR 
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0.029 mmol of Ni(cod)2 and 0.058 mmol of PPh3 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 1.2178 0.060783 
10 1 1.3697 0.068365 
15 1 1.5592 0.077823 
20 1 1.7157 0.085635 
[a] Integration of 1H NMR 
 
Eyring plot: The Eyring plot was determined by studying the initial rate of reactions at different 
temperatures: Inside a glovebox, a round bottom flask was charged with the Ni(cod)2 (6.4 mg, 
0.02 mmol) and PPh3 (12.3 mg, 0.05 mmol). A rubber septa was used to seal the round bottom 
flask and taken out of the glovebox. Immediately, an argon balloon was used to keep the 
round bottom flask under inert atmosphere. Toluene (0.37 ml) was then added via syringe. 
After 5 mins of stirring at rt, a solution of azetidinone (40 mg, 0.23 mmol), alkyne (51 μl, 0.26 
mmol) and triphenylethylene (59.8 mg, 0.23 mmol) in toluene (0.80 ml) was added via syringe. 
Immediately, the round bottom flask was transferred to a pre-heated oil bath (35 – 60°C). 
Aliquots were taken out with a syringe from the reaction vessel at specific times and 
immediately filtered through a plug of SiO2 and washing with Et2O. After all the volatiles were 
removed, product yield from the corresponding reaction was monitored by 1H NMR analysis 
using triphenylethylene as internal standard.  
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At 35°C 
Time (min) Int Std[a] 74[a] 74 (M) 
10 1 0.8565 0.04275 
20 1 1.0764 0.053726 
30 1 1.2736 0.063569 
40 1 1.4459 0.072168 
[a] Integration of 1H NMR 
 
At 40°C 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.9166 0.04575 
10 1 1.0727 0.053541 
15 1 1.201 0.059945 
20 1 1.3401 0.066888 
[a] Integration of 1H NMR 
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At 50°C 
Time (min) Int Std[a] 74[a] 74 (M) 
5 1 0.7997 0.039915 
10 1 1.0986 0.054834 
15 1 1.3971 0.069733 
20 1 1.7018 0.084941 
[a] Integration of 1H NMR 
 
At 60°C 
Time (min) Int Std[a] 74[a] 74 (M) 
4 1 1.022 0.051011 
8 1 1.5725 0.078487 
12 1 2.0797 0.103803 
16 1 2.5262 0.126089 
[a] Integration of 1H NMR 
 
 NMR studies 3.4.2
All solvents used were stored in a schlenk or in a glovebox. All solvents were degasses prior to 
use by standard techniques. 
3.4.2.1 Product Inhibition 
Procedure: In the glovebox, a J-Young NMR tube is charged with Ni(cod)2 (3.2mg, 0.01 mmol) 
and taken out. Under Ar, dissolved in d8-toluene (0.1 ml) and a solution of PPh3 (9.2 mg, 0.04 
mmol) in d8-toluene (0.15 ml) was added. Afterwards, the contents were mixed gently. Finally, 
under Ar, a solution of 74 (8 mg, 0.2 mmol) in d8-toluene (0.3 ml) was added. Again, the 
contents were mixed gently and the NMR study was carried out at rt and 40°C. At rt: Complex 
75; 31P NMR (162 MHz, d8-tol): δ = 39.4. Ni(PPh3)3 or O=PPh3; 
31P NMR (162 MHz, d8-tol): δ = 
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24.4. At 40°C: Complex 75; 31P NMR (162 MHz, d8-tol): δ = 39.1. Ni(PPh3)3 or O=PPh3; 
31P NMR 
(162 MHz, d8-tol): δ = 24.2 
 
 
31P at rt 
 
31P at 40°C 
 
3.4.2.2  Competition Experiment 
Procedure: In the glovebox, a J-Young NMR tube is charged with Ni(cod)2 (3.2mg, 0.01 mmol) 
and taken out. Under Ar, dissolved in d8-toluene (0.1 ml) and a solution of PPh3 (9.2 mg, 0.04 
mmol) in d8-toluene (0.15 ml) was added. Afterwards, the contents were mixed gently. Finally, 
under Ar, a solution of 74 (8 mg, 0.2 mmol) in d8-toluene (0.3 ml) was added. Then, alkyne 73 
(25μl, 0.13 mmol) was added.  Again, the contents were mixed gently and the NMR study was 
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carried out at rt and 40°C. At rt: Complex 77; 31P NMR (162 MHz, d8-tol): δ = 40.5 (d, J = 31.4 
Hz), 37.9 (d, J = 31.3 Hz). Ni(PPh3)3 or O=PPh3; 
31P NMR (162 MHz, d8-tol): δ = 24.4. At 40°C: 
Complex 77; 31P NMR (162 MHz, d8-tol): δ = 40.5 (d, J = 31.3 Hz), 37.9 (d, J = 31.2 Hz). Ni(PPh3)3 
or O=PPh3; 
31P NMR (162 MHz, d8-tol): δ = 24.2. 
 
 
31P at rt 
 
31P at 40°C 
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3.4.2.3 Synthesis of 77 
 
Inside a glovebox, toluene (2.4 ml) was added to a flask containing Ni(cod)2 (100 mg, 0.36 
mmol) and PPh3 (191 mg, 0.73 mmol). After allowing the deep red solution to stir for 10 
minutes, 73 (72 μl, 0.36 mmol) was added dropwise. Allowed to stir at rt for 1 hour 
whereupon the solution became dark brown. Afterwards, all volatiles were removed. The 
orange solid was washed with hexanes (3 x 5 ml) to give a golden yellow solid (269 mg, 97%). 
This is a known compound.11; 1H NMR (500 MHz, C7C8): δ = 7.64 – 7.55 (m, 6H), 7.39 (apt t, J = 
8.5 Hz, 6H), 7.04 – 6.90 (m, 11H), 6.90 – 6.83 (m, 3H), 6.82 – 6.74 (m, 9H), -0.04 (s, 9H); 31P 
NMR (202 MHz, C7D8): δ = 40.5 (d, J = 31.5 Hz), 37.9 (d, J = 30.6 Hz) 
 
3.4.2.4 Catalytic competency of 77 
Inside a glovebox, 77 (8.8 mg, 0.01 mmol) was dissolved in d8-toluene (0.58 ml). After 5 
minutes, 70 (20 mg, 0.12 mmol), 73 (25 μl, 0.13 mmol) and 3,5-dimethoxytoluene (19.6 mg, 
0.12 mmol) were added. After 5 minutes of stirring, the contents were transferred to a J-
Young NMR tube. Taken out of the glovebox and heated at 40°C for 15 hours. NMR integration 
of the product against 3,5-dimethoxytoluene as an internal standard revealed full conversion. 
 
3.4.2.5 Reaction of 77 with excess 73 
Inside a glovebox, 77 (8.8 mg, 0.01 mmol) was dissolved in d8-toluene (0.58 ml). Afterwards, 
73 (11.5 μl, 0.06 mmol) was added. After 5 minutes of stirring, the contents were transferred 
to a J-Young NMR tube. No change in the 1H and 31P NMR spectra was observed between rt 
and 40°C. 
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3.4.2.6 Reaction of 77 with excess 79 
Inside a glovebox, 77 (8.8 mg, 0.01 mmol) was dissolved in d8-toluene (0.58 ml). Afterwards, 
73 (10.4 mg, 0.06 mmol) was added. After 5 minutes of stirring, the contents were transferred 
to a J-Young NMR tube. From the 31P NMR spectra, the appearance of 80 is found at rt and at 
40°C. Complex 80 is a known compound.11 At rt: Complex 77; 31P NMR (202 MHz, d8-tol): δ = 
40.5 (d, J = 30.9 Hz), 37.9 (d, J = 30.4 Hz). Complex 80; 31P NMR (202 MHz, d8-tol): δ = 39.8. At 
40°C: Complex 77; 31P NMR (202 MHz, d8-tol): δ = 40.5 (d, J = 31.1 Hz), 37.9 (d, J = 31.6 Hz). 
Complex 80; 31P NMR (202 MHz, d8-tol): δ = 39.8. 
 
 
31P at rt 
 
31P at 40°C 
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31P at 40°C - zoomed out 
 
3.4.2.7 Reaction of 77 with 70 
Inside a glovebox, 77 (8.8 mg, 0.01 mmol) was dissolved in d8-toluene (0.58 ml). Afterwards, 
70 (4.5 mg, 0.03 mmol) was added. After 5 minutes of stirring, the contents were transferred 
to a J-Young NMR tube. No change was observed in the 31P NMR. By 1H NMR spectra, the 
appearance of 74 is found at rt and at 40°C but trace conversion was found after 1 hour at 
40°C. 
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 Transition Metal-Catalysed Chapter 4
Functionalisation of an Alkene C–H 
Bond with another Alkene 
 
 Introduction 4.1
 
 Transition metal-catalysed activation and subsequent transformation of aromatic C–H bonds 
is an area of research which has experienced a rapid rate of growth.1 Hydrovinylation reactions 
using ethylene to functionalised alkene C–H bonds have been well documented and won’t be 
covered in this review.2 Furthermore, homo co-dimerisation of alkenes will not be covered.3 
However, transition metal-catalysed C–H functionalisation of an alkene with another different 
alkene has been less studied. Regardless, several modes of C–H functionalisation of an alkene 
with another different alkene by a transition metal have been postulated to occur to account 
for the products observed. Oxidative cyclisation, in situ generation of the metal hydride and C–
H bond activation are three modes of C–H functionalisation commonly postulated. 
For example, Mitsudo and co-workers reported a ruthenium-catalysed codimerisation of 
norbornenes 1 with various Michael acceptors 2 to give products 3 and 4.4 The reaction 
generally proceeded in a trans-selective manner. The authors then proposed three pathways 
to account for the results of the reaction. Path A is the oxidative cyclisation which would form 
ruthenacycle 5. Then β-H elimination would form intermediate 6. Afterwards, reductive 
elimination would give mainly 3.  
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Path B is the addition of the in situ generated ruthenium hydride across the alkene of 
norbornene 1 which would form intermediate 7. Insertion of alkene 2 would form 
intermediate 8. Finally reductive elimination would afford product 3.  
Lastly, path C is the carbonyl-directed C–H activation pathway which would form intermediate 
9. Hydrometallation across the alkene of norbornene 1 would afford intermediate 10. Finally, 
reductive elimination would afford product 4. However, path C was postulated to be unlikely 
as products of the C–H activation pathway would have been predominantly cis-products 4. 
This methodology allowed the codimerisation of various norbornenes with various Michael 
acceptors to proceed in good to high yields with good to excellent trans-selectivity. 
 
 
Scheme 1 Ruthenium catalysed codimerisation of norbornenes with various Michael acceptors 
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 Formation of a metallacycle intermediate via oxidative cyclisation 4.1.1
 
Hirano and co-workers reported a ruthenium-catalysed asymmetric codimerisation of methyl 
methacrylate 11 with various alkenes.5 It was observed that the codimerisation of methyl 
methacrylate 11 with alkene 12 proceeded to give 13 in high yields and with high 
enantioselectivity (Scheme 2). Furthermore, three other products 14-16 were also identified. 
To account for the formation of the four products, the authors proposed that the initial 
oxidative cyclisation would form intermediate 17. Then the major product 13 would then 
come about from the endo β-H elimination which would form intermediate 18. Reductive 
elimination would then afford product 13. However, exo β-H elimination from the methyl 
group would form intermediate 19. Reductive elimination would then afford product 14. 
Alternatively, β-H elimination from the tetrahydrofuran core would result in the formation of 
intermediate 20. Finally, reductive elimination would then afford product 15. However, the 
formation of 16 is currently speculative. 
 
234 
 
 
Scheme 2 Ruthenium catalysed asymmetric codimerisation of methyl methacrylate with 
various alkenes 
 
Ogoshi and co-workers reported a nickel-catalysed direct conjugate addition of simple alkenes 
22 to enones 21 to form product 23 (Scheme 3).6 The nickel catalyst would pre-organise alkene 
22 and enone 21 to form intermediate 24. Afterwards, oxidative cyclisation would afford 
intermediate 25. β-H elimination would afford intermediate 26. Finally, reductive elimination 
would then afford product 23. This methodology allowed the synthesis of various conjugate 
addition products in good to high yields. Furthermore, potentially isomerisable alkenes were 
employed successfully.  
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Scheme 3 Nickel-catalysed direct conjugate addition of simple alkenes to enones 
 
 In situ formation of metal hydride 4.1.2
 
Kondo and co-workers reported a ruthenium-catalysed codimerisation reaction of alkenes 28 
with N-vinylamides 27 (Scheme 4).7 After the in situ formation of the putative ruthenium 
hydride, it would then add across alkene 28 to form intermediate 30. The chelation assisted 
insertion of N-vinylamide 27 would form intermediate 31. Then β-H elimination would 
proceed to give product 29. Electron deficient alkenes dimerised with N-vinylamide in good to 
high yields with excellent E-selectivity. However, norbornene or ethene dimerised with N-
vinylamide in poor yields (33% and 16% respectively) but with excellent E-selectivity.  
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Scheme 4 Ruthenium-catalysed codimerisation reaction of alkenes with N-vinylamides 
 
Zhou and co-workers reported a ruthenium-catalysed dimerisation of N-acetyl α-arylenamines 
32 with acrylates 33 to form product 34 (Scheme 5).8 Though there was no mechanistic 
proposal by the authors, N-acetyl α-arylenamine 32 could direct the ruthenium hydride in a 
regioselective manner to form intermediate 35. The coordination of alkene 33 to the metal 
centre would then form intermediate 36. Afterwards, migratory insertion would form 
intermediate 37. Finally, reductive elimination would occur to give product 34. Various N-
acetyl α-arylenamines with different functional groups on the phenyl ring dimerised with 
various acrylates in usually high yields with excellent E-selectivity. 
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Scheme 5 Ruthenium catalysed dimerisation of N-acetyl α-arylenamines with acrylates 
 
 C–H bond activation 4.1.3
4.1.3.1 Oxidative cross coupling 
 
Ishii and co-workers reported a palladium-catalysed oxidative cross coupling of acrylates 38 
with enol acetate 39 to form diene 40.9 It is postulated the palladium catalyst would react with 
enol acetate 39 to form intermediate 41 with concomitant loss of acetic acid. As a comparison, 
C–H bond activation with a Pd(0) catalyst would form a palladium hydride complex. Acrylate 
38 would then insert itself into the Pd–C bond of intermediate 41 to give intermediate 42. 
Finally, β-H elimination would afford product 40. The oxidative cross coupling between a 
variety of acrylates and a variety of enol acetates proceeded in good yields but usually with 
poor E/Z selectivity. 
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Scheme 6 Palladium catalysed oxidative cross coupling of acrylates with enol acetate 
 
Loh and co-workers demonstrated the first example of a direct cross coupling reaction 
between simple alkenes 43 and acrylates 44 (Scheme 7).10 Palladium-catalysed C–H activation 
of simple alkene 43 would form intermediate 46. Acrylate 44 would then insert itself into the 
Pd–C bond of intermediate 46 to give intermediate 47. Finally, β-H elimination would afford 
product 45. A wide range of 2-substituted alkenes 43 were compatible. Generally, the reaction 
was selective for the E-isomer but non-styrene type alkenes were not as stereoselective. Later, 
the same group expanded the scope of the palladium catalysed direct cross coupling of 
indenes with various electron deficient alkenes.11 
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Scheme 7 Palladium catalysed cross coupling between simple alkenes and acrylates 
 
Miura and co-workers reported a rhodium-catalysed oxidative cross-dimerisation of acrylic 
acids 48 with acrylates 49 to form butenolide 50 (Scheme 8).12 It was proposed the carboxylic 
acid of 48 would direct the rhodium catalyst for β C–H activation to form rhodacycle 51. 
Subsequent alkene insertion would form intermediate 52. This would then be followed by β-H 
elimination to give intermediate 53. This intermediate would then undergo nucleophilic 
cyclisation to afford butenolide 50. A variety of butenolides 50 were synthesised in generally 
good yields. However, in certain cases a slight modification of reaction conditions was 
required for higher yields. 
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Scheme 8 Rhodium catalysed oxidative cross-dimerisation of acrylic acids with acrylates 
 
4.1.3.2 Group directed C–H activation 
 
In the 1970s, Yamamoto and co-workers reported the first experimental evidence of an 
oxidative addition of ruthenium complex 54 into the C–H of alkene 55 to generate ruthenium 
complex 56 (Scheme 9).13 Complex 56 was fully characterised and an X-Ray crystal structure 
was obtained. The X-Ray revealed the coordination of the carbonyl moiety to the ruthenium 
complex which could suggest that the carbonyl moiety directed ruthenium complex 63 into 
the cis-C–H alkene bond. 
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Scheme 9 Experimental evidence of group-directed C–H activation 
 
In 1995, Trost and co-workers reported the first catalytic functionalisation of an alkene C–H 
bond with another alkene via group directed C–H bond activation (Scheme 10).14 It is 
remarkable that methyl benzoate failed to couple with an alkene under the optimised reaction 
condition. In an attempt to elucidate the mechanism, the resting state of the catalyst was 
found to have no hydrogen as deduced by NMR. Furthermore, carrying the reaction under an 
atmosphere of CO inhibited the reaction which suggests no CO is likely to be ligated onto the 
active catalyst. Furthermore, if the β-C-H bond is trans to the carbonyl group, no reaction was 
observed.  
Therefore, it was proposed that the conjugated carbonyl moiety of 57 would direct the 
catalyst into the syn-C–H alkene bond to give intermediate 60. Afterwards, 60 would 
coordinate to alkene 58 to form intermediate 61. Migratory insertion of the alkene would 
form intermediate 62. Finally, reductive elimination would afford product 59. It was 
demonstrated that the ester functional group is a better directing group than a ketone. 
Furthermore, various functional groups on the ester were tolerated under the reaction 
conditions. Independently, Murai and co-workers reported similar observations15 and later 
demonstrated that an aldehyde can behave as a directing group16. 
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Scheme 10 Ruthenium catalysed functionalisation of an alkene C–H bond with another alkene 
 
Since then, several groups have reported examples whereby group directed C–H bond 
activation is postulated to occur. For example, Darses and co-workers reported a ruthenium-
catalysed functionalisation of the syn C–H bond of Michael acceptors 63 with vinyl silanes 64 
to form either 65 or 66 (Scheme 11).17 For the synthesis of 65, it was proposed that the 
carbonyl moiety of 63 would direct the ruthenium catalyst into the cis-C–H alkene bond to give 
intermediate 67. Afterwards, 67 would hydrometallate onto alkene 64 to form intermediate 
68. Finally, reductive elimination and dissociation of the ruthenium catalyst would occur to 
afford product 65. For the synthesis of 66, after the formation of putative intermediate 68, 
conjugate addition of the alkyl silane moiety would form intermediate 69. Then β-H 
elimination would happen to form intermediate 70. Afterwards, reductive elimination and 
keto-enol tautomerism would then occur to afford product 66. While most substrates couple 
in a similar manner to the examples observed by Trost14 and Murai15 to form silane 65, crotyl 
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substrates 63 would couple with vinyl silanes 64 to give rise to products 66 with a 
stereodefined trisubstituted allyl silanes (E/Z > 97 : 3 in all examples). 
 
 
Scheme 11 Ruthenium catalysed functionalisation of an alkene C–H bond with another alkene 
with differing reactivity 
 
Another way to direct the functionalisation of the cis-C–H bond of Michael acceptors is 
through temporary chelation assistance. Jun and co-workers reported a rhodium-catalysed 
chelation assisted C–H bond activation of Michael acceptors 71 for β-alkylation (Scheme 12).18 
Control experiments supported the presence of dienamine 75 for the chelation assisted C–H 
bond activation. Therefore it is proposed that after the formation of the putative dienamine 
75, the nitrogen would direct the rhodium catalyst for C–H bond activation to form 
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intermediate 76. Afterwards, migratory insertion of the alkene would form intermediate 77. 
Finally reductive elimination would afford intermediate 78 which would equilibrate with 
intermediate 79. Finally, acid hydrolysis would afford a mixture of products 73 and 74. 
Furthermore, the deconjugation likely happened during the rhodium catalysis step rather than 
at the hydrolysis step. Various β alkylation products were synthesised in good to high yields 
with moderate to high selectivity for the deconjugated product. 
 
 
Scheme 12 Rhodium catalysed chelation assisted C–H bond activation 
 
Bergman and co-workers reported a rhodium-catalysed reaction whereby an imine can behave 
as a directing group (Scheme 13).19 It was found that α,β-unsaturated imines 80 can be 
alkylated with simple alkenes 81 via C–H activation in a highly stereoselective manner when 
both a rhodium catalyst and an electron-donating ligand were used. Therefore, it is proposed 
that the imine would direct the rhodium catalyst into the alkene C–H bond to form 
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intermediate 84. Afterwards, migratory insertion of the alkene would form intermediate 85. 
Finally, reductive elimination and hydrolysis would afford products 82 and 83. While the β-
alkylation is initially Z-selective, the hydrolysis resulted in some isomerisation of the double 
bond. Nonetheless, the process is generally high yielding whereby even alkenes with β-Hs can 
be incorporated successfully. Furthermore, the same group later applied the methodology as a 
key step in the total synthesis of (-)-Incarvillateine 89.20 
 
 
Scheme 13 Rhodium catalysed β alkylation 
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Scheme 14 Synthesis of (-)-Incarvillateine with C–H bond as the key step 
 
In contrast to chelation assisted C–H bond activation for β-alkylation as mentioned previously, 
Dong and Mo reported a rhodium-catalysed chelation assisted C–H bond activation for α-
alkylation (Scheme 15).21 After the formation of the putative enamine, group directed C–H 
activation would afford intermediate 92. Afterwards, the coordination of an alkene would 
form intermediate 93. Next, migratory insertion of the alkene would afford intermediate 94. 
Reductive elimination and hydrolysis would afford product 91. The α-alkylation proceeded in 
good yields and a wide range of functional groups substituted on the cyclopentanone were 
tolerated.  
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Scheme 15 Rhodium catalysed chelation assisted C–H bond activation for α alkylation. 
 
Another directing group used to direct the transition metal into the cis-C–H bond of the alkene 
is pyridine. Kim and co-workers reported a rhodium-catalysed pyridine directed C–H 
activation.22 Alkylation of vinyl pyridines 95 is believed to be Z-selective but under the reaction 
conditions, some isomerisation took place which suggests another reaction pathway could be 
taking place (Scheme 16). Pyridine directed C–H activation would afford intermediate 98. After 
the initial alkene coordination which would form intermediate 99, migratory insertion would 
form intermediate 100. Finally, reductive elimination would afford product 97. The alkylation 
proceeded with a variety of alkenes in generally excellent yields and with moderate to good 
trans-selectivity. Furthermore, this methodology was extended to functionalisation of the vinyl 
pyridine with norbornene23 and allyl ethers.24 
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Scheme 16 Rhodium catalysed pyridine directed C–H activation 
 
Lim and co-workers reported striking ligand effects in the rhodium-catalysed reaction of 2-
vinylpyridines 101 with 1,5-hexadiene 102 (Scheme 17).25 Carrying out the reaction with the 
Wilkinson’s catalyst gave a mixture of three products. Switching the catalyst source to 
[Rh(coe)2Cl]2 and 20 mol% PPh3 did not alter the selectivity of the reaction. On exchanging the 
ligand to 20 mol% PCy3, selective formation of functionalised alkene 105 was observed. 
Furthermore, it was found that other ligands altered the selectivity of the reaction. The small 
electron poor phosphine, P(OMe)3, gave mostly product 106 whereby the alkylation occurs on 
the same side as the pyridine (Scheme 18).  Furthermore, P(nBu)3 gave mostly product 107 
whereby the alkylation occurs predominantly on the same side as the pyridine (Scheme 19). 
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Scheme 17 Rhodium catalysed reaction of 2-vinylpyridine with 1,5-hexadiene 
 
Scheme 18 Rhodium catalysed reaction of 2-vinylpyridine with 1,5-hexadiene 
 
Scheme 19 Rhodium catalysed reaction of 2-vinylpyridine with 1,5-hexadiene 
 
Murai and co-workers reported a rhodium-catalysed intramolecular pyridine directed C–H 
activation with concomitant alkene insertion to form cyclic structures.26 A three carbon unit 
tether 108 resulted in the non-selective formation of six-membered ring 109 and five-
membered ring 110 (Scheme 20). It was postulated that the pyridine directed C–H bond 
activation would form intermediate 111 and then the insertion of the alkene could then 
proceed to give heptarhodacycle 112. Then reductive elimination would give product 109. 
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Alternatively, the insertion of the alkene could proceed to give hexarhodacycle 113 which 
would then undergo reductive elimination to give product 110.  
A two carbon tether 114 resulted in the selective formation of five-membered ring 115 
(Scheme 21). It was proposed that the pyridine directed C–H bond activation would occur to 
form intermediate 116. Afterwards, the insertion of the alkene would then proceed to give 
hexarhodacycle 117. Subsequently, reductive elimination would then occur to give product 
115. The formation of various five-membered rings were synthesised in good to high yields. 
Furthermore, various substitutions on the alkene were tolerated. 
 
 
Scheme 20 Rhodium catalysed intramolecular C–H activation with concomitant alkene 
insertion 
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Scheme 21 Rhodium catalysed intramolecular C–H activation with concomitant alkene 
insertion 
 
Aïssa and Fürstner reported a rhodium-catalysed C–H / C–C bond activation sequence to form 
seven-membered rings 119 (Scheme 22).27 Initial C–H activation with a neutral rhodium 
catalyst would form intermediate 120. Hydrometalation onto an ACP would form 
pentarhodacycle 121. Subsequently, the C–C bond cleavage of the cyclopropane would result 
in a ring enlarged metallacycle 122. Finally, reductive elimination would furnish product 119. 
While the yields were generally moderate to good, it offered a proof of concept of a tandem 
catalytic C–H / C–C bond activation sequence. 
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Scheme 22 Rhodium-catalysed C–H / C–C bond activation sequence to form seven-membered 
rings 
 
 Aims and Hypothesis 4.2
 
Transition metal-catalysed C–H functionalisation of an alkene with another alkene is an area of 
increasing research. This had to lead to the discovery of various modes of activation. Though 
C–H activation by a directing group has been studied extensively, oxidative cyclisation and 
exploitation of in situ generated metal hydrides have contributed to the diversity of products 
generated. 
As mentioned earlier, Aïssa and Fürstner reported a rhodium-catalysed C–H / C–C bond 
activation sequence to form seven-membered rings whereby C–C bond activation is used to 
trap the intermediate formed by the reversible hydrometalation (Scheme 22).27 
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Therefore, it was of interest to determine if there was another way to trap the intermediate 
formed by the reversible hydrometalation. With that in mind, it was postulated a tethered 
alkene could trap the proposed intermediate and to form bicyclo[2.2.1]heptane 125 (Scheme 
23). 
 
 
Scheme 23 Hypothesis 
 
In this context, the aim of the work presented herein is to: 
a.) Synthesise a substrate of type 123 
b.) Optimise the reaction and determine the scope 
c.) Investigate the mechanism of the reaction 
 
 Optimisation of the reaction 4.3
 
Vinyl pyridine 126 was used as a model substrate to test the hypothesis (Table 1). Treating 126 
with 5 mol% [Rh(cod)2Cl]2 in THF at 90°C for 17 hours did not proceed to give the desired 
product 127 but with 33% conversion to the five-membered ring 128. However, when 10 
mol% P(pOMePh)3 was used as a ligand, the formation of 127 was observed despite 
incomplete conversion. When the loading of ligand was increased to 20 mol%, full 
consumption of the 126 was observed with improved selectivity towards 127. However, the 
two products were not separable by standard flash column chromatography. This necessitated 
a need to optimise the reaction to achieve a selectivity to 127 of >95:5. 
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The alkene geometry of starting material 127 was discovered to affect product selectivity. 
When 126 was synthesised by the Wittig method, a variable cis/trans mixture of 126 was 
observed (91:9). Using the cis/trans mixture of 126 resulted in the formation of 127 and 128 in 
ratio of 83:17 under the rhodium catalysis. On the other hand, when 126 was synthesised by 
another method (see synthesis of precursor) to give selectively the E-isomer, improved 
selectivity towards 127 was observed. However, the increase in phosphine loading did not 
improve the selectivity towards 127. Therefore, the method that gave pure E-126 was used in 
the subsequent screenings.  
 
Table 1 Initial optimisation 
 
Entry E:Z ratio of 126 Ligand mol % Conv.[a] Ratio (127:128)[b] 
1 >95:5 No  33% 5:>95 
2 91:9 P(pOMePh)3 10 70% 58:42 
3 91:9 P(pOMePh)3 20 >95% 83:17 
4 >95:5 P(pOMePh)3 20 >95% 92:8 
5 >95:5 P(pOMePh)3 30 >95% 90:10 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
 
Afterwards, it was of interest to see if other rhodium catalysts could provide better selectivity 
towards 126 (Table 2). With 10 mol% [Rh(cod)2)BF4 and 10 mol% P(pMeOC6H4)3 (Table 2, Entry 
1), the starting material was completely consumed but the selectivity between the 127 and 
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128 was the same as with 5 mol% [Rh(cod)Cl]2 and 20 mol% P(pMeOC6H4)3. Increasing the 
phosphine loading to 20 mol% (Table 2, entry 2) improved the selectivity towards 127 slightly 
but the overall conversion was reduced. Increasing the phosphine loading to 30 mol% (Table 2, 
entry 3) eroded the selectivity when compared to with 20 mol% phosphine and the overall 
conversion was barely improved. Furthermore, the catalytic system of 5 mol% [Rh(CO)2Cl]2 and 
10 mol% P(pMeOC6H4)3 (Table 2, Entry 4) was completely ineffective and no conversion was 
observed.  Carrying out the reaction with an increased phosphine loading of 20 mol% 
P(pMeOC6H4)3 (Table 2, entry 5) or 30 mol% P(pMeOC6H4)3 (Table 2, entry 6) were equally 
ineffective as both conditions resulted in no conversion of the starting material. 
 
Table 2 Rhodium catalyst 
 
Entry Rh. cat. mol % Ligand (mol %) Conv.[a] Ratio (127:128)[b] 
1 [Rh(cod)2]BF4 10 10 >95% 88:12 
2 [Rh(cod)2]BF4 10 20 88% 91:9 
3 [Rh(cod)2]BF4 10 30 91% 88:12 
4 [Rh(CO)2Cl]2 5 10 0 N/A 
5 [Rh(CO)2Cl]2 5 20 0 N/A 
6 [Rh(CO)2Cl]2 5 30 0 N/A 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
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A study on the temperature effects on the selectivity of 127 and 128 with 5 mol% [Rh(cod)Cl]2 
and varying mol% of P(pMeOC6H4)3
  was then commenced (Table 3). When the reaction was 
carried out with 10 mol% P(pMeOC6H4)3
  at 110°C (Table 3, entry 1), the selectivity towards 
127 is significantly eroded. This erosion was remedied by increasing the phosphine loading to 
20 mol% P(pMeOC6H4)3
  (Table 3, entry 2) which improved the selectivity towards 127, albeit 
the selectivity remained slightly poorer than in the case of the reaction carried out at 90°C 
(Table 1, entry 4). However, when the temperature of the reaction was reduced to 70°C (Table 
3, entry 3), the conversion dropped significantly and the five-membered ring 128 is formed 
with high selectivity. 
 
Table 3 Temperature effects 
 
Entry Ligand (mol %) Temp (°C) Conv.[a] Ratio (127:128)[b] 
1 10 110 >95% 65:35 
2 20 110 >95% 87:13 
3 20 70 18% 5:>95 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
 
Intrigued by the sudden drop of reactivity when the reaction was carried out at 70°C, it was 
assumed the rhodium concentration was simply too low. Therefore, the concentration of the 
reaction was increased to 100mM from 50mM and a screening of different temperatures was 
carried out (Table 4). Carrying the reaction out at 90°C gave complete conversion with good 
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selectivity of 89:11 for 127 (Table 4, entry 1). When the temperature was reduced to 70°C, the 
conversion vastly improved from 18% to 91% (Table 3, entry 3 vs Table 4, entry 2 and the 
selectivity towards 127 improved to 92:8. Lowering the temperature further to 60°C lowered 
the conversion but the selectivity towards 127 is fractionally better (Table 4, entry 3). 
 
Table 4 Temperature effects at 100mM 
 
Entry Temp (°C) Conv.[a] Ratio (127:128)[b] 
1 90 >95% 89:11 
2 70 91% 92:8 
3 60 55% 93:7 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
 
A screen of different ligands was then carried out to see if the selectivity towards 127 could be 
increased further (Table 5). Furthermore, as the conversion at 60°C was very low, the screen 
was carried out at 70°C. When the reaction was carried out with 20 mol% PPh3, there was full 
conversion and the selectivity was found to be 90:10. Modifications of the phenyl ring which 
made the phosphine more electron deficient resulted in the reaction to proceed with lower 
conversion but the selectivity remained unaffected (Table 5, entry 2 and 3). However, electron 
deficient P(2-furyl)
3
 (Table 5, Entry 4) proved to be an exception with full conversion and 
slightly improved selectivity towards 127 of 91:9. On the other hand, modification of the 
phenyl ring which made the phosphine more electron rich resulted in the reaction to proceed 
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with excellent to full conversion and with a selectivity of 91:9 (Table 5, entry 5 and 6). It was 
noted that a phosphine with a large cone angle is an ineffective ligand (Table 5, entry 7). 
Substitution of a phenyl ring with a cyclohexyl group gave poor conversion and reduced the 
selectivity towards 127 (Table 5, entry 8). Replacement of another phenyl ring with a 
cyclohexyl group gave poor conversion and the reaction is now more or less non-selective 
(Table 5, entry 9). These last two results suggest that incremental increase in the cone angle is 
detrimental to the rate of reaction and selectivity for 127. Electron poor triphenyl phosphite is 
an ineffective ligand (Table 5, entry 10). Furthermore, hemi-lable ligand JohnPhos is also an 
ineffective ligand (Table 5, entry 11). 
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Table 5 Ligand Screen 
 
Entry Ligand mol % Conv.[a] Ratio (127:128)[b] 
1 PPh3 20 >95% 90:10 
2 P(pCF3Ph)3 20 80% 90:10 
3 P(pClPh)3 20 68% 91:9 
4 P(2-furyl)3 20 >95% 91:9 
5 P(3, 5-xylyl)3 20 >95% 91:9 
6 P(p-tol)3 20 93% 91:9 
7 P(o-tol)3 20 0 n/a 
8 PPh2Cy 20 32% 68:32 
9 PPhCy2 20 40% 55:45 
10 P(OPh)3 20 0 n/a 
11 JohnPhos 10 0 n/a 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
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After the identification of ligands which displayed excellent conversion and selectivity, they 
were then tested with the temperature of the reaction reduced to 60°C (Table 6). It was 
previously found that 20 mol% P(pMeOC6H4)3 at 60°C resulted in a conversion of 55% and with 
a selectivity of 93:7. Interestingly, carrying out the reaction with PPh3 gave 87% conversion 
and a selectivity of 91:9 (Table 6, Entry 1). P(3, 5-xylyl)3 is an effective ligand with excellent 
conversion and with an even better selectivity of 93:7 (Table 6, Entry 2). The electron poor 
P(2-fur)2 also proved to be an effective ligand with excellent conversion and with a selectivity 
of 92:8 (Table 6, Entry 3). However, P(ptol)3 proved to be ineffective at 60°C as the conversion 
was reduced from 93% at 70°C to 29%. Furthermore, the selectivity dropped from 91:9 to 
65:35 (Table 6, Entry 4). This result appears to indicate if the rate of formation of 127 is slowed 
down, then the formation of five-membered ring 128 becomes more noticeable. 
 
Table 6 Selected ligands at 60°C 
 
Entry Ligand Conv.[a] Ratio (127:128)[b] 
1 PPh3 87% 91:9 
2 P(3, 5-xylyl)3 92% 93:7 
3 P(2-furyl)3 91% 92:8 
4 P(ptol)3 29% 65:35 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
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A change of model substrate to 129 was then decided and was used to continue the 
optimisation as we became interested if 126 was the optimal substrate for the methodology. 
Phosphines P(3, 5-xylyl)3 and P(2-furyl)3 were chosen because both ligands gave excellent 
conversion and good selectivity for 127 at 60°C (Table 7). However, carrying out the reaction 
with 5 mol% [Rh(cod)Cl]2 and 20 mol% P(3, 5-xylyl)3  gave poor conversion and poor selectivity 
which appears to confirm that the new substrate might be more challenging than the original 
substrate (Table 7, entry 1). Using 20 mol% P(2-furyl)3 gave even worst conversion and the 
selectivity of the reaction becomes in favour of 130 (Table 7, entry 2). On changing the source 
of rhodium catalyst to 5 mol% [Rh(coe)2Cl]2 and with 20 mol% P(3, 5-xylyl)3  gave a much 
improved conversion of 86% but the selectivity remains poor (Table 7, entry 3). Using 20 mol% 
P(2-furyl)3 did not improve the conversion and the reaction becomes non-selective (Table 7, 
entry 4). 
 
Table 7 Rhodium and Phosphine screen 
 
Entry Rh cat. Ligand Conv.[a] Ratio (130:131)[b] 
1 [Rh(cod)Cl]2 P(3, 5-xylyl)3 35% 56:44 
2 [Rh(cod)Cl]2 P(2-furyl)3 16% 37:63 
3 [Rh(coe)2Cl]2 P(3, 5-xylyl)3 86% 56:44 
4 [Rh(coe)2Cl]2 P(2-furyl)3 64% 48:52 
[a] Conversion based on ratio of 129 against the combined ratio of 130:131 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
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After the identification of P(3, 5-xylyl)3 as the ideal ligand, a screen of different solvents was 
carried out to determine if the selectivity towards 130 could be improved further (Table 8). 
Non-polar toluene gave a conversion of 82% but there was almost no selectivity (Table 8, entry 
1). Polar acetone gave a conversion of 79% but, there was no selectivity (Table 8, entry 2). The 
more polar MeCN gave no conversion which could be because of the increased coordinating 
capability of MeCN which could render the catalyst inactive (Table 8, entry 3). The polar and 
protic iPrOH gave full conversion and with a selectivity for 130 of 75:25 (Table 8, entry 4). 
Interestingly, if HPLC grade iPrOH was used, full conversion was observed and the selectivity 
towards 130 improved slightly to 78:22 (Table 8, Entry 5). Using EtOH which came from a 
bottle exposed to air and moisture gave a conversion of 85% but the selectivity towards 130 
improved further to 82:18 (Table 8, Entry 6). Using MeOH which came from a bottle exposed 
to air and moisture gave only a conversion of 52% but the selectivity towards 130 increased to 
84:16 (Table 8, Entry 7). Interestingly, when dry methanol was used instead, the conversion 
lowered to 29% and the selectivity towards 130 dropped to 73:27 (Table 8, Entry 8). This 
suggests that trace water or air is actually beneficial to the selectivity towards 130. 
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Table 8 Solvent Screen 
 
Entry Solvent Conv.[a] Ratio (130:131)[b] 
1 Toluene 82% 45:55 
2 Acetone 79% 47:53 
3 MeCN 0% n/a 
4 iPrOH >95% 75:25 
5 iPrOH (HPLC) >95% 78:22 
6 EtOH (GPR grade) 85% 82:18 
7 MeOH (GPR grade) 52% 84:16 
8 MeOH 29% 73:27 
[a] Conversion based on ratio of 129 against the combined ratio of 130:131 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
 
Due to the lack of selectivity towards 130 with model substrate 129, full characterisation of 
130 was not carried out. Furthermore, 130 and 131 could not be separated by flash column 
chromatography. As a result, a screen of different solvents with the original substrate 126 was 
then investigated (Table 9). Therefore with 5 mol% [Rh(coe)2Cl]2 and 20 mol% P(3, 5-xylyl)3 in 
dried methanol, the reaction proceeded with an improved conversion of 83% and a selectivity 
of 83:17 (Table 9, entry 1). As suspected earlier of the positive influence of water, doping the 
reaction with water resulted in an increase conversion from 83% to 88% and a slightly 
improved selectivity of 87:13 (Table 9, entry 2). However, when MeOH was used directly out 
of a bottle that has been exposed to air and moisture, the reaction proceeded with poorer 
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conversion of 68% and with an even poorer selectivity towards 127 of 67:33 (Table 9, entry 3). 
A mixed solvent system of MeOH and THF in a 1:1 ratio gave excellent conversion and 
selectivity towards 127 of 94:6 (Table 9, entry 4).  
 
Table 9 Solvent screen  
 
Entry Solvent Conv.[a] Ratio (127:128)[b] 
1 MeOH 83% 83:17 
2 MeOH/H2O (5:1) 88% 87:13 
3 MeOH (bottle) 69% 67:33 
4 MeOH/THF (1:1) 94% 94:6 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
 
Afterwards, a screening of other ligands and different solvent ratios was then commenced 
(Table 10). Sterically demanding NHC IPr is an ineffective ligand (Table 10, Entry 1). However, 
the electron poor P(2-furyl)3 improved the selectivity towards 127 and gave full conversion 
(Table 10, Entry 2). Then it was decided to retest P(pMeOC6H4)3 and the reaction proceeded 
with an excellent selectivity towards 127 of 97:3 and with full conversion (Table 10, Entry 3). 
Then the solvent ratio was modified but it was found that increasing the ratio in favour of THF 
had no effect on both the selectivity and conversion (Table 10, Entry 4-6). Except, the 
THF/MeOH solvent ratio of 9:1 reduced the conversion and decreased the selectivity towards 
127 (Table 10, entry 6). 
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Table 10 A screening of other ligands and different solvent ratios 
 
Entry Ligand Solvent Conv.[a] Ratio (127:128)[b] 
1 Ipr MeOH/THF (1:1) 0% n/a 
2 P(2-furyl)3 MeOH/THF (1:1) >95% 95:5 
3 P(pMeOC6H4)3 MeOH/THF (1:1) >95% 97:3 
4 P(pMeOC6H4)3 MeOH/THF (1:2) >95% 96:4 
5 P(pMeOC6H4)3 MeOH/THF (1:4) >95% 96:4 
6 P(pMeOC6H4)3 MeOH/THF (1:9) 83% 88:12 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
 
 
Then other bidentate ligands were tested to see if the selectivity towards 127 could be 
improved (Table 11). The solvent system of MeOH/THF in a 1:2 ratio was used as it was more 
practical than 1:4. However, all bidentate ligands that were examined led to no conversion 
(Table 11, entry 1-6).  
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Table 11 Screening of other ligands  
 
Entry Ligand Conv.[a] Ratio (127:128)[b] 
1 DPePhos 0% n/a 
2 DM-BINAP 0% n/a 
3 R-Segphos 0% n/a 
4 XantPhos 0% n/a 
5 DPPF 0% n/a 
6 XPhos 0% n/a 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy 
 
 
It was then thought that a cationic rhodium complex would be more active. Freeing up a 
coordination site on the rhodium centre might allow the second alkene to coordinate more 
readily to the rhodium centre and thus improve the selectivity towards 127. A common 
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method used to make a neutral complex cationic is by halide abstraction with a silver salt 
(Table 12). Pleasingly, the halide abstraction with AgBF
4
 gave complete conversion and with 
excellent selectivity towards 127 (Table 12, entry 1). A quick re-examination with different 
bidentate ligands gave no conversion despite the use of a silver salt (Table 12, entry 2 and 3). 
Abstraction of the halide with AgSbF
6
 also proceeded with full conversion and with excellent 
selectivity towards 127 (Table 12, entry 4). However, halide abstraction with AgOBz or AgOTs 
proceeded with full conversion but the selectivity towards 127 was a little lower in both cases 
(Table 12, entry 5 and 6). The lower selectivity could be imputed to the greater coordinating 
ability of the OBz and OTs anion. It was assumed MeOH could complex to the cationic rhodium 
and as a result, diminished the selectivity towards 127. Finally, carrying out the reaction in THF 
with AgBF
4
 gave a selectivity of 98:2 with an isolated yield of 89% and further optimisation was 
halted (Table 12, entry 7). Therefore, the condition to be used for the subsequent screening is 
5 mol% [Rh(coe)2Cl]2, 20 mol% P(pMeOC6H4)3, 10 mol% AgBF4 in 100mM THF at 60°C for 17 
hours.  
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Table 12 Screening of ligands and silver cation 
 
Entry Ligand mol % AgX Solvent Conv.[a] Ratio (127:128)[b] 
1 P(p MeOC6H4)3 20 AgBF4 THF/MeOH (2:1) >95% 97:3 
2 DM-BINAP (S) 10 AgBF4 THF/MeOH (2:1) 0 n/a 
3 Segphos (R) 10 AgBF4 THF/MeOH (2:1) 0 n/a 
4 P(p MeOC6H4)3 20 AgSbF6  THF/MeOH (2:1) >95% 97:3 
5 P(p MeOC6H4)3 20 AgOBz  THF/MeOH (2:1) >95% 95 
6 P(p MeOC6H4)3 20 AgOTs  THF/MeOH (2:1) >95% 93:7 
7 P(p MeOC6H4)3 20 AgBF4  THF >95% 98:2
[c] 
[a] Conversion based on ratio of 126 against the combined ratio of 127:128 as determined by 
1H NMR spectroscopy. [b] Ratio determined by 1H NMR spectroscopy. [c] Isolated yield of 89% 
 
127 was fully characterised by 1H, 13C NMR, 2D NMR, IR and HRMS analysis. NOESY was used 
to ascertain the stereochemistry and revealed the bridgehead hydrogen 1 and one of the 
hydrogens of the exo-methyl 2 are syn in space (Scheme 24). Furthermore, endo-hydrogen 3 
has a NOESY correlation with endo-hydrogen 4. Furthermore, only one diastereoisomer is 
formed. It was then of interest to get an X-Ray to confirm the stereochemistry of 127. As 127 is 
an oil, the hydrochloride salt was made which allowed crystals of sufficient X-ray quality to be 
grown (Scheme 25). The X-ray structure confirmed the stereochemistry of product 127 by 
analogy.  
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Scheme 24 NOESY experiments 
 
 
Scheme 25 X-Ray of Pyridinium Salt of 127 
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 Scope of the reaction 4.4
 
With the optimised conditions in hand, the scope of the reaction was examined (Table 13). All 
products were fully characterised by 1H, 13C NMR, 2D NMR, IR and HRMS analysis. In all cases 
whereby 133 is formed, 133 is isolated as a single diastereoisomer. Unfortunately in all cases, 
133 and five-membered ring 134 were inseparable by flash column chromatography. As a 
result, the ratio described is the crude ratio of 133 and 134 as judged by 1H NMR. 
Furthermore, the yield mentioned is the combined isolated yield of 133 and 134. 
The starting materials 132a-d, f and g were prepared and subjected to the corresponding 
rhodium-catalysed reaction by Daniel J. Tetlow and are not described in this thesis. It is found 
that the selectivity for 133 over 134 is greater when R is large. Vinylpyridines 132a – c, with R = 
aryl, gave high selectivity towards 133 in good to high yields (Table 13, Entry 1- 3). Modulation 
of the electronic properties of the aryl ring did not have a significant effect on the selectivity 
between the corresponding 133 and 134. However, small erosion in selectivity is observed 
when a vinyl pyridine that contains an electron rich substituent was tested (Table 13, Entry 3). 
Interestingly, vinylpyridine 132d with R = benzofuran gave poorer selectivity towards 133d 
(Table 13, Entry 4). It was then of interest to determine what other functional groups are 
tolerated under the reaction conditions. 
Vinylpyridines 132e-g (Table 13, Entry 5-7), whereby R is a large group, gave excellent 
selectivity towards the corresponding 133e-g. Vinylpyridine 132h gave good selectivity 
towards 133h when the loading of phosphine was reduced to 15 mol% (Table 13, Entry 8). 
Vinylpyridines 132i and 132j (Table 13, Entry 9 and 10), whereby R is a small group, gave 
moderate selectivity towards the 133i and 133j respectively.  
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Table 13 Reaction scope 
 
Entry Start Material 132 Major Product 
Ratio 
(133:134)[b] 
Yield 
1[a] 
  
96 : 4 97% 
2[a] 
  
96 : 4 81% 
3[a] 
  
95 : 5 76% 
4[a] 
  
85 : 15 84% 
272 
 
5 
  
97 : 3 88% 
6[a] 
  
95 : 5 76% 
7[a] 
  
96 : 4 75% 
8 
  
95 : 5[b] 83% 
9 
  
67 : 33 71% 
10 
  
75 : 25 72 % 
[a] Syntheis of substrate and Rh-catalysed cyclisation were carried out by Daniel J. Tetlow. [b] 
Ratio determined by 1H NMR spectroscopy. [c] Rh : L (1:1.5) 
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 Another directing group 4.4.1
 
Other directing groups have been successfully employed in C–H bond activation. It was of 
interest to see if the selectivity towards bicyclo[2.2.1]heptanes could be improved by a change 
in directing group. It was thought an imidazole directing group would be more effective as it is 
more basic. However, under the optimised conditions, no reaction was observed with vinyl 
imidazole 135 (Scheme 26). 
 
 
Scheme 26 Imidazole directing group 
 
 Mechanistic studies 4.5
 
Daniel J. Tetlow then studied the conversion of 132f by monitoring the reaction by 1H NMR. 
Over the course of the reaction, an extra set of signals were observed which would gradually 
build up and then disappear when the reaction was over. Monitoring the reaction by TLC 
revealed a new spot would form but would disappear by the end of the reaction. Therefore, 
the reaction was quenched after 30 mins and the intermediate 137 was isolated in a 33% yield 
(Scheme 27). Characterisation of the intermediate by 1H, 13C NMR, 2D NMR, IR and HRMS 
revealed the structure of the intermediate to be four-membered ring 137. NOESY experiments 
allowed the assignment of the relative configuration at the stereocentres. Furthermore, the 
stereochemistry of 137 is inverted when compared to 133f. 
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Scheme 27 Formation of the four-membered ring as judged by 1H NMR 
 
Therefore, it was then of interest to see if the four-membered ring intermediate could be 
isolated with substrate 126. A kinetic profile using the standard reaction condition of the 
transformation of 126 was carried out by taking aliquots from the reaction and analysing the 
aliquot by 1H NMR (Scheme 28). As expected, an extra set of signals would gradually build up 
and would then disappear by the end of the reaction. These extra set of signals were assumed 
to the four-membered ring 138. To confirm this, attempts were made to isolate 138 because 
isolation of 138 would allow the stereochemistry to be assigned. Furthermore, this would also 
allow the relative configuration of 138 and bicyclic 127 to be compared. However, 138 could 
not be separated from 127 by flash column chromatography as they co-elute together.  
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Scheme 28 Formation of the four-membered ring 
 
 Deuterium-labelling experiment 4.5.1
 
To obtain more mechanistic information, a deuterium labelling study of 139 was then carried 
out (Scheme 29). Subjecting a deuterium labelled 139 to the standard reaction conditions 
furnished bicyclic 140 and 141 in a combined 90% yield with a ratio of 60:40 as confirmed by 
2H NMR (Scheme 30). Furthermore, there was complete transfer of the deuterium to the 
indicated positions. 140 has the deuterium on the exo-methyl carbon. 141 has the deuterium 
on the carbon α to the vinyl pyridine. Also, the deuterium on 141 is equally distributed on the 
exo- and endo- position.  
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Scheme 29 Deuterium Scrambling 
 
Scheme 30 Deuterium NMR 
 
Before determining the kinetic isotopic effect, it was of interest to understand a little bit more 
why the deuterium was scrambled over two carbons. In the study of the rhodium-catalysed 
intramolecular cyclisation of 1,5-diene 142, Murai and co-workers reported the C–H activation 
and hydrometalation steps occur reversibly at room temperature with the deuterium atom 
scrambled over three positions (Scheme 31).28 Furthermore, the hydrometalation of the 
alkene preferentially occurs in the 2,1-fashion. 
 
 
Scheme 31 Kinetic experiment by Murai 
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To account for the non-statistical distribution of the deuterium atom, Murai and co-workers 
then subjected the labelled compound 142 to the standard reaction conditions (Scheme 32). 
Analysis of the product 144 revealed a near statistical distribution of the deuterium atom 
which suggests the equilibration is far faster than the alkene migratory insertion. 
 
 
Scheme 32 Labelled compound 142 to the standard reaction conditions 
 
From these experiments, a mechanism was formulated by Murai and co-workers (Scheme 33). 
After the pyridine directed C–H bond activation to form intermediate 145, hydrometalation of 
the alkene can occur in the 1,2- or 2,1-fashion. From the deuterium scrambling studies, the 
hydrometalation onto the alkene in the 2,1-fashion is fast and reversible. On the other hand, 
the hydrometalation onto the alkene in the 1,2- fashion is slow but, when it does occur, 
irreversible reductive elimination would furnish five membered ring 144.  
 
 
Scheme 33 Proposed mechanism 
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Therefore, it was of interest to see if this phenomenon exists in our system. Subjecting 
deuterium labelled 139 to the standard reaction condition resulted in the deuterium 
remaining in the original position or being incorporated to the external alkene double bond 
148 (Scheme 34). Interestingly, the alternative product 149 was not observed (Scheme 35). 
This is similar to the observations by Murai, whereby in our system, the deuterium atom is 
scrambled over two carbons. Like Murai’s example, the 1,2-hydrometallation is a slow process 
and the deuterium incorporation at C2 is very small. On the other hand, the 2,1-
hydrometallation is much faster as reflected in the deuterium incorporation into the alkene C1 
being noticeably higher. No formation of the five-membered ring or 140 or 141 were observed 
after 1 hr. This therefore demonstrates that the C–H cleavage process is facile at room 
temperature. Also, the migratory insertion of the first alkene is reversible and happens much 
faster than the subsequent steps of the catalytic cycle. 
 
 
Time Ratio (139:148) 
10 min 52 : 48 
60 min 26 :  74 
 
Scheme 34 Scrambling at r.t. 
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Scheme 35 Deuterium-labelled product not observed 
 
Then a study on the kinetic isotopic effect was commenced to gain insight into the 
mechanism. If the C–H activation step is indeed the rate determining step, this would be 
reflected in the rate of reaction between 126 and deuterated 139. Therefore, parallel 
completion experiments of 126 and 139 were carried out (Scheme 36). By comparing the rate 
of the reaction between 126 and 139, an average kinetic isotopic effect of kH / kD of 1.2 was 
obtained. Furthermore, the ratio of 126 and 139 does not change with time. This result 
demonstrated the C–H bond activation is not the rate determining step and a normal 
secondary kinetic isotopic effect is observed. Also, the formation of 127 is not reversible. 
 
 
Scheme 36 Study on the kinetic isotopic effect 
 
280 
 
Crossover experiment was then carried out to determine if the reaction is an intra- or inter-
molecular process (Scheme 37). The rhodium-catalysed reaction was carried out with both 
substrate 139 and substrate 132f in the same reaction vessel. However, at the end of the 
reaction substrate 132f was isolated in 89% yield with no deuterium incorporation. 
Furthermore, product 140 and 141 were isolated in a combined 95% yield with a ratio of 
64:36. Moreover, there was complete transfer of the deuterium to the indicated positions. 
140 has the deuterium atom on the exo-methyl carbon. 141 has the deuterium atom on the 
carbon α to the vinyl pyridine. Also, the deuterium atom on 141 is equally distributed between 
the exo- and endo- position. The lack of crossover confirmed that the reaction is purely 
intramolecular. 
 
 
Scheme 37 Crossover experiment 
 
The deuterium scrambling studies revealed the C–H bond activation step and hydrometalation 
is reversible and both steps happen a lot faster than the subsequent steps. The crossover 
experiment confirms it is an intramolecular reaction. From the optimisation, the formation of 
five-membered ring 128 occurs faster at higher temperature than the formation of 127. The 
stereocentres found in the four-membered ring side 137 is inverted when compared to 
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stereocenters of 133f. Furthermore, the four-membered ring is not seen if the reaction is 
allowed to proceed to completion. The formation of the bicyclo[2.2.1]heptane is completely 
diastereoselective.  
To account for all these observations, a potential mechanism have been postulated (Scheme 
38). After the pyridine directed C–H bond activation to form intermediate 150, 
hydrometalation onto the alkene can occur in the 1,2- or 2,1-fashion. The hydrometalation 
onto the alkene in the 1,2-fashion to form 152 is slow as determined by deuterium labelling 
studies. However, when it does occur, irreversible reductive elimination furnishes five-
membered ring 134.  
From the deuterium-labelling studies, hydrometalation onto the alkene in the 2,1-fashion is 
considerably faster and reversible but it is also clear that the hydrometalation is not 
completely stereoselective. If the hydrometalation proceeds to give intermediate 153 whereby 
the exo-methyl group and the allyl group are anti, reductive elimination can occur to give four 
membered ring 154. From the time profile studies, four membered ring 154 is not observed at 
the end of the reaction and therefore is reversibly formed. 
The formation of 133 occurs when hydrometalation onto the alkene occurs in the 2,1-fashion 
to give intermediate 151 whereby the exo-methyl group and the allyl group are syn. After the 
formation of 151, the migratory insertion of the pendant alkene occurs to furnish the seven-
membered rhodacycle 155. Finally, reductive elimination occurs to furnish 133. 
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Scheme 38 Postulated mechanism 
 
 Conclusion 4.6
 
The generation of bicyclo[2.2.1]heptane 133 from vinyl pyridines 132 by a rhodium catalyst 
have been accomplished (Scheme 39). Interestingly, 133 was formed as a single 
diastereoisomer in all cases whereby the bridgehead carbon and the exo-methyl carbon are 
syn in space. However, the 133 is always contaminated with 132 to varying degrees as neither 
could be separated by flash column chromatography. It has been noted that a large Thorpe-
Ingold effect influences the selectivity in favour of 133. Furthermore, this work could be 
further enhanced by carrying out the reaction enantioselectively. 
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Scheme 39 Summary 
 
 Future work 4.7
 
The generation of bicyclo[2.2.1]heptane 133 from vinyl pyridines 132 proceeded in a 
diastereoselective manner. Therefore, a further extension to this methodology would be an 
enantioselective synthesis of 133 (Scheme 40). This would make the methodology extremely 
attractive as there would be potentially complete stereocontrol on the formation of all 3 chiral 
centres of 133 despite starting from prochiral 132.  
 
 
Scheme 40 Possible enantioselective synthesis of 133  
 
Employing a chiral ligand should enable a catalytic enantioselective synthesis of 133. As there 
is a large library of different chiral bidentate phosphine ligands available, chiral bidentate 
phosphines would be a good starting point to find conditions for the enantioselective 
synthesis of 133. However, during the optimisation of this reaction, it became clear that 
bidentate ligands were ineffective.   
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On the other hand, chiral monodentate phosphine ligands have been recognised as effective 
ligands for many enantioselective transition-catalysed reactions.29 Therefore, a suitable chiral 
monodentate phosphine ligand could potentially enable an enantioselective synthesis of 133. 
  
 Synthesis of precursors 4.8
 
The synthesis of aldehyde S5 started from commercially available ester S1 (Scheme 41). The 
first allylation with allyl bromide afforded the mono-allylated ester S2 in 97% yield. The 
allylation was then repeated with allyl bromide with TBAI to afford the bis-allylated ester S3 in 
97% yield. Reduction with LiAlH4 gave alcohol S4 in 97% yield. Finally, oxidation to aldehyde S5 
was achieved by Swern oxidation30 which was then used directly in the next step. 
 
 
Scheme 41 Synthesis of aldehyde S5 
 
The synthesis of vinyl pyridine 126 via the Wittig olefination was achieved (Scheme 44). 
However, Wittig olefination with triphenyl(2-pyridylmethyl)phosphonium chloride 
hydrochloride generally proceeded with E-selectivities of roughly 91:9. Attempts to vary the 
reaction conditions did not drastically improve the selectivity for E-126. Therefore, a new 
method was devised which gave a E-selectivity of >95:5. 
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Scheme 42 Synthesis of vinyl pyridine 126 via the Wittig method 
 
The synthesis of vinyl pyridine 126 with an E-selectivity of >95:5 was achieved by E2 
elimination with a strong base (Scheme 44). Aldehyde S5 was added to the vinyl pyridine anion 
at -78°C. After purification by aqueous workup to form secondary alcohol S7, mesylation with 
mesyl chloride in DCM was then carried out. After purification by aqueous workup, the 
mesylated product was used directly in the next step. To the crude mesylate, E2 elimination 
was carried out with NaHMDS as base to afford vinyl pyridine 126 in 55% yield over four steps 
from S4 with a E/Z ratio of >95:5. 
 
 
Scheme 43 Synthesis of vinyl pyridine 126 via mesylation and E2 elimination 
 
The synthesis of vinyl pyridine 132e started from the commercially available β-ketoester S8 
(Scheme 44). One pot double allylation of β-ketoester S8 with NaH as base afforded β-
ketoester S9 in 96% yield. The protection of ketone with ethylene glycol and then reduction 
with LiAlH4 afforded S10 in 52% over 2 steps. Afterwards, a Swern oxidation
30 was carried out. 
After a quick purification by filtration over a silica plug, the aldehyde was added to the vinyl 
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pyridine anion at -78°C to form the secondary alcohol. Finally, mesylation and E2 elimination 
with NaHMDS afforded vinyl pyridine 132e in 52% yield over the four steps from S10. 
 
 
Scheme 44 Synthesis of vinyl pyridine 132e 
 
The synthesis of vinyl pyridine 132h started from the commercially available malonate S11 
(Scheme 45). Benzylation of malonate S11 with NaH as base afforded malonate S12.  Krapcho 
decarboxylation31 using lithium chloride in DMSO under reflux gave monoester S13. Now, 
allyllation of malonate S13 with LDA as base afforded malonate S14 in quantitative yield. 
Afterwards, reduction with LiAlH4 followed by the oxidation of the alcohol by the Swern 
oxidation30 afforded the aldehyde. After a quick filtration over a silica plug, the crude material 
was of sufficient purity as judged by 1HMR to be used directly in the next step. Then, the 
aldehyde was added to the vinyl pyridine anion at -78°C to form the secondary alcohol. Finally, 
mesylation and E2 elimination with NaHMDS afforded vinyl pyridine 132h in 64% yield over 4 
steps. 
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Scheme 45 Synthesis of vinyl pyridine 132h 
 
The synthesis of diol S17 started from the bis-allylation of the commercially available malonate 
S17. The synthesis of 129 and 132i began with the mono-protection of diol S17 using either 
tert-butyldimethylsilyl chloride or benzylbromide or as the electrophile which proceeded in a 
84% and 69% yield respectively (Scheme 46). The resulting mono-protected alcohols were 
then subjected to Swern oxidation30 to afford aldehydes. After a quick filtration over a silica 
plug, the crude material was of sufficient purity as judged by 1HMR to be used directly in the 
next step. Then, vinyl pyridine was deprotonated by nBuLi at -78°C and the crude aldehyde 
was added. After an aqueous workup, the secondary alcohol was mesylated with mesyl 
chloride. After another aqueous workup, a E2 elimination was carried out with NaHMDS as 
base to give vinyl pyridine 129 and 132i in a 55% and 57% overall yield respectively from the 
corresponding mono-protected alcohols. 
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Scheme 46 Synthesis of 129 and 132i 
 
The synthesis of S22 began with the one-pot bis-allylation of malonate S20 to form bis-
allylated malonate S21 (Scheme 47). Afterwards, Krapcho decarboxylation31 using lithium 
chloride in DMSO at 160°C gave monoester S22. 
 
 
Scheme 47 Synthesis of S22 
 
From the mono-ester S22, the synthesis of vinyl pyridine 132j was achieved (Scheme 48). Due 
to the volatility of the subsequent intermediates, no attempts on their isolation were made. 
Therefore, the crude material after the aqueous workup was used directly in the next step 
until the formation of the secondary alcohol S23. The synthesis of secondary S23 began with 
the methylation of S22. Afterwards, LiAlH4 reduction followed by the Swern oxidation
30 
afforded the aldehyde. After a quick filtration over a silica plug, the crude material was of 
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sufficient purity as judged by 1HMR to be used directly in the next step. Then, the aldehyde 
was added to the vinyl pyridine anion at -78°C to form the secondary alcohol S23. S23 was 
isolated in a 42% yield over four steps and fully characterised. Finally, mesylation and E2 
elimination with NaHMDS as base afforded vinyl pyridine 132j in 68% yield over two steps. 
 
 
Scheme 48 Synthesis of vinyl pyridine 132j 
 
The synthesis of vinyl-imidazole 135 with a E-selectivity of >95:1 was achieved by E2 
elimination with a strong base (Scheme 49). Swern oxidation30 of S4 afforded the aldehyde. 
After a quick filtration over a silica plug, the crude material was of sufficient purity as judged 
by 1HMR to be used directly in the next step. Aldehyde was added to the vinyl-imidazole anion 
at -78°C. After purification by aqueous workup to form secondary alcohol S24 which was 
isolated in a 86% yield over two steps. Afterwards, mesylation with mesyl chloride in DCM was 
then carried out. After purification by aqueous workup, the mesylated product was used 
directly in the next step. To the crude mesylate, E2 elimination was carried out with NaHMDS 
as base to afford vinyl-imidazole 135 in 58% yield over the two steps. 
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Scheme 49 Synthesis of the vinyl imidazole 135 
 
Deuterium labelled vinyl pyridine 139 was synthesised from ester S3 (Scheme 50). Reduction 
of the ester with LiAlD4 afforded alcohol S25 in 94% yield. Afterwards, the Swern oxidation
30 
was carried out and was purified by filtration over a small plug of silica. Then the aldehyde was 
added to the vinyl pyridine anion at -78°C to form the secondary alcohol. Finally, mesylation 
and E2 elimination with NaHMDS as base afforded vinyl pyridine 139 in 71% yield over four 
steps. 
 
 
Scheme 50 Deuterium labelled vinyl pyridine 139 synthesis 
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 Experimental 4.9
 
General. Otherwise noted, all reactions were carried out in flame-dried glassware under dry 
nitrogen atmosphere. The solvents were purified with the solvent purification system Pure 
Solv MD-6 (THF, Et2O, CH2Cl2, benzene, toluene, hexane) except otherwise noted. Flash 
chromatography: Merck silica gel 60 (230-400 mesh). NMR: Spectra were recorded on a Bruker 
DRX 500 and a Bruker DPX 400 spectrometers in CDCl3; chemical shifts (δ) are given in ppm. 
The solvent signals were used as references and the chemical shifts converted to the TMS 
scale (CDCl3: δC = 77.0 ppm; residual CHCl3 in CDCl3: δH = 7.24 ppm). IR: PerkinElmer Spectrum 
100 FT-IR spectrometer, wavenumbers (ṽ) in cm-1. HRMS at the University of Liverpool: 
micromass LCT mass spectrometer (ES+) and Trio-1000 or Agilent QTOF 7200 mass 
spectrometers (CI). Melting points: Griffin melting point apparatus (not corrected). Elemental 
analyses: University of Liverpool. X-Ray crystallography: Bruker D8 Venture Photon 100 Dual 
Microsource diffractometer. All commercially available compounds were used as received.  
 
Compound S3 
 
At 0°C, 2.5M of Buli in hexane (11.1 ml, 27.9 mmol) was added to a stirred solution of DIPA 
(4.3 ml, 30.3 mmol) in THF (36 ml). It was allowed to stir at 0°C for 10 mins. Cooled to -78°C, 
methyl phenylacetate S1 (3.5 ml, 24.2 mmol) in THF (70 ml) was added. It was then allowed to 
stir at -78°C for 40 mins. Afterwards, allyl bromide (2.7 ml, 21.5 mmol) was added. It was then 
allowed to stir at rt overnight. Afterwards, the reaction was quenched with a saturated 
solution of NH4Cl. Et2O was added and extracted two times with Et2O. The organic layer was 
washed with water and a saturated solution of brine. Dried over Na2SO4, filtered and 
292 
 
concentrated. Purification by flash column chromatography (PE/DE, 50/130/1) gave S2 as a 
colourless oil (4.45g, 97%). At 0°C, 2.5M of Buli in hexane (10.8 ml, 26.9 mmol) was added to a 
stirred solution of DIPA (4.2 ml, 26.2 mmol) in THF (36 ml). It was allowed to stir at 0°C for 10 
mins. Cooled to -78°C, S2 (4.45g, 23.4 mmol) in THF (73 ml) was added. It was then allowed to 
stir at -78°C for 40 mins. Afterwards, allyl bromide (2.7 ml, 30.4 mmol) and TBAI  (864 mg, 2.34 
mmol) were added. It was then allowed to stir at rt overnight. Afterwards, the reaction was 
quenched with a saturated solution of NH4Cl. Et2O was added and extracted three times with 
Et2O. The organic layer was washed with water and a saturated solution of brine. Dried over 
Na2SO4, filtered and concentrated. Purification by flash column chromatography (PE/DE, 
40/130/1) gave S3 as a colourless oil (5.24 g, 97%). This is a known compound. 1H NMR (500 
MHz, CDCl3): δ = 7.35 – 7.28 (m, 2H), 7.26 – 7.18 (m, 3H), 5.56 – 5.44 (m, 2H), 5.09 – 4.99 (m, 
4H), 3.63 (s, 3H), 2.83 – 2.69 (m, 4H) 
 
Compound S9 
 
NaH (927 mg, 23.17 mmol, 60% dispersion in mineral oil) and allyl bromide (2 ml, 23.17 mmol) 
were added to ester S8 (1 ml, 9.27 mmol) in DMF (19 mL) at 0°C under N2. Then the reaction 
mixture was warmed to room temperature and stirred for 16 hours. The reaction mixture was 
re-cooled to 0°C, diluted with Et2O and quenched carefully with H2O (initially via dropwise 
addition). The organic layer was separated and washed repeatedly with H2O to remove excess 
DMF. The organic phase was dried over Na2SO4 and the solvent removed under reduced 
pressure. The crude material was used in the next step without further purification. Pale 
yellow oil (1.72g, 96%); 1H NMR (500 MHz, CDCl3): δ = 5.62 – 5.51 (m, 2H), 5.11 – 5.05 (m, 4H), 
3.70 (s, 3H), 2.62 (ddt, J = 14.6, 7.4, 1.1 Hz, 2H), 2.56 (ddt, J = 14.4, 7.5, 1.1 Hz, 2H), 2.10 (s, 
3H); 13C NMR (125 MHz, CDCl3): δ = 203.9, 172.0, 132.1 (2C), 119.2 (2C), 63.4, 52.3, 36.0 (2C), 
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27.0; IR (neat): ṽ = 3080 (w), 2981 (w), 2953 (w), 1744 (m), 1711 (s), 1641 (w), 1435 (m), 1357 
(w), 1321 (w), 1279 (m), 1250 (w), 1211 (s), 1179 (m), 1141 (m), 1052 (w), 993 (m), 919 (s), 871 
(w), 844 (w), 794 (w), 750 (w), 697 (w) cm-1; MS (CI(CH4)): 197 (24) [M + H], 165 (28), 137 (97), 
123 (100), 95 (21); HRMS (CI(CH4)) calcd for (C11H16O3 + H): 197.1172; found: 197.1170 
 
Compound S12 
 
Obtained from dimethyl allylmalonate (1 ml, 6.22 mmol) following the representative 
procedure except with benzyl bromide (1.1 ml, 9.33 mmol). Colourless oil (1.45 g, 89%). This 
compound is known. 1H NMR (500 MHz, CDCl3): δ = 7.27 – 7.18 (m, 3H), 7.07 (d, J = 7.1 Hz), 
5.79 – 5.68 (m, 1H), 5.17 – 5.09 (m, 2H), 3.69 (s, 6H), 3.22 (s, 2H), 2.54 (d, J = 7.3 Hz, 2H). 
 
Compound S13 
 
Lithium chloride (231 mg, 5.45 mmol) was added to a solution of S12 (650 mg, 2.48 mmol) in 
DMSO (17 mL). Water (15 drops) was added and then the mixture was stirred at 160°C (oil 
bath temperature) overnight. At room temperature, the mixture was then partitioned 
between H2O (10 mL) and Et2O. The organic layer was washed with H2O (2 x 20 mL), then 
brine, and dried over Na2SO4, filtered and concentrated. Purification by flash chromatography 
(petroleum ether/EtOAc : 20/1) gave S13 as a colourless oil (348 mg, 72%): 1H NMR (500 MHz, 
CDCl3): δ = 7.28–7.23 (m, 1H), 7.21–7.16 (m, 1H), 7.15–7.12 (m, 2H), 5.73 (ddt, J = 17.1, 10.2, 
7.0, 1H), 5.08–5.00 (m, 2H), 3.58 (s, 3H), 2.97–2.88 (m, 1H), 2.80–2.69 (m, 2H), 2.40–2.31 (m, 
1H), 2.29–2.21 (m, 1H); 13C NMR (125 MHz, CDCl3): δ = 175.3, 139.1, 135.1, 128.9, 128.4, 
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126.4, 117.1, 51.4, 47.2, 37.7, 36.0 ; IR (neat): ṽ = 3065 (w), 3028 (w), 2950 (w), 1733 (s), 1642 
(w), 1604 (w), 1584 (w), 1495 (w), 1455 (w), 1435 (m), 1370 (w), 1262 (w), 1230 (m), 1195 (m), 
1161 (s), 1116 (w), 1077 (w), 1031 (w), 994 (w), 915 (m), 832 (w), 762 (w), 743 (m), 698 (s), 656 
(w) cm-1; MS (CI(CH4)): 205 (11) [M + H], 173 (11), 145 (100), 91 (25); HRMS (CI(CH4)): calcd for 
(C13H16O2 + H): 205.1229; found: 205.1224. 
 
Compound S14 
 
Under N2, a solution of S13 (150 mg, 0.73 mmol) in THF (0.6 mL) was added to a solution of 
LDA (0.95 mmol) at -78°C {LDA prepared from 0.38 mL of a 2.5 M of nBuLi and 0.14 mL of 
diisopropylamine in THF (1.4 mL) at 0°C}. The resulting solution was stirred at -78°C for 1.5 
hour then allyl bromide (89 μL, 1.03 mmol) was slowly added. The mixture was allowed to 
warm to room temperature overnight before being quenched with few drops of a saturated 
solution of NH4Cl. The mixture was diluted with H2O and extracted three times with diethyl 
ether. The organic layer was then washed with H2O and brine and dried over Na2SO4, then 
filtered and concentrated. Purification by flash chromatography (petroleum ether/EtOAc: 
25/1) afforded S14 as a colourless oil (179 mg, quant.): 1H NMR (500 MHz, CDCl3): δ = 7.26– 
7.16 (m, 3H), 7.11–7.06 (m, 2H), 5.78 (ddt, J = 16.6, 10.6, 7.3 Hz, 2H), 5.14–5.07 (m, 4H), 3.63 
(s, 3H), 2.88 (s, 2H), 2.38 (dd, J = 14.3, 7.2 Hz, 2H), 2.27 (dd, J = 14.3, 7.4 Hz, 2H); 13C NMR (125 
MHz, CDCl3): δ = 175.8, 137.3, 133.6 (2C), 130.0 (2C), 128.1 (2C), 126.5, 118.6 (2C), 51.5, 50.9, 
41.4, 38.2 (2C); IR (neat): ṽ = 3077(w), 3030 (w), 2980 (w), 2949 (w), 1727 (s), 1639 (w), 1605 
(w), 1496 (w), 1435 (m), 1347 (w), 1274 (w), 1200 (m), 1179 (m), 1155 (m), 1079 (w), 1032 (w), 
994 (w), 994 (m), 972 (w), 914 (s), 851 (w), 814 (w), 777 (w), 740 (m), 700 (s) cm-1; elemental 
analysis (%) calcd for C16H20O2: C 78.65, H 8.25; found: C 79.17, H 8.36. 
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Compound S21 
 
Obtained from dimethyl malonate (2.5 ml, 21.9 mmol) following the representative procedure. 
Colourless oil (3.2 g, 68%). This compound is known. 1H NMR (500 MHz, CDCl3): δ = 5.68 – 5.56 
(m, 2H), 5.13 – 5.04 (m, 4H), 3.70 (s, 6H), 2.62 (d, J = 7.4 Hz, 4H). 
 
Compound S22 
 
Obtained from S21 (1.92 mmol, 0.40 mL) following the procedure described for the 
preparation of S13. Colourless oil (155 mg, 52 %): 1H NMR (500 MHz, CDCl3): δ = 5.71 (ddt, J = 
17.1, 10.1, 7.0 Hz, 2H), 5.04 (dt, J = 17.1, 1.6 Hz, 2H), 5.03–4.98 (m, 2H), 3.64 (s, 3H), 2.51 (tt, J 
= 8.1, 6.1 Hz, 1H), 2.39–2.30 (m, 2H), 2.28–2.19 (m, 2H); 13C NMR (125 MHz, CDCl3): δ = 135.2 
(2C), 117.0 (2C), 51.4, 44.9, 35.8 (2C); IR (neat): ṽ = 3080 (w), 2981 (w), 2951 (w), 2846 (w), 
1736 (s), 1642 (w), 1437 (m), 1369 (w), 1266 (w), 1236 (m), 1193 (m), 1168 (s), 1139 (m), 994 
(m), 914 (s), 862 (w), 833 (w), 763 (w), 702 (w) cm-1; elemental analysis (%) calcd for C9H14O2: C 
70.10, H 9.15; found: C 70.18, H 9.28 
 
Representative procedure for the reduction of esters into alcohols – A solution of ester S3 
(7.38 mmol, 1.7g) in Et2O (12 mL) was added under N2 to a suspension of LiAlH4 (4.05 mmol, 
150 mg) in Et2O (24 mL) at 0°C. After stirring at room temperature for 30 minutes, another 
portion of LiAlH4 (4.05 mmol, 150 mg) was added. After stirring for 30 minutes, the reaction 
mixture was quenched carefully at 0°C with a saturated aqueous solution of Na2SO4. After 
filtration over Celite to remove the white precipitate, the solvent was evaporated under 
296 
 
reduced pressure and the crude material was purified by flash chromatography (petroleum 
ether/EtOAc = 10:1) to afford S4 as colourless oil (1.42 g, 95%). 
 
Compound S4 
 
1H NMR (500 MHz, CDCl3): δ = 7.36–7.31 (m, 4H), 7.24–7.19 (m, 1H), 5.62 (ddt, J = 17.1, 10.1, 
7.2 Hz, 2H), 5.11–4.99 (m, 4H), 3.78 (d, J = 6.6 Hz, 2H), 2.53 (dd, J = 13.9, 7.2 Hz, 2H), 2.45 (dd, J 
= 14.1, 7.2 Hz, 2H), 1.26 (t, J = 6.6 Hz, 1H(OH)); 13C NMR (125 MHz, CDCl3): δ = 143.4, 134.3 
(2C), 128.4 (2C), 126.8 (2C), 126.2, 117.8 (2C), 67.8, 45.8, 39.5 (2C); IR (neat): ṽ = 3410 (br), 
3074 (w), 3006 (w), 2978 (w), 2925 (w), 1638 (w), 1600 (w), 1581 (w), 1498 (m), 1445 (m), 
1415 (w), 1385 (w), 1326 (w), 1294 (w), 1218 (w), 1143 (w), 1046 (m), 997 (m), 911 (s), 859 
(w), 768 (m), 744 (w), 698 (s), 672 (m) cm-1; elemental analysis (%) calcd for C14H18O: C 83.12, H 
8.97; found: C 83.25, H 9.04. 
 
Compound S10 
 
Under N2, TsOH•H2O (49 mg, 0.25 mmol) was added to a solution of S9 (508 mg, 2.59 mmol), 
diethylene glycol (0.567 mmol, 10.19 mmol) and trimethyl orthoformate (0.56 mL, 5.10 mmol) 
at room temperature. After stirring overnight, the mixture was quenched with a saturated 
solution of NaHCO3 and extracted with Et2O (3 x 5 mL). The organic layer was washed with H2O 
and then a saturated solution of brine. It was then dried over Na2SO4, filtered and 
concentrated to give 622 mg of an oil which was dissolved in Et2O (3 mL) under N2 and added 
by cannula to a suspension of LiAlH4 (53.0 mg, 1.40 mmol) in Et2O (10 mL) at 0 °C. After 10 
297 
 
mins at 0 °C, another portion of LiAlH4 (53.0 mg, 1.40 mmol) was added. After 2 hours of 
stirring at room temperature, the reaction mixture was quenched carefully at 0°C with a 
saturated aqueous solution of Na2SO4 which will cause a white precipitate to form. After 
filtration over Celite to remove the white precipitate, the solvent was evaporated under 
reduced pressure and the crude material was purified by flash chromatography (petroleum 
ether/EtOAc: 4/1) to afford S9 as a colourless oil (284 mg, 52 % over 2 steps). 1H NMR (500 
MHz, CDCl3): δ = 5.92 (ddt, J = 17.1, 10.0, 7.3 Hz, 2H), 5.05 (d, J = 17.4 Hz, 2H), 5.04 (d, J = 10.0 
Hz, 2H), 3.99–3.89 (m, 4H), 3.51 (d, J = 5.9 Hz, 2H), 3.08 (t, J = 5.9 Hz, 1H(OH)), 2.22 (dd, J = 
14.4, 7.0 Hz, 2H), 2.15 (dd, J = 14.3, 7.6 Hz, 2H), 1.31 (s, 3H); 13C NMR (125 MHz, CDCl3): δ = 
135.0 (2C), 117.3 (2C), 114.7, 66.0, 64.4 (2C), 47.9, 34.9 (2C), 20.0; IR (neat): ṽ = 3526 (br), 
3074 (w), 2980 (w), 2941 (w), 2888 (m), 1638 (w), 1471 (w), 1436 (w), 1413 (w), 1377 (w), 
1334 (w), 1204 (m), 1095 (m), 1038 (s), 998 (m), 950 (m), 912 (s), 874 (m), 765 (w), 693 (w) cm-
1; HRMS (CI(NH3)): calcd for (C12H20O3 + H): 213.1485; found: 213.1490 
 
Compound S15 
 
Obtained from S14 (1.23 mmol, 300 mg) following the representative procedure. Colourless oil 
(246 mg, 93%): 1H NMR (500 MHz, CDCl3): δ = 7.29–7.23 (m, 2H), 7.23–7.17 (m, 3H), 5.98–5.87 
(m, 2H), 5.15–5.06 (m, 4H), 3.36 (d, J = 6.0 Hz, 2H), 2.63 (s, 2H), 2.04 (d, J = 7.4 Hz, 4H), 1.33, (t, 
J = 6.1 Hz, 1H(OH)); 13C NMR (125 MHz, CDCl3): δ = 138.1, 134.6, 130.6, 128.0, 126.1, 118.0, 
66.8, 42.1, 40.4, 38.6; IR (neat): ṽ = 3413 (br), 3075 (w), 3029 (w), 2005 (w), 2977 (w), 2923 
(m), 1638 (m), 1604 (w), 1496 (w), 1441 (m), 1415 (w), 1328 (w), 1230 (w), 1156 (w), 1048 (m), 
1031 (m), 1016 (m), 995 (m), 911 (s), 861 (w), 812 (w), 783 (w), 740 (m), 702 (s), 665 (w) cm-1; 
elemental analysis (%) calcd for C15H20O: C 83.28, H 9.32; found: C 83.37, H 9.35. 
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Compound S17 
 
Obtained from diethyl diallylmalonate (2 mL, 8.27 mmol) following the procedure for the 
synthesis of S10. Clear Oil (1.19g, 92%): 1H NMR (500 MHz, CDCl3): δ = 5.83 (ddt, J = 16.8, 10.3, 
7.5 Hz, 2H), 5.13 – 5.06 (m, 4H), 3.58 (d, J = 4.8 Hz, 4H), 2.08 (dt, J = 7.5, 1.1 Hz, 4H), 2.05 – 
1.98 (m, 2H); 13C NMR (125 MHz, CDCl3): δ = 133.8, 118.1, 68.1, 42.0, 36.0; IR (neat): ṽ = 3343 
(br m), 3076 (w), 3006 (w), 2979 (w), 2924 (w), 1836 (w),  1639 (w), 1465 (w), 1440 (m), 1416 
(w), 1333 (w), 1223 (w), 1146 (w), 1057 (m), 1021 (s), 996 (s), 910 (s), 862 (w), 807 (w), 684 (w) 
cm-1; elemental analysis (%) calcd for C9H16O2: C 69.19, H 10.32; found: C 69.02, H 10.33  
 
Compound S18 
 
 At 0°C, 60 % of NaH (187 mg, 1.24 mmol) was added to a solution of S17 (194 mg, 1.24 mmol) 
in THF (12 mL). The ice bath was removed and allowed to stir at rt for 2 hours. The suspension 
was cooled back down to 0°C and TBSCl (187 mg, 1.24 mmol) was added. The resulting mixture 
was stirred at rt overnight. The mixture was quenched with a saturated solution of NH4Cl and 
extracted three times with diethyl ether.  The organic layer was washed with a saturated 
aqueous solution of brine, dried over Na2SO4, filtered and concentrated. Purification by flash 
chromatography (petroleum ether/EtOAc : 9/1) gave S18 as a clear oil (284 mg, 84%): 1H NMR 
(500 MHz, CDCl3): δ = 5.84 – 5.74 (m, 2H), 5.10 – 5.03 (m, 4H), 3.53 – 3.47 (m, 4H), 2.65 (t, J = 
2.65 Hz, OH), 2.07 (dd, J = 13.9, 7.4 Hz, 2H), 2.02 (dd, J = 13.9, 7.7 Hz, 2H), 0.88 (s, 9H), 0.05 (s, 
6H); 13C NMR (125 MHz, CDCl3): δ = 134.0, 117.9, 68.9, 68.6, 41.9, 36.0, 25.8, 18.1, -5.7 
 
 
299 
 
Compound S19 
 
 At 0°C, 60 % of NaH (58 mg, 1.44 mmol) was added to a solution of S17 in THF (6 mL). The ice 
bath was removed and allowed to stir at rt for 1 hour. The suspension was cooled back down 
to 0°C and benzyl bromide (172 µL, 1.44 mmol) was added. The resulting mixture was stirred 
at rt overnight. The mixture was quenched with a saturated solution of NH4Cl and extracted 
three times with diethyl ether.  The organic layer was washed with a saturated aqueous 
solution of brine, dried over Na2SO4, filtered and concentrated. Purification by flash 
chromatography (petroleum ether/EtOAc : 9/1) gave S19 as a light yellow oil (244 mg, 69%): 1H 
NMR (500 MHz, CDCl3): δ = 7.38 – 7.25 (m, 5H), 5.85 – 5.72 (m, 2H), 5.12 – 5.00 (m, 4H), 4.48 
(s, 2H), 3.52 (d, J = 5.4 Hz, 2H), 3.37 (s, 2H), 2.56 (br s, 1H), 2.15 – 2.03 (m, 4H); 13C NMR (125 
MHz, CDCl3): δ = 137.9, 133.9, 128.4, 127.7, 127.5, 118.0, 75.9, 73.6, 68.4, 41.7, 36.2; IR (neat): 
ṽ = 3437 (br w), 3074 (w), 3031 (w), 3005 (w). 2977 (w), 2861 (m), 1639 (m), 1497 (w), 1454 
(m), 1441 (m), 1415 (w), 1363 (w), 1330 (w), 1251 (w), 1206 (w), 1096 (s), 1075 (m), 1029 (m), 
999 (m), 910 (s), 876 (w), 736 (m), 697 (s) cm-1; elemental analysis (%) calcd for C16H22O2: C 
78.01, H 9.00; found: C 78.16, H 8.99 
 
Compound S25 
 
Obtained from S3 (1.23 mmol, 283 mg) following the representative procedure but using 
LiAlD4. Colourless oil (237 mg, 94%); 
1H NMR (500 MHz, CDCl3): δ = 7.38 – 7.29 (m, 4H), 7.24 – 
7.18 (m, 1H), 5.62 (ddt, J = 17.2, 10.0, 7.3 Hz, 2H), 5.11–5.04 (m, 2H), 5.04–4.99 (m, 2H), 2.53 
(dd, J = 14.1, 7.2 Hz, 2H), 2.45 (dd, J = 13.9, 7.4 Hz, 2H), 1.25 (s, 1H(OH)); 13C NMR (125 MHz, 
CDCl3): δ = 143.3, 134.3 (2C), 128.4 (2C), 126.8 (2C), 126.2, 117.8 (2C), 67.0 (pent, J = 21.8 Hz), 
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45.6, 39.5 (2C); IR (neat): ṽ = 3399 (br), 3074 (w), 3006 (w), 2978 (w), 2923 (w), 2207 (w), 2101 
(w), 1638 (w), 1600 (w), 1580 (w), 1497 (w), 1445 (m), 1415 (w), 1292 (w), 1193 (w), 1158 (w), 
1102 (m), 1030 (w), 998 (m), 975 (m), 910 (s), 838 (w), 807 (w), 759 (m), 733 (w), 697 (s), 665 
(w) cm-1; MS (CI(NH3)): m/z (rel. intensity): 222 (100) [M + NH4]; HRMS (CI(NH3)) calcd for 
(C14H16D2O + NH4): 222.1821; found: 222.1824. 
 
Representative procedure for the Swern oxidation – Under N2, DMSO (87 μL, 1.20 mmol) in 
CH2Cl2 (0.8 mL) was added to a solution of oxalyl chloride (53 μL, 0.61 mmol) in CH2Cl2 (3.9 mL) 
at –78°C. After 10 minutes stirring at –78°C, a solution of the S4 (95 mg, 0.47 mmol) in CH2Cl2 
(0.8 mL) was added. After 20 minutes stirring at –78°C, triethylamine (0.32 mL, 2.34 mmol) 
was added rapidly and the mixture was stirred at room temperature during 20 minutes. A 
saturated solution of NH4Cl was added to the reaction mixture which was then extracted three 
times with diethyl ether. The organic layer was washed with H2O and a saturated solution of 
brine, dried over Na2SO4, filtered, and concentrated to give 93 mg of aldehyde which was used 
without further purification in the next step. Under N2, nBuLi (0.32 mL, 0.55 mmol, 1.7 M in 
hexanes) was added to a –78°C solution of 2-Methylpyridine (59 μL, 0.60 mmol) in THF (2.5 
mL). After 10 minutes of stirring at –78°C, a solution of the aldehyde (93 mg, 0.46 mmol) in 
THF (0.8 mL) was added by cannula. After stirring for 10 minutes at –78°C, the reaction was 
quenched with enough MeOH to turn the deep red solution to yellow and was then allowed to 
warm to room temperature. The crude mixture was then partitioned between a saturated 
aqueous solution of NaHCO3, water and Et2O. After three extractions with Et2O (5 mL), the 
combined organic layers were dried over Na2SO4, filtered and concentrated. Purification by 
flash column chromatography (petroleum ether/EtOAc: 7/1  6/1) afforded 133 mg of a clear 
oil which was dissolved in CH2Cl2 (0.4 mL) under N2 and cooled to –40°C. Et3N (193 μL, 1.36 
mmol) and methanesulfonyl chloride (53 μL, 0.68 mmol) were added dropwise. After stirring 
overnight at room temperature, the precipitate thus formed was then filtered off over Celite, 
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washed with EtOAc, and the filtrate was concentrated under reduce pressure. Under N2, the 
residue was dissolved in THF (2.4 mL) under N2. At – 20°C, NaHMDS (0.6 mL, 0.61 mmol, 1M in 
THF) was added. After stirring at room temperature for 1 hour, the reaction mixture was 
quenched with a saturated solution of NaHCO3 and partitioned between water and EtOAc. 
After three extractions with Et2O (5 mL), the combined organic layers were dried over Na2SO4, 
filtered and concentrated. Purification by flash column chromatography (petroleum 
ether/Et2O: 9/1  8/1) afforded 126 as a white solid (56 mg, 55% over four steps) 
 
Compound E-126 
 
mp.: 27–28°C; 1H NMR (500 MHz, CDCl3): δ = 8.53 (d, J = 4.6 Hz, 1H), 7.62–7.56 (m, 1H), 7.35–
7.26 (m, 5H), 7.22–7.16 (m, 1H), 7.12–7.07 (m, 1H), 6.85 (d, J = 16.4 Hz, m1H), 6.53 (d, J = 16.2 
Hz, 1H), 5.61 (ddt, J = 17.2, 10.0, 7.1 Hz, 2H), 5.08–4.97 (m, 4H), 2.68 (d, J = 7.1 Hz, 4H); 13C 
NMR (125 MHz, CDCl3): δ = 156.0, 149.5, 144.8, 141.8, 136.4, 134.4 (2C), 128.7, 128.1, 127.4, 
126.2, 121.8, 121.0, 117.8 (2C), 46.8, 41.9 (2C); IR (neat): ṽ = 3059 (w), 3034 (w), 3007 (w), 
2922 (w), 2902 (w), 2841 (w), 1953 (w), 1892 (w), 1836 (w), 1650 (m), 1640 (m), 1598 (w), 
1585 (m), 1563 (m), 1493 (m), 1469 (m), 1444 (m), 1429 (m), 1322 (w), 1302 (w), 1262 (w). 
1243 (w), 1189 (w), 1150 (w), 1127 (w), 1097 (w), 1089 (w), 1049 (w), 1030 (w), 1009 (w), 990 
(m), 979 (m), 943 (m), 935 (m), 915 (s), 889 (m), 856 (m), 779 (m), 766 (m), 749 (s), 701 (s), 671 
(w), 654 (w) cm-1; HRMS (ESI): calcd for (C20H21N + Na): 276.1752; found: 276.1750; elemental 
analysis (%) calcd for C20H21N: C 87.23, H 7.69, N 5.09; found: C 87.71, H 7.69, N 4.87. 
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Compound E/Z-126 
 
2.5M of nBuli in hexane (0.4 ml, 1 mmol) was added to a schlenk containing triphenyl(2-
pyridylmethyl)phosphonium chloride hydrochloride (213 mg, 0.50 mmol) in THF (0.1 ml)  at -
78°C. The mixture was stirred at 35°C for 2 hours. Then, S5 in THF (0.2 ml) was added at rt. It 
was then allowed to stir overnight at rt. The reaction was quenched with a saturated solution 
of NaHCO3. The crude material was partitioned between H2O and EtOAc. The aqueous layer 
was then extracted three times with EtOAc. Extracts dried over Na2SO4 and filtered. Silica was 
then added, all volatiles were removed and the dry deposit was loaded on to the top of a 
column. Purification by flash column chromatography (petroleum ether/Et2O: 9/1) afforded 
126 as a white solid (29 mg, 43%) with a E/Z ratio of 91:9 as judged from the 1H NMR spectra; 
Key peaks of Z-126, 1H NMR (500 MHz, CDCl3): δ = 8.36 – 8.33 (m, 1H), 6.63 (d, J = 13.0 Hz, 1H), 
5.97 (d, J = 13.0 Hz, 1H). 
 
Compound 139 
 
Obtained from S25 (1.03 mmol, 211 mg) following the representative procedure. Colourless oil 
(202 mg, 71% over four steps); 1H NMR (500 MHz, CDCl3): δ = 8.53 (ddd, J = 4.8, 1.7, 0.8 Hz, 
1H), 7.59 (dt, J = 7.7, 1.8 Hz, 1H), 7.35–7.26 (m, 5H), 7.21–7.16 (m, 1H), 7.09 (ddd, J = 7.5, 4.8, 
1.1 Hz, 1H), 6.52 (s, 1H), 5.61 (ddt, J = 17.2, 10.1, 7.1 Hz, 2H), 5.07–4.97 (m, 4H), 2.70 – 2.66 
(m, 4H); 13C NMR (125 MHz, CDCl3): δ = 156.0, 149.5, 144.8, 141.4 (t, J = 22.5 Hz), 136.4, 134.4 
(2C), 128.6, 128.1 (2C), 127.4 (2C), 126.2, 121.8, 121.0, 117.8 (2C), 46.7, 41.9 (2C); IR (neat): ṽ = 
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3075 (w), 3003 (w), 2978 (w), 2930 (w), 1638 (m), 1586 (s), 1562 (w), 1494 (w), 1469 (m), 1445 
(m), 1429 (m), 1149 (w), 1033 (w), 996 (m), 910 (s), 753 (m), 700 (s) cm-1; HRMS (CI(NH3)): 
calcd for (C20H20DN + H): 277.1815; found: 277.1808. 
 
Compound 132e 
 
Obtained from S10 (0.56 mmol, 119 mg) following the representative procedure. Colourless oil 
(86 mg, 52% over four steps); 1H NMR (500 MHz, CDCl3): δ = 8.53 (ddd, J = 4.8, 1.7, 0.8 Hz, 1H), 
7.58 (dt, J = 7.7, 1.8 Hz, 1H), 7.32 (d, J = 7.9 Hz, 1H), 7.07 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H), 6.82 (d, 
J = 16.5 Hz, 1H), 6.50 (d, J = 16.5 Hz, 1H), 5.94–5.84 (m, 2H), 5.04 (dt, J = 17.1, 1.5 Hz, 2H), 5.00 
(dt, J = 10.2, 1.1 Hz, 2H), 3.97–3.88 (m, 4H), 2.49 (dd, J = 14.4, 7.7 Hz, 2H), 2.44 (dd, J = 14.4, 
6.8 Hz, 2H), 1.28 (s, 3H); 13C NMR (125 MHz, CDCl3): δ = 156.1, 149.4, 139.2, 136.3, 135.5 (2C), 
130.1, 121.7, 120.9, 116.5 (2C), 113.1, 64.8 (2C), 50.6, 36.6 (2C), 21.1; IR (neat): ṽ = 3073 (w), 
2979 (m), 2939 (w), 2883 (w), 1638 (w), 1586 (s), 1563 (m), 1469 (m), 1430 (m), 1373 (m), 
1304 (w), 1266 (w), 1198 (s), 1149 (m), 1127 (m), 1100 (m), 1083 (m), 1036 (s), 991 (s), 950 
(m), 910 (s), 852 (w), 765 (m), 742 (w) cm-1; MS (CI(CH4)): m/z (rel. intensity): 286 (100) [M + 
H]; HRMS (CI(CH4)): calcd for (C18H23NO2 + H): 286.1802; found: 286.1804; elemental analysis 
(%) calcd for C18H23NO2: C 75.76, H 8.12, N 4.91; found: C 76.44, H 8.33, N 4.93. 
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Compound 132f 
 
Compound prepared by Daniel J. Tetlow. Yellow oil (320 mg, 60% over four steps); 1H NMR 
(500 MHz, CDCl3): δ = 8.50 (d, J = 4.6 Hz, 1H), 7.65 (d, J = 8.2 Hz, 2H), 7.60 (td, J = 7.7, 1.5 Hz, 
1H), 7.21–7.15 (m, 3H), 7.11 (dd, J = 7.4, 4.9 Hz, 1H), 6.58 (d, J = 16.3 Hz, 1H), 6.44 (d, J = 16.3 
Hz, 1H), 5.72 (ddt, J = 17.1, 10.1 and 7.0 Hz, 2H), 5.10 (d, J = 16.2 Hz, 2H), 5.09 (d, J = 9.7 Hz, 
2H), 2.97 (s, 3H), 2.81 (dd, J = 14.2, 7.5 Hz, 2H), 2.64 (dd, J = 14.2, 6.4 Hz, 2H), 2.37 (s, 3H); 13C 
NMR (125 MHz, CDCl3): δ = 154.9, 149.4, 142.7, 139.8, 136.5, 136.4, 133.0 (2C), 130.0, 129.3 
(2C), 127.2 (2C), 122.3, 121.6, 118.9 (2C), 66.3, 40.1 (2C), 33.4, 21.4; IR (neat): ṽ = 3075 (w), 
2977 (w), 2925 (w), 1638 (w), 1584 (m), 1564 (w), 1494 (w), 1469 (m), 1430 (m), 1337 (s), 1304 
(m), 1255 (w), 1211 (w), 1153 (s), 1117 (m), 1088 (s), 1049 (w), 1018 (w), 981 (s), 915 (s), 813 
(s), 770 (m), 743 (m), 720 (s), 657 (s) cm-1; MS (ESI): m/z (rel. intensity): 421 (10) [M + K], 405 
(72) [M + Na], 383 (100) [M + H]; HRMS (ESI) calcd for (C22H27N2O2S + Na): 383.1793; found: 
383.1786. 
 
Compound 132h 
 
 
Obtained from S15 (1.23 mmol, 300 mg) following the representative procedure. Yellow oil 
(199 mg, 64% over four steps); 1H NMR (500 MHz, CDCl3): δ = 8.56–8.51 (m, 1H), 7.58 (dt, J = 
7.7, 1.8 Hz, 1H), 7.23–7.12 (m, 6H), 7.09 (ddd, J = 7.4, 4.9, 1.0 Hz, 1H), 6.69 (d, J = 16.2 Hz, 1H), 
6.28 (d, J = 16.2 Hz, 1H), 5.92–5.82 (m, 2H), 5.13– 5.05 (m, 4H), 2.78 (s, 2H), 2.31–2.20 (m, 4H); 
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13C NMR (125 MHz, CDCl3): δ = 155.9, 149.4, 141.6, 137.8, 136.4, 134.5 (2C), 130.8 (2C), 128.6, 
127.7 (2C), 126.1, 121.7, 121.0, 117.9 (2C), 44.5, 43.0, 40.6 (2C); IR (neat): ṽ = 3074 (w), 3029 9 
(w), 3005 (w), 2977 (w), 2922 (w), 2852 (w), 1638 (w)m 1603 (w), 1584 (m), 1563 (w), 1495 
(w), 1469 (w), 1454 (w), 1429 (m), 1334 (w), 1304 (w), 1262 (w), 1149 (w), 1088 (w), 1049 (w), 
1031 (w), 991 (m), 911 (s), 849 (w), 795 (w), 767 (m), 743 (s), 701 (s), 667 (w) cm-1; elemental 
analysis (%) calcd for C21H23N: C 87.15, H 8.01, N 4.84; found: C 86.98, H 8.20, N 4.75. 
 
Compound 132i 
 
Obtained from S19 (0.80 mmol, 197 mg) following the representative procedure. Yellow oil 
(146 mg, 57% over four steps); 1H NMR (500 MHz, CDCl3): δ = 8.54–8.50 (m, 1H), 7.58 (dt, J = 
7.7, 1.8 Hz, 1H), 7.34 – 7.28 (m, 4H), 7.28 – 7.22 (m, 2H), 7.08 (ddd, J = 7.4, 4.9, 1.0 Hz, 1H), 
6.67 (d, J = 16.3 Hz, 1H), 6.42 (d, J = 16.3 Hz, 1H), 5.77 (ddt, J = 17.1, 10.0, 7.3 Hz, 2H), 5.09–
4.99 (m, 4H), 4.50 (s, 2H), 3.41 (s, 2H), 2.38–2.27 (m, 4H); 13C NMR (125 MHz, CDCl3): δ = 156.0, 
149.4, 139.4, 138.7, 136.3, 134.4 (2C), 128.9, 128.3, 127.5 (2C), 127.4 (2C), 121.7, 121.1, 117.7 
(2C), 74.1, 73.3, 43.5, 40.0 (2C); IR (neat): ṽ = 3074 (w), 3004 (w), 2911 (w), 2857 (m), 1649 (w), 
1639 (w), 1585 (s), 1564 (m), 1497 (w), 1470 (m), 1454 (m), 1430 (m), 1363 (w), 1305 (w), 1206 
(w), 1095 (s), 1029 (w), 992 (m), 976 (s), 914 (s), 767 (s), 739 (s), 698 (s) cm-1; elemental 
analysis (%) calcd for C22H25NO: C 82.72, H 7.89, N 4.38; found: C 83.06, H 7.92, N 4.34. 
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Compound 129 
 
Obtained from S18 (500mg, 1.85 mmol) following the representative procedure. Colourless oil 
(347 mg, 55% over four steps); 1H NMR (500 MHz, CDCl3): δ = 8.51 (d, J = 4.2 Hz, 1H), 7.57 (apt 
dt, J = 7.7, 1.8 Hz, 1H), 7.26 – 7.21 (m, 1H), 7.08 – 7.04 (m, 1H), 6.62 (d, J = 16.5 Hz, 1H), 6.40 
(d, J = 16.5 Hz, 1H), 5.78 (ddt, J = 15.2, 9.9, 7.3 Hz, 2H), 5.09 – 4.97 (m, 4H), 3.52 (s, 2H), 2.30 
(dd, J =13.8, 7.5 Hz, 2H), 2.25 (dd, J =13.8, 7.2 Hz, 2H), 0.87 (s, 9H), 0.01 (s, 6H) ; 13C NMR (125 
MHz, CDCl3): δ = 156.1, 149.4, 139.3, 136.3, 134.6, 129.0, 121.6, 120.8, 117.5, 66.4, 44.1, 39.5, 
25.8, 18.2 , -5.6; IR (neat): ṽ = 3075 (w), 3005 (w), 2954 (m), 2928 (m), 2897 (m), 2856 (m), 
1639 (w), 1585 (m), 1564 (w), 1470 (m), 1430 (w), 1388 (w), 1361 (w), 1304 (w), 1250 (m), 
1147 (w), 1096 (s), 992 (m), 978 (m), 913 (m), 834 (s), 774 (s), 671 (w) cm-1; elemental analysis 
(%) calcd for C21H33NOSi: C 73.41, H 9.68, N 4.08; found: C 73.68, H 7.71, N 4.03. 
 
Compound S23 
 
Under N2, a solution of LDA (1.41 mmol) {prepared from 0.67 mL of a 2.5 M of nBuLi and 0.20 
mL of diisopropylamine in THF (1.8 mL)} at 0 °C, was added to a solution of S22 (155 mg, 1.00 
mmol) in THF (0.7 mL) at -78°C. The resulting solution was stirred at -78°C for 1.5 hour then 
methyl iodide (94 μL, 1.51 mmol) was slowly added. The mixture was allowed to warm to 
room temperature overnight before being quenched with few drops of a saturated aqueous 
solution of NH4Cl. The mixture was diluted with H2O and extracted three times with Et2O (5 
mL). The organic layer was then washed with H2O and a saturated aqueous solution of brine, 
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dried over Na2SO4, filtered and concentrated. Purification by flash chromatography (petroleum 
ether/ Et2O: 29/1) afforded 148 mg of a colourless oil which was dissolved in Et2O (0.8 mL) and 
added by cannula to a suspension of LiAlH4 (19 mg, 0.49 mmol) in Et2O (1.6 mL) at 0°C. After 
10 minutes at 0°C another portion of LiAlH4 (19 mg, 0.49 mmol) was added. After stirring for 1 
hour at room temperature, the reaction mixture was quenched carefully at 0°C with a 
saturated aqueous solution of Na2SO4 which resulted in the formation of a white precipitate. 
After filtration over Celite to remove the white precipitate, the solvent was evaporated under 
reduced pressure to give 107 mg of alcohol. Under N2, DMSO (145 μL, 2.04 mmol) in CH2Cl2 
(0.8 mL) was added to a solution of oxalyl chloride (88 μL, 1.02 mmol) in CH2Cl2 (3.9 mL) at –
78°C. After 10 minutes stirring at –78°C, a solution of the alcohol (107 mg, 0.78 mmol) in 
CH2Cl2 (0.8 mL) was added. After 20 minutes stirring at –78°C, triethylamine (0.55 mL, 3.92 
mmol) was added rapidly and the mixture was stirred at room temperature during 20 minutes. 
A saturated solution of NH4Cl was added to the reaction mixture which was then extracted 
three times with diethyl ether. The organic layer was washed with H2O and a saturated 
solution of aqueous brine, dried over Na2SO4, filtered, and concentrated to give 96 mg of 
aldehyde. Under N2, nBuLi (0.39 mL, 0.81 mmol, 2.1 M in hexanes) was added to a -78°C 
solution of 2-methylpyridine (80 μL, 0.81 mmol) in THF (2.0 mL). After 10 minutes of stirring at 
-78°C, a solution of aldehyde (82 mg, 0.60 mmol) in THF (1 mL) was added by cannula. After 
stirring for 15 minutes at -78°C, the reaction was quenched with enough MeOH to turn the 
deep red solution to yellow and then allowed to warm to room temperature. The crude 
mixture was then partitioned between a saturated solution of NaHCO3, water and ethyl 
acetate and then extracted three times with ethyl acetate (5 mL). The combined organic layers 
were dried over Na2SO4, filtered and concentrated. Purification by flash column 
chromatography (petroleum ether/EtOAc: 5/1) afforded S23 as a clear oil (98 mg, 42% over 
four steps): 1H NMR (500 MHz, CDCl3): δ = 8.48–8.43 (m, 1H), 7.59 (dt, J = 7.6, 1.8 Hz, 1H), 
7.15–7.09 (m, 2H), 5.95–5.82 (m, 2H), 5.10–5.00 (m, 4H + 1H(OH)), 3.80 (dd, J = 10.5, 1.7 Hz, 
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1H), 2.90 (dd, J = 14.6, 1.7 Hz, 1H), 2.80 (d, J = 14.5, 10.4 Hz, 1H), 2.33–2.23 (m, 2H), 2.14 (dd, J 
= 13.9, 7.5 Hz, 1H), 2.03 (dd, J = 13.7, 7.8 Hz, 1H), 0.94 (s, 3H); 13C NMR (125 MHz, CDCl3): δ = 
161.0, 148.6, 136.8, 135.4, 135.2, 123.7, 121.4, 117.24, 117.19, 75.7, 40.6, 40.4, 40.2, 37.7, 
20.5; IR (neat): ṽ = 3351 (br w), 3074 (m), 2975 (m), 2917 (m), 1638 (m), 1597 (s), 1570 (m), 
1475 (m), 1438 (s), 1375 (w), 1317 (w), 1145 (w), 1097 (w), 1049 (m), 999 (m), 912 (s), 756 (s) 
cm-1; elemental analysis (%) calcd for C15H21NO: C 77.88, H 9.15, N 6.05; found: C 77.79, H 9.17, 
N 5.88. 
 
Compound 132j 
 
 
At 0°C, methanesulfonyl chloride (30 μL, 0.39 mmol) was added dropwise to a solution of S23 
(75mg, 0.32 mmol) and Et3N (68 μL, 0.49 mmol) in CH2Cl2 (0.64 mL). After stirring at room 
temperature overnight, the crude mixture was partitioned between a saturated solution of 
NaHCO3 and ethyl acetate, and extracted three times with ethyl acetate (5 mL). The combined 
organic layers were washed with water, then a saturated aqueous solution of brine, then dried 
over Na2SO4, filtered and concentrated. Under N2, the residue was dissolved in THF (0.32 mL). 
At 0 °C, NaHMDS (0.5 mL, 0.49 mmol, 1M in THF) was added. After stirring for 2 hours at room 
temperature, the reaction mixture was quenched with a saturated solution of NaHCO3 and 
extracted three times with ethyl acetate and the combined extracts were washed with water, 
followed by a saturated aqueous solution of brine, then dried over Na2SO4, filtered and 
concentrated. Purification by flash column chromatography (petroleum ether/Et2O: 6/1  
4/1) afforded 132j as a clear oil (47 mg, 68 %): 1H NMR (500 MHz, CDCl3): δ = 8.52 (ddd, J = 4.9, 
1.7, 0.8 Hz, 1H), 7.59 (dt, J = 7.7, 1.8 Hz, 1H), 7.27–7.22 (m, 1H), 7.08 (ddd, J = 7.5, 4.9, 1.0 Hz, 
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1H), 6.69 (d, J = 16.2 Hz, 1H), 6.37 (d, J = 16.1 Hz, 1H), 5.82 – 5.72 (m, 2H), 5.06 – 4.99 (m, 4H), 
2.22 (dd, J = 13.7, 7.0 Hz, 2H), 2.15 (dd, J = 13.7, 7.7 Hz, 2H), 1.08 (s, 3H); 13C NMR (125 MHz, 
CDCl3): δ = 156.1, 149.4, 143.0, 136.4, 134.8 (2C), 127.6, 121.6, 121.1, 117.4 (2C), 45.0 (2C), 
39.3, 23.3; IR (neat): ṽ = 3075 (m), 3004 (w), 2976 (m), 2915 (m), 1640 (m), 1585 (s), 1564 (m), 
1471 (m), 1430 (s), 1377 (w), 1321 (w), 1149 (w), 992 (m), 913 (s), 766 (m), 742 (w) cm-1; 
elemental analysis (%) calcd for C15H19N: C 84.46, H 8.98, N 6.57; found: C 84.17, H 9.11, N 
6.13. 
 
Compound 135 
 
Obtained from S4 (200mg, 0.99 mmol) following the representative procedure, except using 
1,2-dimethylimidazole and S24 was isolated as a yellow oil (254 mg, 86%). Afterwards, 
methanesulfonyl chloride (37 L, 0.47 mmol) was added dropwise to a 0°C solution of S24 
(71mg, 0.24 mmol) and triethylamine (66L, 0.47 mmol) in DCM (0.50 mL). Afterwards, it was 
allowed to stir at r.t. for 2 hours. Afterwards, the crude mixture was partitioned between a 
saturated solution of NaHCO3 and ethyl acetate. Extracted three times with ethyl acetate and 
the combined extracts was washed with H2O, a saturated solution of brine, dried over Na2SO4, 
filtered and concentrated. Under N2, the residue was dissolved in THF (0.5 mL). Cooled to 0
oC, 
NaHMDS (65 mg, 0.35 mmol) was added. It was then allowed to stir overnight at r.t.  The 
reaction mixture was quenched with a saturated solution of NaHCO3. The crude mixture was 
partitioned between water and ethyl acetate. Extracted three times with ethyl acetate and the 
combined extracts was washed with H2O, a saturated solution of brine, dried over Na2SO4, 
filtered and concentrated. Purification by flash column chromatography (PE/EA : 1/1) afforded 
compound 135 as a clear oil (39 mg, 58 %): 1H NMR (500 MHz, CDCl3): δ = 7.35 – 7.26 (m, 4H), 
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7.21 – 7.15 (m, 1H), 7.00 (s, 1H), 6.86 (d, J = 16.2 Hz, 1H), 6.81 (s, 1H), 6.25 (d, J = 16.1 Hz, 1H), 
5.61 (ddt, J = 17.1, 10.1, 7.1 Hz, 2H), 5.08 – 4.98 (m, 4H), 3.59 (s, 3H), 2.66 (d, J = 7.1 Hz, 4H); 
13C NMR (125 MHz, CDCl3): δ = 145.5, 144.5, 141.7, 134.3, 128.3, 128.0, 127.4, 126.1, 121.0, 
117.8, 114.9, 46.9, 42.2, 32.7; IR (neat): ṽ = 3346 (br w), 3073 (w), 3006 (w), 2977 (w), 2920 
(w), 1638 (w), 1598 (w), 1515 (w), 1493 (w), 1483 (m), 1444 (m), 1410 (m), 1284 (m), 1187 (w), 
1135 (w), 1082 (w), 1033 (w), 996 (m), 975 (m), 912 (s), 843 (w), 826 (w), 769 (m), 734 (m), 698 
(s), 657 (w) cm-1; MS (CI): calcd for (C19H22N2 + H): 279.1856; found: 279.1854 
 
Preparation32 of [Rh(coe)2Cl]2 – To a 3-neck round-bottomed flask containing RhCl3•3H2O (175 
mg, 0.84 mmol) were sequentially added degassed water (1 mL), degassed iPrOH (4 mL) and 
cyclooctene (0.56 mL, 4.30 mmol). The resulting dark red solution was heated under reflux for 
2 hours. Afterwards, the resulting orange suspension was cooled to room temperature. The 
precipitate was collected by filtration, washed with cold ethanol, washed with petroleum 
ether and dried in vacuo to give [Rh(coe)2Cl]2 (165 mg, 28 %) as yellow solid. The purity of each 
batch of this pre-catalyst was assessed by elemental analysis (%) calcd for C32H50Cl2Rh2: C 
53.57, H 7.87; found: C 52.23, H 7.62. 
 
Representative procedure for the rhodium-catalysed carbocyclisation of 1,6-dienes – 
[Rh(coe)2Cl]2 (2.6 mg, 0.0036 mmol) and P(pMeOC6H4)3 (5.1 mg, 0.0145 mmol) were added to 
a flame-dried J-Young Schlenk flask under N2. THF (0.17 mL) was added and the red solution 
stirred at room temperature for 5 minutes. AgBF4 (1.4 mg, 0.0073 mmol) in THF (0.1 mL) was 
added and stirred for 5 minutes. Then, under N2, 126 (20 mg, 0.0726 mmol) in THF (0.4 mL) 
was added via cannula, the tube sealed and the reaction heated at 60°C for 17 hours. The 
reaction mixture was cooled to room temperature, filtered through a small plug of silica (using 
CH2Cl2 to rinse) and the solvent was removed under reduced pressure. Purification by flash 
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column chromatography (petroleum ether/Et2O, 25:1  20:1) afforded 127 as colourless oil 
(17.7 mg, 89%, 127/128 = 98:2). 
 
Compound 127 
 
1H NMR (500 MHz, CDCl3): δ = 8.48 (ddd, J = 4.8, 1.7, 0.8 Hz, 1H), 7.50 (dt, J = 7.8, 1.8 Hz, 1H), 
7.36–7.31 (m, 4H), 7.25–7.21 (m, 1H), 7.10 (d, J = 8.1 Hz, 1H), 6.96 (ddd, J = 7.4, 4.9, 0.9 Hz, 
1H), 5.75 (t, J = 2.3 Hz, 1H), 2.86 (dt, J = 17.2, 3.5 Hz, 1H), 2.67 (dt, J = 17.2, 2.5 Hz, 1H), 2.23 (d, 
J = 4.2 Hz, 1H), 2.19 (ddd, J = 11.6, 8.5, 2.5 Hz, 1H), 1.97 (ddt, J = 9.8, 2.1, 1.0 Hz, 1H), 1.93–1.84 
(m, 1H), 1.82 (ddd, J = 9.7, 3.3, 1.7 Hz, 1H), 1.54 (dd, J = 11.8, 4.8 Hz, 1H), 1.02 (d, J = 7.0 Hz, 
3H); 13C NMR (125 MHz, CDCl3): δ = 158.2, 157.6, 149.1, 142.8, 135.7, 128.19 (2C), 128.15 (2C), 
126.3, 122.7, 120.1, 119.7, 59.6, 43.5, 42.6, 41.2, 40.9, 36.4, 22.3; IR (neat): ṽ = 3057 (w), 2951 
(m), 2866 (w), 1655 (w), 1585 (s), 1559 (w), 1497 (w), 1471 (m), 1445 (w), 1427 (m), 1375 (w), 
1346 (w), 1317 (w), 1260 (w), 1236 (w), 1220 (w), 1184 (w), 1148 (w), 1081 (w), 1061 (w), 1035 
(w), 991 (w), 961 (w), 920 (w), 894 (w), 864 (w), 778 (w), 758 (m), 741 (m), 699 (s), 659 (w) cm-
1; HRMS (ESI): calcd for (C20H21N + H): 276.1752; found: 276.1755. 
 
Compound 128 
 
This compound could be isolated by preparative TLC during the optimisation study. Colourless 
oil; 1H NMR (500 MHz, CDCl3): δ = 8.60 (ddd, J = 4.8, 1.7, 0.8 Hz, 1H), 7.61 (dt, J = 7.7, 1.8 Hz, 
1H), 7.43–7.38 (m, 2H), 7.30–7.25 (m, 3H), 7.19–7.14 (m, 1H), 7.06 (ddd, J = 7.4, 4.9, 0.8 Hz, 
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1H), 6.44 (t, J = 2.5 Hz, 1H), 5.80–5.69 (m, 1H), 5.04 (ddt, J = 17.1, 1.9, 1.4 Hz, 1H), 5.00 (ddt, J = 
10.2, 2.1, 1.0 Hz, 1H), 2.89–2.82 (m, 2H), 2.75 (ddt, J = 14.2, 7.4, 1.0 Hz, 1H), 2.64 (ddt, J = 14.2, 
6.6, 1.3 Hz, 1H), 2.21 (ddd, J = 12.6, 6.5, 3.6 Hz, 1H), 1.87 (ddd, J = 12.7, 10.1, 7.1 Hz, 1H), 1.80–
1.70 (m, 1H), 1.64–1.50 (m, 1H); 13C NMR (125 MHz, CDCl3): δ = 157.2, 156.1, 149.2, 146.1, 
135.9, 135.6, 128.1 (2C), 127.1 (2C), 125.9, 123.5, 123.4, 120.5, 117.2, 55.8, 44.9, 37.7, 32.3, 
22.1; HRMS (ESI): calcd for (C20H21N + H): 276.1752; found: 276.1751. 
 
Compound 140 and 141 
 
Obtained from 139 (0.071 mmol, 19.6 mg) following the representative procedure. Colourless 
oil (19.6 mg, quantitative); 1H NMR (500 MHz, CDCl3): δ = 8.48 (ddd, J = 4.8, 1.6, 0.7 Hz, 1H), 
7.51 (dt, J = 7.8, 1.8 Hz, 1H), 7.37–7.31 (m, 4H), 7.26–7.21 (m, 1H), 7.09 (d, J = 8.0 Hz, 1H), 6.96 
(ddd, J = 7.4, 4.8, 0.9 Hz, 1H), 5.77–5.74 (m, 1H), 2.86 (dt, J = 17.3, 3.4 Hz, 0.8H), 2.67 (dt, J = 
17.3, 2.5 Hz, 0.8H), 2.25–2.21 (m, 1H), 2.18 (ddd, J = 11.6, 8.5, 2.5 Hz, 1H), 1.99–1.94 (m, 1H), 
1.93–1.84 (m, 1H), 1.82 (ddd, J = 9.7, 3.1, 1.5 Hz, 1H), 1.54 (dd, J = 11.8, 4.9 Hz, 1H), 1.05–0.98 
(m, 2.4H); 2D NMR (77 MHz, CDCl3): δ = 2.86 (s, 0.2D), 2.78 (s, 0.2D), 1.04 (s, 0.6D); 
13C NMR 
(125 MHz, CDCl3):^ δ = 158.20, [158.16], 157.6, 149.1, 142.7, 135.7, 128.17 (2C), 128.14 (2C), 
126.3, 122.6, 120.1, [119.71], 119.66, 59.6, [43.47], 43.43, 42.51, [42.45], 41.2, 40.9, [40.5 (t, J 
= 20.3 Hz)], [36.32], 36.26, [22.3], 22.0 (t, J = 19.2 Hz); IR (neat): ṽ = 3057 (w), 3002 (w), 2949 
(s), 2866 (w), 2165 (w), 1655 (m), 1602 (w), 1585 (s), 1559 (w), 1497 (w), 1471 (m), 1446 (w), 
1427 (s), 1375 (w), 1318 (w), 1257 (w), 1234 (w), 1220 (w), 1148 (w), 1086 (w), 1060 (w), 1036 
(w), 990 (w), 958 (w), 890 (w), 864 (w), 776 (w), 758 (s), 741 (m), 699 (s) cm-1; MS (CI(CH4)): 
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m/z (rel. intensity): 277 (70) [M + H], 169 (100); HRMS (CI(CH4)): calcd for (C20H20DN + H): 
277.1815; found: 277.1805. 
^ As easily established by comparison of 13C NMR APT, HSQC and HMBC NMR of 127 and the 
mixture of 140 and 141, the chemical shifts in brackets correspond to the mono-deuterated 
isomer for which the deuterium atom is incorporated at the position indicated by a star. 
 
Hydrochloride salt of compound 127 
 
127 (20 mg, 0.073 mmol) was dissolved in Et2O (0.2 mL). Then 3 drops of conc. HCl solution 
were added to give a white suspension. After mixing vigorously for 5 minutes, all volatiles 
were removed. The residue was dissolved in a vial with CH2Cl2 (1 mL) and then petroleum 
ether (5 mL) so that the two layers do not mix. All volatiles evaporated slowly at room 
temperature at atmospheric pressure to give brown crystals which were washed with diethyl 
ether to give brown crystals which were suitable for X-ray crystallography (15 mg, 66 %). mp.: 
167–174°C (decomposition); 1H NMR (500 MHz, CDCl3): δ = 8.71–8.54 (m, 1H), 8.19–8.06 (m, 
1H), 7.67–7.56 (m, 1H), 7.53–7.44 (m, 1H), 7.41 (t, J = 7.4 Hz, 2H), 7.34 (d, J = 7.6 Hz, 2H), 7.30 
(t, J = 7.4 Hz, 3H), 6.37–6.29 (m, 1H), 2.94 (d, J = 16.1 Hz, 1H), 2.66 (d, J = 16.1 Hz, 1H), 2.34 (s, 
1H), 2.28–2.19 (m, 1H), 2.06 (d, J = 9.7 Hz, 1H), 1.97–1.86 (m, 2H), 1.61 (dd, J = 12.0, 4.5 Hz, 
1H), 1.05 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 170.3, 151.6, 144.2, 141.5 (br), 
140.1, 128.7 (2C), 128.0 (2C), 127.3, 124.8, 122.7, 111.9, 61.0, 43.3, 42.2, 41.3, 41.1, 35.9, 
22.0; IR (neat): ṽ = 3086 (w), 3040 (w), 2958 (w), 2916 (w), 2862 (w), 2266 (m), 2209 (m), 2041 
(m), 1980 (m), 1933 (m), 1650 (m), 1608 (s), 1528 (m), 1496 (m), 1456 (m), 1444 (m), 1399 (w), 
1371 (m), 1323 (w), 1290 (m), 1251 (w), 1233 (w), 1155 (m), 1141 (w), 1096 (w), 1064 (w), 
1038 (w), 1025 (w), 988 (m), 961 (w), 950 (w), 923 (w), 896 (w), 882 (w), 871 (w), 847 (w), 827 
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(w), 814 (w), 772 (s), 763 (s), 702 (s), 659 (w) cm-1; elemental analysis (%) calcd for C20H22ClN: C 
77.03, H 7.11, N 4.49; found: C 76.49, H 7.06, N 4.41. 
 
Compound 133e 
 
Obtained from 132e (0.070 mmol, 20 mg) following the representative procedure. Colourless 
oil (18 mg, 88%); 1H NMR (500 MHz, CDCl3): δ = 8.54 (ddd, J = 4.8, 1.8, 0.8 Hz, 1H), 7.55 (dt, J = 
7.7, 1.9 Hz, 1H), 7.22 (d, J = 8.1 Hz, 1H), 6.98 (ddd, J = 7.4, 4.9, 1.0 Hz, 1H), 6.79 (t, J = 2.3 Hz, 
1H), 4.07–3.88 (m, 4H), 2.71 (dt, J = 17.1, 3.4 Hz, 1H), 2.61 (dt, J = 17.1, 2.5 Hz, 1H), 2.04 (d, J = 
3.9 Hz, 1H), 1.74 (ddd, J = 9.6, 3.4, 1.8 Hz, 1H), 1.73–1.67 (m, 1H), 1.62 (ddd, J = 11.4, 8.4, 2.4 
Hz, 1H), 1.45 (s, 3H), 1.44–1.38 (m, 2H), 0.97 (d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 
158.1, 152.8, 149.0, 135.7, 123.1, 120.2, 120.0, 110.9, 65.2, 64.5, 63.0, 42.3, 42.0, 38.9, 38.6, 
35.8, 22.2, 21.7; IR (neat): ṽ = 3052 (w), 2950 (s), 2871 (m), 1650 (m), 1585 (s), 1558 (w), 1470 
(m), 1428 (s), 1371 (m), 1321 (w), 1287 (w), 1264 (m), 1239 (w), 1216 (w), 1198 (s), 1161 (s), 
1111 (m), 1090 (m), 1075 (w), 1063 (m), 1040 (s), 992 (w), 943 (w), 920 (w), 899 (m), 870 (m), 
812 (w), 779 (m), 761 (w), 741 (m), 658 (w) cm-1; HRMS (CI(CH4)): calcd for (C18H23NO2 + H): 
286.1802; found: 286.1000. 
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Compound 133f 
 
Compound prepared by Daniel J. Tetlow. Obtained from 132f (0.146 mmol, 56 mg) following 
the representative procedure. Colourless gum (43 mg, 76%);^ 1H NMR (500 MHz, CDCl3): δ = 
8.54 (dd, J = 4.8 and 1.0 Hz, 1H), 7.73 (d, J = 8.1 Hz, 2H), 7.55 (td, J = 7.8, 1.8 Hz, 1H), 7.26 (d, J 
= 8.1 Hz, 2H), 7.13 (d, J = 7.9 Hz, 1H), 7.02 (ddd, J = 7.3, 4.8, 0.6 Hz, 1H), 6.38 (t, J = 2.2 Hz, 1H), 
3.11 (s, 3H), 2.77–2.62 (m, 2H), 2.39 (s, 3H), 2.19 (ddd, J = 11.2, 8.4, 2.4 Hz, 1H), 1.97 (d, J = 2.6 
Hz, 1H), 1.86 (d, J = 9.5 Hz, 1H), 1.81–1.72 (m, 1H), 1.58 (dd, J = 8.8, 5.0 Hz, 1H), 1.57–1.53 (m, 
1H), 0.88 (d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 159.9, 149.7, 149.0, 142.8, 139.5, 
135.9, 129.5 (2C), 126.8 (2C), 123.6, 120.4, 118.4, 74.9, 43.2, 39.81, 39.76, 38.9, 35.7, 35.4, 
22.1, 21.4; IR (neat): ṽ = 2954 (w), 2923 (w), 2868 (w), 1666 (w), 1585 (m), 1560 (w), 1494 (w), 
1470 (m), 1428 (m), 1377 (w), 1336 (s), 1306 (s), 1280 (w), 1225 (w), 1151 (s), 1119 (w), 1089 
(s), 1042 (s), 1016 (w), 982 (w), 902 (m), 842 (s), 812 (s), 778 (m), 759 (w), 741 (m), 706 (w), 
661 (s) cm-1; HRMS (ESI): calcd for (C22H27N2O2S + H): 383.1793; found: 383.1783. 
^ Over time, we observed a small doublet appearing at 2.64 ppm (J = 5.4 Hz) in 1H NMR which 
could correspond to the Me-N of a minor impurity where the tosyl group is cleaved. A small 
peak (ESI) with the expected m/z = 228 [M – Ts + H] also confirms this analysis. 
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Compound 133h 
 
Obtained from 132h (0.070 mmol, 20.3 mg) following the representative procedure, except 
that P(pMeOC6H4)3 (3.6 mg, 0.0101 mmol) was used. Colourless oil. (17 mg, 83%, 133h/134h = 
95:5); 1H NMR (500 MHz, CDCl3): δ = 8.55 (ddd, J = 4.9, 1.7, 0.8 Hz, 1H), 7.59 (dt, J = 7.7, 1.9 Hz, 
1H), 7.29– 7.24 (m, 3H), 7.21–7.16 (m, 3H), 7.02 (ddd, J = 7.4, 4.9, 1.0 Hz, 1H), 6.44–6.40 (m, 
1H), 3.05 (d, J = 13.4 Hz, 1H), 2.99 (d, J = 13.4 Hz, 1H), 2.67 (dt, J = 17.1, 3.4 Hz, 1H), 2.57 (dt, J 
= 16.9, 2.5 Hz, 1H), 1.98 (d, J = 4.1 Hz, 1H), 1.72–1.62 (m, 1H), 1.50 (ddd, J = 11.7, 8.5, 2.5 Hz, 
1H), 1.33 (ddd, J = 9.8, 3.1, 1.7 Hz, 1H), 1.26–1.21 (m, 1H), 1.06 (dd, J = 11.8, 4.9 Hz, 1H), 0.77 
(d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 157.7, 156.9, 149.2, 139.7, 135.8, 130.3 (2C), 
127.8 (2C), 125.8, 122.5, 120.2, 117.7, 55.3, 42.7, 41.8, 41.7, 39.3, 38.2, 36.0, 22.0; IR (neat): ṽ 
= 3061 (w), 3027 (w), 3002 (w), 2950 (m), 2866 (w), 1655 (m), 1603 (w), 1585 (s), 1559 (w), 
1496 (w), 1471 (m), 1454 (w), 1428 (m), 1375 (w), 1346 (w), 1308 (w), 1276 (w), 1221 (w), 
1149 (w), 1096 (w), 1062 (w), 1031 (w), 991 (w), 889 (w), 858 (w), 804 (w), 771 (w), 754 (m), 
741 (w), 702 (s), 658 (w) cm-1; HRMS (ESI): calcd for (C21H24N + H): 290.1911; found: 290.1909; 
elemental analysis (%) calcd for C21H23N: C 87.15, H 8.01, N 4.84; found: C 86.55, H 8.13, N 
4.63. 
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Compound 133i 
 
Obtained from 132i (0.070 mmol, 22.4 mg) following the representative procedure (15.9 mg, 
71%, 133i/134i = 2:1). Isomers 133i and 134i could be separated by preparative TLC 
(petroleum ether/EtOAc = 14:1). Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 8.54–8.49 (m, 
1H), 7.56 (dt, J = 7.7, 1.8 Hz, 1H), 7.38–7.30 (m, 4H), 7.29–7.24 (m, 1H), 7.21 (d, J = 8.0 Hz, 1H), 
6.99 (ddd, J = 7.4, 4.9, 0.7 Hz, 1H), 6.25–6.23 (m, 1H), 4.60 (s, 2H), 3.77 (d, J = 9.6 Hz, 1H), 3.73 
(d, J = 9.6 Hz, 1H), 2.68 (dt, J = 17.1, 3.5 Hz, 1H), 2.53 (dt, J = 17.1, 2.5 Hz, 1H), 2.08 (d, J = 
4.1Hz, 1H), 1.77–1.68 (m, 1H), 1.64 (ddd, J = 9.7, 3.2, 1.6 Hz, 1H), 1.56 (ddd, J = 11.9, 8.5, 2.4 
Hz, 1H), 1.41–1.36 (m, 1H), 1.26 (dd, J = 11.9, 4.9 Hz, 1H), 0.98 (d, J = 7.0 Hz, 3H); 13C NMR (125 
MHz, CDCl3): δ = 157.6, 154.1, 149.1, 138.8, 135.8, 128.3 (2C), 127.5 (2C), 127.4, 122.5, 120.2, 
117.7, 73.4, 71.2, 55.3, 42.5, 41.4, 41.2, 38.8, 36.0, 22.2; IR (neat): ṽ = 3058 (w), 303 (w), 3002 
(w), 2950 (s), 2864 (m), 1720 (w), 1658 (m), 1585 (s), 1559 (w), 1495 (w), 1470 (m), 1454 (m), 
1428 (s), 1364 (w), 1271 (w), 1205 (w), 1148 (w), 1093 (s), 1028 (w), 927 (w), 889 (w), 857 (w), 
739 (s), 697 (m) ; MS (ESI): calcd for (C22H25NO + H): 320.2014; found: 320.2013. 
 
Compound 134i 
 
Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 8.55 (ddd, J = 4.7, 1.6, 0.8 Hz, 1H), 7.58 (dt, J = 
7.8, 1.8 Hz, 1H), 7.33–7.28 (m, 4H), 7.27–7.20 (m, 2H), 7.02 (ddd, J = 7.5, 4.8, 1.0 Hz, 1H), 6.37 
(t, J = 2.4 Hz, 1H), 5.85 – 5.73 (m, 1H), 5.08 – 4.97 (m, 2H), 4.53 (d, J = 12.4 Hz, 1H), 4.49 (d, J = 
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12.4 Hz, 1H), 3.36 (s, 2H), 2.90–2.81 (m, 1H), 2.80–2.70 (m, 1H), 2.47 (dd, J = 13.8, 8.0 Hz, 1H), 
2.35 (dd, J = 13.8, 6.6 Hz, 1H), 1.84–1.62 (m, 4H); 13C NMR (125 MHz, CDCl3): δ = 157.5, 155.2, 
149.1, 138.8, 135.8, 135.4, 128.3 (2C), 127.4 (2C), 127.3, 123.2, 122.0, 120.4, 117.3, 76.4, 73.3, 
51.5, 41.5, 33.5, 33.4, 23.5; IR (neat): ṽ = 3065 (w), 2020 (w), 3004 (w), 2951 (w), 2856 (w), 
1647 (w), 1584 (m), 1559 (w), 1496 (w), 1471 (m), 1454 (w), 1427 (m), 1360 (w), 1287 (w), 
1218 (w), 1204 (w), 1148 (w), 1094 (s), 1028 (w), 991 (w), 911 (m), 890 (w), 864 (w), 818 (w), 
775 (w), 736 (s), 696 (s) cm-1; elemental analysis (%) calcd for C22H25NO: C 82.72, H 7.89, N 
4.38; found: C 82.64, H 7.99, N 4.12. 
 
Compound 133j 
 
Obtained from 132j (0.080 mmol, 17.1 mg) following the representative procedure, except 
that P(pMeOC6H4)3 (3.6 mg, 0.0101 mmol) was used. Colourless oil (12.3 mg, 72%, 133j/134j = 
3:1, not separable);^ 1H NMR (500 MHz, CDCl3): δ = 8.53–8.50 (m, 1H), 7.56 (dt, J = 7.8, 1.8 Hz, 
1H), 7.27–7.22 (m, 1H), 6.98 (ddd, J = 7.4, 4.9, 0.9 Hz, 1H), 6.27–6.24 (m, 1H), 2.64 (dt, J = 17.1, 
3.5 Hz, 1H), 2.50 (dt, J = 17.1, 2.5 Hz, 1H), 2.04 (d, J = 4.2 Hz, 1H), 1.76–1.62 (m, 1H), 1.57 (ddd, 
J = 11.8, 8.5, 2.5, 1H), 1.52 (ddd, J = 9.6, 3.1, 1.5 Hz, 1H), 1.31 (s, 3H), 1.27–1.22 (m, 1H), 1.04 
(dd, J = 11.9, 4.9 Hz, 1H), 0.96 (d, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ = 157.8, 157.5, 
149.1, 135.8, 122.3, 120.0, 117.0, 51.0, 46.0, 42.7, 42.6, 41.0, 36.8, 22.3, 18.1; IR (neat): ṽ = 
3073 (w), 3003 (w), 2950 (s), 2868 (w), 1731 (w), 1657 (m), 1585 (s), 1559 (w), 1471 (m), 1463 
(m), 1427 (s), 1375 (w), 1316 (w), 1279 (w), 1265 (w), 1227 (w), 1149 (w), 1088 (w), 1061 (w), 
989 (w), 966 (w), 912 (w), 887 (w), 858 (w), 823 (w), 775 (m), 740 (m) cm-1; HRMS (CI(CH4)): 
calcd for (C15H19N + H): 214.1590; found: 214.1594. 
^IR recorded and HRMS recorder on the 133j/134j mixture 
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Compound 134j 
 
1H NMR (500 MHz, CDCl3): δ = 8.57–8.53 (m, 1H), 7.61 – 7.54 (m, 1H), 7.27 – 7.22 (m, 1H), 7.00 
(ddd, J = 7.5, 5.0, 0.9 Hz, 1H), 6.29 (t, J = 2.4 Hz, 1H), 5.84–5.73 (m, 1H), 5.06–4.98 (m, 2H), 
2.92–2.82 (m, 1H), 2.80–2.69 (m, 1H), 2.26 – 2.15 (m, 2H), 1.80–1.63 (m, 3H), 1.48–1.41 (m, 
1H), 1.13 (s, 3H); 13C NMR (125 MHz, CDCl3): δ = 159.3, 157.7, 149.1, 135.8, 135.6, 122.9, 
120.5, 120.2, 116.9, 47.1, 45.4, 38.0, 32.6, 26.6, 23.0. 
 
Compound 137 
 
Compound prepared by Daniel J. Tetlow. Obtained from 132f (0.117 mmol, 45 mg) using the 
representative procedure for the Rh(I)- catalysed cycloisomerisation, except that the reaction 
was stopped after 30 minutes heating. Purification by flash column chromatography 
(petroleum ether/EtOAc, 10:1) yielded the title compound as colourless oil (15 mg, 33%). 1H 
NMR (500 MHz, CDCl3): δ = 8.53 (ddd, J = 4.7, 1.6 and 0.7 Hz, 1H), 7.72 (d, J = 8.2 Hz, 2H), 7.59 
(td, J = 7.7, 1.6 Hz, 1H), 7.25 (d, J = 8.0 Hz, 2H), 7.18 (d, J = 7.8 Hz, 1H), 7.06 (ddd, J = 7.5, 4.7, 
0.8 Hz, 1H), 6.50 (d, J = 2.2 Hz, 1H), 5.90–5.79 (m, 1H), 5.18–5.12 (m, 1H), 5.09 (dt, J = 10.2, 0.8 
Hz, 1H), 3.26–3.15 (m, 1H), 2.92 (s, 3H), 2.94–2.86 (m, 1H), 2.77 (dd, J = 13.9, 8.5 Hz, 1H), 2.55 
(dd, J = 12.8, 9.0 Hz, 1H), 2.38 (s, 3H), 2.27 (dd, J = 12.8, 5.3 Hz, 1H), 1.12 (d, J = 7.0 Hz, 3H); 13C 
NMR (125 MHz, CDCl3): δ = 155.2, 152.0, 149.5, 143.0, 138.6, 136.1, 133.8, 129.4 (2C), 127.3 
(2C), 127.1, 123.0, 121.4, 118.9, 68.6, 42.5, 37.0, 34.6, 33.6, 21.5, 18.5; IR (neat) ṽ = 3074 (w), 
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2958 (w), 2869 (w), 1665 (w), 1638 (w), 1584 (m), 1563 (w), 1494 (w), 1469 (m), 1430 (m), 
1329 (s), 1304 (m), 1289 (m), 1270 (w), 1214 (w), 1184 (w), 1150 (s), 1086 (s), 1018 (w), 993 
(w), 893 (s), 846 (m), 813 (s), 743 (s), 707 (m), 688 (w), 658 (s) cm-1; MS (ESI): m/z (rel. 
intensity): 421 (12) [M + K], 405 (27) [M + Na], 383 (100) [M + H]; HRMS (ESI) calcd for 
(C22H26N2O2S + H): 383.1793, found: 383.1792. 
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Table 14 Crystal data and structure refinement for Hydrochloride salt of 127 
 
Empirical formula   C20H22NCl 
Formula weight   311.84 
Temperature    100.01°K 
Crystal system    orthorhombic 
Space group    Pca21 
Unit cell dimensions   a = 7.0429(4) Å   α = 90.00° 
b = 14.2625(9) Å β = 90.00° 
c = 16.0706(10) Å  γ = 90.00° 
Volume    1614.28(17) Å3 
Z     4 
Density (calculated)   1.283 mg/mm3 
Absorption coefficient   2.038 mm-1 
F(000)     664.0 
Crystal size    0.3 × 0.145 × 0.045 mm3 
Radiation    Cu Kα (λ = 1.54178) 
2Θ range for data collection  6.2 to 144.52° 
Index ranges    -7 ≤ h ≤ 8, -17 ≤ k ≤ 17, -19 ≤ l ≤ 19 
Reflections collected   17764 
Independent reflections  3082[R(int) = 0.0205] 
Data/restraints/parameters  3082/1/200 
Goodness-of-fit on F2   1.065 
Final R indexes [I>=2σ (I)]  R1 = 0.0259, wR2 = 0.0693 
Final R indexes [all data]  R1 = 0.0259, wR2 = 0.0693 
Largest diff. peak/hole  0.24/-0.27 e.Å-3 
Flack parameter   0.040(10) 
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